data_1xg1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xg1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.642 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 16.4 m95 . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -87.03 154.6 20.64 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.585 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 14.7 p -57.6 -42.53 81.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -60.37 -45.68 92.65 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.784 0.325 . . . . 0.0 110.941 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.469 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 68.7 mt-10 -61.28 -36.41 79.99 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.493 0.663 . . . . 0.0 110.107 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.448 ' O ' HG22 ' A' ' 25' ' ' VAL . 22.0 m -69.8 -29.69 67.05 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.705 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 68.1 mm-40 -69.57 -39.25 77.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.243 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.493 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 33.6 m0 -61.17 -43.77 98.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.219 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.626 HG21 ' N ' ' A' ' 26' ' ' LYS . 3.1 m -58.63 -38.31 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.001 0.429 . . . . 0.0 110.263 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.626 ' N ' HG21 ' A' ' 25' ' ' VAL . 11.9 ttmm -67.18 -49.58 64.14 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.793 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.88 -43.22 99.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.736 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.9 -38.84 96.68 Favored Glycine 0 C--O 1.224 -0.524 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.566 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.589 HG21 ' O ' ' A' ' 25' ' ' VAL . 55.7 t -63.21 -35.76 73.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.037 0.446 . . . . 0.0 110.909 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.28 -46.61 15.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.947 0.403 . . . . 0.0 110.866 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.715 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 39.5 ttmt -74.46 -45.72 44.41 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.715 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -93.28 -46.11 7.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.211 0.529 . . . . 0.0 110.98 -177.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.78 134.05 5.05 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.168 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -54.23 118.65 4.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.871 0.367 . . . . 0.0 110.476 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.12 -38.54 2.0 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.817 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.512 ' O ' HG13 ' A' ' 40' ' ' ILE . 74.0 m-20 -79.83 54.11 1.78 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.142 0.496 . . . . 0.0 111.114 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -62.76 -39.11 93.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.581 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.11 -46.58 89.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.105 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.68 87.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.966 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 36' ' ' ASN . 75.1 mt -66.87 -43.21 89.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.003 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.9 m -60.37 -39.05 85.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.229 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -70.61 -55.13 9.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.885 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -72.48 -40.9 66.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 60.8 m-85 -83.1 146.15 50.89 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.546 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.493 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 35.9 Cg_endo -66.09 43.12 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.723 2.949 . . . . 0.0 115.041 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.642 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 64.6 m-85 -72.92 111.56 8.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.858 0.361 . . . . 0.0 110.079 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.413 ' C ' ' H ' ' A' ' 49' ' ' ARG . 7.5 p -99.4 127.86 51.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 72.97 -41.52 0.51 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.475 0.71 . . . . 0.0 111.368 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.429 ' NH2' ' HA ' ' A' ' 17' ' ' TRP . 1.0 OUTLIER -58.48 120.39 8.72 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 122.598 0.359 . . . . 0.0 111.277 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.3 p -86.04 172.17 10.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.206 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.68 83.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.455 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.29 -39.78 86.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.102 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 19.1 mmt -62.09 -41.71 98.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.317 -0.402 . . . . 0.0 109.959 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.0 mt -67.28 -42.3 87.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -56.94 -50.66 71.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.557 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -64.53 -44.46 90.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.627 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -58.47 -45.13 89.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.388 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -62.66 -41.91 99.32 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.297 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -58.11 -44.97 88.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.934 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.5 p . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.959 179.486 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.452 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 14.0 m95 . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 120.694 0.283 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -79.5 156.39 27.82 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.81 -41.83 76.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.511 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -65.75 -45.83 81.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.528 0.204 . . . . 0.0 110.5 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.459 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 35.1 mt-10 -55.55 -43.44 75.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.638 0.733 . . . . 0.0 110.533 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.5 m -66.75 -37.15 84.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.819 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.417 ' CD ' ' HZ2' ' A' ' 26' ' ' LYS . 62.0 mm-40 -63.66 -35.27 79.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.982 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.459 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 44.2 m0 -61.89 -44.96 95.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.822 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.673 HG22 ' N ' ' A' ' 26' ' ' LYS . 1.4 m -62.2 -40.17 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.673 ' N ' HG22 ' A' ' 25' ' ' VAL . 24.2 ttpt -65.14 -46.81 79.39 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.273 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.12 -44.08 97.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.158 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.26 95.97 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.273 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 25' ' ' VAL . 50.2 t -63.22 -41.06 91.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.25 0.547 . . . . 0.0 110.178 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.03 -45.62 40.5 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.77 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.47 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 61.7 tttm -79.64 -52.97 7.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.47 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -82.68 -54.65 4.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.483 0.658 . . . . 0.0 110.456 -178.583 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.74 130.86 3.29 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.096 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -51.39 128.88 23.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.811 0.339 . . . . 0.0 110.892 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.37 -35.3 4.18 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.837 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.49 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.0 m-80 -81.11 51.85 1.67 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.884 0.373 . . . . 0.0 111.08 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.481 ' CE3' HG22 ' A' ' 54' ' ' ILE . 32.9 m95 -62.26 -42.91 99.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.788 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.39 88.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.791 0.329 . . . . 0.0 110.731 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.66 -42.91 98.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.473 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 36' ' ' ASN . 89.0 mt -62.47 -45.6 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.598 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.623 ' HB2' HD13 ' A' ' 54' ' ' ILE . 29.5 t -61.43 -36.33 80.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.068 0.461 . . . . 0.0 111.087 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -68.18 -49.96 57.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.95 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -77.8 -52.69 8.5 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.612 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.46 ' CD1' HG22 ' A' ' 40' ' ' ILE . 57.6 m-85 -67.9 147.45 98.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.119 0.485 . . . . 0.0 111.329 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.6 Cg_endo -66.98 44.57 0.22 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.819 3.012 . . . . 0.0 115.212 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.452 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 75.7 m-85 -71.36 124.85 25.48 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.774 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.454 ' C ' ' H ' ' A' ' 49' ' ' ARG . 2.4 p -101.83 118.54 48.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.089 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.1 -30.38 0.15 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.543 1.137 . . . . 0.0 112.964 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.553 ' N ' ' HD2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -60.91 119.51 8.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.234 0.54 . . . . 0.0 111.771 -179.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 p -79.05 169.95 17.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.945 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.23 -38.61 89.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.303 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.87 -40.21 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.4 mmt -61.3 -40.84 95.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.623 HD13 ' HB2' ' A' ' 41' ' ' SER . 82.3 mt -67.11 -44.16 88.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 37.7 ttpt -56.98 -48.87 77.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.696 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -66.64 -39.46 88.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.883 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.437 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 27.6 tpt180 -59.32 -43.58 92.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.32 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.9 t-105 -58.62 -45.27 89.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -60.9 -46.25 91.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.722 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 27.9 p . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.288 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.478 ' HZ3' ' HE2' ' A' ' 46' ' ' PHE . 14.3 m95 . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.941 0.4 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.0 p -79.33 156.41 28.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.344 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.52 -31.52 50.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.414 ' HG3' ' CZ2' ' A' ' 24' ' ' TRP . 3.2 tp10 -59.76 -51.74 68.47 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.593 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.501 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 29.1 mt-10 -64.31 -38.15 90.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.596 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.6 m -64.89 -41.92 95.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.341 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -63.04 -32.9 74.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.96 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.501 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 47.0 m0 -65.88 -46.23 79.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.887 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.627 HG12 HG23 ' A' ' 54' ' ' ILE . 2.3 m -60.93 -39.31 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.58 ' N ' HG23 ' A' ' 25' ' ' VAL . 22.0 ttpt -67.21 -47.31 71.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.621 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.66 -42.39 98.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.516 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.32 -36.46 93.1 Favored Glycine 0 C--O 1.222 -0.645 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.969 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 25' ' ' VAL . 53.7 t -65.7 -34.28 69.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.181 0.515 . . . . 0.0 110.072 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -75.43 -48.08 24.42 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.214 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.478 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 24.8 ttmm -79.9 -48.22 13.8 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -177.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.478 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -90.8 -44.01 9.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.414 0.626 . . . . 0.0 111.101 -178.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 29' ' ' VAL . . . 106.97 132.37 6.98 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -56.62 139.17 50.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.373 0.606 . . . . 0.0 110.834 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.31 -38.11 3.01 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -85.65 49.34 1.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.107 0.479 . . . . 0.0 110.148 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.431 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 42.1 m95 -60.22 -38.28 82.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.222 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.22 -45.66 90.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.995 0.426 . . . . 0.0 110.133 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 -44.59 91.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.81 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.5 mt -61.31 -44.1 97.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.786 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.9 t -64.65 -37.66 88.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.814 0.34 . . . . 0.0 111.039 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -64.9 -49.23 71.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.258 0.551 . . . . 0.0 111.604 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -79.0 -48.61 14.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.956 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -75.31 141.53 73.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 0.0 111.869 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.491 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.4 Cg_endo -66.39 48.93 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 124.298 3.332 . . . . 0.0 115.257 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.478 ' HE2' ' HZ3' ' A' ' 17' ' ' TRP . 60.8 m-85 -72.15 109.85 6.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.87 0.366 . . . . 0.0 110.202 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' A' ' 49' ' ' ARG . 4.0 p -84.82 122.26 37.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.471 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.7 m120 69.88 -34.04 0.27 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.557 0.743 . . . . 0.0 112.27 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.623 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -63.06 127.88 33.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.248 0.547 . . . . 0.0 111.789 -179.131 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.4 p -93.29 176.56 6.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.127 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.95 -38.57 91.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.667 0.27 . . . . 0.0 110.299 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.7 t -63.52 -38.76 83.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.763 ' HA ' ' HE2' ' A' ' 53' ' ' MET . 14.0 mmt -59.37 -44.99 92.65 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.627 HG23 HG12 ' A' ' 25' ' ' VAL . 68.4 mt -65.49 -46.49 89.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.504 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 36.0 ttpt -55.05 -50.44 69.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.345 0.593 . . . . 0.0 110.378 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -66.33 -39.55 89.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.401 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.425 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 30.8 tpt180 -59.99 -41.6 92.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.587 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.433 ' CE2' HG22 ' A' ' 29' ' ' VAL . 16.0 t-105 -61.18 -45.5 94.36 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.81 -44.45 86.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.901 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.425 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.461 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.441 ' HZ2' ' HB3' ' A' ' 53' ' ' MET . 17.3 m95 . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.3 p -76.81 152.74 35.42 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 10.9 p -60.51 -38.61 78.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.219 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.461 ' N ' HG12 ' A' ' 19' ' ' VAL . 42.0 tt0 -59.71 -54.1 50.29 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.524 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 50.3 mt-10 -58.57 -39.28 79.85 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.429 0.633 . . . . 0.0 111.096 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.5 m -68.16 -37.6 81.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.203 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 68.0 mm-40 -61.26 -34.64 75.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.873 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.524 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 42.5 m0 -62.54 -43.66 98.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.15 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.659 HG23 ' N ' ' A' ' 26' ' ' LYS . 1.1 m -60.04 -37.55 73.12 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.659 ' N ' HG23 ' A' ' 25' ' ' VAL . 19.5 ttmt -62.21 -46.3 89.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.639 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.86 78.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.744 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.06 -40.68 99.24 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 25' ' ' VAL . 51.5 t -61.09 -37.39 77.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.006 0.432 . . . . 0.0 111.01 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -79.28 -41.42 28.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.696 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -78.81 -49.49 12.88 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.44 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -86.05 -42.12 14.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.462 0.648 . . . . 0.0 110.805 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.17 131.54 5.88 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -50.55 130.4 23.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.808 0.337 . . . . 0.0 110.914 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.41 -37.07 3.44 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.906 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.468 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.9 m-80 -81.53 53.72 2.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.102 0.477 . . . . 0.0 111.115 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -63.83 -38.3 90.57 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.559 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 51' ' ' ALA . . . -61.54 -46.2 90.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.51 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.23 -43.08 99.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.64 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 36' ' ' ASN . 79.6 mt -63.05 -45.07 99.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.449 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.554 ' HB2' HD13 ' A' ' 54' ' ' ILE . 47.6 t -62.91 -36.0 81.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.229 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -68.76 -47.91 65.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.908 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -80.34 -49.96 10.8 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.413 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 51.0 m-85 -70.41 145.56 93.18 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 121.171 0.51 . . . . 0.0 111.826 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.47 44.28 0.24 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 124.073 3.182 . . . . 0.0 114.841 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.438 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 53.4 m-85 -68.65 122.95 19.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.969 0.414 . . . . 0.0 110.489 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.58 127.25 62.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.256 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.617 ' C ' ' HD2' ' A' ' 49' ' ' ARG . 73.2 m-80 61.79 17.18 8.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.738 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.617 ' HD2' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -118.03 124.37 47.96 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -178.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.503 ' OG1' ' HG2' ' A' ' 53' ' ' MET . 31.1 p -87.01 175.38 8.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.624 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . . . -66.78 -38.59 86.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.538 0.208 . . . . 0.0 110.824 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.72 -36.23 74.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.503 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 79.8 mmm -61.79 -45.27 94.61 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' A' ' 41' ' ' SER . 66.3 mt -66.45 -41.96 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.958 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -54.92 -49.28 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.148 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 3.5 t0 -71.31 -36.59 71.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.262 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.452 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 27.8 tpt180 -59.7 -40.52 88.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.116 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.4 t-105 -59.59 -43.34 93.71 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 56' ' ' ASP . 21.7 ttm180 -58.06 -49.46 76.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.457 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 1.7 p . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.955 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.514 ' HZ3' ' HE2' ' A' ' 46' ' ' PHE . 10.6 m95 . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 120.572 0.225 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -77.3 154.43 32.9 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.1 p -57.21 -35.29 48.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.503 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -60.23 -53.92 51.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.682 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.613 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 37.7 mt-10 -59.44 -42.4 91.83 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.689 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.5 m -65.59 -34.87 79.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.145 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.423 ' CD ' ' HZ1' ' A' ' 26' ' ' LYS . 26.0 mm-40 -69.52 -33.14 72.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.906 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.613 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 44.6 m0 -61.82 -42.8 99.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.653 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.613 HG11 HG22 ' A' ' 54' ' ' ILE . 2.5 m -62.3 -38.16 80.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.597 ' N ' HG22 ' A' ' 25' ' ' VAL . 20.8 ttmt -63.76 -48.96 74.86 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.276 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.32 -40.78 90.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.721 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.05 -38.05 94.91 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.659 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.556 HG21 ' O ' ' A' ' 25' ' ' VAL . 54.8 t -63.16 -36.15 74.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.958 0.408 . . . . 0.0 110.752 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -78.84 -43.92 24.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.225 0.536 . . . . 0.0 111.102 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.576 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 88.1 tttt -74.09 -45.68 47.62 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.576 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -96.61 -49.04 5.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.275 0.56 . . . . 0.0 111.053 -178.206 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.07 134.58 4.4 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.166 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -55.15 106.69 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.168 0.509 . . . . 0.0 110.658 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.39 -37.9 1.51 Allowed Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.673 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.496 ' O ' HG13 ' A' ' 40' ' ' ILE . 73.0 m-80 -78.88 54.58 1.58 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.042 0.448 . . . . 0.0 111.386 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.436 ' NE1' ' HG3' ' A' ' 55' ' ' LYS . 36.0 m95 -65.31 -37.08 86.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.279 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.44 -42.1 96.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.163 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.466 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -67.62 -37.04 81.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.022 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 36' ' ' ASN . 74.4 mt -66.96 -45.81 86.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.66 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.465 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 4.1 p -65.4 -34.67 78.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.135 0.493 . . . . 0.0 111.154 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.52 -43.28 81.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.087 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -88.03 -44.64 10.83 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.449 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 55.6 m-85 -76.05 146.72 79.23 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 121.108 0.48 . . . . 0.0 111.627 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.32 46.3 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.08 3.187 . . . . 0.0 115.47 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.514 ' HE2' ' HZ3' ' A' ' 17' ' ' TRP . 75.6 m-85 -71.47 134.63 46.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.564 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.449 ' C ' ' H ' ' A' ' 49' ' ' ARG . 3.5 p -123.05 132.3 71.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 75.9 m-20 73.91 -39.87 0.44 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.567 0.747 . . . . 0.0 110.709 -177.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.484 ' HD3' ' OE2' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -67.31 138.39 56.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.266 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.7 p -102.77 177.45 4.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.628 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.02 -39.56 90.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.713 0.292 . . . . 0.0 110.415 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.9 t -63.49 -37.21 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.417 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 18.7 mmt -62.4 -42.31 99.33 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.613 HG22 HG11 ' A' ' 25' ' ' VAL . 82.4 mt -65.6 -44.49 93.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.012 0.434 . . . . 0.0 109.864 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' HG3' ' NE1' ' A' ' 37' ' ' TRP . 25.8 ttpp -56.47 -49.51 74.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.655 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 37.7 t70 -67.59 -39.4 84.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.838 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.489 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 13.0 tpp180 -59.84 -37.74 80.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.204 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.482 ' CE2' HG23 ' A' ' 29' ' ' VAL . 8.5 t-105 -60.61 -42.88 97.71 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 56' ' ' ASP . 98.5 mtt180 -53.54 -49.95 66.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.021 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.411 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.8 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.558 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 16.8 m95 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.5 p -82.53 160.88 22.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.346 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.73 -40.71 80.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.426 0.155 . . . . 0.0 111.152 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -61.94 -47.29 85.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.691 0.281 . . . . 0.0 111.585 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.514 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 49.8 mt-10 -63.66 -36.23 83.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.333 0.587 . . . . 0.0 110.695 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.2 m -67.58 -36.03 80.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.02 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.65 -35.3 80.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.833 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.514 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 44.6 m0 -62.18 -46.73 87.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.379 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.567 HG21 ' N ' ' A' ' 26' ' ' LYS . 3.3 m -60.75 -37.46 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.873 0.368 . . . . 0.0 110.815 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.567 ' N ' HG21 ' A' ' 25' ' ' VAL . 19.2 ttmt -66.17 -46.12 78.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.771 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.2 -38.57 75.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.039 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.07 -36.18 80.34 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.625 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 25' ' ' VAL . 97.5 t -62.28 -36.38 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.518 0.675 . . . . 0.0 110.074 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -81.18 -49.08 11.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.395 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.53 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 84.5 tttt -69.11 -42.49 76.02 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.917 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.53 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -102.74 -55.7 2.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.338 0.59 . . . . 0.0 110.973 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.89 138.23 3.96 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.228 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -57.04 117.81 4.37 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.26 -32.1 4.65 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.019 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.48 ' O ' HG13 ' A' ' 40' ' ' ILE . 71.4 m-80 -81.62 48.19 1.16 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.896 0.379 . . . . 0.0 111.345 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 36.9 m95 -62.85 -37.91 88.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.832 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.17 -48.93 78.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 0.0 110.528 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.27 98.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.689 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 36' ' ' ASN . 79.1 mt -60.72 -45.54 97.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.593 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.463 ' HB2' HD12 ' A' ' 54' ' ' ILE . 23.1 t -64.69 -35.02 79.7 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.096 0.474 . . . . 0.0 110.924 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -67.65 -47.45 69.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.754 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -82.31 -49.45 10.04 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.472 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 56.4 m-85 -70.23 143.31 90.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.095 0.474 . . . . 0.0 111.374 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.507 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 39.4 Cg_endo -67.6 48.27 0.35 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.922 3.081 . . . . 0.0 115.204 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.558 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 67.8 m-85 -72.48 133.47 44.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.761 0.315 . . . . 0.0 110.283 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.58 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 5.9 p -110.48 121.11 62.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.84 -30.92 0.14 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.6 1.16 . . . . 0.0 112.293 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.58 ' HD2' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -61.71 118.0 6.56 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.964 0.411 . . . . 0.0 110.9 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.2 p -81.02 167.39 19.84 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.703 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.56 85.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.9 t -63.23 -36.96 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.43 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 61.1 mmm -64.17 -41.33 97.16 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 41' ' ' SER . 85.1 mt -65.36 -45.01 94.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.814 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.55 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 38.8 ttpt -56.7 -49.61 74.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.337 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -63.47 -44.88 93.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.523 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.44 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 30.9 tpt180 -60.55 -38.59 84.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.144 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -58.8 -43.17 90.48 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.635 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.55 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 1.6 mpt_? -60.04 -49.17 78.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.758 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 2.9 p . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.796 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.443 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 10.4 m95 . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 120.462 0.172 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.9 p -78.66 147.74 33.44 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.428 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 11.5 p -53.71 -35.58 27.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.61 0.243 . . . . 0.0 110.969 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.416 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 39.8 tt0 -59.71 -53.46 57.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.362 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.565 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 45.5 mt-10 -61.09 -39.45 89.99 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.439 0.638 . . . . 0.0 111.015 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.4 m -66.09 -33.36 75.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.613 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 58.7 mm-40 -68.29 -30.91 70.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.777 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.565 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 43.1 m0 -64.27 -42.99 96.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.736 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.594 HG23 ' N ' ' A' ' 26' ' ' LYS . 2.0 m -60.81 -38.16 78.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.094 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.594 ' N ' HG23 ' A' ' 25' ' ' VAL . 15.0 ttpp -65.7 -50.4 65.02 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.469 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.52 -41.84 98.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.741 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.47 -37.86 94.83 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.471 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 25' ' ' VAL . 47.5 t -64.9 -43.16 96.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.08 0.467 . . . . 0.0 110.337 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -71.38 -42.28 68.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.207 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.459 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 63.7 tttp -76.72 -48.52 18.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.459 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -94.76 -55.87 2.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.599 0.714 . . . . 0.0 110.975 -178.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.19 132.0 3.45 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -58.48 118.46 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.546 0.688 . . . . 0.0 110.554 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.45 -37.5 1.87 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.424 ' O ' HG13 ' A' ' 40' ' ' ILE . 62.2 m-80 -83.49 50.77 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.039 0.447 . . . . 0.0 110.228 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -62.2 -41.45 98.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.908 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.78 -45.41 89.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.871 0.367 . . . . 0.0 110.332 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.27 93.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.485 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.486 HG22 ' CD1' ' A' ' 44' ' ' TYR . 82.0 mt -62.55 -46.55 96.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.4 t -60.71 -36.66 79.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.199 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -69.11 -51.16 41.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.69 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -74.54 -43.73 54.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.722 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.486 ' CD1' HG22 ' A' ' 40' ' ' ILE . 47.4 m-85 -77.49 146.91 74.48 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 120.983 0.42 . . . . 0.0 110.928 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 36.8 Cg_endo -66.31 43.02 0.18 Allowed 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.774 2.982 . . . . 0.0 115.304 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.443 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 77.0 m-85 -74.05 128.36 35.31 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.941 -0.474 . . . . 0.0 110.12 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.406 ' C ' ' H ' ' A' ' 49' ' ' ARG . 7.7 p -115.59 129.2 72.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.0 m120 71.33 -40.67 0.48 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.19 0.596 . . . . 0.0 111.924 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.469 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 2.0 mpt_? -60.74 127.16 30.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.682 0.277 . . . . 0.0 110.612 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.479 ' OG1' ' HG3' ' A' ' 53' ' ' MET . 67.5 p -89.55 169.03 11.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.333 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.7 -37.33 83.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.805 0.336 . . . . 0.0 110.263 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.23 -38.41 82.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.829 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.479 ' HG3' ' OG1' ' A' ' 50' ' ' THR . 68.1 mtt -62.3 -42.1 99.07 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.576 HG23 HG13 ' A' ' 25' ' ' VAL . 70.2 mt -67.22 -44.36 87.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.868 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -55.56 -49.98 71.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.007 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.64 -37.0 79.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.388 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 53' ' ' MET . 15.0 tpt85 -61.28 -39.73 91.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.343 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.407 ' CD2' HG22 ' A' ' 29' ' ' VAL . 36.7 t-105 -67.49 -43.7 80.3 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.3 mtt-85 -59.39 -42.75 92.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.383 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.794 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.413 ' HH2' HG12 ' A' ' 54' ' ' ILE . 11.2 m95 . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.667 0.27 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.479 ' HG1' ' CD ' ' A' ' 21' ' ' GLU . 77.7 p -77.83 154.22 32.03 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.439 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 13.8 p -57.51 -38.46 63.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.265 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.513 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 87.2 tt0 -64.07 -48.05 77.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.793 0.33 . . . . 0.0 111.076 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.532 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 68.0 mt-10 -59.59 -37.35 78.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.344 0.592 . . . . 0.0 111.58 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 25' ' ' VAL . 14.3 m -67.86 -32.03 72.25 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.997 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 5.7 mm-40 -65.68 -38.29 88.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.4 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.532 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 35.3 m0 -61.4 -43.68 98.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.837 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.545 HG12 HG22 ' A' ' 54' ' ' ILE . 3.8 m -62.59 -36.45 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.168 0.508 . . . . 0.0 110.248 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.535 ' N ' HG22 ' A' ' 25' ' ' VAL . 16.9 ttpt -66.93 -49.32 65.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.753 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.63 -39.91 76.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.299 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.72 -41.21 98.93 Favored Glycine 0 C--O 1.224 -0.476 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.999 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 25' ' ' VAL . 54.8 t -64.72 -41.79 93.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 117.237 0.518 . . . . 0.0 110.72 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -70.82 -36.72 73.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.323 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.599 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 5.1 ttmp? -84.77 -52.08 6.31 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.599 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -84.77 -54.17 4.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.28 0.562 . . . . 0.0 111.221 -177.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.56 130.75 3.33 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -55.56 125.57 21.58 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.958 0.409 . . . . 0.0 110.852 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.49 -35.13 3.41 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.459 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.4 m-80 -82.97 52.81 2.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.986 0.422 . . . . 0.0 110.532 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.486 ' CE3' HG23 ' A' ' 54' ' ' ILE . 40.8 m95 -61.18 -40.26 93.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.636 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.6 97.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.965 0.412 . . . . 0.0 110.384 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.82 -38.14 82.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.097 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 36' ' ' ASN . 78.5 mt -67.45 -47.31 81.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.531 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.516 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 5.7 p -63.52 -37.18 86.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.519 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -62.99 -48.42 78.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.515 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -80.41 -50.31 10.28 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.423 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 55.7 m-85 -69.09 146.32 97.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.01 0.433 . . . . 0.0 110.895 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.454 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 44.4 Cg_endo -68.68 46.46 0.38 Allowed 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.537 2.824 . . . . 0.0 114.799 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -69.72 126.49 29.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.1 0.476 . . . . 0.0 110.564 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.515 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 5.6 p -118.3 131.25 71.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 74.5 m-80 74.35 -43.5 0.53 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.039 0.535 . . . . 0.0 110.378 -177.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.686 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -66.45 125.67 26.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.346 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.8 p -96.15 175.58 6.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.919 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.3 -42.72 99.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.491 0.186 . . . . 0.0 110.91 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.09 -37.57 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.686 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 63.6 mtt -59.96 -42.42 94.04 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.545 HG22 HG12 ' A' ' 25' ' ' VAL . 63.6 mt -66.99 -44.51 88.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.027 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -55.7 -47.5 76.71 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.171 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -69.79 -41.95 74.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.99 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.48 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 12.1 tpp180 -60.18 -39.15 85.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.267 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.419 ' HA ' ' CE3' ' A' ' 58' ' ' TRP . 16.7 t-105 -61.74 -45.3 94.51 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.345 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.9 mtt85 -58.5 -44.47 89.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.377 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.48 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 24.5 p . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.735 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 13.7 m95 . . . . . 0 N--CA 1.446 -0.628 0 CA-C-O 120.682 0.277 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.2 p -80.38 151.12 29.57 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.481 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 7.2 p -55.44 -39.16 51.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.64 0.257 . . . . 0.0 110.734 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.536 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 84.6 tt0 -62.13 -46.6 88.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.911 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.541 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 53.6 mt-10 -62.53 -38.89 91.74 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.236 0.541 . . . . 0.0 110.676 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.3 t -64.58 -34.51 78.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.302 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 49.7 mm-40 -66.87 -37.59 84.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.707 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.545 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 40.0 m0 -62.46 -44.68 95.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.509 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.61 HG13 HG22 ' A' ' 54' ' ' ILE . 3.3 m -62.0 -35.77 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.143 0.497 . . . . 0.0 109.988 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.56 ' N ' HG23 ' A' ' 25' ' ' VAL . 18.0 ttpt -69.7 -47.7 62.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.759 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.32 -42.9 78.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.766 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.94 -33.02 67.41 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 116.191 -0.458 . . . . 0.0 113.133 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 25' ' ' VAL . 78.4 t -66.41 -36.91 78.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.174 0.511 . . . . 0.0 110.658 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -79.35 -44.68 21.08 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.188 0.518 . . . . 0.0 110.933 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -73.85 -46.33 45.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.491 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.413 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -98.02 -57.45 2.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.467 0.651 . . . . 0.0 110.888 -179.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 29' ' ' VAL . . . 126.53 133.31 3.83 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -59.12 138.71 57.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.327 0.585 . . . . 0.0 110.438 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.18 -37.29 3.55 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -84.95 46.49 1.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.154 0.502 . . . . 0.0 110.546 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.449 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 41.5 m95 -61.17 -36.51 80.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.786 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.46 92.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 0.0 110.223 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.09 84.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.661 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 40' ' ' ILE . 61.6 mt -61.77 -47.54 92.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.509 ' HB2' HD12 ' A' ' 54' ' ' ILE . 44.2 t -63.47 -36.27 83.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.973 0.416 . . . . 0.0 110.468 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -63.4 -47.53 81.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.658 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -82.93 -52.33 6.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.396 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -68.45 140.19 92.36 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.066 0.46 . . . . 0.0 110.986 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.545 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 32.5 Cg_endo -64.87 47.17 0.16 Allowed 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.155 3.237 . . . . 0.0 115.395 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -74.16 134.9 42.83 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.965 -0.46 . . . . 0.0 110.223 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 7.3 p -124.36 125.23 70.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 75.4 m-20 76.5 -33.91 0.22 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.276 0.63 . . . . 0.0 111.146 -178.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.509 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 7.7 mpt_? -76.03 112.94 12.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.714 0.292 . . . . 0.0 110.518 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.6 p -82.19 173.52 12.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.635 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.11 82.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.938 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 t -64.23 -39.44 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.3 mmt -61.52 -42.96 99.6 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.61 HG22 HG13 ' A' ' 25' ' ' VAL . 72.0 mt -66.47 -45.48 88.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.428 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 39.0 ttpt -56.03 -50.87 69.72 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.531 0.681 . . . . 0.0 109.853 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.27 -40.42 93.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.429 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -60.75 -42.23 97.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.433 ' CE2' HG22 ' A' ' 29' ' ' VAL . 23.4 t-105 -61.18 -43.01 99.56 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -56.26 -45.31 80.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.038 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.531 ' CE3' ' HG2' ' A' ' 57' ' ' ARG . 11.7 m95 . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 121.19 0.519 . . . . 0.0 111.873 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 51.1 p -82.13 157.04 24.2 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.596 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.622 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 8.0 p -60.24 -38.66 78.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.78 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.22 -49.33 78.27 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.711 0.291 . . . . 0.0 110.803 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.589 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 48.1 mt-10 -59.43 -41.66 90.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.336 0.589 . . . . 0.0 111.502 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.546 ' O ' HG23 ' A' ' 25' ' ' VAL . 14.8 m -66.61 -29.63 69.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.555 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 70.9 mm-40 -68.4 -36.72 79.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.589 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 33.2 m0 -63.61 -41.51 98.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.377 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.565 HG13 HG22 ' A' ' 54' ' ' ILE . 4.3 m -61.44 -37.61 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.386 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -65.54 -50.85 63.66 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.95 0.405 . . . . 0.0 110.725 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.0 98.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.73 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.52 -41.81 99.76 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.001 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 25' ' ' VAL . 67.9 t -65.94 -38.43 82.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.322 0.582 . . . . 0.0 109.762 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -68.99 -47.39 65.67 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.088 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -83.49 -46.53 12.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.498 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -88.01 -54.9 3.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.547 0.689 . . . . 0.0 110.647 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.39 133.57 4.17 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.669 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -52.58 146.67 9.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.047 0.451 . . . . 0.0 111.259 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.11 -37.05 3.73 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.636 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.421 ' O ' HG13 ' A' ' 40' ' ' ILE . 67.1 m-80 -82.62 48.59 1.33 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.019 0.438 . . . . 0.0 110.407 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -60.15 -40.47 89.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.73 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.405 ' HA ' ' HB3' ' A' ' 51' ' ' ALA . . . -61.35 -34.65 75.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.164 0.507 . . . . 0.0 111.158 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.71 -34.65 64.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.296 0.569 . . . . 0.0 110.187 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.453 HG23 ' CD1' ' A' ' 44' ' ' TYR . 75.4 mt -70.61 -46.72 68.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.022 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.444 ' HB3' HD12 ' A' ' 54' ' ' ILE . 12.5 p -61.55 -38.16 86.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.881 0.372 . . . . 0.0 111.374 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -63.41 -45.84 89.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.413 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -85.38 -45.36 11.96 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.453 ' CD1' HG23 ' A' ' 40' ' ' ILE . 56.1 m-85 -73.56 150.1 88.83 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 121.033 0.444 . . . . 0.0 111.463 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.426 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 48.2 Cg_endo -68.99 44.1 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.675 2.917 . . . . 0.0 114.707 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.467 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 69.3 m-85 -73.14 107.35 5.42 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.508 ' C ' ' H ' ' A' ' 49' ' ' ARG . 2.9 p -86.53 119.56 34.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.984 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 65.4 -25.37 0.09 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.442 1.097 . . . . 0.0 112.801 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.508 ' H ' ' C ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -64.91 121.07 13.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 111.025 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.8 p -78.62 171.32 15.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.07 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . . . -63.79 -38.6 91.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.773 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.93 -37.16 77.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.438 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.406 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 19.9 mmt -59.86 -45.33 92.78 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.565 HG22 HG13 ' A' ' 25' ' ' VAL . 64.7 mt -65.36 -43.96 94.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.089 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -55.63 -49.59 72.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.83 0.824 . . . . 0.0 110.059 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -67.28 -42.35 83.97 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.81 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.531 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 10.0 tpp180 -59.75 -42.74 93.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.864 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.507 ' HE3' HG22 ' A' ' 25' ' ' VAL . 26.2 t-105 -56.86 -44.11 81.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.114 0.483 . . . . 0.0 109.736 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -55.87 -45.8 78.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.424 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.399 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.483 ' HZ2' ' HB3' ' A' ' 53' ' ' MET . 10.6 m95 . . . . . 0 CA--C 1.513 -0.447 0 CA-C-O 121.287 0.565 . . . . 0.0 112.424 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.51 ' HG1' ' CD ' ' A' ' 21' ' ' GLU . 70.1 p -88.42 151.89 22.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.99 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.4 p -55.95 -37.24 47.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.837 -0.165 . . . . 0.0 111.377 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.484 ' HG3' ' CZ2' ' A' ' 24' ' ' TRP . 36.3 tp10 -59.32 -51.78 68.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.809 0.338 . . . . 0.0 110.777 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.51 ' CD ' ' HG1' ' A' ' 18' ' ' THR . 52.3 mt-10 -60.73 -39.36 88.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.687 0.756 . . . . 0.0 110.862 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 25' ' ' VAL . 13.2 m -67.96 -34.02 75.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.259 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.71 -36.19 82.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.19 0.519 . . . . 0.0 110.337 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.484 ' CZ2' ' HG3' ' A' ' 20' ' ' GLU . 32.5 m0 -65.75 -43.98 87.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.518 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.55 HG22 ' N ' ' A' ' 26' ' ' LYS . 3.0 m -58.82 -40.29 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.933 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.55 ' N ' HG22 ' A' ' 25' ' ' VAL . 22.7 ttpt -66.49 -44.85 81.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.819 0.342 . . . . 0.0 110.785 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.64 -44.31 90.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.779 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.65 96.13 Favored Glycine 0 C--O 1.224 -0.478 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.287 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 25' ' ' VAL . 22.8 t -60.08 -41.32 86.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.133 0.492 . . . . 0.0 110.965 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -74.48 -40.31 61.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.771 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.508 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 62.8 tttm -80.67 -46.13 16.07 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.508 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -91.73 -37.66 12.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.084 0.469 . . . . 0.0 111.35 -177.531 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.88 134.72 8.29 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -48.95 130.37 18.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.949 0.404 . . . . 0.0 111.47 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.18 -39.06 2.83 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.194 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.541 ' O ' HG13 ' A' ' 40' ' ' ILE . 66.6 m-80 -81.17 52.08 1.73 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.983 0.42 . . . . 0.0 110.932 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.431 ' NE1' ' HG3' ' A' ' 55' ' ' LYS . 33.8 m95 -63.7 -45.11 91.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.703 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.28 -44.03 79.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.808 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.15 -37.44 87.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.645 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 36' ' ' ASN . 82.8 mt -67.4 -48.19 78.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.356 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.875 ' HB3' HD11 ' A' ' 54' ' ' ILE . 6.4 p -61.47 -35.03 76.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.819 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -71.15 -52.27 20.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.003 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -75.09 -44.94 44.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.473 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 30.1 m-85 -71.65 154.44 93.09 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.116 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.89 38.0 0.15 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.147 2.565 . . . . 0.0 114.579 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 24' ' ' TRP . 78.9 m-85 -76.18 134.03 40.02 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.204 0.525 . . . . 0.0 109.832 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 4.3 p -134.25 135.26 54.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 74.9 m-80 76.5 -38.79 0.33 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.746 0.654 . . . . 0.0 110.422 -177.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.473 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 1.0 OUTLIER -69.87 128.96 38.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.416 179.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.3 p -92.14 169.7 10.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.107 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.85 -36.84 85.63 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.0 t -62.76 -36.25 74.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.483 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 17.9 mmt -64.77 -45.36 86.71 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.875 HD11 ' HB3' ' A' ' 41' ' ' SER . 78.6 mt -64.77 -44.2 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.18 0.514 . . . . 0.0 109.814 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HG3' ' NE1' ' A' ' 37' ' ' TRP . 39.5 ttmt -54.41 -50.81 66.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.323 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -70.93 -39.42 72.68 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.347 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.48 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 16.6 tpp180 -58.92 -35.62 73.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.714 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -59.55 -48.16 82.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.5 ttm105 -56.67 -46.93 80.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.393 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.48 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 7.5 p . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.577 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.533 ' HA ' ' NH2' ' A' ' 49' ' ' ARG . 15.1 m95 . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 121.674 0.75 . . . . 0.0 112.581 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.54 149.62 21.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.902 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.8 p -53.32 -36.76 27.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.555 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 35.8 tt0 -55.66 -60.17 3.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.737 0.303 . . . . 0.0 110.952 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.635 ' HG3' ' CZ3' ' A' ' 24' ' ' TRP . 2.7 mp0 -66.28 -30.98 71.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.193 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.487 ' O ' HG21 ' A' ' 25' ' ' VAL . 9.1 t -63.79 -39.84 95.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.761 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 21.1 mm-40 -65.28 -37.91 88.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.089 0.471 . . . . 0.0 111.08 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.635 ' CZ3' ' HG3' ' A' ' 21' ' ' GLU . 37.2 m0 -62.91 -43.1 99.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.587 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.578 ' O ' HG21 ' A' ' 29' ' ' VAL . 4.2 m -60.21 -40.2 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.906 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.541 ' N ' HG23 ' A' ' 25' ' ' VAL . 11.2 ttpp -64.74 -44.59 89.66 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.875 0.369 . . . . 0.0 110.934 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.07 -43.99 73.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.244 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.95 -42.47 96.82 Favored Glycine 0 C--O 1.225 -0.426 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.924 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.578 HG21 ' O ' ' A' ' 25' ' ' VAL . 98.5 t -61.45 -38.95 81.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.199 0.523 . . . . 0.0 110.499 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -70.49 -45.81 64.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.794 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -78.93 -45.89 19.53 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -177.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.412 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -88.32 -39.97 13.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.165 0.507 . . . . 0.0 111.336 -177.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.46 132.09 6.38 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -50.9 128.58 21.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.005 0.431 . . . . 0.0 111.053 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.73 -35.36 3.87 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.177 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.484 ' O ' HG13 ' A' ' 40' ' ' ILE . 77.2 m-20 -82.45 50.62 1.67 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.914 0.388 . . . . 0.0 111.292 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.42 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 35.7 m95 -60.66 -44.06 96.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.646 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 42' ' ' LYS . . . -59.5 -47.47 85.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.576 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.5 -42.99 93.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.702 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 36' ' ' ASN . 86.6 mt -60.8 -45.19 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.274 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.6 t -63.75 -38.19 90.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.154 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 73.0 mmtt -65.77 -46.14 79.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.059 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -82.65 -45.36 14.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.406 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 50.1 m-85 -76.15 147.39 79.85 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 120.925 0.393 . . . . 0.0 111.281 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.28 46.85 0.36 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.777 2.985 . . . . 0.0 114.854 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -73.59 126.07 29.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.141 0.496 . . . . 0.0 111.281 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.443 ' O ' ' HD3' ' A' ' 49' ' ' ARG . 7.4 p -118.98 132.63 68.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 75.8 m-20 74.49 -40.31 0.44 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.379 0.671 . . . . 0.0 110.819 -177.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.689 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 0.8 OUTLIER -73.26 118.04 15.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.76 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.441 ' OG1' ' HG3' ' A' ' 53' ' ' MET . 45.6 p -86.93 179.08 6.78 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.19 95.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.829 0.347 . . . . 0.0 110.136 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -62.29 -37.71 79.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.821 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.689 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 90.4 mtp -61.9 -43.36 99.0 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.561 HG23 HG11 ' A' ' 25' ' ' VAL . 75.8 mt -65.06 -44.32 95.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 37.9 ttpt -57.47 -48.24 79.71 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.715 0.769 . . . . 0.0 109.793 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.17 -37.77 84.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.007 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.437 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 26.7 tpt180 -59.63 -44.85 93.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.842 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -58.86 -45.04 91.07 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.636 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 51.4 ttm-85 -59.23 -42.74 91.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.376 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 1.2 p . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.271 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.586 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 41.5 m95 . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.077 0.465 . . . . 0.0 111.956 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.1 p -82.71 161.56 22.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.634 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.412 ' H ' HG22 ' A' ' 19' ' ' VAL . 10.0 t -60.79 -46.31 96.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.427 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.05 -42.57 85.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.273 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.634 ' HG2' ' CZ3' ' A' ' 24' ' ' TRP . 45.8 mt-10 -70.51 -33.53 71.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.174 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.1 m -68.49 -35.5 77.6 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.233 0.539 . . . . 0.0 110.603 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 49.2 mt-10 -62.41 -37.72 86.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.83 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.634 ' CZ3' ' HG2' ' A' ' 21' ' ' GLU . 37.3 m0 -63.09 -41.96 99.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.819 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.604 HG23 ' N ' ' A' ' 26' ' ' LYS . 2.0 m -59.01 -39.12 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.493 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.604 ' N ' HG23 ' A' ' 25' ' ' VAL . 26.0 ttmt -66.21 -46.03 78.66 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.06 0.457 . . . . 0.0 110.628 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.76 -43.43 96.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.48 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.421 ' HA3' HD13 ' A' ' 40' ' ' ILE . . . -61.21 -39.17 96.81 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.119 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 25' ' ' VAL . 54.0 t -61.95 -42.11 93.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.296 0.569 . . . . 0.0 110.332 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -72.79 -44.84 61.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.105 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -81.34 -49.5 10.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.479 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -84.84 -45.82 11.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.442 0.639 . . . . 0.0 111.017 -177.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.76 131.15 4.14 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.992 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -55.34 108.57 0.43 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.065 0.459 . . . . 0.0 110.801 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.97 -35.28 1.93 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.554 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 74.3 m-80 -82.2 53.2 2.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.14 0.495 . . . . 0.0 110.501 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.454 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 41.0 m95 -60.73 -43.17 98.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.965 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.31 99.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.68 0.276 . . . . 0.0 110.295 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -61.09 -43.0 99.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.945 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 36' ' ' ASN . 82.9 mt -63.26 -46.15 96.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.032 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.55 ' HB2' HD11 ' A' ' 54' ' ' ILE . 46.6 t -63.04 -38.32 90.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.339 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -68.1 -43.87 77.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.032 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -85.16 -46.43 11.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.437 ' CD1' HG22 ' A' ' 40' ' ' ILE . 50.3 m-85 -73.24 149.49 89.26 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.98 0.419 . . . . 0.0 111.171 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.485 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 37.6 Cg_endo -68.96 45.69 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.449 2.766 . . . . 0.0 114.638 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.586 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 58.6 m-85 -72.25 131.2 42.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.152 -0.343 . . . . 0.0 110.286 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.485 ' C ' ' H ' ' A' ' 49' ' ' ARG . 4.7 p -104.62 123.57 58.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.616 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 p30 63.92 -23.88 0.07 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.641 1.176 . . . . 0.0 113.431 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.596 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 5.1 mpt_? -65.42 133.19 50.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.047 0.451 . . . . 0.0 111.737 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.3 p -98.74 176.57 5.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.88 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.3 98.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.584 0.23 . . . . 0.0 111.092 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.53 -38.19 77.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.126 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.596 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 68.7 mtt -61.69 -43.74 98.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.709 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.55 HD11 ' HB2' ' A' ' 41' ' ' SER . 62.8 mt -67.38 -42.78 87.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.224 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 40.3 ttpt -56.52 -49.12 75.67 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.541 0.686 . . . . 0.0 109.403 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -66.29 -43.17 87.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.239 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.407 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 29.8 tpt180 -58.58 -43.61 89.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.052 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.41 ' CH2' ' HG3' ' A' ' 26' ' ' LYS . 15.6 t-105 -61.14 -44.77 96.81 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -56.99 -47.63 80.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.641 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.666 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.529 ' HZ3' ' HE2' ' A' ' 46' ' ' PHE . 11.9 m95 . . . . . 0 N--CA 1.449 -0.508 0 CA-C-O 121.377 0.608 . . . . 0.0 112.047 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.5 p -84.36 151.2 24.86 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.352 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.42 HG11 ' N ' ' A' ' 20' ' ' GLU . 14.5 p -59.39 -29.41 42.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.355 0.597 . . . . 0.0 109.755 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.42 ' N ' HG11 ' A' ' 19' ' ' VAL . 52.3 tt0 -60.68 -52.49 64.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.375 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.558 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 94.3 mt-10 -68.76 -36.56 78.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.065 0.459 . . . . 0.0 111.018 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.42 ' O ' HG21 ' A' ' 25' ' ' VAL . 23.9 m -59.23 -39.24 82.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.501 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -67.2 -32.1 72.94 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.938 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.558 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 37.9 m0 -66.28 -40.55 90.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.274 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.56 ' O ' HG22 ' A' ' 29' ' ' VAL . 3.6 m -62.85 -36.82 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 120.847 0.356 . . . . 0.0 110.076 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.424 ' N ' HG21 ' A' ' 25' ' ' VAL . 9.8 mtpm? -66.38 -45.0 81.57 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.972 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.54 -40.89 80.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.029 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.6 -38.81 94.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.133 -0.555 . . . . 0.0 112.841 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 25' ' ' VAL . 85.1 t -62.78 -39.16 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.357 0.599 . . . . 0.0 110.103 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -72.71 -49.99 27.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.218 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.592 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 39.7 ttmt -72.17 -47.92 47.28 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.592 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -93.96 -51.8 4.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.43 0.633 . . . . 0.0 111.123 -177.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.73 136.33 4.35 Favored Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.222 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -53.06 120.74 6.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.991 0.424 . . . . 0.0 110.27 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.52 -35.05 3.87 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.943 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.479 ' O ' HG13 ' A' ' 40' ' ' ILE . 77.6 m-20 -80.1 53.75 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.008 0.432 . . . . 0.0 111.096 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.405 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 34.6 m95 -64.65 -40.7 95.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.514 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.62 -39.87 85.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.915 0.388 . . . . 0.0 110.933 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.04 -35.38 74.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.463 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 36' ' ' ASN . 89.0 mt -69.84 -45.83 75.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.616 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.86 ' HB3' HD11 ' A' ' 54' ' ' ILE . 19.8 p -64.87 -36.85 85.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.271 0.558 . . . . 0.0 110.696 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -64.75 -45.88 84.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.81 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -86.04 -50.39 7.08 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.548 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 54.8 m-85 -69.06 146.79 97.45 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.197 0.522 . . . . 0.0 111.465 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.34 41.18 0.19 Allowed 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.926 3.084 . . . . 0.0 115.406 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.529 ' HE2' ' HZ3' ' A' ' 17' ' ' TRP . 73.3 m-85 -68.65 127.33 32.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.468 ' C ' ' H ' ' A' ' 49' ' ' ARG . 4.0 p -106.04 121.57 58.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.716 0.293 . . . . 0.0 110.459 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 69.97 -29.83 0.19 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.55 0.74 . . . . 0.0 112.366 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.578 ' N ' ' HD2' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -69.18 123.08 20.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.752 0.31 . . . . 0.0 110.604 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.596 ' OG1' ' HG2' ' A' ' 53' ' ' MET . 42.1 p -86.85 174.44 8.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.799 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.02 95.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.701 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.37 -38.83 82.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.596 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 21.5 mmt -60.91 -43.37 98.65 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.86 HD11 ' HB3' ' A' ' 41' ' ' SER . 83.5 mt -65.37 -45.35 93.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.352 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 39.6 ttpt -55.96 -50.34 71.07 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.367 0.603 . . . . 0.0 109.958 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.26 -40.91 94.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.225 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.499 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 12.7 tpp180 -60.61 -41.65 95.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.554 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -57.48 -42.4 82.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.961 0.41 . . . . 0.0 110.223 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -56.28 -45.17 80.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.068 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.54 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.447 ' CE3' ' HB3' ' A' ' 21' ' ' GLU . 27.5 m95 . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 121.66 0.743 . . . . 0.0 112.666 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.04 155.76 20.02 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.891 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.465 HG11 ' N ' ' A' ' 20' ' ' GLU . 10.3 p -58.32 -39.03 72.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.447 0.165 . . . . 0.0 111.138 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.465 ' N ' HG11 ' A' ' 19' ' ' VAL . 5.1 tp10 -58.65 -52.76 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.111 0.482 . . . . 0.0 110.155 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.509 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 5.6 mp0 -58.35 -39.55 79.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.33 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.0 m -67.26 -35.85 80.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.001 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 65.4 mm-40 -64.58 -36.85 85.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.327 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.509 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 44.3 m0 -63.32 -46.38 86.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.419 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.561 HG23 ' N ' ' A' ' 26' ' ' LYS . 3.5 m -61.17 -35.68 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.312 0.577 . . . . 0.0 109.983 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.561 ' N ' HG23 ' A' ' 25' ' ' VAL . 19.3 ttpt -65.59 -49.3 69.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.029 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.81 -41.3 68.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.314 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.81 -45.52 93.42 Favored Glycine 0 C--O 1.22 -0.737 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.408 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 25' ' ' VAL . 91.9 t -64.05 -39.27 84.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 117.67 0.735 . . . . 0.0 110.861 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -66.7 -37.49 84.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.399 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -90.35 -41.92 11.23 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -177.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.439 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -89.69 -52.28 5.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.387 0.613 . . . . 0.0 110.879 -178.04 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.08 134.93 4.71 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.353 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -51.77 139.64 21.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.044 0.449 . . . . 0.0 110.972 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.87 -32.9 7.01 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.479 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 74.3 m-80 -84.25 48.64 1.52 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.037 0.446 . . . . 0.0 111.126 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.428 ' HH2' ' CD1' ' A' ' 58' ' ' TRP . 28.2 m95 -60.87 -38.2 84.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.697 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.97 89.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.608 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -68.43 -39.55 81.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.856 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 36' ' ' ASN . 60.9 mt -68.62 -44.76 82.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.821 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.768 ' HB3' HD12 ' A' ' 54' ' ' ILE . 3.7 p -65.15 -32.38 74.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.646 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -70.89 -50.69 32.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.054 0.454 . . . . 0.0 111.528 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -76.61 -47.32 22.72 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.415 ' CD1' HG21 ' A' ' 40' ' ' ILE . 59.4 m-85 -75.89 144.63 76.5 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.092 0.472 . . . . 0.0 111.567 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.436 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 36.6 Cg_endo -67.13 46.78 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.191 3.261 . . . . 0.0 115.309 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -71.97 135.32 46.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.348 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 9.0 p -129.74 133.46 64.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 6.8 m120 76.81 -35.94 0.25 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.284 0.633 . . . . 0.0 110.574 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.714 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 7.1 mpt_? -77.46 130.04 36.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.311 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.6 p -92.9 174.21 7.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.704 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.3 -35.41 80.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.406 HG12 ' HE3' ' A' ' 55' ' ' LYS . 38.9 t -64.93 -38.61 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.599 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.714 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 60.1 mtt -62.57 -40.68 97.62 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.768 HD12 ' HB3' ' A' ' 41' ' ' SER . 86.4 mt -68.06 -44.77 84.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.406 ' HE3' HG12 ' A' ' 52' ' ' VAL . 24.1 ttpp -53.92 -49.91 67.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.868 0.842 . . . . 0.0 109.467 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -67.84 -44.12 77.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.573 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -58.38 -40.37 82.11 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.503 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.523 ' CZ3' ' HA ' ' A' ' 26' ' ' LYS . 30.3 t-105 -60.73 -45.37 94.54 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.864 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -56.83 -43.19 80.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.704 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.226 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.64 ' HA ' ' NH2' ' A' ' 49' ' ' ARG . 35.8 m95 . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.9 p -111.85 161.09 16.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.222 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 20' ' ' GLU . 7.3 p -53.82 -41.58 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.466 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 87.2 tt0 -59.13 -50.12 75.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.894 0.378 . . . . 0.0 110.942 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.47 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 54.1 mt-10 -64.59 -34.27 77.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.203 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.594 ' O ' HG21 ' A' ' 25' ' ' VAL . 23.1 t -69.21 -24.7 64.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.85 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 31.6 mm-40 -69.31 -40.66 77.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.082 0.467 . . . . 0.0 110.362 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.527 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 15.2 m0 -66.48 -40.12 89.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.418 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.633 ' O ' HG23 ' A' ' 29' ' ' VAL . 34.6 m -61.02 -46.13 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.692 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -65.31 -41.73 93.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.112 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.41 -43.65 80.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.056 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.42 -38.12 95.88 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.188 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 25' ' ' VAL . 68.4 t -61.17 -33.6 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.477 0.656 . . . . 0.0 110.118 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -77.12 -50.99 11.79 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.923 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.688 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 14.5 tmtt? -78.41 -47.57 17.3 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.688 ' CE1' ' HD2' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -86.71 -36.03 18.92 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.321 0.581 . . . . 0.0 110.965 -177.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.9 130.78 7.1 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -54.68 125.71 21.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.222 0.534 . . . . 0.0 110.48 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.07 -40.73 1.72 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.525 ' O ' HG13 ' A' ' 40' ' ' ILE . 74.4 m-80 -82.78 51.08 1.82 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.126 0.489 . . . . 0.0 110.385 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.547 ' CE3' HG23 ' A' ' 54' ' ' ILE . 40.9 m95 -60.27 -40.74 91.45 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.823 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.69 -46.67 84.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.703 0.287 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.01 85.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.439 . . . . 0.0 110.764 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 36' ' ' ASN . 67.8 mt -65.76 -43.52 93.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.679 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.471 ' OG ' HD11 ' A' ' 54' ' ' ILE . 12.9 m -62.22 -40.32 95.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.839 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.728 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -64.1 -55.52 21.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.356 -179.026 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -75.47 -47.48 26.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.428 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 61.0 m-85 -72.52 148.19 90.25 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.117 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.527 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 49.6 Cg_endo -69.56 43.94 0.38 Allowed 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.504 2.803 . . . . 0.0 114.164 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 24' ' ' TRP . 47.2 m-85 -72.56 99.03 2.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.862 0.363 . . . . 0.0 110.426 178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 6.5 p -88.32 127.19 41.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.5 m120 74.34 -36.03 0.32 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.238 0.615 . . . . 0.0 111.732 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.64 ' NH2' ' HA ' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -60.46 128.45 36.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.051 0.453 . . . . 0.0 112.175 -179.009 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.4 p -90.59 165.05 13.96 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.139 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.91 82.21 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.26 -38.66 82.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.38 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.518 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 3.5 mmt -59.77 -45.41 92.35 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.547 HG23 ' CE3' ' A' ' 37' ' ' TRP . 75.2 mt -65.48 -44.04 94.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.181 0.515 . . . . 0.0 110.055 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.418 ' HG3' ' NE1' ' A' ' 37' ' ' TRP . 38.9 ttmt -55.11 -51.97 64.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.429 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.51 -39.29 81.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.292 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.498 ' HG3' HH11 ' A' ' 57' ' ' ARG . 3.6 tpt85 -57.5 -40.07 77.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.8 t-105 -63.57 -42.49 98.32 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -56.18 -44.84 79.75 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.367 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.389 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 28.8 m95 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 121.36 0.6 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -94.55 148.52 22.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.999 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.678 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 14.6 p -49.51 -37.99 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.488 ' N ' HG12 ' A' ' 19' ' ' VAL . 42.3 tt0 -59.12 -49.17 78.9 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -64.38 -36.41 84.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.404 0.621 . . . . 0.0 110.082 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.501 ' O ' HG23 ' A' ' 25' ' ' VAL . 47.4 m -67.45 -27.57 67.15 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.923 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.678 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 69.7 mm-40 -66.37 -40.75 89.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.219 0.533 . . . . 0.0 110.167 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.523 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 21.6 m0 -64.16 -38.04 89.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.948 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 22' ' ' SER . 4.2 m -62.92 -38.58 82.3 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.81 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -68.93 -46.5 68.09 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.053 0.454 . . . . 0.0 110.388 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.13 99.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.606 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.59 -38.96 93.72 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.265 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 25' ' ' VAL . 38.6 t -64.32 -38.23 82.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.304 0.552 . . . . 0.0 110.422 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -73.34 -43.3 61.04 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.279 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -80.49 -50.54 9.91 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.463 ' CE1' ' HE1' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -88.72 -45.18 10.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.448 0.642 . . . . 0.0 111.186 -178.354 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 29' ' ' VAL . . . 112.44 131.69 5.65 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -57.82 124.69 20.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.416 0.627 . . . . 0.0 110.608 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.06 -39.57 1.69 Allowed Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.455 ' O ' HG13 ' A' ' 40' ' ' ILE . 75.5 m-80 -82.51 51.03 1.76 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.962 0.411 . . . . 0.0 110.482 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -60.44 -38.62 84.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.565 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.28 99.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.058 0.456 . . . . 0.0 110.276 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.37 -37.04 77.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.055 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 36' ' ' ASN . 67.1 mt -67.36 -45.58 85.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.658 ' HB3' HD12 ' A' ' 54' ' ' ILE . 4.5 p -63.7 -33.85 76.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 0.0 110.8 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -67.11 -48.81 67.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.601 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -82.86 -41.38 19.07 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.523 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 45.1 m-85 -79.5 147.43 67.88 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.09 0.471 . . . . 0.0 111.528 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.25 44.26 0.19 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 124.171 3.247 . . . . 0.0 114.735 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.427 ' CG ' HD13 ' A' ' 54' ' ' ILE . 60.3 m-85 -76.52 106.52 8.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.888 0.375 . . . . 0.0 110.148 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.484 ' C ' ' H ' ' A' ' 49' ' ' ARG . 7.7 p -100.14 131.08 48.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 73.14 -26.22 0.19 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.549 0.74 . . . . 0.0 111.256 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.484 ' H ' ' C ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -72.23 125.61 27.74 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 111.56 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.3 p -89.5 154.94 19.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.499 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.34 -38.91 69.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.644 0.259 . . . . 0.0 110.9 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -63.85 -41.1 91.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.359 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 68.8 mmm -63.27 -41.19 99.0 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.658 HD12 ' HB3' ' A' ' 41' ' ' SER . 76.7 mt -63.34 -44.94 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -56.92 -53.73 54.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.152 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -64.95 -37.5 87.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.728 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.431 ' O ' ' HD3' ' A' ' 57' ' ' ARG . 8.3 tpp180 -59.58 -33.81 71.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.528 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.441 ' CZ2' HG11 ' A' ' 29' ' ' VAL . 12.6 t-105 -60.68 -43.92 97.14 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -55.45 -49.19 73.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.21 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.715 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.579 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 12.3 m95 . . . . . 0 CA--C 1.519 -0.234 0 CA-C-O 120.821 0.344 . . . . 0.0 111.836 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -77.35 151.56 34.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.545 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 9.8 p -55.5 -36.17 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.919 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.482 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 32.7 tt0 -59.77 -45.49 92.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.045 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 42.1 mt-10 -64.71 -42.36 95.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.685 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.434 ' O ' HG22 ' A' ' 25' ' ' VAL . 2.0 p -66.9 -28.36 68.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.445 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 66.3 mm-40 -67.73 -35.95 79.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.897 0.38 . . . . 0.0 110.328 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.482 ' CZ2' ' HG2' ' A' ' 20' ' ' GLU . 30.9 m0 -66.57 -42.84 86.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.411 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.596 ' O ' HG22 ' A' ' 29' ' ' VAL . 3.3 m -58.95 -39.46 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.815 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.556 ' N ' HG21 ' A' ' 25' ' ' VAL . 22.1 ttmt -64.67 -43.51 93.36 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.044 0.45 . . . . 0.0 110.344 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.69 -44.1 91.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.618 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.03 -38.09 95.52 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.427 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 25' ' ' VAL . 69.3 t -62.97 -39.97 87.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.253 0.549 . . . . 0.0 110.323 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -74.4 -45.95 43.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.008 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.471 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 60.3 tttm -80.98 -45.51 16.51 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -177.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.493 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -89.63 -51.22 5.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.32 0.581 . . . . 0.0 110.594 -177.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.34 135.44 4.23 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.513 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -55.16 113.54 1.42 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.979 0.418 . . . . 0.0 110.16 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.44 -35.26 2.72 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.998 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.528 ' O ' HG13 ' A' ' 40' ' ' ILE . 75.4 m-20 -80.48 49.26 1.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.006 0.432 . . . . 0.0 111.187 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.442 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 33.5 m95 -60.68 -40.45 92.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.432 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.89 -37.43 79.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 110.965 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.73 -32.75 68.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.403 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 36' ' ' ASN . 73.7 mt -71.57 -46.81 61.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.736 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.861 ' HB3' HD13 ' A' ' 54' ' ' ILE . 54.6 p -62.72 -35.31 79.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.186 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -65.6 -53.45 41.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.617 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.0 -48.43 16.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.52 ' CD1' HG21 ' A' ' 40' ' ' ILE . 62.3 m-85 -71.21 151.11 94.54 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 120.934 0.397 . . . . 0.0 111.581 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.35 43.28 0.22 Allowed 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.787 2.991 . . . . 0.0 114.445 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.579 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 65.6 m-85 -76.33 115.48 16.11 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.493 ' C ' ' H ' ' A' ' 49' ' ' ARG . 3.6 p -95.9 125.28 48.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.193 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 p30 64.54 -30.71 0.12 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.709 1.204 . . . . 0.0 112.904 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.573 ' N ' ' HD2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -61.26 116.18 4.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 111.339 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.6 p -78.9 173.61 12.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.694 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.69 -39.22 93.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.223 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.6 t -62.89 -39.17 83.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.776 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 81.2 mmm -58.87 -42.82 90.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.715 178.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.861 HD13 ' HB3' ' A' ' 41' ' ' SER . 67.6 mt -69.12 -44.49 80.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.298 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.442 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 39.2 ttpt -55.07 -53.8 51.17 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.829 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -62.13 -40.35 95.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.834 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.471 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 6.8 tpp180 -56.41 -42.3 77.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.924 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 15.7 t-105 -59.37 -43.42 92.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.867 0.365 . . . . 0.0 110.357 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.426 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 1.8 mpt_? -59.66 -43.95 93.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.21 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.367 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.604 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 28.6 m95 . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 57.5 p -81.98 162.18 22.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 20' ' ' GLU . 9.6 p -57.9 -40.22 75.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 121.347 -0.141 . . . . 0.0 111.233 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.494 ' HG3' ' CE2' ' A' ' 24' ' ' TRP . 45.4 tp10 -60.92 -50.81 71.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.236 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.574 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 39.1 mt-10 -58.0 -42.41 85.15 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.487 0.66 . . . . 0.0 111.164 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 m -66.81 -36.49 82.5 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.166 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 19.9 mt-10 -67.53 -31.77 72.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.949 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.574 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 47.5 m0 -61.89 -41.93 98.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.49 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.672 HG12 HG22 ' A' ' 54' ' ' ILE . 1.4 m -63.46 -37.5 79.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.391 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.623 ' N ' HG22 ' A' ' 25' ' ' VAL . 26.3 ttpt -66.18 -47.97 72.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.058 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.28 -37.33 85.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.591 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.29 -39.4 94.6 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.827 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 25' ' ' VAL . 92.7 t -61.32 -37.8 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.456 0.646 . . . . 0.0 110.176 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -76.18 -47.15 25.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.027 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.8 -48.79 65.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.99 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -107.67 -47.85 3.53 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.341 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.69 142.63 5.02 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.197 -1.001 . . . . 0.0 112.479 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.402 ' HB2' HG11 ' A' ' 29' ' ' VAL . 37.1 tt0 -56.94 126.3 26.46 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.67 -31.34 6.9 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.718 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.407 ' O ' HG13 ' A' ' 40' ' ' ILE . 68.3 m-80 -83.19 47.71 1.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.071 0.463 . . . . 0.0 110.808 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.477 ' CE3' HG23 ' A' ' 54' ' ' ILE . 36.7 m95 -61.84 -37.54 84.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.111 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.95 -47.54 85.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.045 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.83 -40.83 98.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.219 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.428 HG22 ' CE2' ' A' ' 46' ' ' PHE . 97.8 mt -63.33 -45.67 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.508 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.546 ' HB2' HD11 ' A' ' 54' ' ' ILE . 16.7 t -64.4 -34.69 78.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.225 0.536 . . . . 0.0 110.481 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -67.82 -51.14 52.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.934 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -77.5 -50.73 12.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.947 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.408 ' CD1' HG21 ' A' ' 40' ' ' ILE . 59.2 m-85 -73.02 145.75 86.61 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.055 0.455 . . . . 0.0 111.115 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.486 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.0 Cg_endo -66.63 45.07 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.013 3.142 . . . . 0.0 115.102 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.604 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 70.5 m-85 -71.18 122.74 20.73 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.262 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 49' ' ' ARG . 3.6 p -103.76 124.0 57.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.861 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 m120 70.73 -39.14 0.44 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.537 0.735 . . . . 0.0 111.939 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.418 ' H ' ' C ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -58.05 118.95 5.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.183 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.2 p -80.61 175.26 10.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.163 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.29 -36.93 84.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 t -63.98 -38.83 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.603 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 84.9 mmm -59.39 -43.16 93.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.672 HG22 HG12 ' A' ' 25' ' ' VAL . 70.9 mt -67.43 -44.35 86.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.405 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.426 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 40.1 ttpt -57.14 -47.55 80.87 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.401 0.62 . . . . 0.0 109.828 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -67.33 -40.87 85.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.72 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.409 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 30.0 tpt180 -60.57 -40.36 91.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.099 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -59.85 -44.47 94.1 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 -59.74 -45.56 91.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.335 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.409 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 17.7 p . . . . . 0 CA--C 1.532 0.267 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.857 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.551 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 13.6 m95 . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 120.969 0.414 . . . . 0.0 111.667 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.5 p -79.3 155.33 28.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.284 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.2 p -58.38 -33.85 48.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.926 0.393 . . . . 0.0 110.668 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.73 -49.31 75.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.133 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 33.8 mt-10 -63.97 -40.15 95.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.543 0.687 . . . . 0.0 110.489 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.0 m -63.05 -35.58 80.73 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.365 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -65.46 -32.39 73.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.075 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.435 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 41.1 m0 -66.76 -46.0 76.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.675 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 54' ' ' ILE . 3.3 m -62.51 -37.79 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.998 0.428 . . . . 0.0 110.18 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.576 ' N ' HG21 ' A' ' 25' ' ' VAL . 21.9 ttpt -63.19 -46.18 88.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.913 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.31 -40.28 64.62 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.214 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.44 -41.67 97.18 Favored Glycine 0 C--O 1.226 -0.377 0 CA-C-N 116.114 -0.494 . . . . 0.0 113.052 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 25' ' ' VAL . 66.2 t -62.23 -40.32 87.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.247 0.546 . . . . 0.0 110.748 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.477 HE21 ' HB3' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -73.55 -44.92 56.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.04 -179.633 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.468 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 62.1 tttp -75.46 -50.32 16.13 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.468 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -87.3 -53.15 4.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.443 0.639 . . . . 0.0 110.867 -178.283 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.21 133.2 3.53 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.687 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -55.42 121.5 9.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.918 0.389 . . . . 0.0 110.661 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.15 -34.01 3.83 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.014 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.46 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.2 m-80 -80.19 53.91 1.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.075 0.464 . . . . 0.0 111.243 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -64.52 -36.56 84.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.951 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.83 98.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.072 0.463 . . . . 0.0 110.545 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.77 -37.72 73.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.006 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 36' ' ' ASN . 74.1 mt -66.56 -46.53 86.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.867 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.845 ' HB3' HD11 ' A' ' 54' ' ' ILE . 3.8 p -62.88 -37.51 87.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.193 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -65.83 -52.69 48.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.09 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -76.72 -47.08 23.01 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.403 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 53.3 m-85 -71.25 149.14 94.15 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.989 0.423 . . . . 0.0 111.07 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.435 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 40.7 Cg_endo -67.84 43.19 0.25 Allowed 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.685 2.923 . . . . 0.0 114.773 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.551 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 73.4 m-85 -74.7 127.77 33.93 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.482 ' C ' ' H ' ' A' ' 49' ' ' ARG . 7.5 p -115.72 132.68 64.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 p30 66.03 -30.19 0.14 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.655 1.182 . . . . 0.0 112.366 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.482 ' H ' ' C ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -67.8 125.77 27.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.728 0.299 . . . . 0.0 110.981 179.229 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.9 p -89.34 169.82 11.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.621 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.65 89.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.485 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.95 -38.03 80.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.479 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 14.5 mmt -62.07 -44.1 97.4 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.845 HD11 ' HB3' ' A' ' 41' ' ' SER . 77.4 mt -64.15 -44.51 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.938 0.399 . . . . 0.0 110.009 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -55.91 -50.23 71.25 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.901 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.51 -42.86 86.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.5 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.475 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 8.9 tpp180 -60.42 -38.3 83.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.623 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.46 ' CD2' HG22 ' A' ' 29' ' ' VAL . 27.4 t-105 -60.35 -44.69 95.31 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -57.86 -46.71 84.4 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.533 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.47 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.922 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 m -64.3 130.27 43.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.704 0.288 . . . . 0.0 110.81 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -62.8 -42.89 99.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.946 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.401 ' HE3' ' HA ' ' A' ' 7' ' ' SER . 0.0 OUTLIER -162.26 106.28 1.17 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.209 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -72.73 -47.26 48.48 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.537 0.684 . . . . 0.0 110.223 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -174.63 -44.55 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.097 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.401 ' HA ' ' HE3' ' A' ' 4' ' ' MET . 19.7 m -148.55 41.77 0.96 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.192 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.7 m -59.35 -53.85 53.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.576 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.708 ' HB ' HG13 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -82.64 133.16 35.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.064 0.459 . . . . 0.0 110.742 178.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -80.57 39.2 0.46 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.486 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.708 HG13 ' HB ' ' A' ' 9' ' ' THR . 1.5 pp -90.78 19.44 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.099 0.476 . . . . 0.0 111.375 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 p -83.32 -47.78 11.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.558 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -80.22 141.98 35.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.724 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.497 ' HB3' ' NZ ' ' A' ' 14' ' ' LYS . 1.6 ttpm? 59.17 83.88 0.12 Allowed 'General case' 0 C--O 1.238 0.455 0 O-C-N 123.66 0.6 . . . . 0.0 110.869 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 63.63 -167.72 0.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.151 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -168.46 121.91 0.87 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.642 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 16.4 m95 -133.25 147.39 51.95 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -87.03 154.6 20.64 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.585 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 14.7 p -57.6 -42.53 81.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -60.37 -45.68 92.65 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.784 0.325 . . . . 0.0 110.941 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.469 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 68.7 mt-10 -61.28 -36.41 79.99 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.493 0.663 . . . . 0.0 110.107 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.448 ' O ' HG22 ' A' ' 25' ' ' VAL . 22.0 m -69.8 -29.69 67.05 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.705 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 68.1 mm-40 -69.57 -39.25 77.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.243 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.493 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 33.6 m0 -61.17 -43.77 98.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.219 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.626 HG21 ' N ' ' A' ' 26' ' ' LYS . 3.1 m -58.63 -38.31 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.001 0.429 . . . . 0.0 110.263 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.626 ' N ' HG21 ' A' ' 25' ' ' VAL . 11.9 ttmm -67.18 -49.58 64.14 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.793 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.88 -43.22 99.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.736 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.9 -38.84 96.68 Favored Glycine 0 C--O 1.224 -0.524 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.566 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.589 HG21 ' O ' ' A' ' 25' ' ' VAL . 55.7 t -63.21 -35.76 73.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.037 0.446 . . . . 0.0 110.909 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.28 -46.61 15.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.947 0.403 . . . . 0.0 110.866 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.715 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 39.5 ttmt -74.46 -45.72 44.41 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.715 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -93.28 -46.11 7.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.211 0.529 . . . . 0.0 110.98 -177.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.78 134.05 5.05 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.168 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -54.23 118.65 4.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.871 0.367 . . . . 0.0 110.476 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.12 -38.54 2.0 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.817 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.512 ' O ' HG13 ' A' ' 40' ' ' ILE . 74.0 m-20 -79.83 54.11 1.78 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.142 0.496 . . . . 0.0 111.114 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -62.76 -39.11 93.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.581 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.11 -46.58 89.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.105 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.68 87.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.966 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 36' ' ' ASN . 75.1 mt -66.87 -43.21 89.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.003 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.9 m -60.37 -39.05 85.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.229 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -70.61 -55.13 9.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.885 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -72.48 -40.9 66.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 60.8 m-85 -83.1 146.15 50.89 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.546 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.493 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 35.9 Cg_endo -66.09 43.12 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.723 2.949 . . . . 0.0 115.041 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.642 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 64.6 m-85 -72.92 111.56 8.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.858 0.361 . . . . 0.0 110.079 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.413 ' C ' ' H ' ' A' ' 49' ' ' ARG . 7.5 p -99.4 127.86 51.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 72.97 -41.52 0.51 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.475 0.71 . . . . 0.0 111.368 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.429 ' NH2' ' HA ' ' A' ' 17' ' ' TRP . 1.0 OUTLIER -58.48 120.39 8.72 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 122.598 0.359 . . . . 0.0 111.277 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.3 p -86.04 172.17 10.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.206 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.68 83.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.455 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.29 -39.78 86.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.102 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 19.1 mmt -62.09 -41.71 98.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.317 -0.402 . . . . 0.0 109.959 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.0 mt -67.28 -42.3 87.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -56.94 -50.66 71.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.557 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -64.53 -44.46 90.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.627 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -58.47 -45.13 89.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.388 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.474 ' CD1' ' HD2' ' A' ' 62' ' ' LYS . 30.7 t-105 -62.66 -41.91 99.32 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.297 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -58.11 -44.97 88.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.934 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.571 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 24.5 p -66.02 -39.61 90.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.959 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.478 ' SD ' ' HE2' ' A' ' 66' ' ' MET . 63.5 mmm -59.45 -47.25 86.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.998 0.428 . . . . 0.0 110.026 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.474 ' HD2' ' CD1' ' A' ' 58' ' ' TRP . 49.7 mtpt -60.72 -42.91 98.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.643 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -61.32 -42.59 98.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.892 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 60' ' ' THR . 62.4 mt -75.54 -4.56 40.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.033 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.56 37.41 35.35 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.244 -0.503 . . . . 0.0 112.199 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.478 ' HE2' ' SD ' ' A' ' 61' ' ' MET . 69.3 mtm -119.16 47.31 1.7 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.993 0.425 . . . . 0.0 110.464 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 . . . . . 0 C--O 1.248 1.015 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.626 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t -164.98 120.24 1.36 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -82.75 57.49 3.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.88 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.4 mmt -125.13 63.45 1.16 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.042 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -72.24 134.57 45.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.686 0.279 . . . . 0.0 110.541 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.607 ' HA ' HG23 ' A' ' 12' ' ' THR . 2.8 p30 -167.07 -169.38 1.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.177 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.8 t -171.26 -139.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.4 m -162.57 -51.26 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 m -68.04 -46.22 71.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.975 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -162.03 155.41 20.84 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.272 -0.171 . . . . 0.0 111.049 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.5 mt 69.46 112.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 124.04 0.838 . . . . 0.0 111.637 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.607 HG23 ' HA ' ' A' ' 6' ' ' ASP . 28.3 m 70.95 -44.13 0.58 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.356 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 71.38 -178.06 0.21 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.377 0.671 . . . . 0.0 110.272 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.809 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.6 OUTLIER -86.13 76.1 9.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.898 0.38 . . . . 0.0 110.608 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -79.28 45.77 0.67 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.053 0.454 . . . . 0.0 110.722 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.583 ' HD3' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -66.31 143.7 57.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.088 0.47 . . . . 0.0 111.297 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.452 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 14.0 m95 -116.19 132.31 56.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.585 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -79.5 156.39 27.82 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.81 -41.83 76.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.511 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -65.75 -45.83 81.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.528 0.204 . . . . 0.0 110.5 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.459 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 35.1 mt-10 -55.55 -43.44 75.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.638 0.733 . . . . 0.0 110.533 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.5 m -66.75 -37.15 84.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.819 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.417 ' CD ' ' HZ2' ' A' ' 26' ' ' LYS . 62.0 mm-40 -63.66 -35.27 79.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.982 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.459 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 44.2 m0 -61.89 -44.96 95.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.822 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.673 HG22 ' N ' ' A' ' 26' ' ' LYS . 1.4 m -62.2 -40.17 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.673 ' N ' HG22 ' A' ' 25' ' ' VAL . 24.2 ttpt -65.14 -46.81 79.39 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.273 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.12 -44.08 97.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.158 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.26 95.97 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.273 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 25' ' ' VAL . 50.2 t -63.22 -41.06 91.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.25 0.547 . . . . 0.0 110.178 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.03 -45.62 40.5 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.77 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.47 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 61.7 tttm -79.64 -52.97 7.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.47 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -82.68 -54.65 4.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.483 0.658 . . . . 0.0 110.456 -178.583 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.74 130.86 3.29 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.096 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -51.39 128.88 23.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.811 0.339 . . . . 0.0 110.892 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.37 -35.3 4.18 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.837 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.49 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.0 m-80 -81.11 51.85 1.67 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.884 0.373 . . . . 0.0 111.08 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.481 ' CE3' HG22 ' A' ' 54' ' ' ILE . 32.9 m95 -62.26 -42.91 99.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.788 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.39 88.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.791 0.329 . . . . 0.0 110.731 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.66 -42.91 98.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.473 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 36' ' ' ASN . 89.0 mt -62.47 -45.6 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.598 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.623 ' HB2' HD13 ' A' ' 54' ' ' ILE . 29.5 t -61.43 -36.33 80.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.068 0.461 . . . . 0.0 111.087 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -68.18 -49.96 57.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.95 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -77.8 -52.69 8.5 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.612 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.46 ' CD1' HG22 ' A' ' 40' ' ' ILE . 57.6 m-85 -67.9 147.45 98.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.119 0.485 . . . . 0.0 111.329 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.6 Cg_endo -66.98 44.57 0.22 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.819 3.012 . . . . 0.0 115.212 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.452 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 75.7 m-85 -71.36 124.85 25.48 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.774 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.454 ' C ' ' H ' ' A' ' 49' ' ' ARG . 2.4 p -101.83 118.54 48.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.089 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.1 -30.38 0.15 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.543 1.137 . . . . 0.0 112.964 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.553 ' N ' ' HD2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -60.91 119.51 8.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.234 0.54 . . . . 0.0 111.771 -179.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 p -79.05 169.95 17.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.945 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.23 -38.61 89.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.303 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.87 -40.21 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.4 mmt -61.3 -40.84 95.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.623 HD13 ' HB2' ' A' ' 41' ' ' SER . 82.3 mt -67.11 -44.16 88.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 37.7 ttpt -56.98 -48.87 77.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.696 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -66.64 -39.46 88.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.883 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.437 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 27.6 tpt180 -59.32 -43.58 92.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.32 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.413 ' O ' ' HG3' ' A' ' 62' ' ' LYS . 10.9 t-105 -58.62 -45.27 89.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.455 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 57.2 ttp180 -60.9 -46.25 91.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.722 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 27.9 p -62.1 -39.12 91.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.288 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 84.3 mtp -64.38 -41.18 96.83 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 59' ' ' ARG . 54.6 mtpt -63.74 -38.25 90.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.409 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.534 ' NE ' ' HA ' ' A' ' 63' ' ' ARG . 4.7 tpm_? -60.09 -46.14 90.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.144 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.57 -22.36 61.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.304 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.83 28.58 31.41 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 63.7 mtt -107.13 26.66 9.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.232 0.539 . . . . 0.0 110.22 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.302 179.852 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.672 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.8 m 62.42 -91.84 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.023 0.529 . . . . 0.0 112.277 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -80.09 38.12 0.4 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.201 0.524 . . . . 0.0 111.12 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 20.7 mmt -151.05 131.89 14.14 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -80.88 38.48 0.46 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.461 0.648 . . . . 0.0 110.941 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.69 -15.81 50.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.029 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.9 p 57.1 25.4 10.8 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.555 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.5 p -75.78 -43.36 46.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -69.5 138.17 53.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.772 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -67.72 129.68 40.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.2 mt -140.2 34.26 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.621 0.724 . . . . 0.0 109.906 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.7 m -66.7 -35.71 80.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.774 0.797 . . . . 0.0 109.379 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 14' ' ' LYS . 19.4 ptpt -72.82 -9.1 58.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.994 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.42 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 39.2 ttpt 76.29 145.64 0.09 Allowed 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.904 0.752 . . . . 0.0 109.446 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -50.08 125.19 11.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.398 0.618 . . . . 0.0 112.165 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -100.05 150.51 22.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.379 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.478 ' HZ3' ' HE2' ' A' ' 46' ' ' PHE . 14.3 m95 -124.25 134.12 53.32 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.435 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.0 p -79.33 156.41 28.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.344 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.52 -31.52 50.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.414 ' HG3' ' CZ2' ' A' ' 24' ' ' TRP . 3.2 tp10 -59.76 -51.74 68.47 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.593 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.501 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 29.1 mt-10 -64.31 -38.15 90.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.596 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.6 m -64.89 -41.92 95.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.341 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -63.04 -32.9 74.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.96 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.501 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 47.0 m0 -65.88 -46.23 79.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.887 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.627 HG12 HG23 ' A' ' 54' ' ' ILE . 2.3 m -60.93 -39.31 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.58 ' N ' HG23 ' A' ' 25' ' ' VAL . 22.0 ttpt -67.21 -47.31 71.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.621 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.66 -42.39 98.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.516 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.32 -36.46 93.1 Favored Glycine 0 C--O 1.222 -0.645 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.969 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 25' ' ' VAL . 53.7 t -65.7 -34.28 69.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.181 0.515 . . . . 0.0 110.072 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -75.43 -48.08 24.42 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.214 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.478 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 24.8 ttmm -79.9 -48.22 13.8 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -177.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.478 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -90.8 -44.01 9.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.414 0.626 . . . . 0.0 111.101 -178.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 29' ' ' VAL . . . 106.97 132.37 6.98 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -56.62 139.17 50.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.373 0.606 . . . . 0.0 110.834 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.31 -38.11 3.01 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -85.65 49.34 1.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.107 0.479 . . . . 0.0 110.148 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.431 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 42.1 m95 -60.22 -38.28 82.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.222 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.22 -45.66 90.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.995 0.426 . . . . 0.0 110.133 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 -44.59 91.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.81 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.5 mt -61.31 -44.1 97.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.786 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.9 t -64.65 -37.66 88.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.814 0.34 . . . . 0.0 111.039 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -64.9 -49.23 71.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.258 0.551 . . . . 0.0 111.604 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -79.0 -48.61 14.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.956 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -75.31 141.53 73.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 0.0 111.869 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.491 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.4 Cg_endo -66.39 48.93 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 124.298 3.332 . . . . 0.0 115.257 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.478 ' HE2' ' HZ3' ' A' ' 17' ' ' TRP . 60.8 m-85 -72.15 109.85 6.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.87 0.366 . . . . 0.0 110.202 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' A' ' 49' ' ' ARG . 4.0 p -84.82 122.26 37.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.471 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.7 m120 69.88 -34.04 0.27 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.557 0.743 . . . . 0.0 112.27 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.623 ' N ' ' HD2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -63.06 127.88 33.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.248 0.547 . . . . 0.0 111.789 -179.131 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.4 p -93.29 176.56 6.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.127 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.95 -38.57 91.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.667 0.27 . . . . 0.0 110.299 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.7 t -63.52 -38.76 83.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.763 ' HE2' ' HA ' ' A' ' 53' ' ' MET . 14.0 mmt -59.37 -44.99 92.65 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.627 HG23 HG12 ' A' ' 25' ' ' VAL . 68.4 mt -65.49 -46.49 89.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.504 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 36.0 ttpt -55.05 -50.44 69.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.345 0.593 . . . . 0.0 110.378 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -66.33 -39.55 89.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.401 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.425 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 30.8 tpt180 -59.99 -41.6 92.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.587 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.433 ' CE2' HG22 ' A' ' 29' ' ' VAL . 16.0 t-105 -61.18 -45.5 94.36 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.81 -44.45 86.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.901 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.609 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.6 OUTLIER -63.89 -45.63 88.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.461 179.388 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 75.6 mtp -58.34 -41.63 85.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.856 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -66.05 -40.56 91.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.821 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -66.52 -46.09 77.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.656 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 60' ' ' THR . 64.7 mt -65.51 -30.47 71.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.337 0.589 . . . . 0.0 110.464 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.23 34.99 5.65 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.776 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 88.2 mtp -82.71 -43.5 16.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.256 0.551 . . . . 0.0 109.703 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.0 t30 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.386 -0.816 . . . . 0.0 110.448 179.499 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.8 p 66.83 -42.59 0.42 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.138 1.375 . . . . 0.0 112.611 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.47 127.03 4.19 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.438 ' HE1' ' HB3' ' A' ' 4' ' ' MET . 0.0 OUTLIER -73.39 -26.15 60.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.304 -179.4 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.613 ' OE1' ' HA ' ' A' ' 48' ' ' ASN . 40.1 mt-10 -58.51 137.18 57.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.08 0.467 . . . . 0.0 111.504 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -74.61 148.86 40.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.422 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.598 ' HB3' HD11 ' A' ' 11' ' ' ILE . 27.0 m 62.57 54.73 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.441 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -64.98 -24.68 67.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.353 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.1 m -56.95 141.47 45.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.26 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.54 ' HB2' ' HG2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -68.19 50.81 0.07 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.598 HD11 ' HB3' ' A' ' 7' ' ' SER . 28.7 pt -83.89 28.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.734 0.302 . . . . 0.0 111.794 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.3 m -157.35 -51.18 0.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.54 ' HG2' ' HB2' ' A' ' 10' ' ' ASN . 35.7 mtmm 54.44 57.68 5.6 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.567 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -58.15 105.47 0.28 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.849 0.356 . . . . 0.0 110.575 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.426 ' O ' ' HD1' ' A' ' 17' ' ' TRP . 89.3 mm-40 -71.87 -24.93 61.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.62 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -66.12 120.86 13.92 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.103 0.477 . . . . 0.0 110.13 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.441 ' HZ2' ' HB3' ' A' ' 53' ' ' MET . 17.3 m95 -135.97 140.08 43.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.218 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.3 p -76.81 152.74 35.42 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 10.9 p -60.51 -38.61 78.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.219 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.461 ' N ' HG12 ' A' ' 19' ' ' VAL . 42.0 tt0 -59.71 -54.1 50.29 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.524 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 50.3 mt-10 -58.57 -39.28 79.85 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.429 0.633 . . . . 0.0 111.096 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.515 ' HB3' ' SD ' ' A' ' 61' ' ' MET . 15.5 m -68.16 -37.6 81.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.203 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 68.0 mm-40 -61.26 -34.64 75.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.873 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.524 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 42.5 m0 -62.54 -43.66 98.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.15 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.659 HG23 ' N ' ' A' ' 26' ' ' LYS . 1.1 m -60.04 -37.55 73.12 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.659 ' N ' HG23 ' A' ' 25' ' ' VAL . 19.5 ttmt -62.21 -46.3 89.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.639 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.86 78.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.744 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.06 -40.68 99.24 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 25' ' ' VAL . 51.5 t -61.09 -37.39 77.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.006 0.432 . . . . 0.0 111.01 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -79.28 -41.42 28.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.696 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -78.81 -49.49 12.88 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.44 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -86.05 -42.12 14.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.462 0.648 . . . . 0.0 110.805 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.17 131.54 5.88 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -50.55 130.4 23.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.808 0.337 . . . . 0.0 110.914 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.41 -37.07 3.44 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.906 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.468 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.9 m-80 -81.53 53.72 2.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.102 0.477 . . . . 0.0 111.115 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -63.83 -38.3 90.57 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.559 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 51' ' ' ALA . . . -61.54 -46.2 90.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.51 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.23 -43.08 99.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.64 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 36' ' ' ASN . 79.6 mt -63.05 -45.07 99.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.449 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.554 ' HB2' HD13 ' A' ' 54' ' ' ILE . 47.6 t -62.91 -36.0 81.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.229 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -68.76 -47.91 65.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.908 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -80.34 -49.96 10.8 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.413 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 51.0 m-85 -70.41 145.56 93.18 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 121.171 0.51 . . . . 0.0 111.826 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.47 44.28 0.24 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 124.073 3.182 . . . . 0.0 114.841 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.438 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 53.4 m-85 -68.65 122.95 19.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.969 0.414 . . . . 0.0 110.489 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.58 127.25 62.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.256 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.617 ' C ' ' HD2' ' A' ' 49' ' ' ARG . 73.2 m-80 61.79 17.18 8.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.738 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.617 ' HD2' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -118.03 124.37 47.96 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -178.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.503 ' OG1' ' HG2' ' A' ' 53' ' ' MET . 31.1 p -87.01 175.38 8.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.624 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . . . -66.78 -38.59 86.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.538 0.208 . . . . 0.0 110.824 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.72 -36.23 74.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.503 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 79.8 mmm -61.79 -45.27 94.61 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' A' ' 41' ' ' SER . 66.3 mt -66.45 -41.96 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.958 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -54.92 -49.28 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.148 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 3.5 t0 -71.31 -36.59 71.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.262 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.452 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 27.8 tpt180 -59.7 -40.52 88.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.116 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.4 t-105 -59.59 -43.34 93.71 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 56' ' ' ASP . 21.7 ttm180 -58.06 -49.46 76.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.457 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 1.7 p -61.73 -46.06 91.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.955 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.55 ' HB3' ' HB2' ' A' ' 66' ' ' MET . 4.6 mtm -57.11 -41.36 78.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.622 0.249 . . . . 0.0 111.0 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -61.62 -35.37 77.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.301 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.425 ' HB3' HD21 ' A' ' 64' ' ' LEU . 29.8 ttp180 -59.88 -60.7 3.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.623 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' A' ' 63' ' ' ARG . 2.7 mm? -63.37 -53.0 59.38 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.493 0.663 . . . . 0.0 110.155 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.37 40.63 0.3 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.7 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.55 ' HB2' ' HB3' ' A' ' 61' ' ' MET . 78.0 mtp -95.58 38.8 1.14 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.959 0.409 . . . . 0.0 110.439 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 . . . . . 0 C--O 1.25 1.116 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.608 -179.803 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.7 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 14' ' ' LYS . 41.7 m -141.92 45.89 1.67 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.179 0.514 . . . . 0.0 110.287 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -76.87 113.92 15.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.527 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.431 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 51.2 ttm -174.51 129.7 0.34 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.282 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 49.82 54.9 10.24 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.672 0.607 . . . . 0.0 110.42 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -71.83 55.52 0.28 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.093 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 t -75.32 -27.37 59.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.672 0.749 . . . . 0.0 109.122 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.1 m -155.78 -51.8 0.08 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.986 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -147.85 -140.56 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.468 ' C ' ' HD3' ' A' ' 13' ' ' LYS . 7.1 p-10 -139.01 33.9 2.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.096 0.474 . . . . 0.0 110.297 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.419 ' O ' ' CB ' ' A' ' 12' ' ' THR . 57.9 mt -78.1 117.9 24.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.419 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 23.6 m 100.64 -19.0 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.064 1.345 . . . . 0.0 109.086 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HD3' ' C ' ' A' ' 10' ' ' ASN . 1.7 mptp? -88.3 134.09 33.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.83 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.446 ' HD3' ' HA ' ' A' ' 2' ' ' SER . 29.5 mtpp 52.79 57.96 5.84 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.6 0.563 . . . . 0.0 111.379 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -62.69 106.5 0.8 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -102.52 133.12 48.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.27 0.557 . . . . 0.0 111.283 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.514 ' HZ3' ' HE2' ' A' ' 46' ' ' PHE . 10.6 m95 -77.59 141.97 39.22 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.243 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -77.3 154.43 32.9 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.1 p -57.21 -35.29 48.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.503 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -60.23 -53.92 51.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.682 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.613 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 37.7 mt-10 -59.44 -42.4 91.83 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.689 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.5 m -65.59 -34.87 79.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.145 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.423 ' CD ' ' HZ1' ' A' ' 26' ' ' LYS . 26.0 mm-40 -69.52 -33.14 72.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.906 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.613 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 44.6 m0 -61.82 -42.8 99.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.653 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.613 HG11 HG22 ' A' ' 54' ' ' ILE . 2.5 m -62.3 -38.16 80.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.597 ' N ' HG22 ' A' ' 25' ' ' VAL . 20.8 ttmt -63.76 -48.96 74.86 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.276 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.32 -40.78 90.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.721 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.05 -38.05 94.91 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.659 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.556 HG21 ' O ' ' A' ' 25' ' ' VAL . 54.8 t -63.16 -36.15 74.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.958 0.408 . . . . 0.0 110.752 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -78.84 -43.92 24.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.225 0.536 . . . . 0.0 111.102 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.576 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 88.1 tttt -74.09 -45.68 47.62 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.576 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -96.61 -49.04 5.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.275 0.56 . . . . 0.0 111.053 -178.206 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.07 134.58 4.4 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.166 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -55.15 106.69 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.168 0.509 . . . . 0.0 110.658 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.39 -37.9 1.51 Allowed Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.673 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.496 ' O ' HG13 ' A' ' 40' ' ' ILE . 73.0 m-80 -78.88 54.58 1.58 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.042 0.448 . . . . 0.0 111.386 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.436 ' NE1' ' HG3' ' A' ' 55' ' ' LYS . 36.0 m95 -65.31 -37.08 86.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.279 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.44 -42.1 96.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.163 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.466 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -67.62 -37.04 81.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.022 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 36' ' ' ASN . 74.4 mt -66.96 -45.81 86.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.66 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.465 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 4.1 p -65.4 -34.67 78.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.135 0.493 . . . . 0.0 111.154 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.52 -43.28 81.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.087 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -88.03 -44.64 10.83 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.449 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 55.6 m-85 -76.05 146.72 79.23 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 121.108 0.48 . . . . 0.0 111.627 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.32 46.3 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.08 3.187 . . . . 0.0 115.47 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.514 ' HE2' ' HZ3' ' A' ' 17' ' ' TRP . 75.6 m-85 -71.47 134.63 46.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.564 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.449 ' C ' ' H ' ' A' ' 49' ' ' ARG . 3.5 p -123.05 132.3 71.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 75.9 m-20 73.91 -39.87 0.44 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.567 0.747 . . . . 0.0 110.709 -177.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.484 ' HD3' ' OE2' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -67.31 138.39 56.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.266 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.7 p -102.77 177.45 4.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.628 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.02 -39.56 90.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.713 0.292 . . . . 0.0 110.415 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.9 t -63.49 -37.21 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.417 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 18.7 mmt -62.4 -42.31 99.33 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.613 HG22 HG11 ' A' ' 25' ' ' VAL . 82.4 mt -65.6 -44.49 93.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.012 0.434 . . . . 0.0 109.864 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' HG3' ' NE1' ' A' ' 37' ' ' TRP . 25.8 ttpp -56.47 -49.51 74.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.655 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 37.7 t70 -67.59 -39.4 84.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.838 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 13.0 tpp180 -59.84 -37.74 80.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.204 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.528 ' CD1' ' HD2' ' A' ' 62' ' ' LYS . 8.5 t-105 -60.61 -42.88 97.71 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 56' ' ' ASP . 98.5 mtt180 -53.54 -49.95 66.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.021 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.549 ' O ' HD23 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -62.71 -45.16 94.02 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.8 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.4 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 91.0 mmm -56.79 -44.95 82.39 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.038 0.447 . . . . 0.0 110.783 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.528 ' HD2' ' CD1' ' A' ' 58' ' ' TRP . 46.9 mtpt -65.86 -29.67 70.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.946 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 60' ' ' THR . 57.7 ttm-85 -55.24 -58.04 9.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.15 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.549 HD23 ' O ' ' A' ' 60' ' ' THR . 0.2 OUTLIER -65.05 -51.33 62.12 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.286 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.65 31.34 0.41 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.609 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.9 mtt -91.82 50.38 1.68 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.134 0.493 . . . . 0.0 109.756 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 . . . . . 0 C--O 1.249 1.071 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.646 -179.115 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.832 0 N-CA-C 112.375 -0.29 . . . . 0.0 112.375 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 t -69.3 144.64 53.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -144.22 126.06 15.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.91 0.386 . . . . 0.0 110.59 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.444 ' HE1' ' HB3' ' A' ' 4' ' ' MET . 23.5 ptp -87.85 144.92 26.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.238 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.401 ' HB2' ' HZ1' ' A' ' 16' ' ' LYS . 73.9 tt0 -82.94 149.77 26.84 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.922 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -51.35 125.62 14.76 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.525 0.516 . . . . 0.0 109.715 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.454 ' HB2' HG12 ' A' ' 11' ' ' ILE . 27.5 t -159.89 138.07 10.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.163 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 p -69.81 -37.63 76.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.483 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.3 m -148.34 -52.47 0.18 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.843 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -167.3 120.44 0.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.813 0.816 . . . . 0.0 112.045 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.454 HG12 ' HB2' ' A' ' 7' ' ' SER . 50.4 mm -100.29 147.18 7.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.422 ' N ' HG21 ' A' ' 11' ' ' ILE . 1.3 m -70.31 53.97 0.14 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.6 pttt 178.44 49.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.095 0.958 . . . . 0.0 108.536 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 32.6 mtmm -69.09 131.95 45.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.394 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 70.16 138.27 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.765 0.826 . . . . 0.0 112.775 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.401 ' HZ1' ' HB2' ' A' ' 5' ' ' GLU . 41.6 mmtm -83.72 151.1 25.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.304 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.558 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 16.8 m95 -109.64 142.49 40.7 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.563 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.5 p -82.53 160.88 22.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.346 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.73 -40.71 80.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.426 0.155 . . . . 0.0 111.152 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -61.94 -47.29 85.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.691 0.281 . . . . 0.0 111.585 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.514 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 49.8 mt-10 -63.66 -36.23 83.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.333 0.587 . . . . 0.0 110.695 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.435 ' HB3' ' SD ' ' A' ' 61' ' ' MET . 40.2 m -67.58 -36.03 80.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.02 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.65 -35.3 80.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.833 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.514 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 44.6 m0 -62.18 -46.73 87.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.379 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.567 HG21 ' N ' ' A' ' 26' ' ' LYS . 3.3 m -60.75 -37.46 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.873 0.368 . . . . 0.0 110.815 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.567 ' N ' HG21 ' A' ' 25' ' ' VAL . 19.2 ttmt -66.17 -46.12 78.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.771 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.2 -38.57 75.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.039 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.07 -36.18 80.34 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.625 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 25' ' ' VAL . 97.5 t -62.28 -36.38 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.518 0.675 . . . . 0.0 110.074 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -81.18 -49.08 11.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.395 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.53 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 84.5 tttt -69.11 -42.49 76.02 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.917 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.53 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -102.74 -55.7 2.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.338 0.59 . . . . 0.0 110.973 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.89 138.23 3.96 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.228 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -57.04 117.81 4.37 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.26 -32.1 4.65 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.019 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.48 ' O ' HG13 ' A' ' 40' ' ' ILE . 71.4 m-80 -81.62 48.19 1.16 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.896 0.379 . . . . 0.0 111.345 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 36.9 m95 -62.85 -37.91 88.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.832 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.17 -48.93 78.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 0.0 110.528 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.27 98.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.689 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 36' ' ' ASN . 79.1 mt -60.72 -45.54 97.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.593 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.463 ' HB2' HD12 ' A' ' 54' ' ' ILE . 23.1 t -64.69 -35.02 79.7 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.096 0.474 . . . . 0.0 110.924 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -67.65 -47.45 69.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.754 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -82.31 -49.45 10.04 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.472 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 56.4 m-85 -70.23 143.31 90.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.095 0.474 . . . . 0.0 111.374 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.507 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 39.4 Cg_endo -67.6 48.27 0.35 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.922 3.081 . . . . 0.0 115.204 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.558 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 67.8 m-85 -72.48 133.47 44.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.761 0.315 . . . . 0.0 110.283 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.58 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 5.9 p -110.48 121.11 62.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.84 -30.92 0.14 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.6 1.16 . . . . 0.0 112.293 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.58 ' HD2' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -61.71 118.0 6.56 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.964 0.411 . . . . 0.0 110.9 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.2 p -81.02 167.39 19.84 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.703 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.56 85.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.9 t -63.23 -36.96 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.43 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 61.1 mmm -64.17 -41.33 97.16 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 41' ' ' SER . 85.1 mt -65.36 -45.01 94.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.814 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.55 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 38.8 ttpt -56.7 -49.61 74.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.337 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -63.47 -44.88 93.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.523 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.542 ' O ' ' HG2' ' A' ' 61' ' ' MET . 30.9 tpt180 -60.55 -38.59 84.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.144 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.66 ' CE2' ' HE2' ' A' ' 62' ' ' LYS . 15.4 t-105 -58.8 -43.17 90.48 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.635 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.698 ' HA ' ' HE3' ' A' ' 62' ' ' LYS . 1.6 mpt_? -60.04 -49.17 78.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.758 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.483 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 2.9 p -61.79 -35.71 78.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.796 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 89.8 mmm -57.02 -40.49 76.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.217 0.532 . . . . 0.0 109.991 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.698 ' HE3' ' HA ' ' A' ' 59' ' ' ARG . 49.0 mttt -64.45 -44.36 91.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.787 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 50.7 ttt85 -59.22 -41.6 89.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.654 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 60' ' ' THR . 69.2 mt -72.71 -5.97 41.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.39 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.06 45.58 19.66 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.464 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.532 ' HE3' ' HE2' ' A' ' 61' ' ' MET . 70.0 mtm -132.45 56.54 1.83 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.306 0.574 . . . . 0.0 109.571 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.586 -179.352 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.729 ' HA3' ' HE3' ' A' ' 4' ' ' MET . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 112.162 -0.375 . . . . 0.0 112.162 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.6 m -81.95 131.65 35.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.644 0.259 . . . . 0.0 111.287 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.5 m170 57.8 44.51 20.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.79 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.729 ' HE3' ' HA3' ' A' ' 1' ' ' GLY . 14.1 mmt -70.49 125.87 28.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.119 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 65.14 104.82 0.04 OUTLIER 'General case' 0 C--O 1.235 0.305 0 O-C-N 124.23 0.956 . . . . 0.0 110.317 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -60.05 126.24 26.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.1 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.464 ' HB3' ' ND2' ' A' ' 10' ' ' ASN . 66.4 m 57.76 54.23 6.42 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.6 m -44.29 -47.85 9.49 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.703 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.7 p -133.97 116.87 16.07 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.228 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.464 ' ND2' ' HB3' ' A' ' 7' ' ' SER . 0.5 OUTLIER -179.25 164.95 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.058 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 27.6 pt -71.01 27.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -176.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.3 p -85.54 -49.85 7.71 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.551 -0.718 . . . . 0.0 110.276 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.749 ' HD3' ' H ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -99.78 -21.71 15.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.732 -179.029 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.759 ' HE3' HG21 ' A' ' 60' ' ' THR . 0.7 OUTLIER -170.39 164.12 8.68 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -57.84 147.25 29.03 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.5 0.5 . . . . 0.0 110.445 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -75.83 128.45 35.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.395 0.617 . . . . 0.0 110.015 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.443 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 10.4 m95 -100.62 138.86 37.12 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.67 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.9 p -78.66 147.74 33.44 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.428 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 11.5 p -53.71 -35.58 27.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.61 0.243 . . . . 0.0 110.969 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.416 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 39.8 tt0 -59.71 -53.46 57.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.362 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.565 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 45.5 mt-10 -61.09 -39.45 89.99 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.439 0.638 . . . . 0.0 111.015 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.4 m -66.09 -33.36 75.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.613 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 58.7 mm-40 -68.29 -30.91 70.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.777 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.565 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 43.1 m0 -64.27 -42.99 96.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.736 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.594 HG23 ' N ' ' A' ' 26' ' ' LYS . 2.0 m -60.81 -38.16 78.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.094 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.594 ' N ' HG23 ' A' ' 25' ' ' VAL . 15.0 ttpp -65.7 -50.4 65.02 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.469 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.52 -41.84 98.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.741 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.47 -37.86 94.83 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.471 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 25' ' ' VAL . 47.5 t -64.9 -43.16 96.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.08 0.467 . . . . 0.0 110.337 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -71.38 -42.28 68.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.207 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.459 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 63.7 tttp -76.72 -48.52 18.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.459 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -94.76 -55.87 2.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.599 0.714 . . . . 0.0 110.975 -178.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.19 132.0 3.45 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -58.48 118.46 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.546 0.688 . . . . 0.0 110.554 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.45 -37.5 1.87 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.424 ' O ' HG13 ' A' ' 40' ' ' ILE . 62.2 m-80 -83.49 50.77 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.039 0.447 . . . . 0.0 110.228 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -62.2 -41.45 98.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.908 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.78 -45.41 89.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.871 0.367 . . . . 0.0 110.332 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.27 93.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.485 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.486 HG22 ' CD1' ' A' ' 44' ' ' TYR . 82.0 mt -62.55 -46.55 96.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.4 t -60.71 -36.66 79.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.199 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -69.11 -51.16 41.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.69 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -74.54 -43.73 54.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.722 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.486 ' CD1' HG22 ' A' ' 40' ' ' ILE . 47.4 m-85 -77.49 146.91 74.48 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 120.983 0.42 . . . . 0.0 110.928 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 36.8 Cg_endo -66.31 43.02 0.18 Allowed 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.774 2.982 . . . . 0.0 115.304 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.443 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 77.0 m-85 -74.05 128.36 35.31 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.941 -0.474 . . . . 0.0 110.12 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.406 ' C ' ' H ' ' A' ' 49' ' ' ARG . 7.7 p -115.59 129.2 72.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.0 m120 71.33 -40.67 0.48 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.19 0.596 . . . . 0.0 111.924 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.469 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 2.0 mpt_? -60.74 127.16 30.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.682 0.277 . . . . 0.0 110.612 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.479 ' OG1' ' HG3' ' A' ' 53' ' ' MET . 67.5 p -89.55 169.03 11.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.333 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.7 -37.33 83.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.805 0.336 . . . . 0.0 110.263 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.23 -38.41 82.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.829 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.479 ' HG3' ' OG1' ' A' ' 50' ' ' THR . 68.1 mtt -62.3 -42.1 99.07 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.576 HG23 HG13 ' A' ' 25' ' ' VAL . 70.2 mt -67.22 -44.36 87.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.868 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -55.56 -49.98 71.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.007 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.64 -37.0 79.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.388 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 53' ' ' MET . 15.0 tpt85 -61.28 -39.73 91.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.343 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.407 ' CD2' HG22 ' A' ' 29' ' ' VAL . 36.7 t-105 -67.49 -43.7 80.3 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 81.3 mtt-85 -59.39 -42.75 92.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.383 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.759 HG21 ' HE3' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -61.44 -38.98 89.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.794 178.712 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.457 ' HB3' ' HE1' ' A' ' 61' ' ' MET . 84.2 mtp -62.42 -41.86 99.01 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.033 0.444 . . . . 0.0 109.897 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 59' ' ' ARG . 6.1 mtpm? -65.92 -40.67 91.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.076 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -60.97 -45.99 92.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.536 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 60' ' ' THR . 71.4 mt -72.7 -37.02 67.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.513 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.45 39.23 2.45 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.139 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 63.9 mtt -100.89 38.09 1.61 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.89 0.376 . . . . 0.0 110.671 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.1 p30 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.063 -179.562 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 111.893 -0.483 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 p -141.71 29.19 1.74 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.932 0.366 . . . . 0.0 111.829 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -91.61 -38.76 12.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.379 0.609 . . . . 0.0 109.77 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 88.8 mmm -142.37 -125.77 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.765 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -161.21 144.81 13.0 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -63.54 -47.26 82.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.244 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 p -171.72 -53.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.702 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.498 HG23 HG21 ' A' ' 11' ' ' ILE . 1.9 m 64.25 -77.1 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.666 0.786 . . . . 0.0 111.25 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.7 p 61.04 -40.41 0.11 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -62.27 -17.47 58.59 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.498 HG21 HG23 ' A' ' 8' ' ' THR . 22.6 pt -79.61 2.47 2.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.224 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -92.29 -40.85 10.71 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.494 0.664 . . . . 0.0 109.682 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -88.44 133.63 34.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.934 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -156.12 31.77 0.34 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.932 0.872 . . . . 0.0 109.026 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.453 ' O ' ' HD1' ' A' ' 17' ' ' TRP . 1.9 pm0 -159.09 43.77 0.25 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.543 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 16' ' ' LYS . 43.7 mtpt -66.5 136.79 56.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.471 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.453 ' HD1' ' O ' ' A' ' 15' ' ' GLN . 11.2 m95 -125.16 136.55 53.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.248 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.479 ' HG1' ' CD ' ' A' ' 21' ' ' GLU . 77.7 p -77.83 154.22 32.03 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.439 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 13.8 p -57.51 -38.46 63.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.265 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.513 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 87.2 tt0 -64.07 -48.05 77.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.793 0.33 . . . . 0.0 111.076 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.532 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 68.0 mt-10 -59.59 -37.35 78.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.344 0.592 . . . . 0.0 111.58 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 25' ' ' VAL . 14.3 m -67.86 -32.03 72.25 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.997 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 5.7 mm-40 -65.68 -38.29 88.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.4 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.532 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 35.3 m0 -61.4 -43.68 98.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.837 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.545 HG12 HG22 ' A' ' 54' ' ' ILE . 3.8 m -62.59 -36.45 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.168 0.508 . . . . 0.0 110.248 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.535 ' N ' HG22 ' A' ' 25' ' ' VAL . 16.9 ttpt -66.93 -49.32 65.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.753 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.63 -39.91 76.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.299 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.72 -41.21 98.93 Favored Glycine 0 C--O 1.224 -0.476 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.999 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 25' ' ' VAL . 54.8 t -64.72 -41.79 93.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 117.237 0.518 . . . . 0.0 110.72 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -70.82 -36.72 73.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.323 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.599 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 5.1 ttmp? -84.77 -52.08 6.31 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.599 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -84.77 -54.17 4.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.28 0.562 . . . . 0.0 111.221 -177.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.56 130.75 3.33 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -55.56 125.57 21.58 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.958 0.409 . . . . 0.0 110.852 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.49 -35.13 3.41 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.459 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.4 m-80 -82.97 52.81 2.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.986 0.422 . . . . 0.0 110.532 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.486 ' CE3' HG23 ' A' ' 54' ' ' ILE . 40.8 m95 -61.18 -40.26 93.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.636 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.6 97.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.965 0.412 . . . . 0.0 110.384 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.82 -38.14 82.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.097 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 36' ' ' ASN . 78.5 mt -67.45 -47.31 81.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.531 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.516 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 5.7 p -63.52 -37.18 86.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.519 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -62.99 -48.42 78.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.515 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -80.41 -50.31 10.28 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.423 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 55.7 m-85 -69.09 146.32 97.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.01 0.433 . . . . 0.0 110.895 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.454 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 44.4 Cg_endo -68.68 46.46 0.38 Allowed 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.537 2.824 . . . . 0.0 114.799 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -69.72 126.49 29.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.1 0.476 . . . . 0.0 110.564 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.515 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 5.6 p -118.3 131.25 71.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 74.5 m-80 74.35 -43.5 0.53 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.039 0.535 . . . . 0.0 110.378 -177.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.686 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -66.45 125.67 26.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.346 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.8 p -96.15 175.58 6.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.919 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.3 -42.72 99.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.491 0.186 . . . . 0.0 110.91 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.09 -37.57 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.686 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 63.6 mtt -59.96 -42.42 94.04 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.545 HG22 HG12 ' A' ' 25' ' ' VAL . 63.6 mt -66.99 -44.51 88.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.027 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -55.7 -47.5 76.71 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.171 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -69.79 -41.95 74.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.99 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.48 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 12.1 tpp180 -60.18 -39.15 85.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.267 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.419 ' HA ' ' CE3' ' A' ' 58' ' ' TRP . 16.7 t-105 -61.74 -45.3 94.51 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.345 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.9 mtt85 -58.5 -44.47 89.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.377 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.493 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 24.5 p -66.51 -41.46 88.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.735 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.505 ' SD ' ' HE2' ' A' ' 66' ' ' MET . 79.3 mmm -57.33 -42.69 82.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.122 0.487 . . . . 0.0 110.241 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.519 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 52.6 mtpt -66.73 -45.1 79.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.867 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -62.3 -42.51 99.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.839 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 60' ' ' THR . 80.2 mt -72.77 -18.77 61.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.115 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.53 52.14 4.59 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.194 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.505 ' HE2' ' SD ' ' A' ' 61' ' ' MET . 66.4 mtm -128.94 46.81 2.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.201 0.524 . . . . 0.0 110.299 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.519 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 14.1 p-10 . . . . . 0 C--O 1.247 0.973 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.177 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.878 0 N-CA-C 112.115 -0.394 . . . . 0.0 112.115 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.8 t -166.33 133.46 2.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -90.69 51.68 2.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.124 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.7 mmt 58.33 54.61 5.54 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.234 0.54 . . . . 0.0 110.739 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -53.27 141.1 24.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.588 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -87.35 53.4 2.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.907 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.2 m -86.19 127.63 34.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.417 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.34 -31.56 10.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.694 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.1 m -61.89 116.31 4.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.655 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.416 ' C ' HG13 ' A' ' 11' ' ' ILE . 29.1 t30 61.31 117.12 0.02 OUTLIER 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.188 -0.914 . . . . 0.0 113.266 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.416 HG13 ' C ' ' A' ' 10' ' ' ASN . 17.5 mt -144.9 41.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.8 m -89.35 -47.01 8.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.948 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 16.6 pttp -66.77 -29.46 69.43 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER 53.27 -160.75 0.12 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.97 0.908 . . . . 0.0 110.638 -178.053 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -74.84 114.71 13.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.173 0.511 . . . . 0.0 110.315 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.469 ' HZ2' ' HB2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -92.72 135.23 34.28 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.192 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -119.54 130.01 54.96 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.75 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.2 p -80.38 151.12 29.57 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.481 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 7.2 p -55.44 -39.16 51.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.64 0.257 . . . . 0.0 110.734 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.536 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 84.6 tt0 -62.13 -46.6 88.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.911 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.541 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 53.6 mt-10 -62.53 -38.89 91.74 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.236 0.541 . . . . 0.0 110.676 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.3 t -64.58 -34.51 78.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.302 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 49.7 mm-40 -66.87 -37.59 84.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.707 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.545 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 40.0 m0 -62.46 -44.68 95.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.509 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.61 HG13 HG22 ' A' ' 54' ' ' ILE . 3.3 m -62.0 -35.77 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.143 0.497 . . . . 0.0 109.988 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.56 ' N ' HG23 ' A' ' 25' ' ' VAL . 18.0 ttpt -69.7 -47.7 62.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.759 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.32 -42.9 78.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.766 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.94 -33.02 67.41 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 116.191 -0.458 . . . . 0.0 113.133 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 25' ' ' VAL . 78.4 t -66.41 -36.91 78.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.174 0.511 . . . . 0.0 110.658 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -79.35 -44.68 21.08 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.188 0.518 . . . . 0.0 110.933 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -73.85 -46.33 45.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.491 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -98.02 -57.45 2.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.467 0.651 . . . . 0.0 110.888 -179.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 29' ' ' VAL . . . 126.53 133.31 3.83 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -59.12 138.71 57.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.327 0.585 . . . . 0.0 110.438 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.18 -37.29 3.55 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -84.95 46.49 1.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.154 0.502 . . . . 0.0 110.546 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.449 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 41.5 m95 -61.17 -36.51 80.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.786 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.46 92.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 0.0 110.223 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.09 84.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.661 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 40' ' ' ILE . 61.6 mt -61.77 -47.54 92.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.509 ' HB2' HD12 ' A' ' 54' ' ' ILE . 44.2 t -63.47 -36.27 83.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.973 0.416 . . . . 0.0 110.468 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -63.4 -47.53 81.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.658 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -82.93 -52.33 6.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.396 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -68.45 140.19 92.36 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.066 0.46 . . . . 0.0 110.986 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.545 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 32.5 Cg_endo -64.87 47.17 0.16 Allowed 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.155 3.237 . . . . 0.0 115.395 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -74.16 134.9 42.83 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.965 -0.46 . . . . 0.0 110.223 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 7.3 p -124.36 125.23 70.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 75.4 m-20 76.5 -33.91 0.22 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.276 0.63 . . . . 0.0 111.146 -178.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.509 ' N ' ' HD2' ' A' ' 49' ' ' ARG . 7.7 mpt_? -76.03 112.94 12.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.714 0.292 . . . . 0.0 110.518 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.6 p -82.19 173.52 12.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.635 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.11 82.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.938 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 t -64.23 -39.44 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.3 mmt -61.52 -42.96 99.6 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.61 HG22 HG13 ' A' ' 25' ' ' VAL . 72.0 mt -66.47 -45.48 88.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.428 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 39.0 ttpt -56.03 -50.87 69.72 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.531 0.681 . . . . 0.0 109.853 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.27 -40.42 93.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.429 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -60.75 -42.23 97.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.433 ' CE2' HG22 ' A' ' 29' ' ' VAL . 23.4 t-105 -61.18 -43.01 99.56 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.645 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 40.5 ttp180 -56.26 -45.31 80.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.038 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.622 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -64.2 -39.31 93.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 178.707 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 98.0 mmm -59.31 -39.52 83.32 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.098 0.475 . . . . 0.0 110.273 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.645 ' HD3' ' HA ' ' A' ' 59' ' ' ARG . 5.9 mtpm? -64.35 -39.22 93.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.975 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -68.43 -42.41 78.95 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.956 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 60' ' ' THR . 83.0 mt -64.77 -28.85 69.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.447 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.53 29.79 42.74 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 82.5 mtp -107.51 51.18 0.75 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.248 -0.476 . . . . 0.0 110.008 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.9 p30 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.241 -179.312 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 112.111 -0.395 . . . . 0.0 112.111 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -64.58 125.72 25.59 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.907 0.384 . . . . 0.0 110.708 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 59.4 37.88 23.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.482 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.488 ' HE1' HG22 ' A' ' 8' ' ' THR . 10.2 tpt -171.8 32.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.233 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -85.4 61.26 6.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.35 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -160.04 151.88 20.2 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.0 m -55.77 131.89 47.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.029 0.443 . . . . 0.0 111.592 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.488 HG22 ' HE1' ' A' ' 4' ' ' MET . 11.5 p -75.68 -34.15 60.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.819 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.423 HG23 ' HE3' ' A' ' 53' ' ' MET . 5.0 m -68.91 123.96 22.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.402 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.646 ' HA ' ' HB3' ' A' ' 13' ' ' LYS . 47.1 t30 63.18 -154.69 0.33 Allowed 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.612 0.57 . . . . 0.0 109.989 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.441 ' H ' ' CG ' ' A' ' 10' ' ' ASN . 46.8 mt 49.25 70.25 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.998 0.428 . . . . 0.0 110.662 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m 68.31 45.4 1.21 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.646 ' HB3' ' HA ' ' A' ' 10' ' ' ASN . 15.5 ptmt -61.82 -52.38 64.42 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.765 -1.561 . . . . 0.0 112.954 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.3 tptp 53.94 44.31 29.59 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 122.002 0.906 . . . . 0.0 108.674 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 13' ' ' LYS . 72.9 mt-30 -116.41 61.74 0.72 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.408 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -65.94 153.42 42.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.269 0.557 . . . . 0.0 110.651 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.531 ' CE3' ' HG2' ' A' ' 57' ' ' ARG . 11.7 m95 -98.24 136.92 37.74 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.873 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 51.1 p -82.13 157.04 24.2 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.596 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.622 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 8.0 p -60.24 -38.66 78.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.78 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.22 -49.33 78.27 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.711 0.291 . . . . 0.0 110.803 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.589 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 48.1 mt-10 -59.43 -41.66 90.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.336 0.589 . . . . 0.0 111.502 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.546 ' O ' HG23 ' A' ' 25' ' ' VAL . 14.8 m -66.61 -29.63 69.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.555 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 70.9 mm-40 -68.4 -36.72 79.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.589 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 33.2 m0 -63.61 -41.51 98.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.377 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.565 HG13 HG22 ' A' ' 54' ' ' ILE . 4.3 m -61.44 -37.61 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.386 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 66' ' ' MET . 36.0 mtmt -65.54 -50.85 63.66 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.95 0.405 . . . . 0.0 110.725 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.0 98.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.73 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.52 -41.81 99.76 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.001 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 25' ' ' VAL . 67.9 t -65.94 -38.43 82.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.322 0.582 . . . . 0.0 109.762 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -68.99 -47.39 65.67 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.088 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -83.49 -46.53 12.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.498 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -88.01 -54.9 3.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.547 0.689 . . . . 0.0 110.647 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.39 133.57 4.17 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.669 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -52.58 146.67 9.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.047 0.451 . . . . 0.0 111.259 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.11 -37.05 3.73 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.636 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.421 ' O ' HG13 ' A' ' 40' ' ' ILE . 67.1 m-80 -82.62 48.59 1.33 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.019 0.438 . . . . 0.0 110.407 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -60.15 -40.47 89.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.73 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.405 ' HA ' ' HB3' ' A' ' 51' ' ' ALA . . . -61.35 -34.65 75.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.164 0.507 . . . . 0.0 111.158 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.71 -34.65 64.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.296 0.569 . . . . 0.0 110.187 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.453 HG23 ' CD1' ' A' ' 44' ' ' TYR . 75.4 mt -70.61 -46.72 68.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.022 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.444 ' HB3' HD12 ' A' ' 54' ' ' ILE . 12.5 p -61.55 -38.16 86.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.881 0.372 . . . . 0.0 111.374 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -63.41 -45.84 89.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.413 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -85.38 -45.36 11.96 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.453 ' CD1' HG23 ' A' ' 40' ' ' ILE . 56.1 m-85 -73.56 150.1 88.83 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 121.033 0.444 . . . . 0.0 111.463 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.426 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 48.2 Cg_endo -68.99 44.1 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.675 2.917 . . . . 0.0 114.707 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.467 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 69.3 m-85 -73.14 107.35 5.42 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.508 ' C ' ' H ' ' A' ' 49' ' ' ARG . 2.9 p -86.53 119.56 34.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.984 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 65.4 -25.37 0.09 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.442 1.097 . . . . 0.0 112.801 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.508 ' H ' ' C ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -64.91 121.07 13.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 111.025 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.8 p -78.62 171.32 15.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.07 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . . . -63.79 -38.6 91.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.773 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.93 -37.16 77.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.438 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.423 ' HE3' HG23 ' A' ' 9' ' ' THR . 19.9 mmt -59.86 -45.33 92.78 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.565 HG22 HG13 ' A' ' 25' ' ' VAL . 64.7 mt -65.36 -43.96 94.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.089 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -55.63 -49.59 72.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.83 0.824 . . . . 0.0 110.059 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -67.28 -42.35 83.97 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.81 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.531 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 10.0 tpp180 -59.75 -42.74 93.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.864 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.507 ' HE3' HG22 ' A' ' 25' ' ' VAL . 26.2 t-105 -56.86 -44.11 81.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.114 0.483 . . . . 0.0 109.736 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -55.87 -45.8 78.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.424 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.496 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -63.33 -43.13 98.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.399 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.441 ' SD ' ' HB3' ' A' ' 22' ' ' SER . 90.0 mmm -57.51 -40.76 79.43 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.236 0.541 . . . . 0.0 109.891 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.513 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 6.9 mtpm? -66.66 -40.19 88.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.586 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -62.39 -40.98 98.23 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 121.384 0.611 . . . . 0.0 109.567 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 60' ' ' THR . 77.2 mt -71.66 -19.92 62.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.184 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.09 33.86 56.36 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.499 ' O ' ' HD3' ' A' ' 26' ' ' LYS . 93.3 mmm -107.41 44.99 1.02 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.911 0.386 . . . . 0.0 110.946 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.513 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 9.3 p-10 . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.683 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -84.72 135.13 34.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.856 0.36 . . . . 0.0 110.91 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.522 ' HB3' ' H ' ' A' ' 4' ' ' MET . 3.7 m-70 -92.37 -140.89 0.2 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.236 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.522 ' H ' ' HB3' ' A' ' 3' ' ' HIS . 86.6 mtp 53.08 35.67 20.25 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.368 0.604 . . . . 0.0 110.03 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -84.38 142.89 29.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.136 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 8' ' ' THR . 6.9 p-10 -63.36 -26.74 68.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.192 0.52 . . . . 0.0 110.16 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.54 ' OG ' ' HA ' ' A' ' 12' ' ' THR . 8.1 t -78.05 39.85 0.32 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.695 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 6' ' ' ASP . 13.6 t -84.99 -19.82 31.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.494 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.8 p -81.75 -152.85 0.1 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.109 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -90.02 -2.29 58.11 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.782 -0.574 . . . . 0.0 110.52 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.8 mt -83.11 45.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.92 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.54 ' HA ' ' OG ' ' A' ' 7' ' ' SER . 20.5 p -75.07 -22.16 58.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.431 0.634 . . . . 0.0 110.206 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -65.48 146.24 55.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.701 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.585 ' HB2' ' OE1' ' A' ' 15' ' ' GLN . 22.7 pttm -129.2 -158.7 0.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.02 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.585 ' OE1' ' HB2' ' A' ' 14' ' ' LYS . 6.1 pm0 -64.73 -28.76 69.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.557 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -71.55 138.23 48.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.483 ' HZ2' ' HB3' ' A' ' 53' ' ' MET . 10.6 m95 -110.19 145.25 37.58 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.287 0.565 . . . . 0.0 112.424 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.51 ' HG1' ' CD ' ' A' ' 21' ' ' GLU . 70.1 p -88.42 151.89 22.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.99 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.4 p -55.95 -37.24 47.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.837 -0.165 . . . . 0.0 111.377 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.484 ' HG3' ' CZ2' ' A' ' 24' ' ' TRP . 36.3 tp10 -59.32 -51.78 68.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.809 0.338 . . . . 0.0 110.777 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.51 ' CD ' ' HG1' ' A' ' 18' ' ' THR . 52.3 mt-10 -60.73 -39.36 88.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.687 0.756 . . . . 0.0 110.862 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 25' ' ' VAL . 13.2 m -67.96 -34.02 75.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.259 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.71 -36.19 82.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.19 0.519 . . . . 0.0 110.337 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.484 ' CZ2' ' HG3' ' A' ' 20' ' ' GLU . 32.5 m0 -65.75 -43.98 87.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.518 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.55 HG22 ' N ' ' A' ' 26' ' ' LYS . 3.0 m -58.82 -40.29 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.933 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.55 ' N ' HG22 ' A' ' 25' ' ' VAL . 22.7 ttpt -66.49 -44.85 81.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.819 0.342 . . . . 0.0 110.785 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.64 -44.31 90.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.779 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.65 96.13 Favored Glycine 0 C--O 1.224 -0.478 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.287 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 25' ' ' VAL . 22.8 t -60.08 -41.32 86.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.133 0.492 . . . . 0.0 110.965 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -74.48 -40.31 61.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.771 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.508 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 62.8 tttm -80.67 -46.13 16.07 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.508 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -91.73 -37.66 12.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.084 0.469 . . . . 0.0 111.35 -177.531 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.88 134.72 8.29 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -48.95 130.37 18.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.949 0.404 . . . . 0.0 111.47 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.18 -39.06 2.83 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.194 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.541 ' O ' HG13 ' A' ' 40' ' ' ILE . 66.6 m-80 -81.17 52.08 1.73 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.983 0.42 . . . . 0.0 110.932 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.431 ' NE1' ' HG3' ' A' ' 55' ' ' LYS . 33.8 m95 -63.7 -45.11 91.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.703 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.28 -44.03 79.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.808 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.15 -37.44 87.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.645 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 36' ' ' ASN . 82.8 mt -67.4 -48.19 78.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.356 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.875 ' HB3' HD11 ' A' ' 54' ' ' ILE . 6.4 p -61.47 -35.03 76.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.819 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -71.15 -52.27 20.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.003 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -75.09 -44.94 44.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.473 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 30.1 m-85 -71.65 154.44 93.09 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.116 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.89 38.0 0.15 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.147 2.565 . . . . 0.0 114.579 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 24' ' ' TRP . 78.9 m-85 -76.18 134.03 40.02 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.204 0.525 . . . . 0.0 109.832 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 4.3 p -134.25 135.26 54.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 74.9 m-80 76.5 -38.79 0.33 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.746 0.654 . . . . 0.0 110.422 -177.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.473 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 1.0 OUTLIER -69.87 128.96 38.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.416 179.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.3 p -92.14 169.7 10.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.107 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.85 -36.84 85.63 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.0 t -62.76 -36.25 74.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.483 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 17.9 mmt -64.77 -45.36 86.71 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.875 HD11 ' HB3' ' A' ' 41' ' ' SER . 78.6 mt -64.77 -44.2 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.18 0.514 . . . . 0.0 109.814 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HG3' ' NE1' ' A' ' 37' ' ' TRP . 39.5 ttmt -54.41 -50.81 66.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.323 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -70.93 -39.42 72.68 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.347 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.506 ' O ' ' HG2' ' A' ' 61' ' ' MET . 16.6 tpp180 -58.92 -35.62 73.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.714 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -59.55 -48.16 82.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.5 ttm105 -56.67 -46.93 80.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.393 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.482 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 7.5 p -63.98 -37.91 89.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.577 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 97.0 mmm -61.99 -42.03 98.69 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.56 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 5.6 mtpm? -65.19 -40.52 94.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.83 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -59.9 -44.26 94.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.146 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 60' ' ' THR . 75.5 mt -70.28 -19.57 63.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.412 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.54 31.79 26.49 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.341 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 86.7 mtp -99.17 47.03 0.97 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.878 0.37 . . . . 0.0 110.368 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.56 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 11.2 p-10 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.672 -0.68 . . . . 0.0 109.738 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 111.939 -0.465 . . . . 0.0 111.939 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -77.66 151.34 34.31 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.553 0.215 . . . . 0.0 110.691 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -63.72 146.4 53.92 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.5 mmt 67.05 -127.5 0.18 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -76.14 127.78 33.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -63.7 -34.86 78.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.913 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.2 p 53.46 47.22 24.55 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.618 0.723 . . . . 0.0 110.873 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.6 m -156.3 56.65 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.671 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.505 HG21 ' HA ' ' A' ' 48' ' ' ASN . 6.7 t -63.33 134.8 56.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.332 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.437 ' N ' HD21 ' A' ' 10' ' ' ASN . 0.0 OUTLIER -177.43 -144.75 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.95 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.4 mm -104.95 26.85 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.27 0.557 . . . . 0.0 111.575 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.6 m -81.37 -43.12 19.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.374 0.607 . . . . 0.0 109.824 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HE3' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -129.85 154.71 47.01 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.504 178.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -53.77 127.18 24.81 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.619 0.574 . . . . 0.0 110.571 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.583 ' HB3' ' HE3' ' A' ' 53' ' ' MET . 21.9 mt-30 -76.59 54.77 0.98 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.947 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -56.77 128.69 37.87 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.291 0.567 . . . . 0.0 110.956 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.533 ' HA ' ' NH2' ' A' ' 49' ' ' ARG . 15.1 m95 -87.44 138.41 31.5 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.674 0.75 . . . . 0.0 112.581 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.54 149.62 21.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.902 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.8 p -53.32 -36.76 27.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.555 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 35.8 tt0 -55.66 -60.17 3.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.737 0.303 . . . . 0.0 110.952 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.635 ' HG3' ' CZ3' ' A' ' 24' ' ' TRP . 2.7 mp0 -66.28 -30.98 71.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.193 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.487 ' O ' HG21 ' A' ' 25' ' ' VAL . 9.1 t -63.79 -39.84 95.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.761 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 21.1 mm-40 -65.28 -37.91 88.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.089 0.471 . . . . 0.0 111.08 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.635 ' CZ3' ' HG3' ' A' ' 21' ' ' GLU . 37.2 m0 -62.91 -43.1 99.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.587 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.578 ' O ' HG21 ' A' ' 29' ' ' VAL . 4.2 m -60.21 -40.2 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.906 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.541 ' N ' HG23 ' A' ' 25' ' ' VAL . 11.2 ttpp -64.74 -44.59 89.66 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.875 0.369 . . . . 0.0 110.934 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.07 -43.99 73.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.244 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.95 -42.47 96.82 Favored Glycine 0 C--O 1.225 -0.426 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.924 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.578 HG21 ' O ' ' A' ' 25' ' ' VAL . 98.5 t -61.45 -38.95 81.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.199 0.523 . . . . 0.0 110.499 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -70.49 -45.81 64.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.794 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -78.93 -45.89 19.53 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -177.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.412 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -88.32 -39.97 13.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.165 0.507 . . . . 0.0 111.336 -177.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.46 132.09 6.38 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -50.9 128.58 21.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.005 0.431 . . . . 0.0 111.053 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.73 -35.36 3.87 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.177 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.484 ' O ' HG13 ' A' ' 40' ' ' ILE . 77.2 m-20 -82.45 50.62 1.67 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.914 0.388 . . . . 0.0 111.292 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.42 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 35.7 m95 -60.66 -44.06 96.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.646 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 42' ' ' LYS . . . -59.5 -47.47 85.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.576 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.5 -42.99 93.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.702 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 36' ' ' ASN . 86.6 mt -60.8 -45.19 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.274 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.6 t -63.75 -38.19 90.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.154 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 73.0 mmtt -65.77 -46.14 79.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.059 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -82.65 -45.36 14.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.406 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 50.1 m-85 -76.15 147.39 79.85 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 120.925 0.393 . . . . 0.0 111.281 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.28 46.85 0.36 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.777 2.985 . . . . 0.0 114.854 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -73.59 126.07 29.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.141 0.496 . . . . 0.0 111.281 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.443 ' O ' ' HD3' ' A' ' 49' ' ' ARG . 7.4 p -118.98 132.63 68.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.505 ' HA ' HG21 ' A' ' 9' ' ' THR . 75.8 m-20 74.49 -40.31 0.44 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.379 0.671 . . . . 0.0 110.819 -177.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.689 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 0.8 OUTLIER -73.26 118.04 15.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.76 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.441 ' OG1' ' HG3' ' A' ' 53' ' ' MET . 45.6 p -86.93 179.08 6.78 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.19 95.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.829 0.347 . . . . 0.0 110.136 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -62.29 -37.71 79.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.821 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.689 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 90.4 mtp -61.9 -43.36 99.0 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.561 HG23 HG11 ' A' ' 25' ' ' VAL . 75.8 mt -65.06 -44.32 95.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 37.9 ttpt -57.47 -48.24 79.71 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.715 0.769 . . . . 0.0 109.793 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.17 -37.77 84.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.007 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.437 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 26.7 tpt180 -59.63 -44.85 93.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.842 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -58.86 -45.04 91.07 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.636 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 51.4 ttm-85 -59.23 -42.74 91.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.376 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.54 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 1.2 p -68.07 -37.21 81.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.271 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.413 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 90.4 mmm -58.76 -44.31 90.55 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.096 0.475 . . . . 0.0 110.176 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -64.23 -41.76 96.85 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.93 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -62.98 -47.9 81.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.293 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 60' ' ' THR . 66.2 mt -68.08 -26.39 65.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.887 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.51 39.38 6.32 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.7 mmt -124.28 7.12 8.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.107 0.48 . . . . 0.0 110.554 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.346 179.533 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.1 p -171.43 -41.27 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.962 0.411 . . . . 0.0 110.68 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -96.75 44.18 1.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.393 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.594 ' HE3' HD22 ' A' ' 10' ' ' ASN . 16.5 ttt -174.8 -50.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.238 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 61.3 mp0 -73.1 58.59 0.5 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.11 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -81.68 -122.66 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 m -81.2 -44.02 18.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.02 0.438 . . . . 0.0 110.252 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.91 61.0 5.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.266 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -59.84 130.88 48.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.697 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.594 HD22 ' HE3' ' A' ' 4' ' ' MET . 6.5 p30 -112.57 -10.9 13.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.396 0.617 . . . . 0.0 110.795 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.488 HD12 HG23 ' A' ' 11' ' ' ILE . 10.2 tt -76.81 -2.16 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 121.703 0.764 . . . . 0.0 111.181 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.3 m -82.55 -44.84 15.4 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.776 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -76.32 58.38 1.28 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.672 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -63.89 149.21 47.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -73.03 39.31 0.09 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -73.55 130.68 40.58 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.586 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 41.5 m95 -67.53 126.73 30.24 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.956 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.1 p -82.71 161.56 22.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.634 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.412 ' H ' HG22 ' A' ' 19' ' ' VAL . 10.0 t -60.79 -46.31 96.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.427 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.05 -42.57 85.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.273 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.634 ' HG2' ' CZ3' ' A' ' 24' ' ' TRP . 45.8 mt-10 -70.51 -33.53 71.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.174 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.1 m -68.49 -35.5 77.6 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.233 0.539 . . . . 0.0 110.603 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 49.2 mt-10 -62.41 -37.72 86.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.83 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.634 ' CZ3' ' HG2' ' A' ' 21' ' ' GLU . 37.3 m0 -63.09 -41.96 99.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.819 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.604 HG23 ' N ' ' A' ' 26' ' ' LYS . 2.0 m -59.01 -39.12 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.493 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.604 ' N ' HG23 ' A' ' 25' ' ' VAL . 26.0 ttmt -66.21 -46.03 78.66 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.06 0.457 . . . . 0.0 110.628 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.76 -43.43 96.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.48 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.421 ' HA3' HD13 ' A' ' 40' ' ' ILE . . . -61.21 -39.17 96.81 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.119 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 25' ' ' VAL . 54.0 t -61.95 -42.11 93.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.296 0.569 . . . . 0.0 110.332 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -72.79 -44.84 61.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.105 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -81.34 -49.5 10.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.479 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -84.84 -45.82 11.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.442 0.639 . . . . 0.0 111.017 -177.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.76 131.15 4.14 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.992 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -55.34 108.57 0.43 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.065 0.459 . . . . 0.0 110.801 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.97 -35.28 1.93 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.554 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 74.3 m-80 -82.2 53.2 2.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.14 0.495 . . . . 0.0 110.501 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.454 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 41.0 m95 -60.73 -43.17 98.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.965 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.31 99.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.68 0.276 . . . . 0.0 110.295 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -61.09 -43.0 99.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.945 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 36' ' ' ASN . 82.9 mt -63.26 -46.15 96.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.032 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.55 ' HB2' HD11 ' A' ' 54' ' ' ILE . 46.6 t -63.04 -38.32 90.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.339 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -68.1 -43.87 77.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.032 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -85.16 -46.43 11.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.437 ' CD1' HG22 ' A' ' 40' ' ' ILE . 50.3 m-85 -73.24 149.49 89.26 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.98 0.419 . . . . 0.0 111.171 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.485 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 37.6 Cg_endo -68.96 45.69 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.449 2.766 . . . . 0.0 114.638 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.586 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 58.6 m-85 -72.25 131.2 42.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.152 -0.343 . . . . 0.0 110.286 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.485 ' C ' ' H ' ' A' ' 49' ' ' ARG . 4.7 p -104.62 123.57 58.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.616 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 p30 63.92 -23.88 0.07 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.641 1.176 . . . . 0.0 113.431 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.596 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 5.1 mpt_? -65.42 133.19 50.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.047 0.451 . . . . 0.0 111.737 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.3 p -98.74 176.57 5.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.88 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.3 98.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.584 0.23 . . . . 0.0 111.092 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.53 -38.19 77.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.126 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.596 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 68.7 mtt -61.69 -43.74 98.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.709 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.55 HD11 ' HB2' ' A' ' 41' ' ' SER . 62.8 mt -67.38 -42.78 87.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.224 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 40.3 ttpt -56.52 -49.12 75.67 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.541 0.686 . . . . 0.0 109.403 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -66.29 -43.17 87.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.239 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.407 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 29.8 tpt180 -58.58 -43.61 89.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.052 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.446 ' O ' ' HG3' ' A' ' 62' ' ' LYS . 15.6 t-105 -61.14 -44.77 96.81 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -56.99 -47.63 80.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.641 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.463 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -63.1 -41.52 99.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.666 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.406 ' HG3' ' O ' ' A' ' 57' ' ' ARG . 83.7 mtp -62.7 -41.69 99.26 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.515 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 56.5 mtpt -63.61 -42.05 98.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.311 0.577 . . . . 0.0 109.74 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -62.0 -50.11 73.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.796 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 60' ' ' THR . 73.0 mt -70.15 -27.73 64.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.289 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.54 36.54 5.32 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.174 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.455 ' HE2' HD11 ' A' ' 64' ' ' LEU . 66.3 mtt -99.23 41.49 1.15 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.017 0.437 . . . . 0.0 109.863 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.515 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 13.0 p-10 . . . . . 0 C--O 1.248 0.974 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.832 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -66.95 -39.14 87.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 0.0 110.789 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -136.15 139.25 42.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.348 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.0 ttt -145.78 47.69 1.25 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 62.77 -155.28 0.34 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.339 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.8 t70 56.55 -114.83 0.86 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.389 0.276 . . . . 0.0 110.401 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 t -171.22 -156.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -91.31 45.1 1.22 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.293 0.568 . . . . 0.0 111.202 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.98 70.28 4.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.04 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.84 40.19 0.11 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.401 HG23 ' HE2' ' A' ' 13' ' ' LYS . 10.9 mt -116.02 44.13 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 14' ' ' LYS . 7.5 m -70.39 -65.42 0.73 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.813 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HE2' HG23 ' A' ' 11' ' ' ILE . 62.5 mttm 68.54 -45.75 0.53 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.707 0.803 . . . . 0.0 112.353 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 12' ' ' THR . 21.7 ptmt -155.23 -158.76 0.86 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -67.18 121.5 15.77 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.078 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -103.57 133.91 47.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.614 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.529 ' HZ3' ' HE2' ' A' ' 46' ' ' PHE . 11.9 m95 -105.9 141.97 36.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.377 0.608 . . . . 0.0 112.047 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.5 p -84.36 151.2 24.86 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.352 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.42 HG11 ' N ' ' A' ' 20' ' ' GLU . 14.5 p -59.39 -29.41 42.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.355 0.597 . . . . 0.0 109.755 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.42 ' N ' HG11 ' A' ' 19' ' ' VAL . 52.3 tt0 -60.68 -52.49 64.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.375 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.558 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 94.3 mt-10 -68.76 -36.56 78.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.065 0.459 . . . . 0.0 111.018 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.42 ' O ' HG21 ' A' ' 25' ' ' VAL . 23.9 m -59.23 -39.24 82.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.501 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -67.2 -32.1 72.94 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.938 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.558 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 37.9 m0 -66.28 -40.55 90.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.274 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.56 ' O ' HG22 ' A' ' 29' ' ' VAL . 3.6 m -62.85 -36.82 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 120.847 0.356 . . . . 0.0 110.076 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.424 ' N ' HG21 ' A' ' 25' ' ' VAL . 9.8 mtpm? -66.38 -45.0 81.57 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.972 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.54 -40.89 80.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.029 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.6 -38.81 94.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.133 -0.555 . . . . 0.0 112.841 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 25' ' ' VAL . 85.1 t -62.78 -39.16 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.357 0.599 . . . . 0.0 110.103 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -72.71 -49.99 27.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.218 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.592 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 39.7 ttmt -72.17 -47.92 47.28 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.592 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -93.96 -51.8 4.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.43 0.633 . . . . 0.0 111.123 -177.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.73 136.33 4.35 Favored Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.222 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -53.06 120.74 6.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.991 0.424 . . . . 0.0 110.27 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.52 -35.05 3.87 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.943 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.479 ' O ' HG13 ' A' ' 40' ' ' ILE . 77.6 m-20 -80.1 53.75 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.008 0.432 . . . . 0.0 111.096 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.405 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 34.6 m95 -64.65 -40.7 95.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.514 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.62 -39.87 85.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.915 0.388 . . . . 0.0 110.933 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.04 -35.38 74.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.463 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 36' ' ' ASN . 89.0 mt -69.84 -45.83 75.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.616 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.86 ' HB3' HD11 ' A' ' 54' ' ' ILE . 19.8 p -64.87 -36.85 85.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.271 0.558 . . . . 0.0 110.696 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -64.75 -45.88 84.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.81 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -86.04 -50.39 7.08 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.548 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 54.8 m-85 -69.06 146.79 97.45 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.197 0.522 . . . . 0.0 111.465 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.34 41.18 0.19 Allowed 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.926 3.084 . . . . 0.0 115.406 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.529 ' HE2' ' HZ3' ' A' ' 17' ' ' TRP . 73.3 m-85 -68.65 127.33 32.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.468 ' C ' ' H ' ' A' ' 49' ' ' ARG . 4.0 p -106.04 121.57 58.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.716 0.293 . . . . 0.0 110.459 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 69.97 -29.83 0.19 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.55 0.74 . . . . 0.0 112.366 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.578 ' N ' ' HD2' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -69.18 123.08 20.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.752 0.31 . . . . 0.0 110.604 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.596 ' OG1' ' HG2' ' A' ' 53' ' ' MET . 42.1 p -86.85 174.44 8.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.799 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.02 95.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.701 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.37 -38.83 82.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.596 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 21.5 mmt -60.91 -43.37 98.65 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.86 HD11 ' HB3' ' A' ' 41' ' ' SER . 83.5 mt -65.37 -45.35 93.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.352 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 39.6 ttpt -55.96 -50.34 71.07 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.367 0.603 . . . . 0.0 109.958 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.26 -40.91 94.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.225 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.499 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 12.7 tpp180 -60.61 -41.65 95.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.554 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -57.48 -42.4 82.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.961 0.41 . . . . 0.0 110.223 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -56.28 -45.17 80.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.068 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.513 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -69.01 -39.07 79.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.54 179.094 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.497 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 90.9 mmm -56.75 -44.13 81.44 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.151 0.501 . . . . 0.0 110.123 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -62.69 -42.43 99.63 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.276 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 43.8 ttm-85 -61.35 -40.27 93.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.075 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 60' ' ' THR . 60.1 mt -73.34 -6.69 47.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.62 32.0 47.95 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.914 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 81.5 mtp -103.59 44.68 1.0 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.225 0.536 . . . . 0.0 110.215 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.0 t30 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.372 179.847 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.3 m 63.41 -164.9 0.25 Allowed 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.713 0.405 . . . . 0.0 110.545 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.1 t60 71.4 -47.98 0.67 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.231 0.612 . . . . 0.0 111.135 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.6 ttm -166.99 114.67 0.82 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.02 131.67 43.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.105 0.478 . . . . 0.0 110.912 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -166.15 -147.09 0.09 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 p -99.48 39.74 1.28 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.18 0.514 . . . . 0.0 110.149 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.5 m 60.22 44.54 12.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.387 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.91 -43.13 10.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.972 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -98.7 150.94 21.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.945 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 11' ' ' ILE . 48.1 mm 56.01 45.85 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 122.298 1.047 . . . . 0.0 109.48 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.5 p -65.87 -46.9 76.71 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.616 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt 64.13 130.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.383 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -84.58 -168.47 2.2 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.467 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -79.65 52.39 1.42 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -53.16 131.97 37.72 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.677 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.447 ' CE3' ' HB3' ' A' ' 21' ' ' GLU . 27.5 m95 -64.42 127.86 33.29 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.666 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.04 155.76 20.02 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.891 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.465 HG11 ' N ' ' A' ' 20' ' ' GLU . 10.3 p -58.32 -39.03 72.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.447 0.165 . . . . 0.0 111.138 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.465 ' N ' HG11 ' A' ' 19' ' ' VAL . 5.1 tp10 -58.65 -52.76 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.111 0.482 . . . . 0.0 110.155 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.509 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 5.6 mp0 -58.35 -39.55 79.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.33 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.0 m -67.26 -35.85 80.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.001 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 65.4 mm-40 -64.58 -36.85 85.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.327 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.509 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 44.3 m0 -63.32 -46.38 86.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.419 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.561 HG23 ' N ' ' A' ' 26' ' ' LYS . 3.5 m -61.17 -35.68 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.312 0.577 . . . . 0.0 109.983 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.561 ' N ' HG23 ' A' ' 25' ' ' VAL . 19.3 ttpt -65.59 -49.3 69.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.029 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.81 -41.3 68.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.314 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.81 -45.52 93.42 Favored Glycine 0 C--O 1.22 -0.737 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.408 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 25' ' ' VAL . 91.9 t -64.05 -39.27 84.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 117.67 0.735 . . . . 0.0 110.861 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -66.7 -37.49 84.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.399 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -90.35 -41.92 11.23 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -177.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.439 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -89.69 -52.28 5.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.387 0.613 . . . . 0.0 110.879 -178.04 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.08 134.93 4.71 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.353 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -51.77 139.64 21.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.044 0.449 . . . . 0.0 110.972 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.87 -32.9 7.01 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.479 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 74.3 m-80 -84.25 48.64 1.52 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.037 0.446 . . . . 0.0 111.126 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.428 ' HH2' ' CD1' ' A' ' 58' ' ' TRP . 28.2 m95 -60.87 -38.2 84.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.697 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.97 89.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.608 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -68.43 -39.55 81.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.856 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 36' ' ' ASN . 60.9 mt -68.62 -44.76 82.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.821 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.768 ' HB3' HD12 ' A' ' 54' ' ' ILE . 3.7 p -65.15 -32.38 74.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.646 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -70.89 -50.69 32.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.054 0.454 . . . . 0.0 111.528 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -76.61 -47.32 22.72 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.415 ' CD1' HG21 ' A' ' 40' ' ' ILE . 59.4 m-85 -75.89 144.63 76.5 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.092 0.472 . . . . 0.0 111.567 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.436 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 36.6 Cg_endo -67.13 46.78 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.191 3.261 . . . . 0.0 115.309 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -71.97 135.32 46.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.348 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 9.0 p -129.74 133.46 64.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 6.8 m120 76.81 -35.94 0.25 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.284 0.633 . . . . 0.0 110.574 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.714 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 7.1 mpt_? -77.46 130.04 36.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.311 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.6 p -92.9 174.21 7.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.704 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.3 -35.41 80.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.406 HG12 ' HE3' ' A' ' 55' ' ' LYS . 38.9 t -64.93 -38.61 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.599 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.714 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 60.1 mtt -62.57 -40.68 97.62 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.768 HD12 ' HB3' ' A' ' 41' ' ' SER . 86.4 mt -68.06 -44.77 84.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.406 ' HE3' HG12 ' A' ' 52' ' ' VAL . 24.1 ttpp -53.92 -49.91 67.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.868 0.842 . . . . 0.0 109.467 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -67.84 -44.12 77.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.573 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -58.38 -40.37 82.11 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.503 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.523 ' CZ3' ' HA ' ' A' ' 26' ' ' LYS . 30.3 t-105 -60.73 -45.37 94.54 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.864 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -56.83 -43.19 80.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.704 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.537 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -63.46 -41.68 98.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.226 179.237 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 92.9 mmm -59.86 -39.8 86.44 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.26 0.553 . . . . 0.0 109.893 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.521 ' HD2' ' CD1' ' A' ' 58' ' ' TRP . 52.8 mtpt -69.27 -39.45 78.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.423 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 50.9 ttm-85 -60.55 -45.88 92.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.958 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.552 HD12 ' HE3' ' A' ' 66' ' ' MET . 54.0 mt -70.54 -29.5 65.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.143 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.06 41.34 7.58 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.867 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.552 ' HE3' HD12 ' A' ' 64' ' ' LEU . 51.1 mtm -114.21 53.7 0.78 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.936 0.398 . . . . 0.0 110.485 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.458 ' ND2' ' HA ' ' A' ' 62' ' ' LYS . 8.7 p30 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.771 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.4 m -106.44 122.48 46.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.829 0.347 . . . . 0.0 110.412 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -78.26 -34.11 49.24 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 96.8 mmm 71.98 132.98 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.323 1.014 . . . . 0.0 110.797 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.22 141.65 57.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.929 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -59.1 -45.84 89.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.456 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 p -169.89 -62.15 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.315 0.579 . . . . 0.0 110.44 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.5 m -158.43 -41.85 0.06 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.54 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.41 ' OG1' HG12 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -159.55 155.88 27.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.195 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -2.04 10.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.41 HG12 ' OG1' ' A' ' 9' ' ' THR . 41.3 pt -90.25 32.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.889 0.852 . . . . 0.0 109.994 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 m -149.79 42.19 0.87 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -86.68 46.95 1.42 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.25 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -150.77 140.28 21.52 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.574 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.564 ' HB3' ' NH1' ' A' ' 49' ' ' ARG . 80.9 mm-40 61.86 45.12 7.85 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.521 0.513 . . . . 0.0 110.478 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -59.53 120.21 8.98 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.119 0.485 . . . . 0.0 109.833 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.64 ' HA ' ' NH2' ' A' ' 49' ' ' ARG . 35.8 m95 -67.48 143.2 56.32 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.9 p -111.85 161.09 16.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.222 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 20' ' ' GLU . 7.3 p -53.82 -41.58 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.466 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 87.2 tt0 -59.13 -50.12 75.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.894 0.378 . . . . 0.0 110.942 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.47 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 54.1 mt-10 -64.59 -34.27 77.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.203 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.594 ' O ' HG21 ' A' ' 25' ' ' VAL . 23.1 t -69.21 -24.7 64.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.85 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 31.6 mm-40 -69.31 -40.66 77.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.082 0.467 . . . . 0.0 110.362 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.527 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 15.2 m0 -66.48 -40.12 89.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.418 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.633 ' O ' HG23 ' A' ' 29' ' ' VAL . 34.6 m -61.02 -46.13 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.692 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -65.31 -41.73 93.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.112 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.41 -43.65 80.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.056 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.42 -38.12 95.88 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.188 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 25' ' ' VAL . 68.4 t -61.17 -33.6 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.477 0.656 . . . . 0.0 110.118 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -77.12 -50.99 11.79 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.923 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.688 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 14.5 tmtt? -78.41 -47.57 17.3 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.688 ' CE1' ' HD2' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -86.71 -36.03 18.92 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.321 0.581 . . . . 0.0 110.965 -177.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.9 130.78 7.1 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -54.68 125.71 21.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.222 0.534 . . . . 0.0 110.48 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.07 -40.73 1.72 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.525 ' O ' HG13 ' A' ' 40' ' ' ILE . 74.4 m-80 -82.78 51.08 1.82 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.126 0.489 . . . . 0.0 110.385 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.547 ' CE3' HG23 ' A' ' 54' ' ' ILE . 40.9 m95 -60.27 -40.74 91.45 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.823 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.69 -46.67 84.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.703 0.287 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.01 85.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.439 . . . . 0.0 110.764 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 36' ' ' ASN . 67.8 mt -65.76 -43.52 93.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.679 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.471 ' OG ' HD11 ' A' ' 54' ' ' ILE . 12.9 m -62.22 -40.32 95.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.839 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.728 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -64.1 -55.52 21.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.356 -179.026 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -75.47 -47.48 26.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.428 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 61.0 m-85 -72.52 148.19 90.25 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.117 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.527 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 49.6 Cg_endo -69.56 43.94 0.38 Allowed 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.504 2.803 . . . . 0.0 114.164 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 24' ' ' TRP . 47.2 m-85 -72.56 99.03 2.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.862 0.363 . . . . 0.0 110.426 178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 6.5 p -88.32 127.19 41.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.5 m120 74.34 -36.03 0.32 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.238 0.615 . . . . 0.0 111.732 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.64 ' NH2' ' HA ' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -60.46 128.45 36.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.051 0.453 . . . . 0.0 112.175 -179.009 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.4 p -90.59 165.05 13.96 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.139 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.91 82.21 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.26 -38.66 82.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.38 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.518 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 3.5 mmt -59.77 -45.41 92.35 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.547 HG23 ' CE3' ' A' ' 37' ' ' TRP . 75.2 mt -65.48 -44.04 94.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.181 0.515 . . . . 0.0 110.055 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.418 ' HG3' ' NE1' ' A' ' 37' ' ' TRP . 38.9 ttmt -55.11 -51.97 64.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.429 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.51 -39.29 81.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.292 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.498 ' HG3' HH11 ' A' ' 57' ' ' ARG . 3.6 tpt85 -57.5 -40.07 77.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.546 ' CD1' ' HD2' ' A' ' 62' ' ' LYS . 11.8 t-105 -63.57 -42.49 98.32 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.455 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 64.8 ttt180 -56.18 -44.84 79.75 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.367 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.467 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -59.48 -44.89 92.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.389 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 77.5 mtp -62.4 -45.53 92.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.673 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.546 ' HD2' ' CD1' ' A' ' 58' ' ' TRP . 6.0 mtpm? -59.58 -42.06 91.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.174 0.511 . . . . 0.0 110.386 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -60.24 -40.72 91.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.653 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 60' ' ' THR . 59.9 mt -82.57 -3.25 55.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.027 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.55 40.14 47.81 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.039 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 75.4 mtp -115.41 36.89 3.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.813 0.34 . . . . 0.0 110.713 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.487 ' HA ' ' CH2' ' A' ' 58' ' ' TRP . 27.2 t-20 . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.613 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m 57.48 41.05 26.63 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.078 0.466 . . . . 0.0 110.972 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.564 ' HD2' ' HB3' ' A' ' 5' ' ' GLU . 55.8 t60 -95.3 -34.39 12.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.452 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.8 mtp 60.67 57.39 2.72 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.661 0.601 . . . . 0.0 110.722 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.564 ' HB3' ' HD2' ' A' ' 3' ' ' HIS . 8.6 tm-20 -169.56 -56.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 44.83 41.32 5.03 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.487 ' C ' ' HG1' ' A' ' 8' ' ' THR . 28.2 p -74.22 -43.84 55.51 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.487 ' HG1' ' C ' ' A' ' 7' ' ' SER . 4.0 m -154.48 34.99 0.41 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.8 m -73.12 -43.08 62.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.988 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -67.74 119.27 12.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.433 0.635 . . . . 0.0 111.279 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.8 mt -94.49 36.79 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.545 ' HB ' ' SD ' ' A' ' 53' ' ' MET . 19.5 m 71.97 -64.61 0.38 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.387 -177.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp 52.57 -164.26 0.08 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.453 0.701 . . . . 0.0 112.351 177.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt 63.56 169.68 0.16 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.506 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 56.74 89.18 0.05 OUTLIER 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.157 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -61.74 134.48 56.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.016 0.436 . . . . 0.0 109.95 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 28.8 m95 -73.12 132.94 43.89 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.462 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -94.55 148.52 22.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.999 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.678 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 14.6 p -49.51 -37.99 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.488 ' N ' HG12 ' A' ' 19' ' ' VAL . 42.3 tt0 -59.12 -49.17 78.9 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -64.38 -36.41 84.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.404 0.621 . . . . 0.0 110.082 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.501 ' O ' HG23 ' A' ' 25' ' ' VAL . 47.4 m -67.45 -27.57 67.15 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.923 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.678 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 69.7 mm-40 -66.37 -40.75 89.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.219 0.533 . . . . 0.0 110.167 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.523 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 21.6 m0 -64.16 -38.04 89.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.948 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 22' ' ' SER . 4.2 m -62.92 -38.58 82.3 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.81 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -68.93 -46.5 68.09 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.053 0.454 . . . . 0.0 110.388 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.13 99.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.606 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.59 -38.96 93.72 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.265 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 25' ' ' VAL . 38.6 t -64.32 -38.23 82.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.304 0.552 . . . . 0.0 110.422 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -73.34 -43.3 61.04 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.279 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -80.49 -50.54 9.91 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.463 ' CE1' ' HE1' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -88.72 -45.18 10.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.448 0.642 . . . . 0.0 111.186 -178.354 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 29' ' ' VAL . . . 112.44 131.69 5.65 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -57.82 124.69 20.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.416 0.627 . . . . 0.0 110.608 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.06 -39.57 1.69 Allowed Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.455 ' O ' HG13 ' A' ' 40' ' ' ILE . 75.5 m-80 -82.51 51.03 1.76 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.962 0.411 . . . . 0.0 110.482 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -60.44 -38.62 84.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.565 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.28 99.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.058 0.456 . . . . 0.0 110.276 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.37 -37.04 77.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.055 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 36' ' ' ASN . 67.1 mt -67.36 -45.58 85.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.658 ' HB3' HD12 ' A' ' 54' ' ' ILE . 4.5 p -63.7 -33.85 76.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 0.0 110.8 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -67.11 -48.81 67.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.601 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -82.86 -41.38 19.07 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.523 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 45.1 m-85 -79.5 147.43 67.88 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.09 0.471 . . . . 0.0 111.528 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.25 44.26 0.19 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 124.171 3.247 . . . . 0.0 114.735 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.427 ' CG ' HD13 ' A' ' 54' ' ' ILE . 60.3 m-85 -76.52 106.52 8.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.888 0.375 . . . . 0.0 110.148 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.484 ' C ' ' H ' ' A' ' 49' ' ' ARG . 7.7 p -100.14 131.08 48.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 73.14 -26.22 0.19 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.549 0.74 . . . . 0.0 111.256 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.484 ' H ' ' C ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -72.23 125.61 27.74 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 111.56 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.3 p -89.5 154.94 19.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.499 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.34 -38.91 69.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.644 0.259 . . . . 0.0 110.9 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -63.85 -41.1 91.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.359 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.545 ' SD ' ' HB ' ' A' ' 12' ' ' THR . 68.8 mmm -63.27 -41.19 99.0 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.658 HD12 ' HB3' ' A' ' 41' ' ' SER . 76.7 mt -63.34 -44.94 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -56.92 -53.73 54.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.152 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -64.95 -37.5 87.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.728 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 61' ' ' MET . 8.3 tpp180 -59.58 -33.81 71.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.528 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.441 ' CZ2' HG11 ' A' ' 29' ' ' VAL . 12.6 t-105 -60.68 -43.92 97.14 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -55.45 -49.19 73.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.21 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.586 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.89 -38.58 88.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.715 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 96.9 mmm -60.59 -44.39 96.29 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.575 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 46.3 mtpt -65.26 -38.92 91.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.711 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -60.48 -46.1 91.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.084 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 60' ' ' THR . 67.0 mt -71.21 -17.66 62.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.029 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.91 26.58 31.3 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.548 ' HE2' HD12 ' A' ' 64' ' ' LEU . 65.3 mtt -97.63 50.91 1.06 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.874 0.369 . . . . 0.0 110.298 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.575 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 13.3 p-10 . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.77 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.0 t -66.92 128.52 36.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.962 0.41 . . . . 0.0 110.268 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.425 ' HB3' ' HG2' ' A' ' 5' ' ' GLU . 91.2 m-70 -141.89 135.24 29.3 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.467 ' HE1' HG23 ' A' ' 8' ' ' THR . 0.0 OUTLIER -78.95 53.56 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.357 0.599 . . . . 0.0 109.965 -179.786 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.425 ' HG2' ' HB3' ' A' ' 3' ' ' HIS . 4.8 mm-40 -86.47 -41.96 13.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.353 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.672 ' HA ' ' HD3' ' A' ' 16' ' ' LYS . 70.7 m-20 -65.44 135.96 55.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.666 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.462 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 61.7 p -65.82 129.45 39.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.997 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.9 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 7.5 t -167.76 131.31 1.69 Allowed 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.422 0.629 . . . . 0.0 110.843 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.46 ' H ' ' HB3' ' A' ' 13' ' ' LYS . 9.3 t 177.11 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.456 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.427 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 11.5 p30 -179.02 149.11 0.42 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 10' ' ' ASN . 62.2 mt 69.82 -52.81 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.1 t -118.44 28.1 8.55 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.613 -178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.9 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 38.2 pttt -70.92 -42.23 70.17 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.528 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -106.55 32.65 4.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.487 0.66 . . . . 0.0 109.704 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -144.01 60.03 1.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.37 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.672 ' HD3' ' HA ' ' A' ' 6' ' ' ASP . 19.3 tptm -70.93 132.95 45.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.419 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.579 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 12.3 m95 -127.46 134.72 49.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.821 0.344 . . . . 0.0 111.836 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -77.35 151.56 34.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.545 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 9.8 p -55.5 -36.17 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.919 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.482 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 32.7 tt0 -59.77 -45.49 92.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.045 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 42.1 mt-10 -64.71 -42.36 95.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.685 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.434 ' O ' HG22 ' A' ' 25' ' ' VAL . 2.0 p -66.9 -28.36 68.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.445 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 66.3 mm-40 -67.73 -35.95 79.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.897 0.38 . . . . 0.0 110.328 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.482 ' CZ2' ' HG2' ' A' ' 20' ' ' GLU . 30.9 m0 -66.57 -42.84 86.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.411 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.596 ' O ' HG22 ' A' ' 29' ' ' VAL . 3.3 m -58.95 -39.46 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.815 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.556 ' N ' HG21 ' A' ' 25' ' ' VAL . 22.1 ttmt -64.67 -43.51 93.36 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.044 0.45 . . . . 0.0 110.344 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.69 -44.1 91.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.618 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.03 -38.09 95.52 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.427 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 25' ' ' VAL . 69.3 t -62.97 -39.97 87.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.253 0.549 . . . . 0.0 110.323 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -74.4 -45.95 43.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.008 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.471 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 60.3 tttm -80.98 -45.51 16.51 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -177.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.493 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -89.63 -51.22 5.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.32 0.581 . . . . 0.0 110.594 -177.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.34 135.44 4.23 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.513 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -55.16 113.54 1.42 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.979 0.418 . . . . 0.0 110.16 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.44 -35.26 2.72 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.998 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.528 ' O ' HG13 ' A' ' 40' ' ' ILE . 75.4 m-20 -80.48 49.26 1.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.006 0.432 . . . . 0.0 111.187 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.442 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 33.5 m95 -60.68 -40.45 92.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.432 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.89 -37.43 79.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 110.965 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.73 -32.75 68.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.403 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 36' ' ' ASN . 73.7 mt -71.57 -46.81 61.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.736 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.861 ' HB3' HD13 ' A' ' 54' ' ' ILE . 54.6 p -62.72 -35.31 79.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.186 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -65.6 -53.45 41.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.617 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.0 -48.43 16.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.52 ' CD1' HG21 ' A' ' 40' ' ' ILE . 62.3 m-85 -71.21 151.11 94.54 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 120.934 0.397 . . . . 0.0 111.581 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.35 43.28 0.22 Allowed 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.787 2.991 . . . . 0.0 114.445 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.579 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 65.6 m-85 -76.33 115.48 16.11 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.493 ' C ' ' H ' ' A' ' 49' ' ' ARG . 3.6 p -95.9 125.28 48.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.193 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 p30 64.54 -30.71 0.12 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.709 1.204 . . . . 0.0 112.904 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.573 ' N ' ' HD2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -61.26 116.18 4.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 111.339 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.6 p -78.9 173.61 12.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.694 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.69 -39.22 93.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.223 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.6 t -62.89 -39.17 83.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.776 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 81.2 mmm -58.87 -42.82 90.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.715 178.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.861 HD13 ' HB3' ' A' ' 41' ' ' SER . 67.6 mt -69.12 -44.49 80.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.298 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.442 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 39.2 ttpt -55.07 -53.8 51.17 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.829 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -62.13 -40.35 95.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.834 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.504 ' O ' ' HG2' ' A' ' 61' ' ' MET . 6.8 tpp180 -56.41 -42.3 77.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.924 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 15.7 t-105 -59.37 -43.42 92.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.867 0.365 . . . . 0.0 110.357 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.426 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 1.8 mpt_? -59.66 -43.95 93.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.21 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.572 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -60.95 -44.12 97.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.367 178.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 86.2 mmm -56.91 -46.7 81.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.22 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.561 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 19.9 mtpp -62.8 -39.5 94.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.119 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -68.75 -44.08 74.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.681 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 60' ' ' THR . 72.9 mt -71.62 -21.8 61.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.167 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.16 30.58 19.46 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.453 ' HE3' HD12 ' A' ' 64' ' ' LEU . 65.5 mtt -100.1 47.05 0.94 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.561 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 16.9 p-10 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.733 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.495 ' HA ' ' HB2' ' A' ' 6' ' ' ASP . 15.0 m 56.65 36.29 27.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.779 0.432 . . . . 0.0 111.634 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -73.02 -43.56 61.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.45 0.643 . . . . 0.0 109.535 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 53.6 ttm -155.8 -41.82 0.08 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -129.66 134.3 47.59 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.517 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 3.1 t70 -155.01 24.95 0.43 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.549 0.69 . . . . 0.0 109.291 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 p -144.86 85.51 1.76 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.969 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 m -58.89 -45.07 91.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.238 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -84.13 -92.87 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.812 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -172.21 126.75 0.55 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 11' ' ' ILE . 32.0 mm 57.61 48.03 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 122.291 1.043 . . . . 0.0 109.678 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.53 -22.44 18.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.824 -178.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.517 ' HG2' ' HB3' ' A' ' 6' ' ' ASP . 9.9 mtmp? -67.79 -66.82 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.89 128.79 43.09 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 53.16 57.1 6.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.724 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.452 ' HE3' ' HB3' ' A' ' 16' ' ' LYS . 1.2 tmmt? -79.03 112.3 16.09 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.604 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 28.6 m95 -139.71 134.92 32.59 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.908 -177.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 57.5 p -81.98 162.18 22.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 20' ' ' GLU . 9.6 p -57.9 -40.22 75.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 121.347 -0.141 . . . . 0.0 111.233 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.494 ' HG3' ' CE2' ' A' ' 24' ' ' TRP . 45.4 tp10 -60.92 -50.81 71.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.236 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.574 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 39.1 mt-10 -58.0 -42.41 85.15 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.487 0.66 . . . . 0.0 111.164 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.1 m -66.81 -36.49 82.5 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.166 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 19.9 mt-10 -67.53 -31.77 72.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.949 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.574 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 47.5 m0 -61.89 -41.93 98.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.49 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.672 HG12 HG22 ' A' ' 54' ' ' ILE . 1.4 m -63.46 -37.5 79.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.391 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.623 ' N ' HG22 ' A' ' 25' ' ' VAL . 26.3 ttpt -66.18 -47.97 72.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.058 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.28 -37.33 85.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.591 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.29 -39.4 94.6 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.827 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 25' ' ' VAL . 92.7 t -61.32 -37.8 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.456 0.646 . . . . 0.0 110.176 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -76.18 -47.15 25.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.027 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.8 -48.79 65.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.99 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -107.67 -47.85 3.53 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.341 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.69 142.63 5.02 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.197 -1.001 . . . . 0.0 112.479 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.402 ' HB2' HG11 ' A' ' 29' ' ' VAL . 37.1 tt0 -56.94 126.3 26.46 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.67 -31.34 6.9 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.718 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.407 ' O ' HG13 ' A' ' 40' ' ' ILE . 68.3 m-80 -83.19 47.71 1.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.071 0.463 . . . . 0.0 110.808 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.477 ' CE3' HG23 ' A' ' 54' ' ' ILE . 36.7 m95 -61.84 -37.54 84.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.111 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.95 -47.54 85.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.045 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.83 -40.83 98.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.219 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.428 HG22 ' CE2' ' A' ' 46' ' ' PHE . 97.8 mt -63.33 -45.67 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.508 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.546 ' HB2' HD11 ' A' ' 54' ' ' ILE . 16.7 t -64.4 -34.69 78.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.225 0.536 . . . . 0.0 110.481 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -67.82 -51.14 52.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.934 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -77.5 -50.73 12.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.947 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.408 ' CD1' HG21 ' A' ' 40' ' ' ILE . 59.2 m-85 -73.02 145.75 86.61 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.055 0.455 . . . . 0.0 111.115 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.0 Cg_endo -66.63 45.07 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.013 3.142 . . . . 0.0 115.102 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.604 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 70.5 m-85 -71.18 122.74 20.73 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.262 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 49' ' ' ARG . 3.6 p -103.76 124.0 57.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.861 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 m120 70.73 -39.14 0.44 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.537 0.735 . . . . 0.0 111.939 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.418 ' H ' ' C ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -58.05 118.95 5.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.183 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.2 p -80.61 175.26 10.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.163 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.29 -36.93 84.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 t -63.98 -38.83 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.603 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 84.9 mmm -59.39 -43.16 93.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.672 HG22 HG12 ' A' ' 25' ' ' VAL . 70.9 mt -67.43 -44.35 86.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.405 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.426 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 40.1 ttpt -57.14 -47.55 80.87 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.401 0.62 . . . . 0.0 109.828 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -67.33 -40.87 85.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.72 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.409 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 30.0 tpt180 -60.57 -40.36 91.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.099 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.444 ' O ' ' HG3' ' A' ' 62' ' ' LYS . 12.4 t-105 -59.85 -44.47 94.1 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 -59.74 -45.56 91.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.335 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.494 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 17.7 p -62.42 -39.41 93.21 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.857 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.574 ' HE1' ' HE2' ' A' ' 66' ' ' MET . 66.8 mmm -62.13 -46.42 89.11 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.076 0.465 . . . . 0.0 110.007 178.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 58' ' ' TRP . 23.7 mtpp -61.47 -42.44 98.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.0 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 -61.92 -44.22 97.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.424 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 60' ' ' THR . 79.9 mt -68.1 -28.53 67.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.157 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.58 31.57 7.4 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.646 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.574 ' HE2' ' HE1' ' A' ' 61' ' ' MET . 84.1 mtp -95.16 51.96 1.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.938 0.399 . . . . 0.0 110.491 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.473 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.814 -0.515 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.5 p -53.87 -45.0 70.87 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.112 0.482 . . . . 0.0 110.559 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -120.81 -55.19 2.01 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.424 ' HB3' ' H ' ' A' ' 5' ' ' GLU . 53.7 tpp -179.42 -92.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.976 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.424 ' H ' ' HB3' ' A' ' 4' ' ' MET . 26.5 tt0 47.55 50.03 15.43 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 123.736 0.647 . . . . 0.0 111.47 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -80.76 42.02 0.6 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.71 0.766 . . . . 0.0 110.701 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.428 ' C ' ' HG1' ' A' ' 8' ' ' THR . 38.8 t -82.96 -16.16 48.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.192 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.428 ' HG1' ' C ' ' A' ' 7' ' ' SER . 24.8 p 51.55 48.27 23.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.623 0.725 . . . . 0.0 110.333 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.8 t -65.34 134.04 52.7 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.882 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.499 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER -75.05 64.77 1.39 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.132 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 13' ' ' LYS . 60.2 mt -56.05 128.74 16.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 O-C-N 122.297 -0.252 . . . . 0.0 110.626 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 m 75.63 -29.01 0.18 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.336 0.654 . . . . 0.0 112.029 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 11' ' ' ILE . 60.0 mttm 58.05 -140.59 0.77 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.03 26.55 8.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 176.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -94.8 26.75 3.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.219 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -75.63 126.22 30.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.551 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 13.6 m95 -102.85 137.91 40.43 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.667 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.5 p -79.3 155.33 28.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.284 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.2 p -58.38 -33.85 48.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.926 0.393 . . . . 0.0 110.668 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.73 -49.31 75.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.133 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 33.8 mt-10 -63.97 -40.15 95.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.543 0.687 . . . . 0.0 110.489 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.0 m -63.05 -35.58 80.73 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.365 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -65.46 -32.39 73.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.075 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.435 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 41.1 m0 -66.76 -46.0 76.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.675 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 54' ' ' ILE . 3.3 m -62.51 -37.79 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.998 0.428 . . . . 0.0 110.18 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.576 ' N ' HG21 ' A' ' 25' ' ' VAL . 21.9 ttpt -63.19 -46.18 88.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.913 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.31 -40.28 64.62 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.214 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.44 -41.67 97.18 Favored Glycine 0 C--O 1.226 -0.377 0 CA-C-N 116.114 -0.494 . . . . 0.0 113.052 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 25' ' ' VAL . 66.2 t -62.23 -40.32 87.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.247 0.546 . . . . 0.0 110.748 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.477 HE21 ' HB3' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -73.55 -44.92 56.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.04 -179.633 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.468 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 62.1 tttp -75.46 -50.32 16.13 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.468 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -87.3 -53.15 4.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.443 0.639 . . . . 0.0 110.867 -178.283 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.21 133.2 3.53 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.687 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -55.42 121.5 9.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.918 0.389 . . . . 0.0 110.661 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.15 -34.01 3.83 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.014 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.46 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.2 m-80 -80.19 53.91 1.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.075 0.464 . . . . 0.0 111.243 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -64.52 -36.56 84.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.951 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.83 98.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.072 0.463 . . . . 0.0 110.545 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.77 -37.72 73.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.006 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 36' ' ' ASN . 74.1 mt -66.56 -46.53 86.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.867 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.845 ' HB3' HD11 ' A' ' 54' ' ' ILE . 3.8 p -62.88 -37.51 87.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.193 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -65.83 -52.69 48.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.09 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -76.72 -47.08 23.01 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.403 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 53.3 m-85 -71.25 149.14 94.15 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.989 0.423 . . . . 0.0 111.07 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.435 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 40.7 Cg_endo -67.84 43.19 0.25 Allowed 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.685 2.923 . . . . 0.0 114.773 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.551 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 73.4 m-85 -74.7 127.77 33.93 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.482 ' C ' ' H ' ' A' ' 49' ' ' ARG . 7.5 p -115.72 132.68 64.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 p30 66.03 -30.19 0.14 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.655 1.182 . . . . 0.0 112.366 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.482 ' H ' ' C ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -67.8 125.77 27.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.728 0.299 . . . . 0.0 110.981 179.229 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.9 p -89.34 169.82 11.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.621 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.65 89.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.485 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.95 -38.03 80.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.479 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 14.5 mmt -62.07 -44.1 97.4 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.845 HD11 ' HB3' ' A' ' 41' ' ' SER . 77.4 mt -64.15 -44.51 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.938 0.399 . . . . 0.0 110.009 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -55.91 -50.23 71.25 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.901 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.51 -42.86 86.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.5 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.492 ' O ' ' HG2' ' A' ' 61' ' ' MET . 8.9 tpp180 -60.42 -38.3 83.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.623 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.46 ' CD2' HG22 ' A' ' 29' ' ' VAL . 27.4 t-105 -60.35 -44.69 95.31 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.534 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 68.2 mtp85 -57.86 -46.71 84.4 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.533 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.488 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -63.81 -36.96 85.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.922 179.085 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 87.5 mmm -62.56 -45.07 94.62 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.57 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 22.3 mtpp -61.37 -40.19 93.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.144 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.0 mtp85 -62.94 -47.5 82.97 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.921 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 60' ' ' THR . 74.9 mt -72.36 -10.17 59.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.613 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.18 32.11 60.73 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.255 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.417 ' HE2' ' HE1' ' A' ' 61' ' ' MET . 88.3 mtp -98.74 47.86 0.98 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.089 0.471 . . . . 0.0 110.124 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.57 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 14.8 p-10 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.222 -0.894 . . . . 0.0 109.61 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.636 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 16.4 m95 . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -87.03 154.6 20.64 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.595 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 14.7 p -57.6 -42.53 81.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -60.37 -45.68 92.65 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.784 0.325 . . . . 0.0 110.941 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.477 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 68.7 mt-10 -61.28 -36.41 79.99 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.493 0.663 . . . . 0.0 110.107 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.675 ' O ' HG22 ' A' ' 25' ' ' VAL . 22.0 m -69.8 -29.69 67.05 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.705 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.595 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 68.1 mm-40 -69.57 -39.25 77.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.243 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.515 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 33.6 m0 -61.17 -43.77 98.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.219 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 22' ' ' SER . 3.1 m -58.63 -38.31 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.001 0.429 . . . . 0.0 110.263 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -67.18 -49.58 64.14 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.793 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.88 -43.22 99.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.736 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.9 -38.84 96.68 Favored Glycine 0 C--O 1.224 -0.524 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.566 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 25' ' ' VAL . 55.7 t -63.21 -35.76 73.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.037 0.446 . . . . 0.0 110.909 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.3 tm0? -80.28 -46.61 15.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.947 0.403 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.723 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 39.5 ttmt -74.46 -45.72 44.41 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.723 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -93.28 -46.11 7.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.211 0.529 . . . . 0.0 110.98 -177.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.78 134.05 5.05 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.168 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.423 ' HB2' HG13 ' A' ' 29' ' ' VAL . 87.3 tt0 -54.23 118.65 4.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.871 0.367 . . . . 0.0 110.476 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.12 -38.54 2.0 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.817 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.503 ' O ' HG13 ' A' ' 40' ' ' ILE . 74.0 m-20 -79.83 54.11 1.78 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.142 0.496 . . . . 0.0 111.114 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -62.76 -39.11 93.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.581 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.11 -46.58 89.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.105 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.68 87.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.966 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 36' ' ' ASN . 75.1 mt -66.87 -43.21 89.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.003 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.467 ' OG ' HD12 ' A' ' 54' ' ' ILE . 14.9 m -60.37 -39.05 85.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.229 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -70.61 -55.13 9.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.885 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -72.48 -40.9 66.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 60.8 m-85 -83.1 146.15 50.89 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.546 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.515 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 35.9 Cg_endo -66.09 43.12 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.723 2.949 . . . . 0.0 115.041 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.636 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 64.6 m-85 -72.92 111.56 8.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.858 0.361 . . . . 0.0 110.079 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.4 127.86 51.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 33.0 m120 72.97 -41.52 0.51 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.475 0.71 . . . . 0.0 111.368 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.447 ' NH2' ' HA ' ' A' ' 17' ' ' TRP . 1.0 OUTLIER -58.48 120.39 8.72 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 122.598 0.359 . . . . 0.0 111.277 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.3 p -86.04 172.17 10.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.206 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.68 83.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.455 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.29 -39.78 86.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.102 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 19.1 mmt -62.09 -41.71 98.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.317 -0.402 . . . . 0.0 109.959 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.467 HD12 ' OG ' ' A' ' 41' ' ' SER . 66.0 mt -67.28 -42.3 87.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -56.94 -50.66 71.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.557 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -64.53 -44.46 90.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.627 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.415 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 32.0 tpt180 -58.47 -45.13 89.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.388 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -62.66 -41.91 99.32 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.297 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -58.11 -44.97 88.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.934 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 24.5 p . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.959 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.466 ' CE3' ' HB3' ' A' ' 21' ' ' GLU . 14.0 m95 . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 120.694 0.283 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -79.5 156.39 27.82 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.81 -41.83 76.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.511 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -65.75 -45.83 81.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.528 0.204 . . . . 0.0 110.5 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.466 ' HB3' ' CE3' ' A' ' 17' ' ' TRP . 35.1 mt-10 -55.55 -43.44 75.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.638 0.733 . . . . 0.0 110.533 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.572 ' O ' HG22 ' A' ' 25' ' ' VAL . 17.5 m -66.75 -37.15 84.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.819 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -63.66 -35.27 79.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.982 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.465 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 44.2 m0 -61.89 -44.96 95.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.822 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 22' ' ' SER . 1.4 m -62.2 -40.17 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 26' ' ' LYS . 24.2 ttpt -65.14 -46.81 79.39 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.273 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.12 -44.08 97.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.158 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.26 95.97 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.273 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.659 HG13 ' HB2' ' A' ' 34' ' ' GLU . 50.2 t -63.22 -41.06 91.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.25 0.547 . . . . 0.0 110.178 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -75.03 -45.62 40.5 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.77 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.478 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 61.7 tttm -79.64 -52.97 7.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.478 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -82.68 -54.65 4.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.483 0.658 . . . . 0.0 110.456 -178.583 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.74 130.86 3.29 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.096 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.659 ' HB2' HG13 ' A' ' 29' ' ' VAL . 36.8 tt0 -51.39 128.88 23.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.811 0.339 . . . . 0.0 110.892 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.37 -35.3 4.18 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.837 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.484 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.0 m-80 -81.11 51.85 1.67 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.884 0.373 . . . . 0.0 111.08 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.451 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 32.9 m95 -62.26 -42.91 99.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.788 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.39 88.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.791 0.329 . . . . 0.0 110.731 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.66 -42.91 98.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.473 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 36' ' ' ASN . 89.0 mt -62.47 -45.6 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.598 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.543 ' HB2' HD12 ' A' ' 54' ' ' ILE . 29.5 t -61.43 -36.33 80.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.068 0.461 . . . . 0.0 111.087 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -68.18 -49.96 57.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.95 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -77.8 -52.69 8.5 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.612 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.436 ' CD1' HG23 ' A' ' 40' ' ' ILE . 57.6 m-85 -67.9 147.45 98.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.119 0.485 . . . . 0.0 111.329 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.429 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.6 Cg_endo -66.98 44.57 0.22 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.819 3.012 . . . . 0.0 115.212 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.451 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 75.7 m-85 -71.36 124.85 25.48 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.774 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.42 ' C ' ' H ' ' A' ' 49' ' ' ARG . 2.4 p -101.83 118.54 48.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.089 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.1 -30.38 0.15 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.543 1.137 . . . . 0.0 112.964 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.557 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -60.91 119.51 8.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.234 0.54 . . . . 0.0 111.771 -179.16 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 p -79.05 169.95 17.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.945 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.23 -38.61 89.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.303 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.87 -40.21 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.4 mmt -61.3 -40.84 95.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.543 HD12 ' HB2' ' A' ' 41' ' ' SER . 82.3 mt -67.11 -44.16 88.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 37.7 ttpt -56.98 -48.87 77.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.696 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -66.64 -39.46 88.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.883 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.445 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 27.6 tpt180 -59.32 -43.58 92.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.32 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.401 ' CE3' ' HA ' ' A' ' 58' ' ' TRP . 10.9 t-105 -58.62 -45.27 89.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -60.9 -46.25 91.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.722 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 27.9 p . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.288 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.474 ' HZ3' ' HE2' ' A' ' 46' ' ' PHE . 14.3 m95 . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.941 0.4 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.0 p -79.33 156.41 28.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.344 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.52 -31.52 50.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.437 ' HG3' ' CZ2' ' A' ' 24' ' ' TRP . 3.2 tp10 -59.76 -51.74 68.47 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.593 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.511 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 29.1 mt-10 -64.31 -38.15 90.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.596 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.585 ' O ' HG22 ' A' ' 25' ' ' VAL . 22.6 m -64.89 -41.92 95.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.341 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -63.04 -32.9 74.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.96 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.511 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 47.0 m0 -65.88 -46.23 79.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.887 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 22' ' ' SER . 2.3 m -60.93 -39.31 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -67.21 -47.31 71.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.621 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.66 -42.39 98.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.516 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.32 -36.46 93.1 Favored Glycine 0 C--O 1.222 -0.645 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.969 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 25' ' ' VAL . 53.7 t -65.7 -34.28 69.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.181 0.515 . . . . 0.0 110.072 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -75.43 -48.08 24.42 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.214 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.496 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 24.8 ttmm -79.9 -48.22 13.8 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -177.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.496 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -90.8 -44.01 9.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.414 0.626 . . . . 0.0 111.101 -178.112 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 29' ' ' VAL . . . 106.97 132.37 6.98 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -56.62 139.17 50.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.373 0.606 . . . . 0.0 110.834 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.31 -38.11 3.01 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -85.65 49.34 1.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.107 0.479 . . . . 0.0 110.148 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.425 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 42.1 m95 -60.22 -38.28 82.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.222 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.22 -45.66 90.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.995 0.426 . . . . 0.0 110.133 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 -44.59 91.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.81 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.5 mt -61.31 -44.1 97.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.786 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.503 ' HB2' HD12 ' A' ' 54' ' ' ILE . 31.9 t -64.65 -37.66 88.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.814 0.34 . . . . 0.0 111.039 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -64.9 -49.23 71.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.258 0.551 . . . . 0.0 111.604 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -79.0 -48.61 14.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.956 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -75.31 141.53 73.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 0.0 111.869 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.511 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.4 Cg_endo -66.39 48.93 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 124.298 3.332 . . . . 0.0 115.257 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.474 ' HE2' ' HZ3' ' A' ' 17' ' ' TRP . 60.8 m-85 -72.15 109.85 6.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.87 0.366 . . . . 0.0 110.202 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 49' ' ' ARG . 4.0 p -84.82 122.26 37.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.471 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 69.88 -34.04 0.27 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.557 0.743 . . . . 0.0 112.27 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.626 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -63.06 127.88 33.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.248 0.547 . . . . 0.0 111.789 -179.131 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.4 p -93.29 176.56 6.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.127 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.95 -38.57 91.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.667 0.27 . . . . 0.0 110.299 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.7 t -63.52 -38.76 83.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.485 ' HA ' ' CE ' ' A' ' 53' ' ' MET . 14.0 mmt -59.37 -44.99 92.65 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.551 HG23 HG12 ' A' ' 25' ' ' VAL . 68.4 mt -65.49 -46.49 89.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.504 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 36.0 ttpt -55.05 -50.44 69.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.345 0.593 . . . . 0.0 110.378 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -66.33 -39.55 89.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.401 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.444 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 30.8 tpt180 -59.99 -41.6 92.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.587 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.46 ' CE2' HG21 ' A' ' 29' ' ' VAL . 16.0 t-105 -61.18 -45.5 94.36 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.81 -44.45 86.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.901 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.461 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.457 ' HZ2' ' HB3' ' A' ' 53' ' ' MET . 17.3 m95 . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.3 p -76.81 152.74 35.42 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 10.9 p -60.51 -38.61 78.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.219 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -59.71 -54.1 50.29 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.532 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 50.3 mt-10 -58.57 -39.28 79.85 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.429 0.633 . . . . 0.0 111.096 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.538 ' O ' HG22 ' A' ' 25' ' ' VAL . 15.5 m -68.16 -37.6 81.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.203 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 68.0 mm-40 -61.26 -34.64 75.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.873 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.532 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 42.5 m0 -62.54 -43.66 98.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.15 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 29' ' ' VAL . 1.1 m -60.04 -37.55 73.12 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -62.21 -46.3 89.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.639 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.86 78.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.744 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.06 -40.68 99.24 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 25' ' ' VAL . 51.5 t -61.09 -37.39 77.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.006 0.432 . . . . 0.0 111.01 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -79.28 -41.42 28.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.696 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -78.81 -49.49 12.88 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.431 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -86.05 -42.12 14.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.462 0.648 . . . . 0.0 110.805 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.17 131.54 5.88 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -50.55 130.4 23.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.808 0.337 . . . . 0.0 110.914 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.41 -37.07 3.44 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.906 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.464 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.9 m-80 -81.53 53.72 2.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.102 0.477 . . . . 0.0 111.115 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -63.83 -38.3 90.57 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.559 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.54 -46.2 90.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.51 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.23 -43.08 99.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.64 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 36' ' ' ASN . 79.6 mt -63.05 -45.07 99.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.449 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.566 ' HB2' HD12 ' A' ' 54' ' ' ILE . 47.6 t -62.91 -36.0 81.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.229 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -68.76 -47.91 65.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.908 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -80.34 -49.96 10.8 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.409 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 51.0 m-85 -70.41 145.56 93.18 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 121.171 0.51 . . . . 0.0 111.826 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.47 44.28 0.24 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 124.073 3.182 . . . . 0.0 114.841 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.437 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 53.4 m-85 -68.65 122.95 19.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.969 0.414 . . . . 0.0 110.489 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.58 127.25 62.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.256 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.631 ' C ' ' HD2' ' A' ' 49' ' ' ARG . 33.4 m120 61.79 17.18 8.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.738 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.631 ' HD2' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -118.03 124.37 47.96 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -178.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.517 ' OG1' ' HG2' ' A' ' 53' ' ' MET . 31.1 p -87.01 175.38 8.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.624 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.78 -38.59 86.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.538 0.208 . . . . 0.0 110.824 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.72 -36.23 74.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.517 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 79.8 mmm -61.79 -45.27 94.61 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.566 HD12 ' HB2' ' A' ' 41' ' ' SER . 66.3 mt -66.45 -41.96 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.958 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -54.92 -49.28 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.148 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 3.5 t0 -71.31 -36.59 71.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.262 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.457 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 27.8 tpt180 -59.7 -40.52 88.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.116 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.4 t-105 -59.59 -43.34 93.71 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 56' ' ' ASP . 21.7 ttm180 -58.06 -49.46 76.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.457 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.457 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 1.7 p . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.955 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.515 ' HZ3' ' HE2' ' A' ' 46' ' ' PHE . 10.6 m95 . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 120.572 0.225 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -77.3 154.43 32.9 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.1 p -57.21 -35.29 48.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.503 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -60.23 -53.92 51.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.682 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.62 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 37.7 mt-10 -59.44 -42.4 91.83 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.689 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.662 ' O ' HG22 ' A' ' 25' ' ' VAL . 8.5 m -65.59 -34.87 79.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.145 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -69.52 -33.14 72.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.906 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.62 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 44.6 m0 -61.82 -42.8 99.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.653 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 22' ' ' SER . 2.5 m -62.3 -38.16 80.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -63.76 -48.96 74.86 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.276 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.32 -40.78 90.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.721 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.05 -38.05 94.91 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.659 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 25' ' ' VAL . 54.8 t -63.16 -36.15 74.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.958 0.408 . . . . 0.0 110.752 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -78.84 -43.92 24.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.225 0.536 . . . . 0.0 111.102 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.577 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 88.1 tttt -74.09 -45.68 47.62 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.577 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -96.61 -49.04 5.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.275 0.56 . . . . 0.0 111.053 -178.206 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.07 134.58 4.4 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.166 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.517 ' HB2' HG13 ' A' ' 29' ' ' VAL . 76.3 tt0 -55.15 106.69 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.168 0.509 . . . . 0.0 110.658 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.39 -37.9 1.51 Allowed Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.673 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.494 ' O ' HG13 ' A' ' 40' ' ' ILE . 73.0 m-80 -78.88 54.58 1.58 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.042 0.448 . . . . 0.0 111.386 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.433 ' NE1' ' HG3' ' A' ' 55' ' ' LYS . 36.0 m95 -65.31 -37.08 86.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.279 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.44 -42.1 96.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.163 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.62 -37.04 81.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.022 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 36' ' ' ASN . 74.4 mt -66.96 -45.81 86.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.66 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.474 ' HB3' HD12 ' A' ' 54' ' ' ILE . 4.1 p -65.4 -34.67 78.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.135 0.493 . . . . 0.0 111.154 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.52 -43.28 81.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.087 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -88.03 -44.64 10.83 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.45 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 55.6 m-85 -76.05 146.72 79.23 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 121.108 0.48 . . . . 0.0 111.627 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.32 46.3 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.08 3.187 . . . . 0.0 115.47 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.515 ' HE2' ' HZ3' ' A' ' 17' ' ' TRP . 75.6 m-85 -71.47 134.63 46.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.564 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.422 ' C ' ' H ' ' A' ' 49' ' ' ARG . 3.5 p -123.05 132.3 71.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 75.9 m-20 73.91 -39.87 0.44 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.567 0.747 . . . . 0.0 110.709 -177.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.5 ' HD3' ' OE2' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -67.31 138.39 56.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.266 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.7 p -102.77 177.45 4.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.628 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.02 -39.56 90.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.713 0.292 . . . . 0.0 110.415 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.9 t -63.49 -37.21 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.438 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 18.7 mmt -62.4 -42.31 99.33 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.484 HG23 HG12 ' A' ' 25' ' ' VAL . 82.4 mt -65.6 -44.49 93.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.012 0.434 . . . . 0.0 109.864 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.433 ' HG3' ' NE1' ' A' ' 37' ' ' TRP . 25.8 ttpp -56.47 -49.51 74.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.655 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 37.7 t70 -67.59 -39.4 84.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.838 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.492 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 13.0 tpp180 -59.84 -37.74 80.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.204 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.485 ' CE2' HG21 ' A' ' 29' ' ' VAL . 8.5 t-105 -60.61 -42.88 97.71 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 56' ' ' ASP . 98.5 mtt180 -53.54 -49.95 66.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.021 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.411 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.8 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.557 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 16.8 m95 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.5 p -82.53 160.88 22.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.346 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.73 -40.71 80.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.426 0.155 . . . . 0.0 111.152 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -61.94 -47.29 85.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.691 0.281 . . . . 0.0 111.585 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.521 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 49.8 mt-10 -63.66 -36.23 83.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.333 0.587 . . . . 0.0 110.695 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.616 ' O ' HG22 ' A' ' 25' ' ' VAL . 40.2 m -67.58 -36.03 80.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.02 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.65 -35.3 80.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.833 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.527 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 44.6 m0 -62.18 -46.73 87.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.379 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 22' ' ' SER . 3.3 m -60.75 -37.46 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.873 0.368 . . . . 0.0 110.815 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -66.17 -46.12 78.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.771 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.2 -38.57 75.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.039 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.07 -36.18 80.34 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.625 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 25' ' ' VAL . 97.5 t -62.28 -36.38 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.518 0.675 . . . . 0.0 110.074 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -81.18 -49.08 11.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.395 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.526 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 84.5 tttt -69.11 -42.49 76.02 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.917 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.526 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -102.74 -55.7 2.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.338 0.59 . . . . 0.0 110.973 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.89 138.23 3.96 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.228 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.5 ' HB2' HG13 ' A' ' 29' ' ' VAL . 7.8 tm-20 -57.04 117.81 4.37 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.26 -32.1 4.65 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.019 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.473 ' O ' HG13 ' A' ' 40' ' ' ILE . 71.4 m-80 -81.62 48.19 1.16 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.896 0.379 . . . . 0.0 111.345 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 36.9 m95 -62.85 -37.91 88.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.832 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.17 -48.93 78.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 0.0 110.528 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.27 98.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.689 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 36' ' ' ASN . 79.1 mt -60.72 -45.54 97.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.593 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.492 ' HB2' HD12 ' A' ' 54' ' ' ILE . 23.1 t -64.69 -35.02 79.7 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.096 0.474 . . . . 0.0 110.924 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -67.65 -47.45 69.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.754 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -82.31 -49.45 10.04 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.474 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 56.4 m-85 -70.23 143.31 90.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.095 0.474 . . . . 0.0 111.374 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.527 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 39.4 Cg_endo -67.6 48.27 0.35 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.922 3.081 . . . . 0.0 115.204 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.557 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 67.8 m-85 -72.48 133.47 44.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.761 0.315 . . . . 0.0 110.283 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.596 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 5.9 p -110.48 121.11 62.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.84 -30.92 0.14 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.6 1.16 . . . . 0.0 112.293 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.596 ' HD2' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -61.71 118.0 6.56 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.964 0.411 . . . . 0.0 110.9 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.404 ' OG1' ' HG2' ' A' ' 53' ' ' MET . 34.2 p -81.02 167.39 19.84 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.703 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.56 85.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.9 t -63.23 -36.96 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.45 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 61.1 mmm -64.17 -41.33 97.16 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.596 HG23 HG12 ' A' ' 25' ' ' VAL . 85.1 mt -65.36 -45.01 94.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.814 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.566 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 38.8 ttpt -56.7 -49.61 74.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.337 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -63.47 -44.88 93.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.523 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.463 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 30.9 tpt180 -60.55 -38.59 84.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.144 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -58.8 -43.17 90.48 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.635 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.566 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 1.6 mpt_? -60.04 -49.17 78.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.758 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 2.9 p . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.796 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.439 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 10.4 m95 . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 120.462 0.172 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.9 p -78.66 147.74 33.44 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.439 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 11.5 p -53.71 -35.58 27.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.61 0.243 . . . . 0.0 110.969 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.419 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 39.8 tt0 -59.71 -53.46 57.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.362 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.569 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 45.5 mt-10 -61.09 -39.45 89.99 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.439 0.638 . . . . 0.0 111.015 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.606 ' O ' HG22 ' A' ' 25' ' ' VAL . 6.4 m -66.09 -33.36 75.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.613 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 58.7 mm-40 -68.29 -30.91 70.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.777 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.569 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 43.1 m0 -64.27 -42.99 96.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.736 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 22' ' ' SER . 2.0 m -60.81 -38.16 78.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.094 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -65.7 -50.4 65.02 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.469 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.52 -41.84 98.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.741 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.47 -37.86 94.83 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.471 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 25' ' ' VAL . 47.5 t -64.9 -43.16 96.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.08 0.467 . . . . 0.0 110.337 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -71.38 -42.28 68.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.207 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.458 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 63.7 tttp -76.72 -48.52 18.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.458 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -94.76 -55.87 2.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.599 0.714 . . . . 0.0 110.975 -178.521 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.19 132.0 3.45 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -58.48 118.46 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.546 0.688 . . . . 0.0 110.554 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.45 -37.5 1.87 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.415 ' O ' HG13 ' A' ' 40' ' ' ILE . 62.2 m-80 -83.49 50.77 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.039 0.447 . . . . 0.0 110.228 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -62.2 -41.45 98.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.908 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.78 -45.41 89.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.871 0.367 . . . . 0.0 110.332 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.27 93.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.485 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 36' ' ' ASN . 82.0 mt -62.55 -46.55 96.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.451 ' HB2' HD12 ' A' ' 54' ' ' ILE . 32.4 t -60.71 -36.66 79.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.199 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -69.11 -51.16 41.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.69 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -74.54 -43.73 54.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.722 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.456 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 47.4 m-85 -77.49 146.91 74.48 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 120.983 0.42 . . . . 0.0 110.928 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.466 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 36.8 Cg_endo -66.31 43.02 0.18 Allowed 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.774 2.982 . . . . 0.0 115.304 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.439 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 77.0 m-85 -74.05 128.36 35.31 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.941 -0.474 . . . . 0.0 110.12 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.59 129.2 72.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 71.33 -40.67 0.48 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.19 0.596 . . . . 0.0 111.924 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.493 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 2.0 mpt_? -60.74 127.16 30.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.682 0.277 . . . . 0.0 110.612 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.471 ' OG1' ' HG3' ' A' ' 53' ' ' MET . 67.5 p -89.55 169.03 11.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.333 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.7 -37.33 83.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.805 0.336 . . . . 0.0 110.263 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.23 -38.41 82.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.829 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.471 ' HG3' ' OG1' ' A' ' 50' ' ' THR . 68.1 mtt -62.3 -42.1 99.07 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.508 HG23 HG12 ' A' ' 25' ' ' VAL . 70.2 mt -67.22 -44.36 87.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.868 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -55.56 -49.98 71.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.007 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.64 -37.0 79.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.388 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 53' ' ' MET . 15.0 tpt85 -61.28 -39.73 91.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.343 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.434 ' CD2' HG21 ' A' ' 29' ' ' VAL . 36.7 t-105 -67.49 -43.7 80.3 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.3 mtt-85 -59.39 -42.75 92.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.383 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.436 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.794 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.444 ' HH2' HG12 ' A' ' 54' ' ' ILE . 11.2 m95 . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.667 0.27 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.7 p -77.83 154.22 32.03 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 13.8 p -57.51 -38.46 63.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.265 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.515 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 87.2 tt0 -64.07 -48.05 77.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.793 0.33 . . . . 0.0 111.076 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.536 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 68.0 mt-10 -59.59 -37.35 78.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.344 0.592 . . . . 0.0 111.58 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.618 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.3 m -67.86 -32.03 72.25 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.997 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 5.7 mm-40 -65.68 -38.29 88.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.4 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.536 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 35.3 m0 -61.4 -43.68 98.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.837 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 22' ' ' SER . 3.8 m -62.59 -36.45 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.168 0.508 . . . . 0.0 110.248 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -66.93 -49.32 65.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.753 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.63 -39.91 76.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.299 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.72 -41.21 98.93 Favored Glycine 0 C--O 1.224 -0.476 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.999 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' A' ' 34' ' ' GLU . 54.8 t -64.72 -41.79 93.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 117.237 0.518 . . . . 0.0 110.72 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -70.82 -36.72 73.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.323 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.614 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 5.1 ttmp? -84.77 -52.08 6.31 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.614 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -84.77 -54.17 4.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.28 0.562 . . . . 0.0 111.221 -177.733 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.56 130.75 3.33 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.62 ' HB2' HG13 ' A' ' 29' ' ' VAL . 86.9 tt0 -55.56 125.57 21.58 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.958 0.409 . . . . 0.0 110.852 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.49 -35.13 3.41 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.457 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.4 m-80 -82.97 52.81 2.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.986 0.422 . . . . 0.0 110.532 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 40.8 m95 -61.18 -40.26 93.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.636 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.6 97.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.965 0.412 . . . . 0.0 110.384 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -67.82 -38.14 82.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.097 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 36' ' ' ASN . 78.5 mt -67.45 -47.31 81.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.531 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.523 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 5.7 p -63.52 -37.18 86.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.519 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -62.99 -48.42 78.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.515 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -80.41 -50.31 10.28 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.424 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 55.7 m-85 -69.09 146.32 97.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.01 0.433 . . . . 0.0 110.895 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.472 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 44.4 Cg_endo -68.68 46.46 0.38 Allowed 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.537 2.824 . . . . 0.0 114.799 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -69.72 126.49 29.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.1 0.476 . . . . 0.0 110.564 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.525 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 5.6 p -118.3 131.25 71.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 74.5 m-80 74.35 -43.5 0.53 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.039 0.535 . . . . 0.0 110.378 -177.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.699 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -66.45 125.67 26.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.346 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.8 p -96.15 175.58 6.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.919 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.3 -42.72 99.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.491 0.186 . . . . 0.0 110.91 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.09 -37.57 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.699 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 63.6 mtt -59.96 -42.42 94.04 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.539 HG23 HG12 ' A' ' 25' ' ' VAL . 63.6 mt -66.99 -44.51 88.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.027 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -55.7 -47.5 76.71 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.171 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -69.79 -41.95 74.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.99 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.501 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 12.1 tpp180 -60.18 -39.15 85.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.267 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.442 ' HA ' ' CE3' ' A' ' 58' ' ' TRP . 16.7 t-105 -61.74 -45.3 94.51 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.345 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.9 mtt85 -58.5 -44.47 89.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.377 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.501 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 24.5 p . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.735 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 13.7 m95 . . . . . 0 N--CA 1.446 -0.628 0 CA-C-O 120.682 0.277 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.2 p -80.38 151.12 29.57 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.495 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 7.2 p -55.44 -39.16 51.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.64 0.257 . . . . 0.0 110.734 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.542 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 84.6 tt0 -62.13 -46.6 88.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.911 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 53.6 mt-10 -62.53 -38.89 91.74 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.236 0.541 . . . . 0.0 110.676 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.61 ' O ' HG22 ' A' ' 25' ' ' VAL . 24.3 t -64.58 -34.51 78.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.302 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 49.7 mm-40 -66.87 -37.59 84.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.707 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.564 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 40.0 m0 -62.46 -44.68 95.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.509 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.618 HG12 HG23 ' A' ' 54' ' ' ILE . 3.3 m -62.0 -35.77 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.143 0.497 . . . . 0.0 109.988 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 26' ' ' LYS . 18.0 ttpt -69.7 -47.7 62.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.759 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.32 -42.9 78.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.766 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.94 -33.02 67.41 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 116.191 -0.458 . . . . 0.0 113.133 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 25' ' ' VAL . 78.4 t -66.41 -36.91 78.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.174 0.511 . . . . 0.0 110.658 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -79.35 -44.68 21.08 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.188 0.518 . . . . 0.0 110.933 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -73.85 -46.33 45.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.491 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -98.02 -57.45 2.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.467 0.651 . . . . 0.0 110.888 -179.073 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 29' ' ' VAL . . . 126.53 133.31 3.83 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' HB3' HG13 ' A' ' 29' ' ' VAL . 11.1 pt-20 -59.12 138.71 57.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.327 0.585 . . . . 0.0 110.438 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.18 -37.29 3.55 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -84.95 46.49 1.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.154 0.502 . . . . 0.0 110.546 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.44 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 41.5 m95 -61.17 -36.51 80.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.786 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.46 92.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 0.0 110.223 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.09 84.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.661 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.44 HG23 ' CD1' ' A' ' 44' ' ' TYR . 61.6 mt -61.77 -47.54 92.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.413 ' HB2' HD12 ' A' ' 54' ' ' ILE . 44.2 t -63.47 -36.27 83.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.973 0.416 . . . . 0.0 110.468 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -63.4 -47.53 81.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.658 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -82.93 -52.33 6.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.396 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.44 ' CD1' HG23 ' A' ' 40' ' ' ILE . 65.0 m-85 -68.45 140.19 92.36 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.066 0.46 . . . . 0.0 110.986 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.564 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 32.5 Cg_endo -64.87 47.17 0.16 Allowed 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.155 3.237 . . . . 0.0 115.395 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -74.16 134.9 42.83 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.965 -0.46 . . . . 0.0 110.223 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 7.3 p -124.36 125.23 70.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 75.4 m-20 76.5 -33.91 0.22 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.276 0.63 . . . . 0.0 111.146 -178.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.517 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 7.7 mpt_? -76.03 112.94 12.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.714 0.292 . . . . 0.0 110.518 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.6 p -82.19 173.52 12.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.635 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.11 82.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.938 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 t -64.23 -39.44 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.3 mmt -61.52 -42.96 99.6 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.618 HG23 HG12 ' A' ' 25' ' ' VAL . 72.0 mt -66.47 -45.48 88.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.428 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 39.0 ttpt -56.03 -50.87 69.72 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.531 0.681 . . . . 0.0 109.853 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.27 -40.42 93.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.429 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -60.75 -42.23 97.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.436 ' CD2' HG21 ' A' ' 29' ' ' VAL . 23.4 t-105 -61.18 -43.01 99.56 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -56.26 -45.31 80.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.038 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.54 ' CE3' ' HG2' ' A' ' 57' ' ' ARG . 11.7 m95 . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 121.19 0.519 . . . . 0.0 111.873 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 51.1 p -82.13 157.04 24.2 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.596 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.633 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 8.0 p -60.24 -38.66 78.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.78 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.22 -49.33 78.27 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.711 0.291 . . . . 0.0 110.803 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.593 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 48.1 mt-10 -59.43 -41.66 90.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.336 0.589 . . . . 0.0 111.502 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.693 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.8 m -66.61 -29.63 69.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.555 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.633 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 70.9 mm-40 -68.4 -36.72 79.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.593 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 33.2 m0 -63.61 -41.51 98.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.377 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 22' ' ' SER . 4.3 m -61.44 -37.61 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.386 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -65.54 -50.85 63.66 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.95 0.405 . . . . 0.0 110.725 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.0 98.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.73 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.52 -41.81 99.76 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.001 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 25' ' ' VAL . 67.9 t -65.94 -38.43 82.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.322 0.582 . . . . 0.0 109.762 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -68.99 -47.39 65.67 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.088 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -83.49 -46.53 12.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.491 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -88.01 -54.9 3.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.547 0.689 . . . . 0.0 110.647 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.39 133.57 4.17 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.669 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -52.58 146.67 9.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.047 0.451 . . . . 0.0 111.259 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.11 -37.05 3.73 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.636 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.416 ' O ' HG13 ' A' ' 40' ' ' ILE . 67.1 m-80 -82.62 48.59 1.33 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.019 0.438 . . . . 0.0 110.407 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -60.15 -40.47 89.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.73 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.35 -34.65 75.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.164 0.507 . . . . 0.0 111.158 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.71 -34.65 64.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.296 0.569 . . . . 0.0 110.187 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 36' ' ' ASN . 75.4 mt -70.61 -46.72 68.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.022 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 12.5 p -61.55 -38.16 86.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.881 0.372 . . . . 0.0 111.374 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -63.41 -45.84 89.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.413 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -85.38 -45.36 11.96 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 56.1 m-85 -73.56 150.1 88.83 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 121.033 0.444 . . . . 0.0 111.463 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.448 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 48.2 Cg_endo -68.99 44.1 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.675 2.917 . . . . 0.0 114.707 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.466 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 69.3 m-85 -73.14 107.35 5.42 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.474 ' C ' ' H ' ' A' ' 49' ' ' ARG . 2.9 p -86.53 119.56 34.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.984 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 65.4 -25.37 0.09 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.442 1.097 . . . . 0.0 112.801 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -64.91 121.07 13.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 111.025 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.8 p -78.62 171.32 15.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.07 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.79 -38.6 91.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.773 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.93 -37.16 77.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.438 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.429 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 19.9 mmt -59.86 -45.33 92.78 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.582 HG23 HG12 ' A' ' 25' ' ' VAL . 64.7 mt -65.36 -43.96 94.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.089 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -55.63 -49.59 72.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.83 0.824 . . . . 0.0 110.059 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -67.28 -42.35 83.97 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.81 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.54 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 10.0 tpp180 -59.75 -42.74 93.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.864 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -56.86 -44.11 81.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.114 0.483 . . . . 0.0 109.736 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -55.87 -45.8 78.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.424 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.399 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.514 ' HZ2' ' HB3' ' A' ' 53' ' ' MET . 10.6 m95 . . . . . 0 CA--C 1.513 -0.447 0 CA-C-O 121.287 0.565 . . . . 0.0 112.424 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -88.42 151.89 22.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.99 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.4 p -55.95 -37.24 47.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.837 -0.165 . . . . 0.0 111.377 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.501 ' HG3' ' CZ2' ' A' ' 24' ' ' TRP . 36.3 tp10 -59.32 -51.78 68.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.809 0.338 . . . . 0.0 110.777 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.497 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 52.3 mt-10 -60.73 -39.36 88.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.687 0.756 . . . . 0.0 110.862 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.662 ' O ' HG22 ' A' ' 25' ' ' VAL . 13.2 m -67.96 -34.02 75.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.259 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.71 -36.19 82.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.19 0.519 . . . . 0.0 110.337 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.501 ' CZ2' ' HG3' ' A' ' 20' ' ' GLU . 32.5 m0 -65.75 -43.98 87.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.518 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 22' ' ' SER . 3.0 m -58.82 -40.29 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.933 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -66.49 -44.85 81.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.819 0.342 . . . . 0.0 110.785 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.64 -44.31 90.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.779 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.65 96.13 Favored Glycine 0 C--O 1.224 -0.478 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.287 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.504 HG11 ' CZ2' ' A' ' 58' ' ' TRP . 22.8 t -60.08 -41.32 86.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.133 0.492 . . . . 0.0 110.965 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -74.48 -40.31 61.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.771 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.513 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 62.8 tttm -80.67 -46.13 16.07 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.513 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -91.73 -37.66 12.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.084 0.469 . . . . 0.0 111.35 -177.531 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.88 134.72 8.29 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.483 ' CG ' HG13 ' A' ' 29' ' ' VAL . 43.4 mt-10 -48.95 130.37 18.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.949 0.404 . . . . 0.0 111.47 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.18 -39.06 2.83 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.194 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.534 ' O ' HG13 ' A' ' 40' ' ' ILE . 66.6 m-80 -81.17 52.08 1.73 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.983 0.42 . . . . 0.0 110.932 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.428 ' NE1' ' HG3' ' A' ' 55' ' ' LYS . 33.8 m95 -63.7 -45.11 91.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.703 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.408 ' HA ' ' HB2' ' A' ' 51' ' ' ALA . . . -56.28 -44.03 79.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.808 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.15 -37.44 87.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.645 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 36' ' ' ASN . 82.8 mt -67.4 -48.19 78.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.356 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.559 ' HB3' HD12 ' A' ' 54' ' ' ILE . 6.4 p -61.47 -35.03 76.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.819 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -71.15 -52.27 20.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.003 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -75.09 -44.94 44.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.472 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 30.1 m-85 -71.65 154.44 93.09 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.116 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.89 38.0 0.15 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.147 2.565 . . . . 0.0 114.579 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 24' ' ' TRP . 78.9 m-85 -76.18 134.03 40.02 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.204 0.525 . . . . 0.0 109.832 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 4.3 p -134.25 135.26 54.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 74.9 m-80 76.5 -38.79 0.33 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.746 0.654 . . . . 0.0 110.422 -177.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.497 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 1.0 OUTLIER -69.87 128.96 38.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.416 179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.3 p -92.14 169.7 10.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.107 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . . . -64.85 -36.84 85.63 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.0 t -62.76 -36.25 74.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.514 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 17.9 mmt -64.77 -45.36 86.71 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.559 HD12 ' HB3' ' A' ' 41' ' ' SER . 78.6 mt -64.77 -44.2 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.18 0.514 . . . . 0.0 109.814 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HG3' ' NE1' ' A' ' 37' ' ' TRP . 39.5 ttmt -54.41 -50.81 66.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.323 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -70.93 -39.42 72.68 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.347 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.486 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 16.6 tpp180 -58.92 -35.62 73.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.714 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.504 ' CZ2' HG11 ' A' ' 29' ' ' VAL . 14.6 t-105 -59.55 -48.16 82.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.5 ttm105 -56.67 -46.93 80.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.393 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 7.5 p . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.577 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.549 ' HA ' ' NH2' ' A' ' 49' ' ' ARG . 15.1 m95 . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 121.674 0.75 . . . . 0.0 112.581 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.54 149.62 21.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.902 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.8 p -53.32 -36.76 27.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.563 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 35.8 tt0 -55.66 -60.17 3.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.737 0.303 . . . . 0.0 110.952 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.647 ' HG3' ' CZ3' ' A' ' 24' ' ' TRP . 2.7 mp0 -66.28 -30.98 71.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.193 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.662 ' O ' HG22 ' A' ' 25' ' ' VAL . 9.1 t -63.79 -39.84 95.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.761 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 21.1 mm-40 -65.28 -37.91 88.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.089 0.471 . . . . 0.0 111.08 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.647 ' CZ3' ' HG3' ' A' ' 21' ' ' GLU . 37.2 m0 -62.91 -43.1 99.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.587 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 22' ' ' SER . 4.2 m -60.21 -40.2 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.906 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -64.74 -44.59 89.66 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.875 0.369 . . . . 0.0 110.934 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.07 -43.99 73.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.244 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.95 -42.47 96.82 Favored Glycine 0 C--O 1.225 -0.426 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.924 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 25' ' ' VAL . 98.5 t -61.45 -38.95 81.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.199 0.523 . . . . 0.0 110.499 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -70.49 -45.81 64.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.794 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -78.93 -45.89 19.53 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -177.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CE1' ' HE1' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -88.32 -39.97 13.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.165 0.507 . . . . 0.0 111.336 -177.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.46 132.09 6.38 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -50.9 128.58 21.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.005 0.431 . . . . 0.0 111.053 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.73 -35.36 3.87 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.177 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.483 ' O ' HG13 ' A' ' 40' ' ' ILE . 77.2 m-20 -82.45 50.62 1.67 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.914 0.388 . . . . 0.0 111.292 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.413 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 35.7 m95 -60.66 -44.06 96.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.646 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.44 ' O ' ' HG2' ' A' ' 42' ' ' LYS . . . -59.5 -47.47 85.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.576 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.5 -42.99 93.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.702 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 36' ' ' ASN . 86.6 mt -60.8 -45.19 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.274 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.511 ' HB2' HD12 ' A' ' 54' ' ' ILE . 14.6 t -63.75 -38.19 90.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.154 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 73.0 mmtt -65.77 -46.14 79.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.059 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -82.65 -45.36 14.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.408 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 50.1 m-85 -76.15 147.39 79.85 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 120.925 0.393 . . . . 0.0 111.281 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.405 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 39.3 Cg_endo -68.28 46.85 0.36 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.777 2.985 . . . . 0.0 114.854 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -73.59 126.07 29.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.141 0.496 . . . . 0.0 111.281 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.462 ' O ' ' HD3' ' A' ' 49' ' ' ARG . 7.4 p -118.98 132.63 68.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 75.8 m-20 74.49 -40.31 0.44 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.379 0.671 . . . . 0.0 110.819 -177.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.698 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 0.8 OUTLIER -73.26 118.04 15.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.76 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.436 ' OG1' ' HG3' ' A' ' 53' ' ' MET . 45.6 p -86.93 179.08 6.78 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.19 95.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.829 0.347 . . . . 0.0 110.136 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -62.29 -37.71 79.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.821 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.698 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 90.4 mtp -61.9 -43.36 99.0 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.511 HD12 ' HB2' ' A' ' 41' ' ' SER . 75.8 mt -65.06 -44.32 95.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.413 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 37.9 ttpt -57.47 -48.24 79.71 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.715 0.769 . . . . 0.0 109.793 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.17 -37.77 84.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.007 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.449 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 26.7 tpt180 -59.63 -44.85 93.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.842 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -58.86 -45.04 91.07 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.636 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 51.4 ttm-85 -59.23 -42.74 91.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.376 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.449 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 1.2 p . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.271 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.584 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 41.5 m95 . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.077 0.465 . . . . 0.0 111.956 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.1 p -82.71 161.56 22.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.634 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.406 ' O ' ' HG3' ' A' ' 23' ' ' GLU . 10.0 t -60.79 -46.31 96.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.427 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.05 -42.57 85.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.273 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.646 ' HG2' ' CZ3' ' A' ' 24' ' ' TRP . 45.8 mt-10 -70.51 -33.53 71.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.174 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.592 ' O ' HG22 ' A' ' 25' ' ' VAL . 51.1 m -68.49 -35.5 77.6 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.233 0.539 . . . . 0.0 110.603 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 49.2 mt-10 -62.41 -37.72 86.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.83 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.646 ' CZ3' ' HG2' ' A' ' 21' ' ' GLU . 37.3 m0 -63.09 -41.96 99.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.819 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 22' ' ' SER . 2.0 m -59.01 -39.12 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.493 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.431 ' HG3' ' CH2' ' A' ' 58' ' ' TRP . 26.0 ttmt -66.21 -46.03 78.66 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.06 0.457 . . . . 0.0 110.628 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.76 -43.43 96.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.48 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.21 -39.17 96.81 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.119 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.589 HG13 ' HB2' ' A' ' 34' ' ' GLU . 54.0 t -61.95 -42.11 93.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.296 0.569 . . . . 0.0 110.332 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -72.79 -44.84 61.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.105 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -81.34 -49.5 10.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.473 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -84.84 -45.82 11.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.442 0.639 . . . . 0.0 111.017 -177.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.76 131.15 4.14 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.992 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.589 ' HB2' HG13 ' A' ' 29' ' ' VAL . 86.2 tt0 -55.34 108.57 0.43 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.065 0.459 . . . . 0.0 110.801 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.97 -35.28 1.93 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.495 ' O ' HG13 ' A' ' 40' ' ' ILE . 74.3 m-80 -82.2 53.2 2.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.14 0.495 . . . . 0.0 110.501 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.45 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 41.0 m95 -60.73 -43.17 98.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.965 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.31 99.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.68 0.276 . . . . 0.0 110.295 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -61.09 -43.0 99.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.945 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 36' ' ' ASN . 82.9 mt -63.26 -46.15 96.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.032 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.413 ' HB2' HD12 ' A' ' 54' ' ' ILE . 46.6 t -63.04 -38.32 90.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.339 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -68.1 -43.87 77.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.032 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -85.16 -46.43 11.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.41 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 50.3 m-85 -73.24 149.49 89.26 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.98 0.419 . . . . 0.0 111.171 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.506 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 37.6 Cg_endo -68.96 45.69 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.449 2.766 . . . . 0.0 114.638 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.584 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 58.6 m-85 -72.25 131.2 42.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.152 -0.343 . . . . 0.0 110.286 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.448 ' C ' ' H ' ' A' ' 49' ' ' ARG . 4.7 p -104.62 123.57 58.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.616 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 p30 63.92 -23.88 0.07 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.641 1.176 . . . . 0.0 113.431 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.598 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 5.1 mpt_? -65.42 133.19 50.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.047 0.451 . . . . 0.0 111.737 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.3 p -98.74 176.57 5.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.88 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.3 98.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.584 0.23 . . . . 0.0 111.092 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.53 -38.19 77.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.126 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.598 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 68.7 mtt -61.69 -43.74 98.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.709 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 41' ' ' SER . 62.8 mt -67.38 -42.78 87.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.224 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.45 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 40.3 ttpt -56.52 -49.12 75.67 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.541 0.686 . . . . 0.0 109.403 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -66.29 -43.17 87.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.239 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.425 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 29.8 tpt180 -58.58 -43.61 89.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.052 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.431 ' CH2' ' HG3' ' A' ' 26' ' ' LYS . 15.6 t-105 -61.14 -44.77 96.81 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -56.99 -47.63 80.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.641 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.425 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.666 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.528 ' HZ3' ' HE2' ' A' ' 46' ' ' PHE . 11.9 m95 . . . . . 0 N--CA 1.449 -0.508 0 CA-C-O 121.377 0.608 . . . . 0.0 112.047 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.5 p -84.36 151.2 24.86 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.352 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.39 -29.41 42.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.355 0.597 . . . . 0.0 109.755 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -60.68 -52.49 64.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.375 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.563 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 94.3 mt-10 -68.76 -36.56 78.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.065 0.459 . . . . 0.0 111.018 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.653 ' O ' HG22 ' A' ' 25' ' ' VAL . 23.9 m -59.23 -39.24 82.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.501 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -67.2 -32.1 72.94 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.938 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.563 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 37.9 m0 -66.28 -40.55 90.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.274 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 22' ' ' SER . 3.6 m -62.85 -36.82 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 120.847 0.356 . . . . 0.0 110.076 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -66.38 -45.0 81.57 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.972 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.54 -40.89 80.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.029 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.6 -38.81 94.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.133 -0.555 . . . . 0.0 112.841 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 25' ' ' VAL . 85.1 t -62.78 -39.16 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.357 0.599 . . . . 0.0 110.103 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -72.71 -49.99 27.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.218 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.594 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 39.7 ttmt -72.17 -47.92 47.28 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.594 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -93.96 -51.8 4.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.43 0.633 . . . . 0.0 111.123 -177.664 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.73 136.33 4.35 Favored Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.222 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.418 ' HB2' HG13 ' A' ' 29' ' ' VAL . 36.6 tt0 -53.06 120.74 6.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.991 0.424 . . . . 0.0 110.27 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.52 -35.05 3.87 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.943 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.471 ' O ' HG13 ' A' ' 40' ' ' ILE . 77.6 m-20 -80.1 53.75 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.008 0.432 . . . . 0.0 111.096 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -64.65 -40.7 95.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.514 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.62 -39.87 85.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.915 0.388 . . . . 0.0 110.933 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.04 -35.38 74.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.463 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 36' ' ' ASN . 89.0 mt -69.84 -45.83 75.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.616 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.607 ' HB3' HD12 ' A' ' 54' ' ' ILE . 19.8 p -64.87 -36.85 85.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.271 0.558 . . . . 0.0 110.696 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -64.75 -45.88 84.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.81 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -86.04 -50.39 7.08 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.549 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 54.8 m-85 -69.06 146.79 97.45 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.197 0.522 . . . . 0.0 111.465 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.414 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.5 Cg_endo -67.34 41.18 0.19 Allowed 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.926 3.084 . . . . 0.0 115.406 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.528 ' HE2' ' HZ3' ' A' ' 17' ' ' TRP . 73.3 m-85 -68.65 127.33 32.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.432 ' C ' ' H ' ' A' ' 49' ' ' ARG . 4.0 p -106.04 121.57 58.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.716 0.293 . . . . 0.0 110.459 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 30.0 m120 69.97 -29.83 0.19 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.55 0.74 . . . . 0.0 112.366 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.578 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -69.18 123.08 20.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.752 0.31 . . . . 0.0 110.604 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.612 ' OG1' ' HG2' ' A' ' 53' ' ' MET . 42.1 p -86.85 174.44 8.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.799 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.02 95.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.701 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.37 -38.83 82.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.612 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 21.5 mmt -60.91 -43.37 98.65 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.607 HD12 ' HB3' ' A' ' 41' ' ' SER . 83.5 mt -65.37 -45.35 93.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.352 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -55.96 -50.34 71.07 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.367 0.603 . . . . 0.0 109.958 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.26 -40.91 94.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.225 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.507 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 12.7 tpp180 -60.61 -41.65 95.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.554 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -57.48 -42.4 82.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.961 0.41 . . . . 0.0 110.223 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -56.28 -45.17 80.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.068 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.54 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.46 ' CE3' ' HB3' ' A' ' 21' ' ' GLU . 27.5 m95 . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 121.66 0.743 . . . . 0.0 112.666 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.04 155.76 20.02 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.891 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.417 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 10.3 p -58.32 -39.03 72.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.447 0.165 . . . . 0.0 111.138 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.402 ' HG3' ' CZ2' ' A' ' 24' ' ' TRP . 5.1 tp10 -58.65 -52.76 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.111 0.482 . . . . 0.0 110.155 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.521 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 5.6 mp0 -58.35 -39.55 79.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.33 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.602 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.0 m -67.26 -35.85 80.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.001 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 65.4 mm-40 -64.58 -36.85 85.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.327 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.521 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 44.3 m0 -63.32 -46.38 86.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.419 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 22' ' ' SER . 3.5 m -61.17 -35.68 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.312 0.577 . . . . 0.0 109.983 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.52 ' HA ' ' CZ3' ' A' ' 58' ' ' TRP . 19.3 ttpt -65.59 -49.3 69.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.029 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.81 -41.3 68.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.314 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.81 -45.52 93.42 Favored Glycine 0 C--O 1.22 -0.737 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.408 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 25' ' ' VAL . 91.9 t -64.05 -39.27 84.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 117.67 0.735 . . . . 0.0 110.861 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -66.7 -37.49 84.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.399 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -90.35 -41.92 11.23 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -177.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.434 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -89.69 -52.28 5.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.387 0.613 . . . . 0.0 110.879 -178.04 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.08 134.93 4.71 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.353 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -51.77 139.64 21.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.044 0.449 . . . . 0.0 110.972 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.87 -32.9 7.01 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.479 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.45 ' O ' HG13 ' A' ' 40' ' ' ILE . 74.3 m-80 -84.25 48.64 1.52 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.037 0.446 . . . . 0.0 111.126 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.425 ' HH2' ' CD1' ' A' ' 58' ' ' TRP . 28.2 m95 -60.87 -38.2 84.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.697 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.97 89.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.608 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -68.43 -39.55 81.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.856 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 36' ' ' ASN . 60.9 mt -68.62 -44.76 82.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.821 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.545 ' HB3' HD12 ' A' ' 54' ' ' ILE . 3.7 p -65.15 -32.38 74.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.646 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -70.89 -50.69 32.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.054 0.454 . . . . 0.0 111.528 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -76.61 -47.32 22.72 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -75.89 144.63 76.5 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.092 0.472 . . . . 0.0 111.567 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.454 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 36.6 Cg_endo -67.13 46.78 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.191 3.261 . . . . 0.0 115.309 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -71.97 135.32 46.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.348 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 9.0 p -129.74 133.46 64.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 78.8 m-20 76.81 -35.94 0.25 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.284 0.633 . . . . 0.0 110.574 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.719 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 7.1 mpt_? -77.46 130.04 36.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.311 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.6 p -92.9 174.21 7.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.704 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.3 -35.41 80.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -64.93 -38.61 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.599 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.719 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 60.1 mtt -62.57 -40.68 97.62 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.545 HD12 ' HB3' ' A' ' 41' ' ' SER . 86.4 mt -68.06 -44.77 84.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.403 ' HB3' ' HE3' ' A' ' 55' ' ' LYS . 24.1 ttpp -53.92 -49.91 67.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.868 0.842 . . . . 0.0 109.467 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -67.84 -44.12 77.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.573 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -58.38 -40.37 82.11 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.503 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.52 ' CZ3' ' HA ' ' A' ' 26' ' ' LYS . 30.3 t-105 -60.73 -45.37 94.54 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.864 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -56.83 -43.19 80.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.704 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.226 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.651 ' HA ' ' NH2' ' A' ' 49' ' ' ARG . 35.8 m95 . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.9 p -111.85 161.09 16.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.222 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.416 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 7.3 p -53.82 -41.58 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.473 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 87.2 tt0 -59.13 -50.12 75.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.894 0.378 . . . . 0.0 110.942 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.494 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 54.1 mt-10 -64.59 -34.27 77.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.203 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.474 ' O ' HG22 ' A' ' 25' ' ' VAL . 23.1 t -69.21 -24.7 64.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.85 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 31.6 mm-40 -69.31 -40.66 77.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.082 0.467 . . . . 0.0 110.362 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.547 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 15.2 m0 -66.48 -40.12 89.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.418 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.916 HG12 HG23 ' A' ' 54' ' ' ILE . 34.6 m -61.02 -46.13 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.692 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -65.31 -41.73 93.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.112 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.41 -43.65 80.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.056 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.42 -38.12 95.88 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.188 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.684 HG13 ' HB3' ' A' ' 34' ' ' GLU . 68.4 t -61.17 -33.6 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.477 0.656 . . . . 0.0 110.118 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -77.12 -50.99 11.79 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.923 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.705 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 14.5 tmtt? -78.41 -47.57 17.3 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.705 ' CE1' ' HD2' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -86.71 -36.03 18.92 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.321 0.581 . . . . 0.0 110.965 -177.807 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.9 130.78 7.1 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.684 ' HB3' HG13 ' A' ' 29' ' ' VAL . 22.1 pt-20 -54.68 125.71 21.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.222 0.534 . . . . 0.0 110.48 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.07 -40.73 1.72 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.527 ' O ' HG13 ' A' ' 40' ' ' ILE . 74.4 m-80 -82.78 51.08 1.82 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.126 0.489 . . . . 0.0 110.385 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.415 ' NE1' ' HG3' ' A' ' 55' ' ' LYS . 40.9 m95 -60.27 -40.74 91.45 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.823 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.69 -46.67 84.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.703 0.287 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.01 85.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.439 . . . . 0.0 110.764 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 36' ' ' ASN . 67.8 mt -65.76 -43.52 93.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.679 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.411 ' OG ' HD12 ' A' ' 54' ' ' ILE . 12.9 m -62.22 -40.32 95.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.839 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.708 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -64.1 -55.52 21.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.356 -179.026 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -75.47 -47.48 26.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.421 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 61.0 m-85 -72.52 148.19 90.25 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.117 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.547 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 49.6 Cg_endo -69.56 43.94 0.38 Allowed 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.504 2.803 . . . . 0.0 114.164 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 24' ' ' TRP . 47.2 m-85 -72.56 99.03 2.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.862 0.363 . . . . 0.0 110.426 178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 6.5 p -88.32 127.19 41.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 50.0 m-20 74.34 -36.03 0.32 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.238 0.615 . . . . 0.0 111.732 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.651 ' NH2' ' HA ' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -60.46 128.45 36.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.051 0.453 . . . . 0.0 112.175 -179.009 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.4 p -90.59 165.05 13.96 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.139 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.91 82.21 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.26 -38.66 82.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.38 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.537 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 3.5 mmt -59.77 -45.41 92.35 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.916 HG23 HG12 ' A' ' 25' ' ' VAL . 75.2 mt -65.48 -44.04 94.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.181 0.515 . . . . 0.0 110.055 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.415 ' HG3' ' NE1' ' A' ' 37' ' ' TRP . 38.9 ttmt -55.11 -51.97 64.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.429 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.51 -39.29 81.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.292 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.527 HH11 ' HG3' ' A' ' 57' ' ' ARG . 3.6 tpt85 -57.5 -40.07 77.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.4 ' CE3' ' HA ' ' A' ' 58' ' ' TRP . 11.8 t-105 -63.57 -42.49 98.32 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -56.18 -44.84 79.75 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.367 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.389 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 28.8 m95 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 121.36 0.6 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -94.55 148.52 22.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.999 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.69 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 14.6 p -49.51 -37.99 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -59.12 -49.17 78.9 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -64.38 -36.41 84.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.404 0.621 . . . . 0.0 110.082 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.67 ' O ' HG22 ' A' ' 25' ' ' VAL . 47.4 m -67.45 -27.57 67.15 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.923 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.69 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 69.7 mm-40 -66.37 -40.75 89.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.219 0.533 . . . . 0.0 110.167 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.522 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 21.6 m0 -64.16 -38.04 89.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.948 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 22' ' ' SER . 4.2 m -62.92 -38.58 82.3 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.81 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -68.93 -46.5 68.09 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.053 0.454 . . . . 0.0 110.388 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.13 99.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.606 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.59 -38.96 93.72 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.265 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 25' ' ' VAL . 38.6 t -64.32 -38.23 82.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.304 0.552 . . . . 0.0 110.422 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -73.34 -43.3 61.04 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.279 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -80.49 -50.54 9.91 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.463 ' CE1' ' HE1' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -88.72 -45.18 10.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.448 0.642 . . . . 0.0 111.186 -178.354 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 29' ' ' VAL . . . 112.44 131.69 5.65 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -57.82 124.69 20.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.416 0.627 . . . . 0.0 110.608 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.06 -39.57 1.69 Allowed Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.453 ' O ' HG13 ' A' ' 40' ' ' ILE . 75.5 m-80 -82.51 51.03 1.76 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.962 0.411 . . . . 0.0 110.482 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -60.44 -38.62 84.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.565 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.28 99.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.058 0.456 . . . . 0.0 110.276 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.37 -37.04 77.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.055 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 36' ' ' ASN . 67.1 mt -67.36 -45.58 85.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.685 ' HB3' HD12 ' A' ' 54' ' ' ILE . 4.5 p -63.7 -33.85 76.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 0.0 110.8 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -67.11 -48.81 67.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.601 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -82.86 -41.38 19.07 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 45.1 m-85 -79.5 147.43 67.88 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.09 0.471 . . . . 0.0 111.528 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.25 44.26 0.19 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 124.171 3.247 . . . . 0.0 114.735 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.412 ' HB3' ' HB2' ' A' ' 49' ' ' ARG . 60.3 m-85 -76.52 106.52 8.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.888 0.375 . . . . 0.0 110.148 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 49' ' ' ARG . 7.7 p -100.14 131.08 48.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 73.14 -26.22 0.19 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.549 0.74 . . . . 0.0 111.256 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.451 ' H ' ' C ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -72.23 125.61 27.74 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 111.56 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.3 p -89.5 154.94 19.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.499 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.34 -38.91 69.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.644 0.259 . . . . 0.0 110.9 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -63.85 -41.1 91.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.359 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 68.8 mmm -63.27 -41.19 99.0 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.685 HD12 ' HB3' ' A' ' 41' ' ' SER . 76.7 mt -63.34 -44.94 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -56.92 -53.73 54.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.152 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -64.95 -37.5 87.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.728 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.425 ' O ' ' HD3' ' A' ' 57' ' ' ARG . 8.3 tpp180 -59.58 -33.81 71.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.528 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.45 ' CZ2' HG11 ' A' ' 29' ' ' VAL . 12.6 t-105 -60.68 -43.92 97.14 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -55.45 -49.19 73.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.21 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.41 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.715 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.578 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 12.3 m95 . . . . . 0 CA--C 1.519 -0.234 0 CA-C-O 120.821 0.344 . . . . 0.0 111.836 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -77.35 151.56 34.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.553 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 9.8 p -55.5 -36.17 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.919 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.486 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 32.7 tt0 -59.77 -45.49 92.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.045 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 42.1 mt-10 -64.71 -42.36 95.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.685 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.649 ' O ' HG22 ' A' ' 25' ' ' VAL . 2.0 p -66.9 -28.36 68.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.445 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 66.3 mm-40 -67.73 -35.95 79.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.897 0.38 . . . . 0.0 110.328 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.486 ' CZ2' ' HG2' ' A' ' 20' ' ' GLU . 30.9 m0 -66.57 -42.84 86.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.411 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 22' ' ' SER . 3.3 m -58.95 -39.46 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.815 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -64.67 -43.51 93.36 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.044 0.45 . . . . 0.0 110.344 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.69 -44.1 91.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.618 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.03 -38.09 95.52 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.427 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 25' ' ' VAL . 69.3 t -62.97 -39.97 87.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.253 0.549 . . . . 0.0 110.323 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -74.4 -45.95 43.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.008 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.485 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 60.3 tttm -80.98 -45.51 16.51 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -177.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.486 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -89.63 -51.22 5.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.32 0.581 . . . . 0.0 110.594 -177.703 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.34 135.44 4.23 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.513 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -55.16 113.54 1.42 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.979 0.418 . . . . 0.0 110.16 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.44 -35.26 2.72 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.998 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.529 ' O ' HG13 ' A' ' 40' ' ' ILE . 75.4 m-20 -80.48 49.26 1.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.006 0.432 . . . . 0.0 111.187 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 33.5 m95 -60.68 -40.45 92.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.432 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.89 -37.43 79.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 110.965 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.73 -32.75 68.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.403 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 36' ' ' ASN . 73.7 mt -71.57 -46.81 61.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.736 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.469 ' HB3' HD12 ' A' ' 54' ' ' ILE . 54.6 p -62.72 -35.31 79.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.186 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -65.6 -53.45 41.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.617 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.0 -48.43 16.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.406 ' CD1' HG23 ' A' ' 40' ' ' ILE . 62.3 m-85 -71.21 151.11 94.54 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 120.934 0.397 . . . . 0.0 111.581 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.419 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 37.1 Cg_endo -67.35 43.28 0.22 Allowed 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.787 2.991 . . . . 0.0 114.445 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.578 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 65.6 m-85 -76.33 115.48 16.11 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.458 ' C ' ' H ' ' A' ' 49' ' ' ARG . 3.6 p -95.9 125.28 48.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.193 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 p30 64.54 -30.71 0.12 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.709 1.204 . . . . 0.0 112.904 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.571 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -61.26 116.18 4.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 111.339 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.6 p -78.9 173.61 12.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.694 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.69 -39.22 93.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.223 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.6 t -62.89 -39.17 83.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.776 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 81.2 mmm -58.87 -42.82 90.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.715 178.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.474 HG23 HG12 ' A' ' 25' ' ' VAL . 67.6 mt -69.12 -44.49 80.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.298 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 39.2 ttpt -55.07 -53.8 51.17 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.829 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -62.13 -40.35 95.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.834 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.473 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 6.8 tpp180 -56.41 -42.3 77.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.924 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 15.7 t-105 -59.37 -43.42 92.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.867 0.365 . . . . 0.0 110.357 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.445 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 1.8 mpt_? -59.66 -43.95 93.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.21 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.367 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.602 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 28.6 m95 . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 57.5 p -81.98 162.18 22.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.427 ' O ' ' HG3' ' A' ' 23' ' ' GLU . 9.6 p -57.9 -40.22 75.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 121.347 -0.141 . . . . 0.0 111.233 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.507 ' HG3' ' CE2' ' A' ' 24' ' ' TRP . 45.4 tp10 -60.92 -50.81 71.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.236 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.581 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 39.1 mt-10 -58.0 -42.41 85.15 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.487 0.66 . . . . 0.0 111.164 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.63 ' O ' HG22 ' A' ' 25' ' ' VAL . 15.1 m -66.81 -36.49 82.5 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.166 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 19.9 mt-10 -67.53 -31.77 72.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.949 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.581 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 47.5 m0 -61.89 -41.93 98.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.49 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.63 HG22 ' O ' ' A' ' 22' ' ' SER . 1.4 m -63.46 -37.5 79.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.391 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -66.18 -47.97 72.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.058 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.28 -37.33 85.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.591 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.29 -39.4 94.6 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.827 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 25' ' ' VAL . 92.7 t -61.32 -37.8 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.456 0.646 . . . . 0.0 110.176 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -76.18 -47.15 25.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.027 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.8 -48.79 65.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.99 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -107.67 -47.85 3.53 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.341 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.69 142.63 5.02 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.197 -1.001 . . . . 0.0 112.479 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.94 126.3 26.46 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.67 -31.34 6.9 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.718 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.403 ' O ' HG13 ' A' ' 40' ' ' ILE . 68.3 m-80 -83.19 47.71 1.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.071 0.463 . . . . 0.0 110.808 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.42 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 36.7 m95 -61.84 -37.54 84.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.111 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.95 -47.54 85.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.045 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.83 -40.83 98.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.219 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.452 HG22 ' HE2' ' A' ' 46' ' ' PHE . 97.8 mt -63.33 -45.67 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.508 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.405 ' HB2' HD12 ' A' ' 54' ' ' ILE . 16.7 t -64.4 -34.69 78.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.225 0.536 . . . . 0.0 110.481 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -67.82 -51.14 52.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.934 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -77.5 -50.73 12.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.947 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -73.02 145.75 86.61 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.055 0.455 . . . . 0.0 111.115 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.507 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.0 Cg_endo -66.63 45.07 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.013 3.142 . . . . 0.0 115.102 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.602 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 70.5 m-85 -71.18 122.74 20.73 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.262 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 p -103.76 124.0 57.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.861 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 70.73 -39.14 0.44 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.537 0.735 . . . . 0.0 111.939 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.05 118.95 5.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.2 p -80.61 175.26 10.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.163 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.29 -36.93 84.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 t -63.98 -38.83 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.603 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 84.9 mmm -59.39 -43.16 93.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.429 HG23 HG12 ' A' ' 25' ' ' VAL . 70.9 mt -67.43 -44.35 86.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.405 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 40.1 ttpt -57.14 -47.55 80.87 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.401 0.62 . . . . 0.0 109.828 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -67.33 -40.87 85.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.72 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.413 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 30.0 tpt180 -60.57 -40.36 91.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.099 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -59.85 -44.47 94.1 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 -59.74 -45.56 91.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.335 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.413 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 17.7 p . . . . . 0 CA--C 1.532 0.267 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.857 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.549 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 13.6 m95 . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 120.969 0.414 . . . . 0.0 111.667 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.5 p -79.3 155.33 28.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.284 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.2 p -58.38 -33.85 48.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.926 0.393 . . . . 0.0 110.668 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.73 -49.31 75.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.133 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.439 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 33.8 mt-10 -63.97 -40.15 95.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.543 0.687 . . . . 0.0 110.489 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.593 ' O ' HG22 ' A' ' 25' ' ' VAL . 25.0 m -63.05 -35.58 80.73 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.365 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -65.46 -32.39 73.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.075 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.453 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 41.1 m0 -66.76 -46.0 76.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.675 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 22' ' ' SER . 3.3 m -62.51 -37.79 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.998 0.428 . . . . 0.0 110.18 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -63.19 -46.18 88.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.913 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.31 -40.28 64.62 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.214 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.44 -41.67 97.18 Favored Glycine 0 C--O 1.226 -0.377 0 CA-C-N 116.114 -0.494 . . . . 0.0 113.052 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 34' ' ' GLU . 66.2 t -62.23 -40.32 87.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.247 0.546 . . . . 0.0 110.748 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -73.55 -44.92 56.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.04 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.473 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 62.1 tttp -75.46 -50.32 16.13 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.473 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -87.3 -53.15 4.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.443 0.639 . . . . 0.0 110.867 -178.283 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.21 133.2 3.53 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.687 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.607 ' HB2' HG13 ' A' ' 29' ' ' VAL . 35.5 tt0 -55.42 121.5 9.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.918 0.389 . . . . 0.0 110.661 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.15 -34.01 3.83 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.014 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.459 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.2 m-80 -80.19 53.91 1.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.075 0.464 . . . . 0.0 111.243 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -64.52 -36.56 84.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.951 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.83 98.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.072 0.463 . . . . 0.0 110.545 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.77 -37.72 73.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.006 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 36' ' ' ASN . 74.1 mt -66.56 -46.53 86.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.867 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.526 ' HB3' HD12 ' A' ' 54' ' ' ILE . 3.8 p -62.88 -37.51 87.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.193 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -65.83 -52.69 48.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.09 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -76.72 -47.08 23.01 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.402 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 53.3 m-85 -71.25 149.14 94.15 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.989 0.423 . . . . 0.0 111.07 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.453 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 40.7 Cg_endo -67.84 43.19 0.25 Allowed 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.685 2.923 . . . . 0.0 114.773 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.549 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 73.4 m-85 -74.7 127.77 33.93 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 49' ' ' ARG . 7.5 p -115.72 132.68 64.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 p30 66.03 -30.19 0.14 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.655 1.182 . . . . 0.0 112.366 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -67.8 125.77 27.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.728 0.299 . . . . 0.0 110.981 179.229 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.9 p -89.34 169.82 11.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.621 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.65 89.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.485 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.95 -38.03 80.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.501 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 14.5 mmt -62.07 -44.1 97.4 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.526 HD12 ' HB3' ' A' ' 41' ' ' SER . 77.4 mt -64.15 -44.51 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.938 0.399 . . . . 0.0 110.009 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -55.91 -50.23 71.25 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.901 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.51 -42.86 86.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.5 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.493 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 8.9 tpp180 -60.42 -38.3 83.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.623 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.482 ' CD2' HG21 ' A' ' 29' ' ' VAL . 27.4 t-105 -60.35 -44.69 95.31 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -57.86 -46.71 84.4 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.533 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.493 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.922 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 m -64.3 130.27 43.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.704 0.288 . . . . 0.0 110.81 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -62.8 -42.89 99.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.946 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.26 106.28 1.17 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.209 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -72.73 -47.26 48.48 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.537 0.684 . . . . 0.0 110.223 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -174.63 -44.55 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.097 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 m -148.55 41.77 0.96 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.192 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.7 m -59.35 -53.85 53.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.576 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.727 ' HB ' HG13 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -82.64 133.16 35.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.064 0.459 . . . . 0.0 110.742 178.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -80.57 39.2 0.46 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.486 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.727 HG13 ' HB ' ' A' ' 9' ' ' THR . 1.5 pp -90.78 19.44 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.099 0.476 . . . . 0.0 111.375 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 p -83.32 -47.78 11.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.558 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -80.22 141.98 35.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.724 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.493 ' NZ ' ' HB3' ' A' ' 14' ' ' LYS . 1.6 ttpm? 59.17 83.88 0.12 Allowed 'General case' 0 C--O 1.238 0.455 0 O-C-N 123.66 0.6 . . . . 0.0 110.869 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 63.63 -167.72 0.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.151 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -168.46 121.91 0.87 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.636 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 16.4 m95 -133.25 147.39 51.95 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -87.03 154.6 20.64 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.595 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 14.7 p -57.6 -42.53 81.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -60.37 -45.68 92.65 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.784 0.325 . . . . 0.0 110.941 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.477 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 68.7 mt-10 -61.28 -36.41 79.99 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.493 0.663 . . . . 0.0 110.107 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.675 ' O ' HG22 ' A' ' 25' ' ' VAL . 22.0 m -69.8 -29.69 67.05 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.705 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.595 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 68.1 mm-40 -69.57 -39.25 77.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.243 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.515 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 33.6 m0 -61.17 -43.77 98.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.219 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 22' ' ' SER . 3.1 m -58.63 -38.31 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.001 0.429 . . . . 0.0 110.263 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -67.18 -49.58 64.14 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.793 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.88 -43.22 99.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.736 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.9 -38.84 96.68 Favored Glycine 0 C--O 1.224 -0.524 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.566 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 25' ' ' VAL . 55.7 t -63.21 -35.76 73.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.037 0.446 . . . . 0.0 110.909 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.3 tm0? -80.28 -46.61 15.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.947 0.403 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.723 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 39.5 ttmt -74.46 -45.72 44.41 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.723 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -93.28 -46.11 7.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.211 0.529 . . . . 0.0 110.98 -177.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.78 134.05 5.05 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.168 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.423 ' HB2' HG13 ' A' ' 29' ' ' VAL . 87.3 tt0 -54.23 118.65 4.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.871 0.367 . . . . 0.0 110.476 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.12 -38.54 2.0 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.817 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.503 ' O ' HG13 ' A' ' 40' ' ' ILE . 74.0 m-20 -79.83 54.11 1.78 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.142 0.496 . . . . 0.0 111.114 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -62.76 -39.11 93.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.581 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.11 -46.58 89.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.105 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.68 87.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.966 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 36' ' ' ASN . 75.1 mt -66.87 -43.21 89.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.003 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.467 ' OG ' HD12 ' A' ' 54' ' ' ILE . 14.9 m -60.37 -39.05 85.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.229 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -70.61 -55.13 9.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.885 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -72.48 -40.9 66.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 60.8 m-85 -83.1 146.15 50.89 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.546 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.515 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 35.9 Cg_endo -66.09 43.12 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.723 2.949 . . . . 0.0 115.041 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.636 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 64.6 m-85 -72.92 111.56 8.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.858 0.361 . . . . 0.0 110.079 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.4 127.86 51.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 33.0 m120 72.97 -41.52 0.51 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.475 0.71 . . . . 0.0 111.368 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.447 ' NH2' ' HA ' ' A' ' 17' ' ' TRP . 1.0 OUTLIER -58.48 120.39 8.72 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 122.598 0.359 . . . . 0.0 111.277 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.3 p -86.04 172.17 10.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.206 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.68 83.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.455 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.29 -39.78 86.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.102 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 19.1 mmt -62.09 -41.71 98.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.317 -0.402 . . . . 0.0 109.959 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.467 HD12 ' OG ' ' A' ' 41' ' ' SER . 66.0 mt -67.28 -42.3 87.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -56.94 -50.66 71.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.557 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -64.53 -44.46 90.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.627 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.415 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 32.0 tpt180 -58.47 -45.13 89.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.388 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.492 ' CD1' ' HD2' ' A' ' 62' ' ' LYS . 30.7 t-105 -62.66 -41.91 99.32 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.297 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -58.11 -44.97 88.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.934 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.583 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 24.5 p -66.02 -39.61 90.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.959 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 63.5 mmm -59.45 -47.25 86.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.998 0.428 . . . . 0.0 110.026 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.492 ' HD2' ' CD1' ' A' ' 58' ' ' TRP . 49.7 mtpt -60.72 -42.91 98.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.643 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -61.32 -42.59 98.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.892 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 60' ' ' THR . 62.4 mt -75.54 -4.56 40.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.033 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.56 37.41 35.35 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.244 -0.503 . . . . 0.0 112.199 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 69.3 mtm -119.16 47.31 1.7 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.993 0.425 . . . . 0.0 110.464 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 . . . . . 0 C--O 1.248 1.015 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.626 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t -164.98 120.24 1.36 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -82.75 57.49 3.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.88 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.4 mmt -125.13 63.45 1.16 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.042 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -72.24 134.57 45.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.686 0.279 . . . . 0.0 110.541 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -167.07 -169.38 1.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.177 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.8 t -171.26 -139.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.4 m -162.57 -51.26 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 m -68.04 -46.22 71.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.975 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -162.03 155.41 20.84 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.272 -0.171 . . . . 0.0 111.049 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.5 mt 69.46 112.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 124.04 0.838 . . . . 0.0 111.637 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m 70.95 -44.13 0.58 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.356 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 71.38 -178.06 0.21 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.377 0.671 . . . . 0.0 110.272 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.839 ' HA ' ' HE3' ' A' ' 14' ' ' LYS . 0.6 OUTLIER -86.13 76.1 9.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.898 0.38 . . . . 0.0 110.608 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -79.28 45.77 0.67 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.053 0.454 . . . . 0.0 110.722 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.616 ' HD3' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -66.31 143.7 57.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.088 0.47 . . . . 0.0 111.297 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.466 ' CE3' ' HB3' ' A' ' 21' ' ' GLU . 14.0 m95 -116.19 132.31 56.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.585 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -79.5 156.39 27.82 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.81 -41.83 76.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.511 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -65.75 -45.83 81.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.528 0.204 . . . . 0.0 110.5 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.466 ' HB3' ' CE3' ' A' ' 17' ' ' TRP . 35.1 mt-10 -55.55 -43.44 75.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.638 0.733 . . . . 0.0 110.533 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.572 ' O ' HG22 ' A' ' 25' ' ' VAL . 17.5 m -66.75 -37.15 84.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.819 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -63.66 -35.27 79.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.982 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.465 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 44.2 m0 -61.89 -44.96 95.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.822 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 22' ' ' SER . 1.4 m -62.2 -40.17 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 26' ' ' LYS . 24.2 ttpt -65.14 -46.81 79.39 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.273 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.12 -44.08 97.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.158 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.26 95.97 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.273 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.659 HG13 ' HB2' ' A' ' 34' ' ' GLU . 50.2 t -63.22 -41.06 91.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.25 0.547 . . . . 0.0 110.178 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -75.03 -45.62 40.5 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.77 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.478 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 61.7 tttm -79.64 -52.97 7.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.478 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -82.68 -54.65 4.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.483 0.658 . . . . 0.0 110.456 -178.583 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.74 130.86 3.29 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.096 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.659 ' HB2' HG13 ' A' ' 29' ' ' VAL . 36.8 tt0 -51.39 128.88 23.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.811 0.339 . . . . 0.0 110.892 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.37 -35.3 4.18 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.837 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.484 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.0 m-80 -81.11 51.85 1.67 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.884 0.373 . . . . 0.0 111.08 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.451 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 32.9 m95 -62.26 -42.91 99.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.788 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.39 88.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.791 0.329 . . . . 0.0 110.731 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.66 -42.91 98.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.473 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 36' ' ' ASN . 89.0 mt -62.47 -45.6 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.598 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.543 ' HB2' HD12 ' A' ' 54' ' ' ILE . 29.5 t -61.43 -36.33 80.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.068 0.461 . . . . 0.0 111.087 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -68.18 -49.96 57.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.95 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -77.8 -52.69 8.5 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.612 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.436 ' CD1' HG23 ' A' ' 40' ' ' ILE . 57.6 m-85 -67.9 147.45 98.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.119 0.485 . . . . 0.0 111.329 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.429 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.6 Cg_endo -66.98 44.57 0.22 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.819 3.012 . . . . 0.0 115.212 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.451 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 75.7 m-85 -71.36 124.85 25.48 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.774 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.42 ' C ' ' H ' ' A' ' 49' ' ' ARG . 2.4 p -101.83 118.54 48.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.089 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.1 -30.38 0.15 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.543 1.137 . . . . 0.0 112.964 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.557 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -60.91 119.51 8.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.234 0.54 . . . . 0.0 111.771 -179.16 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 p -79.05 169.95 17.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.945 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.23 -38.61 89.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.303 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.87 -40.21 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.4 mmt -61.3 -40.84 95.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.543 HD12 ' HB2' ' A' ' 41' ' ' SER . 82.3 mt -67.11 -44.16 88.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 37.7 ttpt -56.98 -48.87 77.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.696 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -66.64 -39.46 88.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.883 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.445 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 27.6 tpt180 -59.32 -43.58 92.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.32 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.402 ' O ' ' HG3' ' A' ' 62' ' ' LYS . 10.9 t-105 -58.62 -45.27 89.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.464 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 57.2 ttp180 -60.9 -46.25 91.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.722 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 27.9 p -62.1 -39.12 91.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.288 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 84.3 mtp -64.38 -41.18 96.83 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.464 ' HD3' ' HA ' ' A' ' 59' ' ' ARG . 54.6 mtpt -63.74 -38.25 90.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.409 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.544 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 4.7 tpm_? -60.09 -46.14 90.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.144 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.57 -22.36 61.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.304 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.83 28.58 31.41 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 63.7 mtt -107.13 26.66 9.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.232 0.539 . . . . 0.0 110.22 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.302 179.852 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.672 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.8 m 62.42 -91.84 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.023 0.529 . . . . 0.0 112.277 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -80.09 38.12 0.4 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.201 0.524 . . . . 0.0 111.12 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 20.7 mmt -151.05 131.89 14.14 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -80.88 38.48 0.46 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.461 0.648 . . . . 0.0 110.941 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.69 -15.81 50.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.029 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.9 p 57.1 25.4 10.8 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.555 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.5 p -75.78 -43.36 46.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -69.5 138.17 53.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.772 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -67.72 129.68 40.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.2 mt -140.2 34.26 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.621 0.724 . . . . 0.0 109.906 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.7 m -66.7 -35.71 80.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.774 0.797 . . . . 0.0 109.379 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 14' ' ' LYS . 19.4 ptpt -72.82 -9.1 58.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.994 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 39.2 ttpt 76.29 145.64 0.09 Allowed 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.904 0.752 . . . . 0.0 109.446 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -50.08 125.19 11.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.398 0.618 . . . . 0.0 112.165 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -100.05 150.51 22.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.379 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.474 ' HZ3' ' HE2' ' A' ' 46' ' ' PHE . 14.3 m95 -124.25 134.12 53.32 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.435 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.0 p -79.33 156.41 28.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.344 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.52 -31.52 50.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.437 ' HG3' ' CZ2' ' A' ' 24' ' ' TRP . 3.2 tp10 -59.76 -51.74 68.47 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.593 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.511 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 29.1 mt-10 -64.31 -38.15 90.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.596 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.585 ' O ' HG22 ' A' ' 25' ' ' VAL . 22.6 m -64.89 -41.92 95.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.341 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -63.04 -32.9 74.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.96 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.511 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 47.0 m0 -65.88 -46.23 79.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.887 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 22' ' ' SER . 2.3 m -60.93 -39.31 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -67.21 -47.31 71.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.621 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.66 -42.39 98.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.516 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.32 -36.46 93.1 Favored Glycine 0 C--O 1.222 -0.645 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.969 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 25' ' ' VAL . 53.7 t -65.7 -34.28 69.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.181 0.515 . . . . 0.0 110.072 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -75.43 -48.08 24.42 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.214 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.496 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 24.8 ttmm -79.9 -48.22 13.8 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -177.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.496 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -90.8 -44.01 9.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.414 0.626 . . . . 0.0 111.101 -178.112 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 29' ' ' VAL . . . 106.97 132.37 6.98 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -56.62 139.17 50.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.373 0.606 . . . . 0.0 110.834 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.31 -38.11 3.01 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -85.65 49.34 1.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.107 0.479 . . . . 0.0 110.148 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.425 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 42.1 m95 -60.22 -38.28 82.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.222 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.22 -45.66 90.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.995 0.426 . . . . 0.0 110.133 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 -44.59 91.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.81 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.5 mt -61.31 -44.1 97.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.786 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.503 ' HB2' HD12 ' A' ' 54' ' ' ILE . 31.9 t -64.65 -37.66 88.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.814 0.34 . . . . 0.0 111.039 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -64.9 -49.23 71.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.258 0.551 . . . . 0.0 111.604 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -79.0 -48.61 14.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.956 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -75.31 141.53 73.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 0.0 111.869 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.511 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.4 Cg_endo -66.39 48.93 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 124.298 3.332 . . . . 0.0 115.257 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.474 ' HE2' ' HZ3' ' A' ' 17' ' ' TRP . 60.8 m-85 -72.15 109.85 6.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.87 0.366 . . . . 0.0 110.202 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 49' ' ' ARG . 4.0 p -84.82 122.26 37.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.471 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 69.88 -34.04 0.27 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.557 0.743 . . . . 0.0 112.27 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.626 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -63.06 127.88 33.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.248 0.547 . . . . 0.0 111.789 -179.131 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.4 p -93.29 176.56 6.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.127 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.95 -38.57 91.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.667 0.27 . . . . 0.0 110.299 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.7 t -63.52 -38.76 83.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.485 ' HA ' ' CE ' ' A' ' 53' ' ' MET . 14.0 mmt -59.37 -44.99 92.65 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.551 HG23 HG12 ' A' ' 25' ' ' VAL . 68.4 mt -65.49 -46.49 89.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.504 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 36.0 ttpt -55.05 -50.44 69.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.345 0.593 . . . . 0.0 110.378 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -66.33 -39.55 89.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.401 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.444 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 30.8 tpt180 -59.99 -41.6 92.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.587 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.46 ' CE2' HG21 ' A' ' 29' ' ' VAL . 16.0 t-105 -61.18 -45.5 94.36 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.81 -44.45 86.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.901 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.619 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.6 OUTLIER -63.89 -45.63 88.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.461 179.388 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 75.6 mtp -58.34 -41.63 85.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.856 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.403 ' HD2' ' CD1' ' A' ' 58' ' ' TRP . 52.6 mtpt -66.05 -40.56 91.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.821 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -66.52 -46.09 77.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.656 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 60' ' ' THR . 64.7 mt -65.51 -30.47 71.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.337 0.589 . . . . 0.0 110.464 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.23 34.99 5.65 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.776 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 88.2 mtp -82.71 -43.5 16.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.256 0.551 . . . . 0.0 109.703 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.0 t30 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.386 -0.816 . . . . 0.0 110.448 179.499 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.8 p 66.83 -42.59 0.42 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.138 1.375 . . . . 0.0 112.611 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.47 127.03 4.19 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -26.15 60.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.304 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.623 ' OE1' ' HA ' ' A' ' 48' ' ' ASN . 40.1 mt-10 -58.51 137.18 57.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.08 0.467 . . . . 0.0 111.504 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -74.61 148.86 40.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.422 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.55 ' HB3' HD11 ' A' ' 11' ' ' ILE . 27.0 m 62.57 54.73 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.441 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -64.98 -24.68 67.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.353 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.1 m -56.95 141.47 45.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.26 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.577 ' HB2' ' HG2' ' A' ' 13' ' ' LYS . 50.7 p-10 -68.19 50.81 0.07 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.55 HD11 ' HB3' ' A' ' 7' ' ' SER . 28.7 pt -83.89 28.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.734 0.302 . . . . 0.0 111.794 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.3 m -157.35 -51.18 0.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.577 ' HG2' ' HB2' ' A' ' 10' ' ' ASN . 35.7 mtmm 54.44 57.68 5.6 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.567 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -58.15 105.47 0.28 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.849 0.356 . . . . 0.0 110.575 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.421 ' O ' ' HD1' ' A' ' 17' ' ' TRP . 89.3 mm-40 -71.87 -24.93 61.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.62 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -66.12 120.86 13.92 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.103 0.477 . . . . 0.0 110.13 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.457 ' HZ2' ' HB3' ' A' ' 53' ' ' MET . 17.3 m95 -135.97 140.08 43.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.218 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.3 p -76.81 152.74 35.42 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 10.9 p -60.51 -38.61 78.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.219 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -59.71 -54.1 50.29 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.532 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 50.3 mt-10 -58.57 -39.28 79.85 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.429 0.633 . . . . 0.0 111.096 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.538 ' O ' HG22 ' A' ' 25' ' ' VAL . 15.5 m -68.16 -37.6 81.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.203 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 68.0 mm-40 -61.26 -34.64 75.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.873 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.532 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 42.5 m0 -62.54 -43.66 98.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.15 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 29' ' ' VAL . 1.1 m -60.04 -37.55 73.12 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.436 ' HE2' ' O ' ' A' ' 66' ' ' MET . 19.5 ttmt -62.21 -46.3 89.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.639 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.86 78.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.744 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.06 -40.68 99.24 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 25' ' ' VAL . 51.5 t -61.09 -37.39 77.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.006 0.432 . . . . 0.0 111.01 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -79.28 -41.42 28.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.696 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -78.81 -49.49 12.88 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.431 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -86.05 -42.12 14.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.462 0.648 . . . . 0.0 110.805 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.17 131.54 5.88 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -50.55 130.4 23.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.808 0.337 . . . . 0.0 110.914 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.41 -37.07 3.44 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.906 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.464 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.9 m-80 -81.53 53.72 2.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.102 0.477 . . . . 0.0 111.115 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -63.83 -38.3 90.57 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.559 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.54 -46.2 90.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.51 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.23 -43.08 99.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.64 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 36' ' ' ASN . 79.6 mt -63.05 -45.07 99.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.449 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.566 ' HB2' HD12 ' A' ' 54' ' ' ILE . 47.6 t -62.91 -36.0 81.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.229 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -68.76 -47.91 65.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.908 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -80.34 -49.96 10.8 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.409 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 51.0 m-85 -70.41 145.56 93.18 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 121.171 0.51 . . . . 0.0 111.826 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.47 44.28 0.24 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 124.073 3.182 . . . . 0.0 114.841 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.437 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 53.4 m-85 -68.65 122.95 19.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.969 0.414 . . . . 0.0 110.489 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.58 127.25 62.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.256 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.631 ' C ' ' HD2' ' A' ' 49' ' ' ARG . 33.4 m120 61.79 17.18 8.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.738 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.631 ' HD2' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -118.03 124.37 47.96 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -178.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.517 ' OG1' ' HG2' ' A' ' 53' ' ' MET . 31.1 p -87.01 175.38 8.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.624 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.78 -38.59 86.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.538 0.208 . . . . 0.0 110.824 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.72 -36.23 74.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.517 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 79.8 mmm -61.79 -45.27 94.61 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.566 HD12 ' HB2' ' A' ' 41' ' ' SER . 66.3 mt -66.45 -41.96 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.958 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -54.92 -49.28 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.148 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 3.5 t0 -71.31 -36.59 71.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.262 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.457 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 27.8 tpt180 -59.7 -40.52 88.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.116 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.4 t-105 -59.59 -43.34 93.71 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 56' ' ' ASP . 21.7 ttm180 -58.06 -49.46 76.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.457 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.457 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 1.7 p -61.73 -46.06 91.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.955 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.558 ' HB3' ' HB2' ' A' ' 66' ' ' MET . 4.6 mtm -57.11 -41.36 78.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.622 0.249 . . . . 0.0 111.0 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.407 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 8.3 mtpm? -61.62 -35.37 77.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.301 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.524 ' HB3' HD22 ' A' ' 64' ' ' LEU . 29.8 ttp180 -59.88 -60.7 3.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.623 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.534 ' H ' HD22 ' A' ' 64' ' ' LEU . 2.7 mm? -63.37 -53.0 59.38 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.493 0.663 . . . . 0.0 110.155 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.37 40.63 0.3 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.7 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.558 ' HB2' ' HB3' ' A' ' 61' ' ' MET . 78.0 mtp -95.58 38.8 1.14 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.959 0.409 . . . . 0.0 110.439 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.407 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 13.0 p-10 . . . . . 0 C--O 1.25 1.116 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.608 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.7 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 14' ' ' LYS . 41.7 m -141.92 45.89 1.67 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.179 0.514 . . . . 0.0 110.287 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -76.87 113.92 15.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.527 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.44 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 51.2 ttm -174.51 129.7 0.34 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.282 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.433 ' HB2' ' HG2' ' A' ' 13' ' ' LYS . 55.1 mt-10 49.82 54.9 10.24 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.672 0.607 . . . . 0.0 110.42 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -71.83 55.52 0.28 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.093 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 t -75.32 -27.37 59.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.672 0.749 . . . . 0.0 109.122 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.1 m -155.78 -51.8 0.08 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.986 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 10' ' ' ASN . 1.5 m -147.85 -140.56 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.487 ' C ' ' HD3' ' A' ' 13' ' ' LYS . 7.1 p-10 -139.01 33.9 2.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.096 0.474 . . . . 0.0 110.297 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.419 ' O ' ' CB ' ' A' ' 12' ' ' THR . 57.9 mt -78.1 117.9 24.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.419 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 23.6 m 100.64 -19.0 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.064 1.345 . . . . 0.0 109.086 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.487 ' HD3' ' C ' ' A' ' 10' ' ' ASN . 1.7 mptp? -88.3 134.09 33.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.83 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.465 ' HD3' ' HA ' ' A' ' 2' ' ' SER . 29.5 mtpp 52.79 57.96 5.84 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.6 0.563 . . . . 0.0 111.379 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -62.69 106.5 0.8 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -102.52 133.12 48.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.27 0.557 . . . . 0.0 111.283 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.515 ' HZ3' ' HE2' ' A' ' 46' ' ' PHE . 10.6 m95 -77.59 141.97 39.22 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.243 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -77.3 154.43 32.9 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.1 p -57.21 -35.29 48.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.503 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -60.23 -53.92 51.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.682 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.62 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 37.7 mt-10 -59.44 -42.4 91.83 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.689 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.662 ' O ' HG22 ' A' ' 25' ' ' VAL . 8.5 m -65.59 -34.87 79.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.145 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -69.52 -33.14 72.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.906 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.62 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 44.6 m0 -61.82 -42.8 99.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.653 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 22' ' ' SER . 2.5 m -62.3 -38.16 80.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -63.76 -48.96 74.86 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.276 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.32 -40.78 90.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.721 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.05 -38.05 94.91 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.659 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 25' ' ' VAL . 54.8 t -63.16 -36.15 74.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.958 0.408 . . . . 0.0 110.752 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -78.84 -43.92 24.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.225 0.536 . . . . 0.0 111.102 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.577 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 88.1 tttt -74.09 -45.68 47.62 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.577 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -96.61 -49.04 5.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.275 0.56 . . . . 0.0 111.053 -178.206 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.07 134.58 4.4 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.166 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.517 ' HB2' HG13 ' A' ' 29' ' ' VAL . 76.3 tt0 -55.15 106.69 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.168 0.509 . . . . 0.0 110.658 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.39 -37.9 1.51 Allowed Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.673 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.494 ' O ' HG13 ' A' ' 40' ' ' ILE . 73.0 m-80 -78.88 54.58 1.58 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.042 0.448 . . . . 0.0 111.386 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.433 ' NE1' ' HG3' ' A' ' 55' ' ' LYS . 36.0 m95 -65.31 -37.08 86.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.279 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.44 -42.1 96.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.163 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.62 -37.04 81.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.022 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 36' ' ' ASN . 74.4 mt -66.96 -45.81 86.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.66 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.474 ' HB3' HD12 ' A' ' 54' ' ' ILE . 4.1 p -65.4 -34.67 78.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.135 0.493 . . . . 0.0 111.154 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.52 -43.28 81.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.087 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -88.03 -44.64 10.83 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.45 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 55.6 m-85 -76.05 146.72 79.23 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 121.108 0.48 . . . . 0.0 111.627 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.32 46.3 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.08 3.187 . . . . 0.0 115.47 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.515 ' HE2' ' HZ3' ' A' ' 17' ' ' TRP . 75.6 m-85 -71.47 134.63 46.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.564 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.422 ' C ' ' H ' ' A' ' 49' ' ' ARG . 3.5 p -123.05 132.3 71.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 75.9 m-20 73.91 -39.87 0.44 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.567 0.747 . . . . 0.0 110.709 -177.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.5 ' HD3' ' OE2' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -67.31 138.39 56.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.266 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.7 p -102.77 177.45 4.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.628 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.02 -39.56 90.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.713 0.292 . . . . 0.0 110.415 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.9 t -63.49 -37.21 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.438 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 18.7 mmt -62.4 -42.31 99.33 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.484 HG23 HG12 ' A' ' 25' ' ' VAL . 82.4 mt -65.6 -44.49 93.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.012 0.434 . . . . 0.0 109.864 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.433 ' HG3' ' NE1' ' A' ' 37' ' ' TRP . 25.8 ttpp -56.47 -49.51 74.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.655 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 37.7 t70 -67.59 -39.4 84.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.838 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.492 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 13.0 tpp180 -59.84 -37.74 80.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.204 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.544 ' CD1' ' HD2' ' A' ' 62' ' ' LYS . 8.5 t-105 -60.61 -42.88 97.71 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 56' ' ' ASP . 98.5 mtt180 -53.54 -49.95 66.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.021 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.555 ' O ' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -62.71 -45.16 94.02 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.8 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.417 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 91.0 mmm -56.79 -44.95 82.39 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.038 0.447 . . . . 0.0 110.783 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.544 ' HD2' ' CD1' ' A' ' 58' ' ' TRP . 46.9 mtpt -65.86 -29.67 70.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.946 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.521 ' HB3' ' O ' ' A' ' 60' ' ' THR . 57.7 ttm-85 -55.24 -58.04 9.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.15 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.74 ' H ' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -65.05 -51.33 62.12 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.286 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.65 31.34 0.41 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.609 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.9 mtt -91.82 50.38 1.68 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.134 0.493 . . . . 0.0 109.756 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 . . . . . 0 C--O 1.249 1.071 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.646 -179.115 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.832 0 N-CA-C 112.375 -0.29 . . . . 0.0 112.375 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 t -69.3 144.64 53.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -144.22 126.06 15.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.91 0.386 . . . . 0.0 110.59 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.5 ptp -87.85 144.92 26.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.238 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.412 ' HB2' ' NZ ' ' A' ' 16' ' ' LYS . 73.9 tt0 -82.94 149.77 26.84 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.922 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -51.35 125.62 14.76 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.525 0.516 . . . . 0.0 109.715 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.462 ' HB2' HG12 ' A' ' 11' ' ' ILE . 27.5 t -159.89 138.07 10.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.163 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 p -69.81 -37.63 76.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.483 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.3 m -148.34 -52.47 0.18 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.843 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -167.3 120.44 0.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.813 0.816 . . . . 0.0 112.045 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.497 HG22 ' HG2' ' A' ' 13' ' ' LYS . 50.4 mm -100.29 147.18 7.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -70.31 53.97 0.14 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.497 ' HG2' HG22 ' A' ' 11' ' ' ILE . 46.6 pttt 178.44 49.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.095 0.958 . . . . 0.0 108.536 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.407 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 32.6 mtmm -69.09 131.95 45.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.394 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 70.16 138.27 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.765 0.826 . . . . 0.0 112.775 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 16' ' ' LYS . 41.6 mmtm -83.72 151.1 25.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.304 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.557 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 16.8 m95 -109.64 142.49 40.7 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.563 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.5 p -82.53 160.88 22.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.346 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.73 -40.71 80.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.426 0.155 . . . . 0.0 111.152 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -61.94 -47.29 85.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.691 0.281 . . . . 0.0 111.585 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.521 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 49.8 mt-10 -63.66 -36.23 83.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.333 0.587 . . . . 0.0 110.695 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.616 ' O ' HG22 ' A' ' 25' ' ' VAL . 40.2 m -67.58 -36.03 80.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.02 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.65 -35.3 80.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.833 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.527 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 44.6 m0 -62.18 -46.73 87.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.379 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 22' ' ' SER . 3.3 m -60.75 -37.46 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.873 0.368 . . . . 0.0 110.815 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -66.17 -46.12 78.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.771 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.2 -38.57 75.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.039 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.07 -36.18 80.34 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.625 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 25' ' ' VAL . 97.5 t -62.28 -36.38 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.518 0.675 . . . . 0.0 110.074 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -81.18 -49.08 11.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.395 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.526 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 84.5 tttt -69.11 -42.49 76.02 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.917 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.526 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -102.74 -55.7 2.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.338 0.59 . . . . 0.0 110.973 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.89 138.23 3.96 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.228 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.5 ' HB2' HG13 ' A' ' 29' ' ' VAL . 7.8 tm-20 -57.04 117.81 4.37 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.26 -32.1 4.65 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.019 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.473 ' O ' HG13 ' A' ' 40' ' ' ILE . 71.4 m-80 -81.62 48.19 1.16 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.896 0.379 . . . . 0.0 111.345 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 36.9 m95 -62.85 -37.91 88.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.832 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.17 -48.93 78.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 0.0 110.528 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.27 98.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.689 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 36' ' ' ASN . 79.1 mt -60.72 -45.54 97.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.593 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.492 ' HB2' HD12 ' A' ' 54' ' ' ILE . 23.1 t -64.69 -35.02 79.7 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.096 0.474 . . . . 0.0 110.924 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -67.65 -47.45 69.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.754 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -82.31 -49.45 10.04 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.474 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 56.4 m-85 -70.23 143.31 90.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.095 0.474 . . . . 0.0 111.374 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.527 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 39.4 Cg_endo -67.6 48.27 0.35 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.922 3.081 . . . . 0.0 115.204 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.557 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 67.8 m-85 -72.48 133.47 44.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.761 0.315 . . . . 0.0 110.283 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.596 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 5.9 p -110.48 121.11 62.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.84 -30.92 0.14 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.6 1.16 . . . . 0.0 112.293 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.596 ' HD2' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -61.71 118.0 6.56 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.964 0.411 . . . . 0.0 110.9 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.404 ' OG1' ' HG2' ' A' ' 53' ' ' MET . 34.2 p -81.02 167.39 19.84 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.703 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.56 85.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.9 t -63.23 -36.96 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.45 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 61.1 mmm -64.17 -41.33 97.16 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.596 HG23 HG12 ' A' ' 25' ' ' VAL . 85.1 mt -65.36 -45.01 94.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.814 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.566 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 38.8 ttpt -56.7 -49.61 74.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.337 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -63.47 -44.88 93.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.523 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.554 ' O ' ' HG2' ' A' ' 61' ' ' MET . 30.9 tpt180 -60.55 -38.59 84.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.144 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.679 ' CE2' ' HE2' ' A' ' 62' ' ' LYS . 15.4 t-105 -58.8 -43.17 90.48 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.635 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.685 ' HA ' ' HE3' ' A' ' 62' ' ' LYS . 1.6 mpt_? -60.04 -49.17 78.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.758 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.495 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 2.9 p -61.79 -35.71 78.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.796 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.554 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 89.8 mmm -57.02 -40.49 76.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.217 0.532 . . . . 0.0 109.991 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.685 ' HE3' ' HA ' ' A' ' 59' ' ' ARG . 49.0 mttt -64.45 -44.36 91.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.787 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 50.7 ttt85 -59.22 -41.6 89.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.654 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 60' ' ' THR . 69.2 mt -72.71 -5.97 41.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.39 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.06 45.58 19.66 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.464 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 70.0 mtm -132.45 56.54 1.83 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.306 0.574 . . . . 0.0 109.571 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.586 -179.352 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 112.162 -0.375 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.6 m -81.95 131.65 35.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.644 0.259 . . . . 0.0 111.287 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.5 m170 57.8 44.51 20.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.79 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.1 mmt -70.49 125.87 28.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.119 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 65.14 104.82 0.04 OUTLIER 'General case' 0 C--O 1.235 0.305 0 O-C-N 124.23 0.956 . . . . 0.0 110.317 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -60.05 126.24 26.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.1 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.483 ' HB3' ' ND2' ' A' ' 10' ' ' ASN . 66.4 m 57.76 54.23 6.42 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.6 m -44.29 -47.85 9.49 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.703 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.7 p -133.97 116.87 16.07 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.228 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.491 ' OD1' HG23 ' A' ' 12' ' ' THR . 0.5 OUTLIER -179.25 164.95 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.058 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 27.6 pt -71.01 27.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -176.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.491 HG23 ' OD1' ' A' ' 10' ' ' ASN . 7.3 p -85.54 -49.85 7.71 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.551 -0.718 . . . . 0.0 110.276 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.814 ' HD3' ' H ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -99.78 -21.71 15.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.732 -179.029 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.798 ' HE3' HG21 ' A' ' 60' ' ' THR . 0.7 OUTLIER -170.39 164.12 8.68 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -57.84 147.25 29.03 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.5 0.5 . . . . 0.0 110.445 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -75.83 128.45 35.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.395 0.617 . . . . 0.0 110.015 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.439 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 10.4 m95 -100.62 138.86 37.12 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.67 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.9 p -78.66 147.74 33.44 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.439 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 11.5 p -53.71 -35.58 27.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.61 0.243 . . . . 0.0 110.969 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.419 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 39.8 tt0 -59.71 -53.46 57.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.362 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.569 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 45.5 mt-10 -61.09 -39.45 89.99 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.439 0.638 . . . . 0.0 111.015 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.606 ' O ' HG22 ' A' ' 25' ' ' VAL . 6.4 m -66.09 -33.36 75.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.613 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 58.7 mm-40 -68.29 -30.91 70.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.777 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.569 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 43.1 m0 -64.27 -42.99 96.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.736 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 22' ' ' SER . 2.0 m -60.81 -38.16 78.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.094 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -65.7 -50.4 65.02 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.469 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.52 -41.84 98.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.741 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.47 -37.86 94.83 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.471 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 25' ' ' VAL . 47.5 t -64.9 -43.16 96.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.08 0.467 . . . . 0.0 110.337 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -71.38 -42.28 68.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.207 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.458 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 63.7 tttp -76.72 -48.52 18.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.458 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -94.76 -55.87 2.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.599 0.714 . . . . 0.0 110.975 -178.521 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.19 132.0 3.45 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -58.48 118.46 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.546 0.688 . . . . 0.0 110.554 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.45 -37.5 1.87 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.415 ' O ' HG13 ' A' ' 40' ' ' ILE . 62.2 m-80 -83.49 50.77 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.039 0.447 . . . . 0.0 110.228 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -62.2 -41.45 98.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.908 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.78 -45.41 89.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.871 0.367 . . . . 0.0 110.332 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.27 93.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.485 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 36' ' ' ASN . 82.0 mt -62.55 -46.55 96.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.451 ' HB2' HD12 ' A' ' 54' ' ' ILE . 32.4 t -60.71 -36.66 79.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.199 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -69.11 -51.16 41.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.69 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -74.54 -43.73 54.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.722 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.456 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 47.4 m-85 -77.49 146.91 74.48 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 120.983 0.42 . . . . 0.0 110.928 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.466 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 36.8 Cg_endo -66.31 43.02 0.18 Allowed 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.774 2.982 . . . . 0.0 115.304 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.439 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 77.0 m-85 -74.05 128.36 35.31 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.941 -0.474 . . . . 0.0 110.12 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.59 129.2 72.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 71.33 -40.67 0.48 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.19 0.596 . . . . 0.0 111.924 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.493 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 2.0 mpt_? -60.74 127.16 30.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.682 0.277 . . . . 0.0 110.612 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.471 ' OG1' ' HG3' ' A' ' 53' ' ' MET . 67.5 p -89.55 169.03 11.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.333 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.7 -37.33 83.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.805 0.336 . . . . 0.0 110.263 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.23 -38.41 82.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.829 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.471 ' HG3' ' OG1' ' A' ' 50' ' ' THR . 68.1 mtt -62.3 -42.1 99.07 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.508 HG23 HG12 ' A' ' 25' ' ' VAL . 70.2 mt -67.22 -44.36 87.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.868 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -55.56 -49.98 71.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.007 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.64 -37.0 79.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.388 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 53' ' ' MET . 15.0 tpt85 -61.28 -39.73 91.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.343 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.434 ' CD2' HG21 ' A' ' 29' ' ' VAL . 36.7 t-105 -67.49 -43.7 80.3 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.5 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 81.3 mtt-85 -59.39 -42.75 92.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.383 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.798 HG21 ' HE3' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -61.44 -38.98 89.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.794 178.712 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.43 ' HG3' ' O ' ' A' ' 57' ' ' ARG . 84.2 mtp -62.42 -41.86 99.01 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.033 0.444 . . . . 0.0 109.897 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.5 ' HD3' ' HA ' ' A' ' 59' ' ' ARG . 6.1 mtpm? -65.92 -40.67 91.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.076 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -60.97 -45.99 92.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.536 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 60' ' ' THR . 71.4 mt -72.7 -37.02 67.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.513 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.45 39.23 2.45 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.139 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 63.9 mtt -100.89 38.09 1.61 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.89 0.376 . . . . 0.0 110.671 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.1 p30 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.063 -179.562 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 111.893 -0.483 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 p -141.71 29.19 1.74 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.932 0.366 . . . . 0.0 111.829 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -91.61 -38.76 12.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.379 0.609 . . . . 0.0 109.77 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 88.8 mmm -142.37 -125.77 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.765 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -161.21 144.81 13.0 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -63.54 -47.26 82.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.244 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 p -171.72 -53.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.702 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 m 64.25 -77.1 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.666 0.786 . . . . 0.0 111.25 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.7 p 61.04 -40.41 0.11 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -62.27 -17.47 58.59 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.6 pt -79.61 2.47 2.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.224 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -92.29 -40.85 10.71 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.494 0.664 . . . . 0.0 109.682 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -88.44 133.63 34.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.934 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -156.12 31.77 0.34 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.932 0.872 . . . . 0.0 109.026 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.45 ' O ' ' HD1' ' A' ' 17' ' ' TRP . 1.9 pm0 -159.09 43.77 0.25 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.543 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HE2' ' HB3' ' A' ' 16' ' ' LYS . 43.7 mtpt -66.5 136.79 56.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.471 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.45 ' HD1' ' O ' ' A' ' 15' ' ' GLN . 11.2 m95 -125.16 136.55 53.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.248 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.7 p -77.83 154.22 32.03 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 13.8 p -57.51 -38.46 63.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.265 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.515 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 87.2 tt0 -64.07 -48.05 77.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.793 0.33 . . . . 0.0 111.076 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.536 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 68.0 mt-10 -59.59 -37.35 78.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.344 0.592 . . . . 0.0 111.58 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.618 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.3 m -67.86 -32.03 72.25 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.997 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 5.7 mm-40 -65.68 -38.29 88.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.4 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.536 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 35.3 m0 -61.4 -43.68 98.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.837 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 22' ' ' SER . 3.8 m -62.59 -36.45 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.168 0.508 . . . . 0.0 110.248 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -66.93 -49.32 65.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.753 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.63 -39.91 76.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.299 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.72 -41.21 98.93 Favored Glycine 0 C--O 1.224 -0.476 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.999 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' A' ' 34' ' ' GLU . 54.8 t -64.72 -41.79 93.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 117.237 0.518 . . . . 0.0 110.72 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -70.82 -36.72 73.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.323 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.614 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 5.1 ttmp? -84.77 -52.08 6.31 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.614 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -84.77 -54.17 4.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.28 0.562 . . . . 0.0 111.221 -177.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.56 130.75 3.33 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.62 ' HB2' HG13 ' A' ' 29' ' ' VAL . 86.9 tt0 -55.56 125.57 21.58 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.958 0.409 . . . . 0.0 110.852 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.49 -35.13 3.41 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.457 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.4 m-80 -82.97 52.81 2.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.986 0.422 . . . . 0.0 110.532 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 40.8 m95 -61.18 -40.26 93.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.636 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.6 97.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.965 0.412 . . . . 0.0 110.384 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -67.82 -38.14 82.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.097 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 36' ' ' ASN . 78.5 mt -67.45 -47.31 81.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.531 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.523 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 5.7 p -63.52 -37.18 86.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.519 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -62.99 -48.42 78.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.515 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -80.41 -50.31 10.28 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.424 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 55.7 m-85 -69.09 146.32 97.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.01 0.433 . . . . 0.0 110.895 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.472 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 44.4 Cg_endo -68.68 46.46 0.38 Allowed 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.537 2.824 . . . . 0.0 114.799 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -69.72 126.49 29.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.1 0.476 . . . . 0.0 110.564 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.525 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 5.6 p -118.3 131.25 71.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 74.5 m-80 74.35 -43.5 0.53 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.039 0.535 . . . . 0.0 110.378 -177.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.699 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -66.45 125.67 26.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.346 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.8 p -96.15 175.58 6.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.919 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.3 -42.72 99.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.491 0.186 . . . . 0.0 110.91 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.09 -37.57 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.699 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 63.6 mtt -59.96 -42.42 94.04 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.539 HG23 HG12 ' A' ' 25' ' ' VAL . 63.6 mt -66.99 -44.51 88.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.027 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -55.7 -47.5 76.71 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.171 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -69.79 -41.95 74.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.99 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.501 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 12.1 tpp180 -60.18 -39.15 85.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.267 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.442 ' HA ' ' CE3' ' A' ' 58' ' ' TRP . 16.7 t-105 -61.74 -45.3 94.51 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.345 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.9 mtt85 -58.5 -44.47 89.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.377 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.506 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 24.5 p -66.51 -41.46 88.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.735 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.407 ' SD ' ' HE3' ' A' ' 66' ' ' MET . 79.3 mmm -57.33 -42.69 82.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.122 0.487 . . . . 0.0 110.241 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.526 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 52.6 mtpt -66.73 -45.1 79.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.867 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -62.3 -42.51 99.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.839 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 60' ' ' THR . 80.2 mt -72.77 -18.77 61.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.115 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.53 52.14 4.59 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.194 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.407 ' HE3' ' SD ' ' A' ' 61' ' ' MET . 66.4 mtm -128.94 46.81 2.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.201 0.524 . . . . 0.0 110.299 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.526 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 14.1 p-10 . . . . . 0 C--O 1.247 0.973 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.177 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.878 0 N-CA-C 112.115 -0.394 . . . . 0.0 112.115 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.8 t -166.33 133.46 2.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -90.69 51.68 2.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.124 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.7 mmt 58.33 54.61 5.54 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.234 0.54 . . . . 0.0 110.739 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -53.27 141.1 24.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.588 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -87.35 53.4 2.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.907 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.2 m -86.19 127.63 34.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.417 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.34 -31.56 10.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.694 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.1 m -61.89 116.31 4.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.655 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.427 ' C ' HG13 ' A' ' 11' ' ' ILE . 29.1 t30 61.31 117.12 0.02 OUTLIER 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.188 -0.914 . . . . 0.0 113.266 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.427 HG13 ' C ' ' A' ' 10' ' ' ASN . 17.5 mt -144.9 41.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.8 m -89.35 -47.01 8.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.948 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 16.6 pttp -66.77 -29.46 69.43 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER 53.27 -160.75 0.12 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.97 0.908 . . . . 0.0 110.638 -178.053 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -74.84 114.71 13.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.173 0.511 . . . . 0.0 110.315 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.72 135.23 34.28 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.192 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -119.54 130.01 54.96 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.75 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.2 p -80.38 151.12 29.57 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.495 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 7.2 p -55.44 -39.16 51.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.64 0.257 . . . . 0.0 110.734 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.542 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 84.6 tt0 -62.13 -46.6 88.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.911 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 53.6 mt-10 -62.53 -38.89 91.74 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.236 0.541 . . . . 0.0 110.676 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.61 ' O ' HG22 ' A' ' 25' ' ' VAL . 24.3 t -64.58 -34.51 78.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.302 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 49.7 mm-40 -66.87 -37.59 84.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.707 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.564 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 40.0 m0 -62.46 -44.68 95.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.509 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.618 HG12 HG23 ' A' ' 54' ' ' ILE . 3.3 m -62.0 -35.77 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.143 0.497 . . . . 0.0 109.988 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 26' ' ' LYS . 18.0 ttpt -69.7 -47.7 62.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.759 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.32 -42.9 78.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.766 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.94 -33.02 67.41 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 116.191 -0.458 . . . . 0.0 113.133 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 25' ' ' VAL . 78.4 t -66.41 -36.91 78.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.174 0.511 . . . . 0.0 110.658 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -79.35 -44.68 21.08 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.188 0.518 . . . . 0.0 110.933 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -73.85 -46.33 45.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.491 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.413 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -98.02 -57.45 2.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.467 0.651 . . . . 0.0 110.888 -179.073 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 29' ' ' VAL . . . 126.53 133.31 3.83 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.43 ' HB3' HG13 ' A' ' 29' ' ' VAL . 11.1 pt-20 -59.12 138.71 57.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.327 0.585 . . . . 0.0 110.438 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.18 -37.29 3.55 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -84.95 46.49 1.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.154 0.502 . . . . 0.0 110.546 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.44 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 41.5 m95 -61.17 -36.51 80.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.786 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.46 92.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 0.0 110.223 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.09 84.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.661 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.44 HG23 ' CD1' ' A' ' 44' ' ' TYR . 61.6 mt -61.77 -47.54 92.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.413 ' HB2' HD12 ' A' ' 54' ' ' ILE . 44.2 t -63.47 -36.27 83.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.973 0.416 . . . . 0.0 110.468 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -63.4 -47.53 81.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.658 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -82.93 -52.33 6.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.396 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.44 ' CD1' HG23 ' A' ' 40' ' ' ILE . 65.0 m-85 -68.45 140.19 92.36 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.066 0.46 . . . . 0.0 110.986 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.564 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 32.5 Cg_endo -64.87 47.17 0.16 Allowed 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.155 3.237 . . . . 0.0 115.395 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -74.16 134.9 42.83 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.965 -0.46 . . . . 0.0 110.223 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 7.3 p -124.36 125.23 70.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 75.4 m-20 76.5 -33.91 0.22 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.276 0.63 . . . . 0.0 111.146 -178.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.517 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 7.7 mpt_? -76.03 112.94 12.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.714 0.292 . . . . 0.0 110.518 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.6 p -82.19 173.52 12.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.635 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.11 82.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.938 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 t -64.23 -39.44 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.3 mmt -61.52 -42.96 99.6 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.618 HG23 HG12 ' A' ' 25' ' ' VAL . 72.0 mt -66.47 -45.48 88.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.428 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 39.0 ttpt -56.03 -50.87 69.72 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.531 0.681 . . . . 0.0 109.853 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.27 -40.42 93.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.429 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 61' ' ' MET . 14.1 tpp180 -60.75 -42.23 97.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.099 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.436 ' CD2' HG21 ' A' ' 29' ' ' VAL . 23.4 t-105 -61.18 -43.01 99.56 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.654 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 40.5 ttp180 -56.26 -45.31 80.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.038 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.633 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -64.2 -39.31 93.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 178.707 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 98.0 mmm -59.31 -39.52 83.32 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.098 0.475 . . . . 0.0 110.273 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.654 ' HD3' ' HA ' ' A' ' 59' ' ' ARG . 5.9 mtpm? -64.35 -39.22 93.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.975 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -68.43 -42.41 78.95 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.956 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 60' ' ' THR . 83.0 mt -64.77 -28.85 69.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.447 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.53 29.79 42.74 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 82.5 mtp -107.51 51.18 0.75 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.248 -0.476 . . . . 0.0 110.008 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.9 p30 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.241 -179.312 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 112.111 -0.395 . . . . 0.0 112.111 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -64.58 125.72 25.59 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.907 0.384 . . . . 0.0 110.708 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 59.4 37.88 23.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.482 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 10.2 tpt -171.8 32.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.233 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -85.4 61.26 6.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.35 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -160.04 151.88 20.2 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.0 m -55.77 131.89 47.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.029 0.443 . . . . 0.0 111.592 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.5 p -75.68 -34.15 60.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.819 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 m -68.91 123.96 22.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.402 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.62 ' HA ' ' HB3' ' A' ' 13' ' ' LYS . 47.1 t30 63.18 -154.69 0.33 Allowed 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.612 0.57 . . . . 0.0 109.989 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.42 ' H ' ' CG ' ' A' ' 10' ' ' ASN . 46.8 mt 49.25 70.25 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.998 0.428 . . . . 0.0 110.662 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m 68.31 45.4 1.21 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.62 ' HB3' ' HA ' ' A' ' 10' ' ' ASN . 15.5 ptmt -61.82 -52.38 64.42 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.765 -1.561 . . . . 0.0 112.954 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.3 tptp 53.94 44.31 29.59 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 122.002 0.906 . . . . 0.0 108.674 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 13' ' ' LYS . 72.9 mt-30 -116.41 61.74 0.72 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.408 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -65.94 153.42 42.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.269 0.557 . . . . 0.0 110.651 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.54 ' CE3' ' HG2' ' A' ' 57' ' ' ARG . 11.7 m95 -98.24 136.92 37.74 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.873 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 51.1 p -82.13 157.04 24.2 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.596 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.633 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 8.0 p -60.24 -38.66 78.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.78 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.22 -49.33 78.27 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.711 0.291 . . . . 0.0 110.803 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.593 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 48.1 mt-10 -59.43 -41.66 90.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.336 0.589 . . . . 0.0 111.502 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.693 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.8 m -66.61 -29.63 69.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.555 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.633 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 70.9 mm-40 -68.4 -36.72 79.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.593 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 33.2 m0 -63.61 -41.51 98.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.377 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 22' ' ' SER . 4.3 m -61.44 -37.61 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.386 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 66' ' ' MET . 36.0 mtmt -65.54 -50.85 63.66 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.95 0.405 . . . . 0.0 110.725 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.0 98.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.73 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.52 -41.81 99.76 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.001 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 25' ' ' VAL . 67.9 t -65.94 -38.43 82.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.322 0.582 . . . . 0.0 109.762 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -68.99 -47.39 65.67 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.088 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -83.49 -46.53 12.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.491 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -88.01 -54.9 3.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.547 0.689 . . . . 0.0 110.647 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.39 133.57 4.17 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.669 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -52.58 146.67 9.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.047 0.451 . . . . 0.0 111.259 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.11 -37.05 3.73 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.636 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.416 ' O ' HG13 ' A' ' 40' ' ' ILE . 67.1 m-80 -82.62 48.59 1.33 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.019 0.438 . . . . 0.0 110.407 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -60.15 -40.47 89.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.73 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.35 -34.65 75.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.164 0.507 . . . . 0.0 111.158 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.71 -34.65 64.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.296 0.569 . . . . 0.0 110.187 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 36' ' ' ASN . 75.4 mt -70.61 -46.72 68.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.022 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 12.5 p -61.55 -38.16 86.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.881 0.372 . . . . 0.0 111.374 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -63.41 -45.84 89.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.413 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -85.38 -45.36 11.96 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 56.1 m-85 -73.56 150.1 88.83 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 121.033 0.444 . . . . 0.0 111.463 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.448 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 48.2 Cg_endo -68.99 44.1 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.675 2.917 . . . . 0.0 114.707 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.466 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 69.3 m-85 -73.14 107.35 5.42 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.474 ' C ' ' H ' ' A' ' 49' ' ' ARG . 2.9 p -86.53 119.56 34.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.984 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 65.4 -25.37 0.09 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.442 1.097 . . . . 0.0 112.801 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -64.91 121.07 13.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 111.025 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.8 p -78.62 171.32 15.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.07 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.79 -38.6 91.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.773 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.93 -37.16 77.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.438 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.429 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 19.9 mmt -59.86 -45.33 92.78 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.582 HG23 HG12 ' A' ' 25' ' ' VAL . 64.7 mt -65.36 -43.96 94.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.089 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -55.63 -49.59 72.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.83 0.824 . . . . 0.0 110.059 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -67.28 -42.35 83.97 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.81 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.54 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 10.0 tpp180 -59.75 -42.74 93.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.864 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.437 ' CD1' ' HD2' ' A' ' 62' ' ' LYS . 26.2 t-105 -56.86 -44.11 81.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.114 0.483 . . . . 0.0 109.736 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -55.87 -45.8 78.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.424 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.509 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -63.33 -43.13 98.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.399 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.452 ' SD ' ' HB3' ' A' ' 22' ' ' SER . 90.0 mmm -57.51 -40.76 79.43 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.236 0.541 . . . . 0.0 109.891 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.512 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 6.9 mtpm? -66.66 -40.19 88.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.586 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -62.39 -40.98 98.23 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 121.384 0.611 . . . . 0.0 109.567 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 60' ' ' THR . 77.2 mt -71.66 -19.92 62.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.184 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.09 33.86 56.36 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.513 ' O ' ' HD3' ' A' ' 26' ' ' LYS . 93.3 mmm -107.41 44.99 1.02 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.911 0.386 . . . . 0.0 110.946 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.512 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 9.3 p-10 . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.683 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -84.72 135.13 34.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.856 0.36 . . . . 0.0 110.91 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.45 ' HB3' ' H ' ' A' ' 4' ' ' MET . 3.7 m-70 -92.37 -140.89 0.2 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.236 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.45 ' H ' ' HB3' ' A' ' 3' ' ' HIS . 86.6 mtp 53.08 35.67 20.25 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.368 0.604 . . . . 0.0 110.03 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -84.38 142.89 29.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.136 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.36 -26.74 68.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.192 0.52 . . . . 0.0 110.16 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.549 ' OG ' ' HA ' ' A' ' 12' ' ' THR . 8.1 t -78.05 39.85 0.32 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.695 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.6 t -84.99 -19.82 31.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.494 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.8 p -81.75 -152.85 0.1 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.109 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -90.02 -2.29 58.11 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.782 -0.574 . . . . 0.0 110.52 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.8 mt -83.11 45.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.92 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.549 ' HA ' ' OG ' ' A' ' 7' ' ' SER . 20.5 p -75.07 -22.16 58.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.431 0.634 . . . . 0.0 110.206 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -65.48 146.24 55.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.701 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.593 ' HB2' ' OE1' ' A' ' 15' ' ' GLN . 22.7 pttm -129.2 -158.7 0.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.02 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.593 ' OE1' ' HB2' ' A' ' 14' ' ' LYS . 6.1 pm0 -64.73 -28.76 69.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.557 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -71.55 138.23 48.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.514 ' HZ2' ' HB3' ' A' ' 53' ' ' MET . 10.6 m95 -110.19 145.25 37.58 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.287 0.565 . . . . 0.0 112.424 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -88.42 151.89 22.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.99 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.4 p -55.95 -37.24 47.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.837 -0.165 . . . . 0.0 111.377 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.501 ' HG3' ' CZ2' ' A' ' 24' ' ' TRP . 36.3 tp10 -59.32 -51.78 68.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.809 0.338 . . . . 0.0 110.777 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.497 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 52.3 mt-10 -60.73 -39.36 88.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.687 0.756 . . . . 0.0 110.862 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.662 ' O ' HG22 ' A' ' 25' ' ' VAL . 13.2 m -67.96 -34.02 75.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.259 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.71 -36.19 82.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.19 0.519 . . . . 0.0 110.337 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.501 ' CZ2' ' HG3' ' A' ' 20' ' ' GLU . 32.5 m0 -65.75 -43.98 87.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.518 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 22' ' ' SER . 3.0 m -58.82 -40.29 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.933 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -66.49 -44.85 81.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.819 0.342 . . . . 0.0 110.785 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.64 -44.31 90.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.779 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.65 96.13 Favored Glycine 0 C--O 1.224 -0.478 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.287 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.504 HG11 ' CZ2' ' A' ' 58' ' ' TRP . 22.8 t -60.08 -41.32 86.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.133 0.492 . . . . 0.0 110.965 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -74.48 -40.31 61.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.771 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.513 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 62.8 tttm -80.67 -46.13 16.07 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.513 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -91.73 -37.66 12.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.084 0.469 . . . . 0.0 111.35 -177.531 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.88 134.72 8.29 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.483 ' CG ' HG13 ' A' ' 29' ' ' VAL . 43.4 mt-10 -48.95 130.37 18.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.949 0.404 . . . . 0.0 111.47 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.18 -39.06 2.83 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.194 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.534 ' O ' HG13 ' A' ' 40' ' ' ILE . 66.6 m-80 -81.17 52.08 1.73 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.983 0.42 . . . . 0.0 110.932 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.428 ' NE1' ' HG3' ' A' ' 55' ' ' LYS . 33.8 m95 -63.7 -45.11 91.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.703 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.408 ' HA ' ' HB2' ' A' ' 51' ' ' ALA . . . -56.28 -44.03 79.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.808 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.15 -37.44 87.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.645 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 36' ' ' ASN . 82.8 mt -67.4 -48.19 78.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.356 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.559 ' HB3' HD12 ' A' ' 54' ' ' ILE . 6.4 p -61.47 -35.03 76.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.819 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -71.15 -52.27 20.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.003 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -75.09 -44.94 44.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.472 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 30.1 m-85 -71.65 154.44 93.09 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.116 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.89 38.0 0.15 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.147 2.565 . . . . 0.0 114.579 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 24' ' ' TRP . 78.9 m-85 -76.18 134.03 40.02 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.204 0.525 . . . . 0.0 109.832 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 4.3 p -134.25 135.26 54.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 74.9 m-80 76.5 -38.79 0.33 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.746 0.654 . . . . 0.0 110.422 -177.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.497 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 1.0 OUTLIER -69.87 128.96 38.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.416 179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.3 p -92.14 169.7 10.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.107 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . . . -64.85 -36.84 85.63 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.0 t -62.76 -36.25 74.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.514 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 17.9 mmt -64.77 -45.36 86.71 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.559 HD12 ' HB3' ' A' ' 41' ' ' SER . 78.6 mt -64.77 -44.2 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.18 0.514 . . . . 0.0 109.814 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HG3' ' NE1' ' A' ' 37' ' ' TRP . 39.5 ttmt -54.41 -50.81 66.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.323 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -70.93 -39.42 72.68 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.347 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.518 ' O ' ' HG2' ' A' ' 61' ' ' MET . 16.6 tpp180 -58.92 -35.62 73.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.714 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.504 ' CZ2' HG11 ' A' ' 29' ' ' VAL . 14.6 t-105 -59.55 -48.16 82.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 34.5 ttm105 -56.67 -46.93 80.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.393 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.494 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 7.5 p -63.98 -37.91 89.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.577 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 97.0 mmm -61.99 -42.03 98.69 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.571 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 5.6 mtpm? -65.19 -40.52 94.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.83 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -59.9 -44.26 94.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.146 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 60' ' ' THR . 75.5 mt -70.28 -19.57 63.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.412 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.54 31.79 26.49 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.341 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 86.7 mtp -99.17 47.03 0.97 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.878 0.37 . . . . 0.0 110.368 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.571 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 11.2 p-10 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.672 -0.68 . . . . 0.0 109.738 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 111.939 -0.465 . . . . 0.0 111.939 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -77.66 151.34 34.31 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.553 0.215 . . . . 0.0 110.691 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -63.72 146.4 53.92 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.5 mmt 67.05 -127.5 0.18 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -76.14 127.78 33.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -63.7 -34.86 78.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.913 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.2 p 53.46 47.22 24.55 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.618 0.723 . . . . 0.0 110.873 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.6 m -156.3 56.65 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.671 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 t -63.33 134.8 56.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.332 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -177.43 -144.75 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.95 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.4 mm -104.95 26.85 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.27 0.557 . . . . 0.0 111.575 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.6 m -81.37 -43.12 19.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.374 0.607 . . . . 0.0 109.824 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -129.85 154.71 47.01 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.504 178.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -53.77 127.18 24.81 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.619 0.574 . . . . 0.0 110.571 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -76.59 54.77 0.98 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.947 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HE3' ' HB3' ' A' ' 16' ' ' LYS . 28.0 mtpp -56.77 128.69 37.87 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.291 0.567 . . . . 0.0 110.956 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.549 ' HA ' ' NH2' ' A' ' 49' ' ' ARG . 15.1 m95 -87.44 138.41 31.5 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.674 0.75 . . . . 0.0 112.581 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.54 149.62 21.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.902 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.8 p -53.32 -36.76 27.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.563 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 35.8 tt0 -55.66 -60.17 3.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.737 0.303 . . . . 0.0 110.952 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.647 ' HG3' ' CZ3' ' A' ' 24' ' ' TRP . 2.7 mp0 -66.28 -30.98 71.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.193 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.662 ' O ' HG22 ' A' ' 25' ' ' VAL . 9.1 t -63.79 -39.84 95.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.761 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 21.1 mm-40 -65.28 -37.91 88.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.089 0.471 . . . . 0.0 111.08 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.647 ' CZ3' ' HG3' ' A' ' 21' ' ' GLU . 37.2 m0 -62.91 -43.1 99.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.587 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 22' ' ' SER . 4.2 m -60.21 -40.2 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.906 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -64.74 -44.59 89.66 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.875 0.369 . . . . 0.0 110.934 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.07 -43.99 73.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.244 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.95 -42.47 96.82 Favored Glycine 0 C--O 1.225 -0.426 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.924 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 25' ' ' VAL . 98.5 t -61.45 -38.95 81.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.199 0.523 . . . . 0.0 110.499 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -70.49 -45.81 64.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.794 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -78.93 -45.89 19.53 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -177.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CE1' ' HE1' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -88.32 -39.97 13.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.165 0.507 . . . . 0.0 111.336 -177.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.46 132.09 6.38 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -50.9 128.58 21.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.005 0.431 . . . . 0.0 111.053 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.73 -35.36 3.87 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.177 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.483 ' O ' HG13 ' A' ' 40' ' ' ILE . 77.2 m-20 -82.45 50.62 1.67 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.914 0.388 . . . . 0.0 111.292 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.413 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 35.7 m95 -60.66 -44.06 96.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.646 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.44 ' O ' ' HG2' ' A' ' 42' ' ' LYS . . . -59.5 -47.47 85.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.576 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.5 -42.99 93.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.702 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 36' ' ' ASN . 86.6 mt -60.8 -45.19 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.274 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.511 ' HB2' HD12 ' A' ' 54' ' ' ILE . 14.6 t -63.75 -38.19 90.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.154 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 73.0 mmtt -65.77 -46.14 79.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.059 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -82.65 -45.36 14.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.408 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 50.1 m-85 -76.15 147.39 79.85 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 120.925 0.393 . . . . 0.0 111.281 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.405 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 39.3 Cg_endo -68.28 46.85 0.36 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.777 2.985 . . . . 0.0 114.854 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -73.59 126.07 29.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.141 0.496 . . . . 0.0 111.281 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.462 ' O ' ' HD3' ' A' ' 49' ' ' ARG . 7.4 p -118.98 132.63 68.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 75.8 m-20 74.49 -40.31 0.44 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.379 0.671 . . . . 0.0 110.819 -177.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.698 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 0.8 OUTLIER -73.26 118.04 15.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.76 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.436 ' OG1' ' HG3' ' A' ' 53' ' ' MET . 45.6 p -86.93 179.08 6.78 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.19 95.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.829 0.347 . . . . 0.0 110.136 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -62.29 -37.71 79.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.821 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.698 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 90.4 mtp -61.9 -43.36 99.0 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.511 HD12 ' HB2' ' A' ' 41' ' ' SER . 75.8 mt -65.06 -44.32 95.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.413 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 37.9 ttpt -57.47 -48.24 79.71 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.715 0.769 . . . . 0.0 109.793 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.17 -37.77 84.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.007 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.449 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 26.7 tpt180 -59.63 -44.85 93.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.842 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -58.86 -45.04 91.07 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.636 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.414 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 51.4 ttm-85 -59.23 -42.74 91.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.376 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.553 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 1.2 p -68.07 -37.21 81.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.271 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 90.4 mmm -58.76 -44.31 90.55 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.096 0.475 . . . . 0.0 110.176 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 59' ' ' ARG . 47.7 mtpt -64.23 -41.76 96.85 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.93 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -62.98 -47.9 81.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.293 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 60' ' ' THR . 66.2 mt -68.08 -26.39 65.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.887 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.51 39.38 6.32 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.7 mmt -124.28 7.12 8.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.107 0.48 . . . . 0.0 110.554 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.346 179.533 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.1 p -171.43 -41.27 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.962 0.411 . . . . 0.0 110.68 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -96.75 44.18 1.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.393 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.5 ttt -174.8 -50.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.238 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 61.3 mp0 -73.1 58.59 0.5 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.11 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -81.68 -122.66 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 m -81.2 -44.02 18.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.02 0.438 . . . . 0.0 110.252 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.91 61.0 5.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.266 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -59.84 130.88 48.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.697 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.57 -10.9 13.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.396 0.617 . . . . 0.0 110.795 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 11' ' ' ILE . 10.2 tt -76.81 -2.16 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 121.703 0.764 . . . . 0.0 111.181 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.3 m -82.55 -44.84 15.4 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.776 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -76.32 58.38 1.28 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.672 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -63.89 149.21 47.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -73.03 39.31 0.09 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -73.55 130.68 40.58 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.584 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 41.5 m95 -67.53 126.73 30.24 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.956 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.1 p -82.71 161.56 22.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.634 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.406 ' O ' ' HG3' ' A' ' 23' ' ' GLU . 10.0 t -60.79 -46.31 96.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.427 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.05 -42.57 85.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.273 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.646 ' HG2' ' CZ3' ' A' ' 24' ' ' TRP . 45.8 mt-10 -70.51 -33.53 71.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.174 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.592 ' O ' HG22 ' A' ' 25' ' ' VAL . 51.1 m -68.49 -35.5 77.6 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.233 0.539 . . . . 0.0 110.603 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 49.2 mt-10 -62.41 -37.72 86.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.83 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.646 ' CZ3' ' HG2' ' A' ' 21' ' ' GLU . 37.3 m0 -63.09 -41.96 99.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.819 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 22' ' ' SER . 2.0 m -59.01 -39.12 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.493 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.431 ' HG3' ' CH2' ' A' ' 58' ' ' TRP . 26.0 ttmt -66.21 -46.03 78.66 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.06 0.457 . . . . 0.0 110.628 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.76 -43.43 96.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.48 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.21 -39.17 96.81 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.119 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.589 HG13 ' HB2' ' A' ' 34' ' ' GLU . 54.0 t -61.95 -42.11 93.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.296 0.569 . . . . 0.0 110.332 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -72.79 -44.84 61.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.105 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -81.34 -49.5 10.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.473 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -84.84 -45.82 11.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.442 0.639 . . . . 0.0 111.017 -177.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.76 131.15 4.14 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.992 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.589 ' HB2' HG13 ' A' ' 29' ' ' VAL . 86.2 tt0 -55.34 108.57 0.43 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.065 0.459 . . . . 0.0 110.801 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.97 -35.28 1.93 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.495 ' O ' HG13 ' A' ' 40' ' ' ILE . 74.3 m-80 -82.2 53.2 2.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.14 0.495 . . . . 0.0 110.501 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.45 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 41.0 m95 -60.73 -43.17 98.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.965 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.31 99.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.68 0.276 . . . . 0.0 110.295 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -61.09 -43.0 99.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.945 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 36' ' ' ASN . 82.9 mt -63.26 -46.15 96.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.032 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.413 ' HB2' HD12 ' A' ' 54' ' ' ILE . 46.6 t -63.04 -38.32 90.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.339 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -68.1 -43.87 77.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.032 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -85.16 -46.43 11.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.41 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 50.3 m-85 -73.24 149.49 89.26 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.98 0.419 . . . . 0.0 111.171 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.506 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 37.6 Cg_endo -68.96 45.69 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.449 2.766 . . . . 0.0 114.638 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.584 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 58.6 m-85 -72.25 131.2 42.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.152 -0.343 . . . . 0.0 110.286 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.448 ' C ' ' H ' ' A' ' 49' ' ' ARG . 4.7 p -104.62 123.57 58.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.616 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 p30 63.92 -23.88 0.07 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.641 1.176 . . . . 0.0 113.431 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.598 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 5.1 mpt_? -65.42 133.19 50.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.047 0.451 . . . . 0.0 111.737 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.3 p -98.74 176.57 5.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.88 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.3 98.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.584 0.23 . . . . 0.0 111.092 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.53 -38.19 77.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.126 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.598 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 68.7 mtt -61.69 -43.74 98.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.709 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 41' ' ' SER . 62.8 mt -67.38 -42.78 87.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.224 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.45 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 40.3 ttpt -56.52 -49.12 75.67 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.541 0.686 . . . . 0.0 109.403 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -66.29 -43.17 87.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.239 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.425 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 29.8 tpt180 -58.58 -43.61 89.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.052 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.436 ' O ' ' HG3' ' A' ' 62' ' ' LYS . 15.6 t-105 -61.14 -44.77 96.81 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -56.99 -47.63 80.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.641 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -63.1 -41.52 99.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.666 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 57' ' ' ARG . 83.7 mtp -62.7 -41.69 99.26 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.524 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 56.5 mtpt -63.61 -42.05 98.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.311 0.577 . . . . 0.0 109.74 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -62.0 -50.11 73.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.796 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 60' ' ' THR . 73.0 mt -70.15 -27.73 64.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.289 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.54 36.54 5.32 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.174 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.3 mtt -99.23 41.49 1.15 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.017 0.437 . . . . 0.0 109.863 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.524 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 13.0 p-10 . . . . . 0 C--O 1.248 0.974 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.832 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -66.95 -39.14 87.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 0.0 110.789 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -136.15 139.25 42.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.348 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.0 ttt -145.78 47.69 1.25 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 62.77 -155.28 0.34 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.339 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.8 t70 56.55 -114.83 0.86 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.389 0.276 . . . . 0.0 110.401 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 t -171.22 -156.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -91.31 45.1 1.22 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.293 0.568 . . . . 0.0 111.202 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.98 70.28 4.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.04 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -73.84 40.19 0.11 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.9 mt -116.02 44.13 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 14' ' ' LYS . 7.5 m -70.39 -65.42 0.73 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.813 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.5 mttm 68.54 -45.75 0.53 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.707 0.803 . . . . 0.0 112.353 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.433 ' O ' HG22 ' A' ' 12' ' ' THR . 21.7 ptmt -155.23 -158.76 0.86 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -67.18 121.5 15.77 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.078 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -103.57 133.91 47.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.614 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.528 ' HZ3' ' HE2' ' A' ' 46' ' ' PHE . 11.9 m95 -105.9 141.97 36.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.377 0.608 . . . . 0.0 112.047 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.5 p -84.36 151.2 24.86 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.352 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.39 -29.41 42.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.355 0.597 . . . . 0.0 109.755 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -60.68 -52.49 64.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.375 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.563 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 94.3 mt-10 -68.76 -36.56 78.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.065 0.459 . . . . 0.0 111.018 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.653 ' O ' HG22 ' A' ' 25' ' ' VAL . 23.9 m -59.23 -39.24 82.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.501 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -67.2 -32.1 72.94 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.938 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.563 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 37.9 m0 -66.28 -40.55 90.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.274 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 22' ' ' SER . 3.6 m -62.85 -36.82 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 120.847 0.356 . . . . 0.0 110.076 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -66.38 -45.0 81.57 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.972 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.54 -40.89 80.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.029 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.6 -38.81 94.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.133 -0.555 . . . . 0.0 112.841 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 25' ' ' VAL . 85.1 t -62.78 -39.16 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.357 0.599 . . . . 0.0 110.103 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -72.71 -49.99 27.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.218 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.594 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 39.7 ttmt -72.17 -47.92 47.28 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.594 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -93.96 -51.8 4.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.43 0.633 . . . . 0.0 111.123 -177.664 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.73 136.33 4.35 Favored Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.222 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.418 ' HB2' HG13 ' A' ' 29' ' ' VAL . 36.6 tt0 -53.06 120.74 6.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.991 0.424 . . . . 0.0 110.27 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.52 -35.05 3.87 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.943 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.471 ' O ' HG13 ' A' ' 40' ' ' ILE . 77.6 m-20 -80.1 53.75 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.008 0.432 . . . . 0.0 111.096 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -64.65 -40.7 95.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.514 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.62 -39.87 85.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.915 0.388 . . . . 0.0 110.933 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.04 -35.38 74.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.463 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 36' ' ' ASN . 89.0 mt -69.84 -45.83 75.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.616 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.607 ' HB3' HD12 ' A' ' 54' ' ' ILE . 19.8 p -64.87 -36.85 85.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.271 0.558 . . . . 0.0 110.696 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -64.75 -45.88 84.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.81 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -86.04 -50.39 7.08 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.549 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 54.8 m-85 -69.06 146.79 97.45 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.197 0.522 . . . . 0.0 111.465 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.414 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.5 Cg_endo -67.34 41.18 0.19 Allowed 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.926 3.084 . . . . 0.0 115.406 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.528 ' HE2' ' HZ3' ' A' ' 17' ' ' TRP . 73.3 m-85 -68.65 127.33 32.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.432 ' C ' ' H ' ' A' ' 49' ' ' ARG . 4.0 p -106.04 121.57 58.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.716 0.293 . . . . 0.0 110.459 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 30.0 m120 69.97 -29.83 0.19 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.55 0.74 . . . . 0.0 112.366 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.578 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -69.18 123.08 20.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.752 0.31 . . . . 0.0 110.604 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.612 ' OG1' ' HG2' ' A' ' 53' ' ' MET . 42.1 p -86.85 174.44 8.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.799 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.02 95.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.701 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.37 -38.83 82.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.612 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 21.5 mmt -60.91 -43.37 98.65 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.607 HD12 ' HB3' ' A' ' 41' ' ' SER . 83.5 mt -65.37 -45.35 93.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.352 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -55.96 -50.34 71.07 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.367 0.603 . . . . 0.0 109.958 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.26 -40.91 94.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.225 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.513 ' O ' ' HG2' ' A' ' 61' ' ' MET . 12.7 tpp180 -60.61 -41.65 95.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.554 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -57.48 -42.4 82.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.961 0.41 . . . . 0.0 110.223 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -56.28 -45.17 80.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.068 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.524 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -69.01 -39.07 79.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.54 179.094 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.513 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 90.9 mmm -56.75 -44.13 81.44 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.151 0.501 . . . . 0.0 110.123 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -62.69 -42.43 99.63 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.276 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 43.8 ttm-85 -61.35 -40.27 93.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.075 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 60' ' ' THR . 60.1 mt -73.34 -6.69 47.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.62 32.0 47.95 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.914 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 81.5 mtp -103.59 44.68 1.0 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.225 0.536 . . . . 0.0 110.215 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.0 t30 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.372 179.847 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 3' ' ' HIS . 53.3 m 63.41 -164.9 0.25 Allowed 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.713 0.405 . . . . 0.0 110.545 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' A' ' 2' ' ' SER . 77.1 t60 71.4 -47.98 0.67 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.231 0.612 . . . . 0.0 111.135 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.6 ttm -166.99 114.67 0.82 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 1.0 OUTLIER -72.02 131.67 43.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.105 0.478 . . . . 0.0 110.912 -179.403 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -166.15 -147.09 0.09 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 p -99.48 39.74 1.28 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.18 0.514 . . . . 0.0 110.149 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.5 m 60.22 44.54 12.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.387 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.91 -43.13 10.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.972 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -98.7 150.94 21.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.945 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.502 ' O ' HG22 ' A' ' 11' ' ' ILE . 48.1 mm 56.01 45.85 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 122.298 1.047 . . . . 0.0 109.48 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.5 p -65.87 -46.9 76.71 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.616 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt 64.13 130.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.383 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -84.58 -168.47 2.2 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.467 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -79.65 52.39 1.42 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -53.16 131.97 37.72 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.677 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.46 ' CE3' ' HB3' ' A' ' 21' ' ' GLU . 27.5 m95 -64.42 127.86 33.29 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.666 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.04 155.76 20.02 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.891 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.417 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 10.3 p -58.32 -39.03 72.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.447 0.165 . . . . 0.0 111.138 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.402 ' HG3' ' CZ2' ' A' ' 24' ' ' TRP . 5.1 tp10 -58.65 -52.76 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.111 0.482 . . . . 0.0 110.155 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.521 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 5.6 mp0 -58.35 -39.55 79.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.33 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.602 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.0 m -67.26 -35.85 80.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.001 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 65.4 mm-40 -64.58 -36.85 85.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.327 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.521 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 44.3 m0 -63.32 -46.38 86.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.419 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 22' ' ' SER . 3.5 m -61.17 -35.68 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.312 0.577 . . . . 0.0 109.983 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.52 ' HA ' ' CZ3' ' A' ' 58' ' ' TRP . 19.3 ttpt -65.59 -49.3 69.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.029 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.81 -41.3 68.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.314 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.81 -45.52 93.42 Favored Glycine 0 C--O 1.22 -0.737 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.408 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 25' ' ' VAL . 91.9 t -64.05 -39.27 84.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 117.67 0.735 . . . . 0.0 110.861 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -66.7 -37.49 84.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.399 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -90.35 -41.92 11.23 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -177.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.434 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -89.69 -52.28 5.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.387 0.613 . . . . 0.0 110.879 -178.04 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.08 134.93 4.71 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.353 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -51.77 139.64 21.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.044 0.449 . . . . 0.0 110.972 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.87 -32.9 7.01 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.479 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.45 ' O ' HG13 ' A' ' 40' ' ' ILE . 74.3 m-80 -84.25 48.64 1.52 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.037 0.446 . . . . 0.0 111.126 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.425 ' HH2' ' CD1' ' A' ' 58' ' ' TRP . 28.2 m95 -60.87 -38.2 84.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.697 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.97 89.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.608 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -68.43 -39.55 81.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.856 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 36' ' ' ASN . 60.9 mt -68.62 -44.76 82.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.821 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.545 ' HB3' HD12 ' A' ' 54' ' ' ILE . 3.7 p -65.15 -32.38 74.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.646 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -70.89 -50.69 32.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.054 0.454 . . . . 0.0 111.528 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -76.61 -47.32 22.72 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -75.89 144.63 76.5 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.092 0.472 . . . . 0.0 111.567 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.454 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 36.6 Cg_endo -67.13 46.78 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.191 3.261 . . . . 0.0 115.309 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -71.97 135.32 46.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.348 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 9.0 p -129.74 133.46 64.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 78.8 m-20 76.81 -35.94 0.25 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.284 0.633 . . . . 0.0 110.574 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.719 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 7.1 mpt_? -77.46 130.04 36.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.311 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.6 p -92.9 174.21 7.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.704 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.3 -35.41 80.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -64.93 -38.61 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.599 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.719 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 60.1 mtt -62.57 -40.68 97.62 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.545 HD12 ' HB3' ' A' ' 41' ' ' SER . 86.4 mt -68.06 -44.77 84.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.403 ' HB3' ' HE3' ' A' ' 55' ' ' LYS . 24.1 ttpp -53.92 -49.91 67.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.868 0.842 . . . . 0.0 109.467 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -67.84 -44.12 77.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.573 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -58.38 -40.37 82.11 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.503 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.536 ' CD1' ' HD2' ' A' ' 62' ' ' LYS . 30.3 t-105 -60.73 -45.37 94.54 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.864 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -56.83 -43.19 80.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.704 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.55 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -63.46 -41.68 98.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.226 179.237 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 92.9 mmm -59.86 -39.8 86.44 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.26 0.553 . . . . 0.0 109.893 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.536 ' HD2' ' CD1' ' A' ' 58' ' ' TRP . 52.8 mtpt -69.27 -39.45 78.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.423 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 50.9 ttm-85 -60.55 -45.88 92.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.958 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 60' ' ' THR . 54.0 mt -70.54 -29.5 65.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.143 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.06 41.34 7.58 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.867 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 51.1 mtm -114.21 53.7 0.78 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.936 0.398 . . . . 0.0 110.485 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.771 -179.993 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.4 m -106.44 122.48 46.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.829 0.347 . . . . 0.0 110.412 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -78.26 -34.11 49.24 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 96.8 mmm 71.98 132.98 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.323 1.014 . . . . 0.0 110.797 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.22 141.65 57.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.929 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -59.1 -45.84 89.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.456 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 p -169.89 -62.15 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.315 0.579 . . . . 0.0 110.44 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.5 m -158.43 -41.85 0.06 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.54 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.416 ' OG1' HG12 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -159.55 155.88 27.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.195 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -69.79 -2.04 10.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.416 HG12 ' OG1' ' A' ' 9' ' ' THR . 41.3 pt -90.25 32.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.889 0.852 . . . . 0.0 109.994 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 m -149.79 42.19 0.87 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -86.68 46.95 1.42 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.25 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -150.77 140.28 21.52 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.574 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.571 ' HB3' ' NH1' ' A' ' 49' ' ' ARG . 80.9 mm-40 61.86 45.12 7.85 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.521 0.513 . . . . 0.0 110.478 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -59.53 120.21 8.98 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.119 0.485 . . . . 0.0 109.833 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.651 ' HA ' ' NH2' ' A' ' 49' ' ' ARG . 35.8 m95 -67.48 143.2 56.32 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.9 p -111.85 161.09 16.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.222 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.416 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 7.3 p -53.82 -41.58 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.473 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 87.2 tt0 -59.13 -50.12 75.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.894 0.378 . . . . 0.0 110.942 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.494 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 54.1 mt-10 -64.59 -34.27 77.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.203 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.474 ' O ' HG22 ' A' ' 25' ' ' VAL . 23.1 t -69.21 -24.7 64.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.85 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 31.6 mm-40 -69.31 -40.66 77.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.082 0.467 . . . . 0.0 110.362 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.547 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 15.2 m0 -66.48 -40.12 89.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.418 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.916 HG12 HG23 ' A' ' 54' ' ' ILE . 34.6 m -61.02 -46.13 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.692 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -65.31 -41.73 93.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.112 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.41 -43.65 80.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.056 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.42 -38.12 95.88 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.188 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.684 HG13 ' HB3' ' A' ' 34' ' ' GLU . 68.4 t -61.17 -33.6 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.477 0.656 . . . . 0.0 110.118 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -77.12 -50.99 11.79 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.923 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.705 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 14.5 tmtt? -78.41 -47.57 17.3 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.705 ' CE1' ' HD2' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -86.71 -36.03 18.92 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.321 0.581 . . . . 0.0 110.965 -177.807 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.9 130.78 7.1 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.684 ' HB3' HG13 ' A' ' 29' ' ' VAL . 22.1 pt-20 -54.68 125.71 21.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.222 0.534 . . . . 0.0 110.48 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.07 -40.73 1.72 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.527 ' O ' HG13 ' A' ' 40' ' ' ILE . 74.4 m-80 -82.78 51.08 1.82 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.126 0.489 . . . . 0.0 110.385 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.415 ' NE1' ' HG3' ' A' ' 55' ' ' LYS . 40.9 m95 -60.27 -40.74 91.45 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.823 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.69 -46.67 84.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.703 0.287 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.01 85.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.439 . . . . 0.0 110.764 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 36' ' ' ASN . 67.8 mt -65.76 -43.52 93.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.679 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.411 ' OG ' HD12 ' A' ' 54' ' ' ILE . 12.9 m -62.22 -40.32 95.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.839 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.708 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -64.1 -55.52 21.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.356 -179.026 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -75.47 -47.48 26.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.421 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 61.0 m-85 -72.52 148.19 90.25 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.117 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.547 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 49.6 Cg_endo -69.56 43.94 0.38 Allowed 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.504 2.803 . . . . 0.0 114.164 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 24' ' ' TRP . 47.2 m-85 -72.56 99.03 2.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.862 0.363 . . . . 0.0 110.426 178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 6.5 p -88.32 127.19 41.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 50.0 m-20 74.34 -36.03 0.32 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.238 0.615 . . . . 0.0 111.732 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.651 ' NH2' ' HA ' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -60.46 128.45 36.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.051 0.453 . . . . 0.0 112.175 -179.009 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.4 p -90.59 165.05 13.96 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.139 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.91 82.21 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.26 -38.66 82.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.38 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.537 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 3.5 mmt -59.77 -45.41 92.35 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.916 HG23 HG12 ' A' ' 25' ' ' VAL . 75.2 mt -65.48 -44.04 94.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.181 0.515 . . . . 0.0 110.055 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.415 ' HG3' ' NE1' ' A' ' 37' ' ' TRP . 38.9 ttmt -55.11 -51.97 64.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.429 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.51 -39.29 81.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.292 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.527 HH11 ' HG3' ' A' ' 57' ' ' ARG . 3.6 tpt85 -57.5 -40.07 77.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.564 ' CD1' ' HD2' ' A' ' 62' ' ' LYS . 11.8 t-105 -63.57 -42.49 98.32 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.463 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 64.8 ttt180 -56.18 -44.84 79.75 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.367 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -59.48 -44.89 92.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.389 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 77.5 mtp -62.4 -45.53 92.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.673 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.564 ' HD2' ' CD1' ' A' ' 58' ' ' TRP . 6.0 mtpm? -59.58 -42.06 91.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.174 0.511 . . . . 0.0 110.386 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -60.24 -40.72 91.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.653 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 60' ' ' THR . 59.9 mt -82.57 -3.25 55.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.027 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.55 40.14 47.81 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.039 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 75.4 mtp -115.41 36.89 3.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.813 0.34 . . . . 0.0 110.713 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.506 ' HA ' ' CH2' ' A' ' 58' ' ' TRP . 27.2 t-20 . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.613 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m 57.48 41.05 26.63 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.078 0.466 . . . . 0.0 110.972 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -95.3 -34.39 12.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.452 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.8 mtp 60.67 57.39 2.72 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.661 0.601 . . . . 0.0 110.722 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -169.56 -56.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 44.83 41.32 5.03 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.2 p -74.22 -43.84 55.51 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 m -154.48 34.99 0.41 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.8 m -73.12 -43.08 62.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.988 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -67.74 119.27 12.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.433 0.635 . . . . 0.0 111.279 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.8 mt -94.49 36.79 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.547 ' HB ' ' SD ' ' A' ' 53' ' ' MET . 19.5 m 71.97 -64.61 0.38 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.387 -177.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp 52.57 -164.26 0.08 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.453 0.701 . . . . 0.0 112.351 177.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt 63.56 169.68 0.16 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.506 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 56.74 89.18 0.05 OUTLIER 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.157 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -61.74 134.48 56.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.016 0.436 . . . . 0.0 109.95 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 28.8 m95 -73.12 132.94 43.89 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.462 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -94.55 148.52 22.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.999 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.69 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 14.6 p -49.51 -37.99 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -59.12 -49.17 78.9 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -64.38 -36.41 84.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.404 0.621 . . . . 0.0 110.082 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.67 ' O ' HG22 ' A' ' 25' ' ' VAL . 47.4 m -67.45 -27.57 67.15 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.923 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.69 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 69.7 mm-40 -66.37 -40.75 89.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.219 0.533 . . . . 0.0 110.167 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.522 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 21.6 m0 -64.16 -38.04 89.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.948 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 22' ' ' SER . 4.2 m -62.92 -38.58 82.3 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.81 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -68.93 -46.5 68.09 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.053 0.454 . . . . 0.0 110.388 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.13 99.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.606 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.59 -38.96 93.72 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.265 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 25' ' ' VAL . 38.6 t -64.32 -38.23 82.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.304 0.552 . . . . 0.0 110.422 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -73.34 -43.3 61.04 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.279 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -80.49 -50.54 9.91 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.463 ' CE1' ' HE1' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -88.72 -45.18 10.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.448 0.642 . . . . 0.0 111.186 -178.354 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 29' ' ' VAL . . . 112.44 131.69 5.65 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -57.82 124.69 20.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.416 0.627 . . . . 0.0 110.608 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.06 -39.57 1.69 Allowed Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.453 ' O ' HG13 ' A' ' 40' ' ' ILE . 75.5 m-80 -82.51 51.03 1.76 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.962 0.411 . . . . 0.0 110.482 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -60.44 -38.62 84.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.565 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.28 99.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.058 0.456 . . . . 0.0 110.276 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.37 -37.04 77.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.055 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 36' ' ' ASN . 67.1 mt -67.36 -45.58 85.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.685 ' HB3' HD12 ' A' ' 54' ' ' ILE . 4.5 p -63.7 -33.85 76.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 0.0 110.8 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -67.11 -48.81 67.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.601 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -82.86 -41.38 19.07 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 45.1 m-85 -79.5 147.43 67.88 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.09 0.471 . . . . 0.0 111.528 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.25 44.26 0.19 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 124.171 3.247 . . . . 0.0 114.735 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.412 ' HB3' ' HB2' ' A' ' 49' ' ' ARG . 60.3 m-85 -76.52 106.52 8.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.888 0.375 . . . . 0.0 110.148 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 49' ' ' ARG . 7.7 p -100.14 131.08 48.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 73.14 -26.22 0.19 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.549 0.74 . . . . 0.0 111.256 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.451 ' H ' ' C ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -72.23 125.61 27.74 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 111.56 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.3 p -89.5 154.94 19.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.499 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.34 -38.91 69.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.644 0.259 . . . . 0.0 110.9 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -63.85 -41.1 91.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.359 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.547 ' SD ' ' HB ' ' A' ' 12' ' ' THR . 68.8 mmm -63.27 -41.19 99.0 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.685 HD12 ' HB3' ' A' ' 41' ' ' SER . 76.7 mt -63.34 -44.94 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -56.92 -53.73 54.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.152 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -64.95 -37.5 87.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.728 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.534 ' O ' ' HG2' ' A' ' 61' ' ' MET . 8.3 tpp180 -59.58 -33.81 71.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.528 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.45 ' CZ2' HG11 ' A' ' 29' ' ' VAL . 12.6 t-105 -60.68 -43.92 97.14 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -55.45 -49.19 73.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.21 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.6 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.89 -38.58 88.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.715 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 96.9 mmm -60.59 -44.39 96.29 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.595 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 46.3 mtpt -65.26 -38.92 91.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.711 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -60.48 -46.1 91.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.084 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 60' ' ' THR . 67.0 mt -71.21 -17.66 62.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.029 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.91 26.58 31.3 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 65.3 mtt -97.63 50.91 1.06 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.874 0.369 . . . . 0.0 110.298 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.595 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 13.3 p-10 . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.77 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.0 t -66.92 128.52 36.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.962 0.41 . . . . 0.0 110.268 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.463 ' HB3' ' HG2' ' A' ' 5' ' ' GLU . 91.2 m-70 -141.89 135.24 29.3 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.95 53.56 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.357 0.599 . . . . 0.0 109.965 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.463 ' HG2' ' HB3' ' A' ' 3' ' ' HIS . 4.8 mm-40 -86.47 -41.96 13.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.353 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.666 ' HA ' ' HD3' ' A' ' 16' ' ' LYS . 70.7 m-20 -65.44 135.96 55.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.666 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.479 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 61.7 p -65.82 129.45 39.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.997 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.919 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 7.5 t -167.76 131.31 1.69 Allowed 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.422 0.629 . . . . 0.0 110.843 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.514 ' H ' ' HB3' ' A' ' 13' ' ' LYS . 9.3 t 177.11 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.456 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.43 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 11.5 p30 -179.02 149.11 0.42 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 10' ' ' ASN . 62.2 mt 69.82 -52.81 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.1 t -118.44 28.1 8.55 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.613 -178.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.919 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 38.2 pttt -70.92 -42.23 70.17 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.528 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -106.55 32.65 4.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.487 0.66 . . . . 0.0 109.704 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -144.01 60.03 1.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.37 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.666 ' HD3' ' HA ' ' A' ' 6' ' ' ASP . 19.3 tptm -70.93 132.95 45.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.419 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.578 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 12.3 m95 -127.46 134.72 49.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.821 0.344 . . . . 0.0 111.836 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -77.35 151.56 34.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.553 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 9.8 p -55.5 -36.17 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.919 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.486 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 32.7 tt0 -59.77 -45.49 92.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.045 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 42.1 mt-10 -64.71 -42.36 95.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.685 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.649 ' O ' HG22 ' A' ' 25' ' ' VAL . 2.0 p -66.9 -28.36 68.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.445 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 66.3 mm-40 -67.73 -35.95 79.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.897 0.38 . . . . 0.0 110.328 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.486 ' CZ2' ' HG2' ' A' ' 20' ' ' GLU . 30.9 m0 -66.57 -42.84 86.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.411 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 22' ' ' SER . 3.3 m -58.95 -39.46 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.815 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 66' ' ' MET . 22.1 ttmt -64.67 -43.51 93.36 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.044 0.45 . . . . 0.0 110.344 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.69 -44.1 91.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.618 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.03 -38.09 95.52 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.427 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 25' ' ' VAL . 69.3 t -62.97 -39.97 87.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.253 0.549 . . . . 0.0 110.323 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -74.4 -45.95 43.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.008 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.485 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 60.3 tttm -80.98 -45.51 16.51 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -177.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.486 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -89.63 -51.22 5.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.32 0.581 . . . . 0.0 110.594 -177.703 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.34 135.44 4.23 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.513 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -55.16 113.54 1.42 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.979 0.418 . . . . 0.0 110.16 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.44 -35.26 2.72 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.998 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.529 ' O ' HG13 ' A' ' 40' ' ' ILE . 75.4 m-20 -80.48 49.26 1.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.006 0.432 . . . . 0.0 111.187 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 33.5 m95 -60.68 -40.45 92.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.432 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.89 -37.43 79.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 110.965 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.73 -32.75 68.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.403 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 36' ' ' ASN . 73.7 mt -71.57 -46.81 61.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.736 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.469 ' HB3' HD12 ' A' ' 54' ' ' ILE . 54.6 p -62.72 -35.31 79.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.186 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -65.6 -53.45 41.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.617 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.0 -48.43 16.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.406 ' CD1' HG23 ' A' ' 40' ' ' ILE . 62.3 m-85 -71.21 151.11 94.54 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 120.934 0.397 . . . . 0.0 111.581 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.419 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 37.1 Cg_endo -67.35 43.28 0.22 Allowed 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.787 2.991 . . . . 0.0 114.445 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.578 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 65.6 m-85 -76.33 115.48 16.11 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.458 ' C ' ' H ' ' A' ' 49' ' ' ARG . 3.6 p -95.9 125.28 48.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.193 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 p30 64.54 -30.71 0.12 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.709 1.204 . . . . 0.0 112.904 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.571 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -61.26 116.18 4.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 111.339 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.6 p -78.9 173.61 12.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.694 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.69 -39.22 93.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.223 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.6 t -62.89 -39.17 83.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.776 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 81.2 mmm -58.87 -42.82 90.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.715 178.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.474 HG23 HG12 ' A' ' 25' ' ' VAL . 67.6 mt -69.12 -44.49 80.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.298 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 39.2 ttpt -55.07 -53.8 51.17 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.829 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -62.13 -40.35 95.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.834 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.52 ' O ' ' HG2' ' A' ' 61' ' ' MET . 6.8 tpp180 -56.41 -42.3 77.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.924 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 15.7 t-105 -59.37 -43.42 92.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.867 0.365 . . . . 0.0 110.357 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.445 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 1.8 mpt_? -59.66 -43.95 93.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.21 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.583 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -60.95 -44.12 97.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.367 178.713 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 86.2 mmm -56.91 -46.7 81.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.22 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.574 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 19.9 mtpp -62.8 -39.5 94.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.119 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -68.75 -44.08 74.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.681 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 60' ' ' THR . 72.9 mt -71.62 -21.8 61.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.167 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.16 30.58 19.46 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.445 ' O ' ' HE2' ' A' ' 26' ' ' LYS . 65.5 mtt -100.1 47.05 0.94 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.574 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 16.9 p-10 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.733 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' ' 6' ' ' ASP . 15.0 m 56.65 36.29 27.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.779 0.432 . . . . 0.0 111.634 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -73.02 -43.56 61.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.45 0.643 . . . . 0.0 109.535 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 53.6 ttm -155.8 -41.82 0.08 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -129.66 134.3 47.59 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.514 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 3.1 t70 -155.01 24.95 0.43 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.549 0.69 . . . . 0.0 109.291 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 p -144.86 85.51 1.76 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.969 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 m -58.89 -45.07 91.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.238 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -84.13 -92.87 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.812 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -172.21 126.75 0.55 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.453 ' O ' HG22 ' A' ' 11' ' ' ILE . 32.0 mm 57.61 48.03 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 122.291 1.043 . . . . 0.0 109.678 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.53 -22.44 18.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.824 -178.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.514 ' HG2' ' HB3' ' A' ' 6' ' ' ASP . 9.9 mtmp? -67.79 -66.82 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.89 128.79 43.09 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 53.16 57.1 6.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.724 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.46 ' HE3' ' HB3' ' A' ' 16' ' ' LYS . 1.2 tmmt? -79.03 112.3 16.09 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.602 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 28.6 m95 -139.71 134.92 32.59 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.908 -177.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 57.5 p -81.98 162.18 22.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.427 ' O ' ' HG3' ' A' ' 23' ' ' GLU . 9.6 p -57.9 -40.22 75.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 121.347 -0.141 . . . . 0.0 111.233 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.507 ' HG3' ' CE2' ' A' ' 24' ' ' TRP . 45.4 tp10 -60.92 -50.81 71.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.236 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.581 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 39.1 mt-10 -58.0 -42.41 85.15 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.487 0.66 . . . . 0.0 111.164 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.63 ' O ' HG22 ' A' ' 25' ' ' VAL . 15.1 m -66.81 -36.49 82.5 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.166 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 19.9 mt-10 -67.53 -31.77 72.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.949 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.581 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 47.5 m0 -61.89 -41.93 98.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.49 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.63 HG22 ' O ' ' A' ' 22' ' ' SER . 1.4 m -63.46 -37.5 79.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.391 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -66.18 -47.97 72.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.058 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.28 -37.33 85.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.591 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.29 -39.4 94.6 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.827 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 25' ' ' VAL . 92.7 t -61.32 -37.8 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.456 0.646 . . . . 0.0 110.176 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -76.18 -47.15 25.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.027 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.8 -48.79 65.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.99 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -107.67 -47.85 3.53 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.341 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.69 142.63 5.02 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.197 -1.001 . . . . 0.0 112.479 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.94 126.3 26.46 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.67 -31.34 6.9 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.718 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.403 ' O ' HG13 ' A' ' 40' ' ' ILE . 68.3 m-80 -83.19 47.71 1.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.071 0.463 . . . . 0.0 110.808 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.42 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 36.7 m95 -61.84 -37.54 84.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.111 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.95 -47.54 85.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.045 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.83 -40.83 98.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.219 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.452 HG22 ' HE2' ' A' ' 46' ' ' PHE . 97.8 mt -63.33 -45.67 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.508 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.405 ' HB2' HD12 ' A' ' 54' ' ' ILE . 16.7 t -64.4 -34.69 78.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.225 0.536 . . . . 0.0 110.481 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -67.82 -51.14 52.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.934 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -77.5 -50.73 12.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.947 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -73.02 145.75 86.61 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.055 0.455 . . . . 0.0 111.115 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.507 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.0 Cg_endo -66.63 45.07 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.013 3.142 . . . . 0.0 115.102 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.602 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 70.5 m-85 -71.18 122.74 20.73 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.262 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 p -103.76 124.0 57.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.861 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 70.73 -39.14 0.44 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.537 0.735 . . . . 0.0 111.939 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.05 118.95 5.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.2 p -80.61 175.26 10.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.163 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.29 -36.93 84.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 t -63.98 -38.83 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.603 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 84.9 mmm -59.39 -43.16 93.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.429 HG23 HG12 ' A' ' 25' ' ' VAL . 70.9 mt -67.43 -44.35 86.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.405 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 40.1 ttpt -57.14 -47.55 80.87 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.401 0.62 . . . . 0.0 109.828 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -67.33 -40.87 85.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.72 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.413 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 30.0 tpt180 -60.57 -40.36 91.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.099 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.435 ' O ' ' HG3' ' A' ' 62' ' ' LYS . 12.4 t-105 -59.85 -44.47 94.1 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 57.3 ttm-85 -59.74 -45.56 91.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.335 178.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.507 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 17.7 p -62.42 -39.41 93.21 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.857 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.8 mmm -62.13 -46.42 89.11 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.076 0.465 . . . . 0.0 110.007 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.514 ' HG2' ' ND2' ' A' ' 67' ' ' ASN . 23.7 mtpp -61.47 -42.44 98.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.0 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 -61.92 -44.22 97.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.424 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 60' ' ' THR . 79.9 mt -68.1 -28.53 67.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.157 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.58 31.57 7.4 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.646 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 84.1 mtp -95.16 51.96 1.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.938 0.399 . . . . 0.0 110.491 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.514 ' ND2' ' HG2' ' A' ' 62' ' ' LYS . 51.0 p-10 . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.473 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.814 -0.515 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.5 p -53.87 -45.0 70.87 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.112 0.482 . . . . 0.0 110.559 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -120.81 -55.19 2.01 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 53.7 tpp -179.42 -92.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.976 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 47.55 50.03 15.43 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 123.736 0.647 . . . . 0.0 111.47 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -80.76 42.02 0.6 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.71 0.766 . . . . 0.0 110.701 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.8 t -82.96 -16.16 48.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.192 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.8 p 51.55 48.27 23.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.623 0.725 . . . . 0.0 110.333 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.612 HG23 HG13 ' A' ' 11' ' ' ILE . 11.8 t -65.34 134.04 52.7 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.882 -178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.502 ' N ' HD22 ' A' ' 10' ' ' ASN . 0.0 OUTLIER -75.05 64.77 1.39 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.132 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.612 HG13 HG23 ' A' ' 9' ' ' THR . 60.2 mt -56.05 128.74 16.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 O-C-N 122.297 -0.252 . . . . 0.0 110.626 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 m 75.63 -29.01 0.18 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.336 0.654 . . . . 0.0 112.029 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.0 mttm 58.05 -140.59 0.77 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.03 26.55 8.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 176.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -94.8 26.75 3.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.219 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -75.63 126.22 30.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.549 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 13.6 m95 -102.85 137.91 40.43 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.667 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.5 p -79.3 155.33 28.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.284 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.2 p -58.38 -33.85 48.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.926 0.393 . . . . 0.0 110.668 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.73 -49.31 75.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.133 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.439 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 33.8 mt-10 -63.97 -40.15 95.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.543 0.687 . . . . 0.0 110.489 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.593 ' O ' HG22 ' A' ' 25' ' ' VAL . 25.0 m -63.05 -35.58 80.73 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.365 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -65.46 -32.39 73.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.075 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.453 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 41.1 m0 -66.76 -46.0 76.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.675 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 22' ' ' SER . 3.3 m -62.51 -37.79 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.998 0.428 . . . . 0.0 110.18 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -63.19 -46.18 88.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.913 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.31 -40.28 64.62 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.214 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.44 -41.67 97.18 Favored Glycine 0 C--O 1.226 -0.377 0 CA-C-N 116.114 -0.494 . . . . 0.0 113.052 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 34' ' ' GLU . 66.2 t -62.23 -40.32 87.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.247 0.546 . . . . 0.0 110.748 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -73.55 -44.92 56.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.04 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.473 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 62.1 tttp -75.46 -50.32 16.13 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.473 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -87.3 -53.15 4.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.443 0.639 . . . . 0.0 110.867 -178.283 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.21 133.2 3.53 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.687 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.607 ' HB2' HG13 ' A' ' 29' ' ' VAL . 35.5 tt0 -55.42 121.5 9.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.918 0.389 . . . . 0.0 110.661 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.15 -34.01 3.83 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.014 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.459 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.2 m-80 -80.19 53.91 1.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.075 0.464 . . . . 0.0 111.243 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -64.52 -36.56 84.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.951 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.83 98.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.072 0.463 . . . . 0.0 110.545 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.77 -37.72 73.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.006 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 36' ' ' ASN . 74.1 mt -66.56 -46.53 86.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.867 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.526 ' HB3' HD12 ' A' ' 54' ' ' ILE . 3.8 p -62.88 -37.51 87.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.193 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -65.83 -52.69 48.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.09 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -76.72 -47.08 23.01 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.402 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 53.3 m-85 -71.25 149.14 94.15 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.989 0.423 . . . . 0.0 111.07 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.453 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 40.7 Cg_endo -67.84 43.19 0.25 Allowed 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.685 2.923 . . . . 0.0 114.773 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.549 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 73.4 m-85 -74.7 127.77 33.93 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 49' ' ' ARG . 7.5 p -115.72 132.68 64.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 p30 66.03 -30.19 0.14 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.655 1.182 . . . . 0.0 112.366 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -67.8 125.77 27.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.728 0.299 . . . . 0.0 110.981 179.229 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.9 p -89.34 169.82 11.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.621 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.65 89.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.485 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.95 -38.03 80.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.501 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 14.5 mmt -62.07 -44.1 97.4 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.526 HD12 ' HB3' ' A' ' 41' ' ' SER . 77.4 mt -64.15 -44.51 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.938 0.399 . . . . 0.0 110.009 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -55.91 -50.23 71.25 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.901 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.51 -42.86 86.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.5 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.509 ' O ' ' HG2' ' A' ' 61' ' ' MET . 8.9 tpp180 -60.42 -38.3 83.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.623 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.482 ' CD2' HG21 ' A' ' 29' ' ' VAL . 27.4 t-105 -60.35 -44.69 95.31 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.56 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 68.2 mtp85 -57.86 -46.71 84.4 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.533 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.499 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -63.81 -36.96 85.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.922 179.085 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 87.5 mmm -62.56 -45.07 94.62 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.583 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 22.3 mtpp -61.37 -40.19 93.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.144 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.0 mtp85 -62.94 -47.5 82.97 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.921 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 60' ' ' THR . 74.9 mt -72.36 -10.17 59.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.613 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.18 32.11 60.73 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.255 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 88.3 mtp -98.74 47.86 0.98 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.089 0.471 . . . . 0.0 110.124 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.583 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 14.8 p-10 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.222 -0.894 . . . . 0.0 109.61 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.636 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 16.4 m95 . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -87.03 154.6 20.64 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.595 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 14.7 p -57.6 -42.53 81.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -60.37 -45.68 92.65 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.784 0.325 . . . . 0.0 110.941 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.477 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 68.7 mt-10 -61.28 -36.41 79.99 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.493 0.663 . . . . 0.0 110.107 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.675 ' O ' HG22 ' A' ' 25' ' ' VAL . 22.0 m -69.8 -29.69 67.05 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.705 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.595 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 68.1 mm-40 -69.57 -39.25 77.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.243 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.515 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 33.6 m0 -61.17 -43.77 98.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.219 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 22' ' ' SER . 3.1 m -58.63 -38.31 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.001 0.429 . . . . 0.0 110.263 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -67.18 -49.58 64.14 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.793 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.88 -43.22 99.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.736 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.9 -38.84 96.68 Favored Glycine 0 C--O 1.224 -0.524 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.566 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 25' ' ' VAL . 55.7 t -63.21 -35.76 73.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.037 0.446 . . . . 0.0 110.909 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.28 -46.61 15.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.947 0.403 . . . . 0.0 110.866 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.723 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 39.5 ttmt -74.46 -45.72 44.41 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.723 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -93.28 -46.11 7.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.211 0.529 . . . . 0.0 110.98 -177.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.78 134.05 5.05 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.168 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.423 ' HB2' HG13 ' A' ' 29' ' ' VAL . 87.3 tt0 -54.23 118.65 4.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.871 0.367 . . . . 0.0 110.476 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.12 -38.54 2.0 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.817 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.503 ' O ' HG13 ' A' ' 40' ' ' ILE . 74.0 m-20 -79.83 54.11 1.78 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.142 0.496 . . . . 0.0 111.114 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -62.76 -39.11 93.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.581 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.11 -46.58 89.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.105 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.68 87.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.966 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 36' ' ' ASN . 75.1 mt -66.87 -43.21 89.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.003 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.467 ' OG ' HD12 ' A' ' 54' ' ' ILE . 14.9 m -60.37 -39.05 85.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.229 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -70.61 -55.13 9.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.885 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -72.48 -40.9 66.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 60.8 m-85 -83.1 146.15 50.89 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.546 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.515 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 35.9 Cg_endo -66.09 43.12 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.723 2.949 . . . . 0.0 115.041 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.636 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 64.6 m-85 -72.92 111.56 8.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.858 0.361 . . . . 0.0 110.079 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.4 127.86 51.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 72.97 -41.52 0.51 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.475 0.71 . . . . 0.0 111.368 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.447 ' NH2' ' HA ' ' A' ' 17' ' ' TRP . 1.0 OUTLIER -58.48 120.39 8.72 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 122.598 0.359 . . . . 0.0 111.277 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.3 p -86.04 172.17 10.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.206 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.68 83.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.455 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.29 -39.78 86.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.102 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 19.1 mmt -62.09 -41.71 98.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.317 -0.402 . . . . 0.0 109.959 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.467 HD12 ' OG ' ' A' ' 41' ' ' SER . 66.0 mt -67.28 -42.3 87.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -56.94 -50.66 71.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.557 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -64.53 -44.46 90.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.627 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.415 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 32.0 tpt180 -58.47 -45.13 89.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.388 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -62.66 -41.91 99.32 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.297 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -58.11 -44.97 88.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.934 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 24.5 p . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.959 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.466 ' CE3' ' HB3' ' A' ' 21' ' ' GLU . 14.0 m95 . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 120.694 0.283 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -79.5 156.39 27.82 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.81 -41.83 76.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.511 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -65.75 -45.83 81.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.528 0.204 . . . . 0.0 110.5 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.466 ' HB3' ' CE3' ' A' ' 17' ' ' TRP . 35.1 mt-10 -55.55 -43.44 75.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.638 0.733 . . . . 0.0 110.533 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.572 ' O ' HG22 ' A' ' 25' ' ' VAL . 17.5 m -66.75 -37.15 84.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.819 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -63.66 -35.27 79.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.982 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.465 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 44.2 m0 -61.89 -44.96 95.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.822 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 22' ' ' SER . 1.4 m -62.2 -40.17 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 26' ' ' LYS . 24.2 ttpt -65.14 -46.81 79.39 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.273 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.12 -44.08 97.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.158 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.26 95.97 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.273 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.659 HG13 ' HB2' ' A' ' 34' ' ' GLU . 50.2 t -63.22 -41.06 91.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.25 0.547 . . . . 0.0 110.178 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.486 HE21 ' HB3' ' A' ' 30' ' ' GLN . 0.2 OUTLIER -75.03 -45.62 40.5 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.77 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.478 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 61.7 tttm -79.64 -52.97 7.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.478 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -82.68 -54.65 4.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.483 0.658 . . . . 0.0 110.456 -178.583 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.74 130.86 3.29 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.096 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.659 ' HB2' HG13 ' A' ' 29' ' ' VAL . 36.8 tt0 -51.39 128.88 23.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.811 0.339 . . . . 0.0 110.892 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.37 -35.3 4.18 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.837 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.484 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.0 m-80 -81.11 51.85 1.67 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.884 0.373 . . . . 0.0 111.08 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.451 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 32.9 m95 -62.26 -42.91 99.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.788 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.39 88.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.791 0.329 . . . . 0.0 110.731 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.66 -42.91 98.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.473 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 36' ' ' ASN . 89.0 mt -62.47 -45.6 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.598 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.543 ' HB2' HD12 ' A' ' 54' ' ' ILE . 29.5 t -61.43 -36.33 80.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.068 0.461 . . . . 0.0 111.087 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -68.18 -49.96 57.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.95 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -77.8 -52.69 8.5 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.612 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.436 ' CD1' HG23 ' A' ' 40' ' ' ILE . 57.6 m-85 -67.9 147.45 98.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.119 0.485 . . . . 0.0 111.329 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.429 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.6 Cg_endo -66.98 44.57 0.22 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.819 3.012 . . . . 0.0 115.212 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.451 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 75.7 m-85 -71.36 124.85 25.48 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.774 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.42 ' C ' ' H ' ' A' ' 49' ' ' ARG . 2.4 p -101.83 118.54 48.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.089 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.1 -30.38 0.15 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.543 1.137 . . . . 0.0 112.964 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.557 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -60.91 119.51 8.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.234 0.54 . . . . 0.0 111.771 -179.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 p -79.05 169.95 17.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.945 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.23 -38.61 89.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.303 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.87 -40.21 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.4 mmt -61.3 -40.84 95.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.543 HD12 ' HB2' ' A' ' 41' ' ' SER . 82.3 mt -67.11 -44.16 88.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 37.7 ttpt -56.98 -48.87 77.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.696 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -66.64 -39.46 88.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.883 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.445 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 27.6 tpt180 -59.32 -43.58 92.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.32 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.401 ' CE3' ' HA ' ' A' ' 58' ' ' TRP . 10.9 t-105 -58.62 -45.27 89.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -60.9 -46.25 91.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.722 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 27.9 p . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.288 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.474 ' HZ3' ' HE2' ' A' ' 46' ' ' PHE . 14.3 m95 . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.941 0.4 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.0 p -79.33 156.41 28.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.344 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.52 -31.52 50.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.437 ' HG3' ' CZ2' ' A' ' 24' ' ' TRP . 3.2 tp10 -59.76 -51.74 68.47 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.593 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.511 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 29.1 mt-10 -64.31 -38.15 90.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.596 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.585 ' O ' HG22 ' A' ' 25' ' ' VAL . 22.6 m -64.89 -41.92 95.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.341 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -63.04 -32.9 74.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.96 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.511 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 47.0 m0 -65.88 -46.23 79.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.887 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 22' ' ' SER . 2.3 m -60.93 -39.31 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -67.21 -47.31 71.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.621 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.66 -42.39 98.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.516 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.32 -36.46 93.1 Favored Glycine 0 C--O 1.222 -0.645 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.969 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 25' ' ' VAL . 53.7 t -65.7 -34.28 69.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.181 0.515 . . . . 0.0 110.072 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -75.43 -48.08 24.42 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.214 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.496 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 24.8 ttmm -79.9 -48.22 13.8 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -177.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.496 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -90.8 -44.01 9.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.414 0.626 . . . . 0.0 111.101 -178.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 29' ' ' VAL . . . 106.97 132.37 6.98 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -56.62 139.17 50.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.373 0.606 . . . . 0.0 110.834 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.31 -38.11 3.01 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -85.65 49.34 1.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.107 0.479 . . . . 0.0 110.148 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.425 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 42.1 m95 -60.22 -38.28 82.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.222 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.22 -45.66 90.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.995 0.426 . . . . 0.0 110.133 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 -44.59 91.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.81 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.5 mt -61.31 -44.1 97.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.786 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.503 ' HB2' HD12 ' A' ' 54' ' ' ILE . 31.9 t -64.65 -37.66 88.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.814 0.34 . . . . 0.0 111.039 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -64.9 -49.23 71.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.258 0.551 . . . . 0.0 111.604 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -79.0 -48.61 14.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.956 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -75.31 141.53 73.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 0.0 111.869 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.511 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.4 Cg_endo -66.39 48.93 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 124.298 3.332 . . . . 0.0 115.257 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.474 ' HE2' ' HZ3' ' A' ' 17' ' ' TRP . 60.8 m-85 -72.15 109.85 6.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.87 0.366 . . . . 0.0 110.202 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 49' ' ' ARG . 4.0 p -84.82 122.26 37.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.471 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.7 m120 69.88 -34.04 0.27 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.557 0.743 . . . . 0.0 112.27 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.626 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -63.06 127.88 33.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.248 0.547 . . . . 0.0 111.789 -179.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.4 p -93.29 176.56 6.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.127 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.95 -38.57 91.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.667 0.27 . . . . 0.0 110.299 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.7 t -63.52 -38.76 83.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.485 ' HA ' ' CE ' ' A' ' 53' ' ' MET . 14.0 mmt -59.37 -44.99 92.65 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.551 HG23 HG12 ' A' ' 25' ' ' VAL . 68.4 mt -65.49 -46.49 89.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.504 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 36.0 ttpt -55.05 -50.44 69.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.345 0.593 . . . . 0.0 110.378 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -66.33 -39.55 89.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.401 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.444 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 30.8 tpt180 -59.99 -41.6 92.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.587 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.46 ' CE2' HG21 ' A' ' 29' ' ' VAL . 16.0 t-105 -61.18 -45.5 94.36 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.81 -44.45 86.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.901 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.461 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.457 ' HZ2' ' HB3' ' A' ' 53' ' ' MET . 17.3 m95 . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.3 p -76.81 152.74 35.42 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 10.9 p -60.51 -38.61 78.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.219 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -59.71 -54.1 50.29 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.532 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 50.3 mt-10 -58.57 -39.28 79.85 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.429 0.633 . . . . 0.0 111.096 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.538 ' O ' HG22 ' A' ' 25' ' ' VAL . 15.5 m -68.16 -37.6 81.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.203 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 68.0 mm-40 -61.26 -34.64 75.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.873 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.532 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 42.5 m0 -62.54 -43.66 98.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.15 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 29' ' ' VAL . 1.1 m -60.04 -37.55 73.12 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -62.21 -46.3 89.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.639 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.86 78.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.744 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.06 -40.68 99.24 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 25' ' ' VAL . 51.5 t -61.09 -37.39 77.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.006 0.432 . . . . 0.0 111.01 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -79.28 -41.42 28.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.696 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -78.81 -49.49 12.88 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.431 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -86.05 -42.12 14.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.462 0.648 . . . . 0.0 110.805 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.17 131.54 5.88 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -50.55 130.4 23.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.808 0.337 . . . . 0.0 110.914 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.41 -37.07 3.44 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.906 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.464 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.9 m-80 -81.53 53.72 2.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.102 0.477 . . . . 0.0 111.115 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -63.83 -38.3 90.57 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.559 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.54 -46.2 90.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.51 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.23 -43.08 99.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.64 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 36' ' ' ASN . 79.6 mt -63.05 -45.07 99.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.449 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.566 ' HB2' HD12 ' A' ' 54' ' ' ILE . 47.6 t -62.91 -36.0 81.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.229 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -68.76 -47.91 65.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.908 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -80.34 -49.96 10.8 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.409 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 51.0 m-85 -70.41 145.56 93.18 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 121.171 0.51 . . . . 0.0 111.826 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.47 44.28 0.24 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 124.073 3.182 . . . . 0.0 114.841 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.437 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 53.4 m-85 -68.65 122.95 19.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.969 0.414 . . . . 0.0 110.489 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.484 HG22 ' ND2' ' A' ' 48' ' ' ASN . 7.4 p -106.58 127.25 62.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.256 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.631 ' C ' ' HD2' ' A' ' 49' ' ' ARG . 73.2 m-80 61.79 17.18 8.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.738 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.631 ' HD2' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -118.03 124.37 47.96 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -178.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.517 ' OG1' ' HG2' ' A' ' 53' ' ' MET . 31.1 p -87.01 175.38 8.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.624 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.78 -38.59 86.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.538 0.208 . . . . 0.0 110.824 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.72 -36.23 74.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.517 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 79.8 mmm -61.79 -45.27 94.61 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.566 HD12 ' HB2' ' A' ' 41' ' ' SER . 66.3 mt -66.45 -41.96 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.958 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -54.92 -49.28 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.148 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 3.5 t0 -71.31 -36.59 71.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.262 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.457 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 27.8 tpt180 -59.7 -40.52 88.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.116 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.4 t-105 -59.59 -43.34 93.71 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 56' ' ' ASP . 21.7 ttm180 -58.06 -49.46 76.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.457 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.457 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 1.7 p . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.955 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.515 ' HZ3' ' HE2' ' A' ' 46' ' ' PHE . 10.6 m95 . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 120.572 0.225 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -77.3 154.43 32.9 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.1 p -57.21 -35.29 48.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.503 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -60.23 -53.92 51.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.682 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.62 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 37.7 mt-10 -59.44 -42.4 91.83 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.689 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.662 ' O ' HG22 ' A' ' 25' ' ' VAL . 8.5 m -65.59 -34.87 79.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.145 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -69.52 -33.14 72.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.906 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.62 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 44.6 m0 -61.82 -42.8 99.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.653 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 22' ' ' SER . 2.5 m -62.3 -38.16 80.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -63.76 -48.96 74.86 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.276 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.32 -40.78 90.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.721 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.05 -38.05 94.91 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.659 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 25' ' ' VAL . 54.8 t -63.16 -36.15 74.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.958 0.408 . . . . 0.0 110.752 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -78.84 -43.92 24.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.225 0.536 . . . . 0.0 111.102 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.577 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 88.1 tttt -74.09 -45.68 47.62 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.577 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -96.61 -49.04 5.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.275 0.56 . . . . 0.0 111.053 -178.206 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.07 134.58 4.4 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.166 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.517 ' HB2' HG13 ' A' ' 29' ' ' VAL . 76.3 tt0 -55.15 106.69 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.168 0.509 . . . . 0.0 110.658 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.39 -37.9 1.51 Allowed Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.673 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.494 ' O ' HG13 ' A' ' 40' ' ' ILE . 73.0 m-80 -78.88 54.58 1.58 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.042 0.448 . . . . 0.0 111.386 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.433 ' NE1' ' HG3' ' A' ' 55' ' ' LYS . 36.0 m95 -65.31 -37.08 86.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.279 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.44 -42.1 96.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.163 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.62 -37.04 81.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.022 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 36' ' ' ASN . 74.4 mt -66.96 -45.81 86.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.66 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.474 ' HB3' HD12 ' A' ' 54' ' ' ILE . 4.1 p -65.4 -34.67 78.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.135 0.493 . . . . 0.0 111.154 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.52 -43.28 81.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.087 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -88.03 -44.64 10.83 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.45 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 55.6 m-85 -76.05 146.72 79.23 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 121.108 0.48 . . . . 0.0 111.627 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.32 46.3 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.08 3.187 . . . . 0.0 115.47 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.515 ' HE2' ' HZ3' ' A' ' 17' ' ' TRP . 75.6 m-85 -71.47 134.63 46.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.564 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.422 ' C ' ' H ' ' A' ' 49' ' ' ARG . 3.5 p -123.05 132.3 71.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 75.9 m-20 73.91 -39.87 0.44 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.567 0.747 . . . . 0.0 110.709 -177.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.5 ' HD3' ' OE2' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -67.31 138.39 56.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.266 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.7 p -102.77 177.45 4.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.628 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.02 -39.56 90.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.713 0.292 . . . . 0.0 110.415 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.9 t -63.49 -37.21 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.438 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 18.7 mmt -62.4 -42.31 99.33 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.484 HG23 HG12 ' A' ' 25' ' ' VAL . 82.4 mt -65.6 -44.49 93.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.012 0.434 . . . . 0.0 109.864 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.433 ' HG3' ' NE1' ' A' ' 37' ' ' TRP . 25.8 ttpp -56.47 -49.51 74.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.655 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 37.7 t70 -67.59 -39.4 84.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.838 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.492 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 13.0 tpp180 -59.84 -37.74 80.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.204 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.485 ' CE2' HG21 ' A' ' 29' ' ' VAL . 8.5 t-105 -60.61 -42.88 97.71 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 56' ' ' ASP . 98.5 mtt180 -53.54 -49.95 66.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.021 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.411 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.8 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.557 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 16.8 m95 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.5 p -82.53 160.88 22.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.346 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.73 -40.71 80.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.426 0.155 . . . . 0.0 111.152 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -61.94 -47.29 85.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.691 0.281 . . . . 0.0 111.585 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.521 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 49.8 mt-10 -63.66 -36.23 83.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.333 0.587 . . . . 0.0 110.695 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.616 ' O ' HG22 ' A' ' 25' ' ' VAL . 40.2 m -67.58 -36.03 80.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.02 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.65 -35.3 80.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.833 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.527 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 44.6 m0 -62.18 -46.73 87.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.379 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 22' ' ' SER . 3.3 m -60.75 -37.46 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.873 0.368 . . . . 0.0 110.815 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -66.17 -46.12 78.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.771 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.2 -38.57 75.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.039 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.07 -36.18 80.34 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.625 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 25' ' ' VAL . 97.5 t -62.28 -36.38 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.518 0.675 . . . . 0.0 110.074 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -81.18 -49.08 11.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.395 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.526 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 84.5 tttt -69.11 -42.49 76.02 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.917 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.526 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -102.74 -55.7 2.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.338 0.59 . . . . 0.0 110.973 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.89 138.23 3.96 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.228 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.5 ' HB2' HG13 ' A' ' 29' ' ' VAL . 7.8 tm-20 -57.04 117.81 4.37 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.26 -32.1 4.65 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.019 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.473 ' O ' HG13 ' A' ' 40' ' ' ILE . 71.4 m-80 -81.62 48.19 1.16 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.896 0.379 . . . . 0.0 111.345 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 36.9 m95 -62.85 -37.91 88.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.832 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.17 -48.93 78.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 0.0 110.528 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.27 98.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.689 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 36' ' ' ASN . 79.1 mt -60.72 -45.54 97.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.593 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.492 ' HB2' HD12 ' A' ' 54' ' ' ILE . 23.1 t -64.69 -35.02 79.7 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.096 0.474 . . . . 0.0 110.924 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -67.65 -47.45 69.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.754 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -82.31 -49.45 10.04 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.474 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 56.4 m-85 -70.23 143.31 90.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.095 0.474 . . . . 0.0 111.374 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.527 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 39.4 Cg_endo -67.6 48.27 0.35 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.922 3.081 . . . . 0.0 115.204 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.557 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 67.8 m-85 -72.48 133.47 44.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.761 0.315 . . . . 0.0 110.283 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.596 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 5.9 p -110.48 121.11 62.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.84 -30.92 0.14 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.6 1.16 . . . . 0.0 112.293 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.596 ' HD2' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -61.71 118.0 6.56 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.964 0.411 . . . . 0.0 110.9 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.404 ' OG1' ' HG2' ' A' ' 53' ' ' MET . 34.2 p -81.02 167.39 19.84 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.703 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.56 85.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.9 t -63.23 -36.96 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.45 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 61.1 mmm -64.17 -41.33 97.16 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.596 HG23 HG12 ' A' ' 25' ' ' VAL . 85.1 mt -65.36 -45.01 94.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.814 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.566 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 38.8 ttpt -56.7 -49.61 74.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.337 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -63.47 -44.88 93.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.523 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.463 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 30.9 tpt180 -60.55 -38.59 84.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.144 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -58.8 -43.17 90.48 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.635 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.566 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 1.6 mpt_? -60.04 -49.17 78.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.758 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 2.9 p . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.796 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.439 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 10.4 m95 . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 120.462 0.172 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.9 p -78.66 147.74 33.44 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.439 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 11.5 p -53.71 -35.58 27.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.61 0.243 . . . . 0.0 110.969 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.419 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 39.8 tt0 -59.71 -53.46 57.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.362 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.569 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 45.5 mt-10 -61.09 -39.45 89.99 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.439 0.638 . . . . 0.0 111.015 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.606 ' O ' HG22 ' A' ' 25' ' ' VAL . 6.4 m -66.09 -33.36 75.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.613 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 58.7 mm-40 -68.29 -30.91 70.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.777 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.569 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 43.1 m0 -64.27 -42.99 96.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.736 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 22' ' ' SER . 2.0 m -60.81 -38.16 78.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.094 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -65.7 -50.4 65.02 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.469 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.52 -41.84 98.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.741 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.47 -37.86 94.83 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.471 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 25' ' ' VAL . 47.5 t -64.9 -43.16 96.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.08 0.467 . . . . 0.0 110.337 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -71.38 -42.28 68.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.207 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.458 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 63.7 tttp -76.72 -48.52 18.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.458 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -94.76 -55.87 2.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.599 0.714 . . . . 0.0 110.975 -178.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.19 132.0 3.45 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -58.48 118.46 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.546 0.688 . . . . 0.0 110.554 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.45 -37.5 1.87 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.415 ' O ' HG13 ' A' ' 40' ' ' ILE . 62.2 m-80 -83.49 50.77 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.039 0.447 . . . . 0.0 110.228 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -62.2 -41.45 98.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.908 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.78 -45.41 89.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.871 0.367 . . . . 0.0 110.332 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.27 93.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.485 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 36' ' ' ASN . 82.0 mt -62.55 -46.55 96.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.451 ' HB2' HD12 ' A' ' 54' ' ' ILE . 32.4 t -60.71 -36.66 79.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.199 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -69.11 -51.16 41.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.69 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -74.54 -43.73 54.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.722 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.456 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 47.4 m-85 -77.49 146.91 74.48 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 120.983 0.42 . . . . 0.0 110.928 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.466 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 36.8 Cg_endo -66.31 43.02 0.18 Allowed 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.774 2.982 . . . . 0.0 115.304 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.439 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 77.0 m-85 -74.05 128.36 35.31 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.941 -0.474 . . . . 0.0 110.12 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.59 129.2 72.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.0 m120 71.33 -40.67 0.48 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.19 0.596 . . . . 0.0 111.924 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.493 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 2.0 mpt_? -60.74 127.16 30.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.682 0.277 . . . . 0.0 110.612 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.471 ' OG1' ' HG3' ' A' ' 53' ' ' MET . 67.5 p -89.55 169.03 11.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.333 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.7 -37.33 83.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.805 0.336 . . . . 0.0 110.263 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.23 -38.41 82.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.829 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.471 ' HG3' ' OG1' ' A' ' 50' ' ' THR . 68.1 mtt -62.3 -42.1 99.07 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.508 HG23 HG12 ' A' ' 25' ' ' VAL . 70.2 mt -67.22 -44.36 87.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.868 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -55.56 -49.98 71.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.007 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.64 -37.0 79.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.388 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 53' ' ' MET . 15.0 tpt85 -61.28 -39.73 91.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.343 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.434 ' CD2' HG21 ' A' ' 29' ' ' VAL . 36.7 t-105 -67.49 -43.7 80.3 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.3 mtt-85 -59.39 -42.75 92.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.383 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.436 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.794 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.444 ' HH2' HG12 ' A' ' 54' ' ' ILE . 11.2 m95 . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.667 0.27 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.7 p -77.83 154.22 32.03 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 13.8 p -57.51 -38.46 63.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.265 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.515 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 87.2 tt0 -64.07 -48.05 77.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.793 0.33 . . . . 0.0 111.076 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.536 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 68.0 mt-10 -59.59 -37.35 78.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.344 0.592 . . . . 0.0 111.58 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.618 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.3 m -67.86 -32.03 72.25 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.997 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 5.7 mm-40 -65.68 -38.29 88.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.4 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.536 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 35.3 m0 -61.4 -43.68 98.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.837 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 22' ' ' SER . 3.8 m -62.59 -36.45 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.168 0.508 . . . . 0.0 110.248 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -66.93 -49.32 65.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.753 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.63 -39.91 76.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.299 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.72 -41.21 98.93 Favored Glycine 0 C--O 1.224 -0.476 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.999 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' A' ' 34' ' ' GLU . 54.8 t -64.72 -41.79 93.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 117.237 0.518 . . . . 0.0 110.72 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -70.82 -36.72 73.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.323 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.614 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 5.1 ttmp? -84.77 -52.08 6.31 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.614 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -84.77 -54.17 4.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.28 0.562 . . . . 0.0 111.221 -177.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.56 130.75 3.33 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.62 ' HB2' HG13 ' A' ' 29' ' ' VAL . 86.9 tt0 -55.56 125.57 21.58 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.958 0.409 . . . . 0.0 110.852 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.49 -35.13 3.41 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.457 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.4 m-80 -82.97 52.81 2.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.986 0.422 . . . . 0.0 110.532 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 40.8 m95 -61.18 -40.26 93.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.636 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.6 97.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.965 0.412 . . . . 0.0 110.384 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -67.82 -38.14 82.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.097 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 36' ' ' ASN . 78.5 mt -67.45 -47.31 81.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.531 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.523 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 5.7 p -63.52 -37.18 86.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.519 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -62.99 -48.42 78.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.515 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -80.41 -50.31 10.28 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.424 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 55.7 m-85 -69.09 146.32 97.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.01 0.433 . . . . 0.0 110.895 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.472 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 44.4 Cg_endo -68.68 46.46 0.38 Allowed 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.537 2.824 . . . . 0.0 114.799 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -69.72 126.49 29.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.1 0.476 . . . . 0.0 110.564 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.525 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 5.6 p -118.3 131.25 71.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 74.5 m-80 74.35 -43.5 0.53 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.039 0.535 . . . . 0.0 110.378 -177.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.699 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -66.45 125.67 26.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.346 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.8 p -96.15 175.58 6.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.919 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.3 -42.72 99.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.491 0.186 . . . . 0.0 110.91 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.09 -37.57 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.699 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 63.6 mtt -59.96 -42.42 94.04 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.539 HG23 HG12 ' A' ' 25' ' ' VAL . 63.6 mt -66.99 -44.51 88.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.027 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -55.7 -47.5 76.71 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.171 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -69.79 -41.95 74.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.99 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.501 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 12.1 tpp180 -60.18 -39.15 85.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.267 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.442 ' HA ' ' CE3' ' A' ' 58' ' ' TRP . 16.7 t-105 -61.74 -45.3 94.51 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.345 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.9 mtt85 -58.5 -44.47 89.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.377 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.501 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 24.5 p . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.735 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 13.7 m95 . . . . . 0 N--CA 1.446 -0.628 0 CA-C-O 120.682 0.277 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.2 p -80.38 151.12 29.57 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.495 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 7.2 p -55.44 -39.16 51.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.64 0.257 . . . . 0.0 110.734 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.542 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 84.6 tt0 -62.13 -46.6 88.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.911 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 53.6 mt-10 -62.53 -38.89 91.74 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.236 0.541 . . . . 0.0 110.676 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.61 ' O ' HG22 ' A' ' 25' ' ' VAL . 24.3 t -64.58 -34.51 78.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.302 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 49.7 mm-40 -66.87 -37.59 84.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.707 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.564 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 40.0 m0 -62.46 -44.68 95.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.509 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.618 HG12 HG23 ' A' ' 54' ' ' ILE . 3.3 m -62.0 -35.77 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.143 0.497 . . . . 0.0 109.988 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 26' ' ' LYS . 18.0 ttpt -69.7 -47.7 62.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.759 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.32 -42.9 78.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.766 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.94 -33.02 67.41 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 116.191 -0.458 . . . . 0.0 113.133 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 25' ' ' VAL . 78.4 t -66.41 -36.91 78.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.174 0.511 . . . . 0.0 110.658 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -79.35 -44.68 21.08 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.188 0.518 . . . . 0.0 110.933 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -73.85 -46.33 45.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.491 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -98.02 -57.45 2.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.467 0.651 . . . . 0.0 110.888 -179.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 29' ' ' VAL . . . 126.53 133.31 3.83 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' HB3' HG13 ' A' ' 29' ' ' VAL . 11.1 pt-20 -59.12 138.71 57.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.327 0.585 . . . . 0.0 110.438 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.18 -37.29 3.55 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -84.95 46.49 1.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.154 0.502 . . . . 0.0 110.546 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.44 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 41.5 m95 -61.17 -36.51 80.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.786 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.46 92.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 0.0 110.223 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.09 84.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.661 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.44 HG23 ' CD1' ' A' ' 44' ' ' TYR . 61.6 mt -61.77 -47.54 92.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.413 ' HB2' HD12 ' A' ' 54' ' ' ILE . 44.2 t -63.47 -36.27 83.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.973 0.416 . . . . 0.0 110.468 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -63.4 -47.53 81.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.658 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -82.93 -52.33 6.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.396 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.44 ' CD1' HG23 ' A' ' 40' ' ' ILE . 65.0 m-85 -68.45 140.19 92.36 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.066 0.46 . . . . 0.0 110.986 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.564 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 32.5 Cg_endo -64.87 47.17 0.16 Allowed 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.155 3.237 . . . . 0.0 115.395 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -74.16 134.9 42.83 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.965 -0.46 . . . . 0.0 110.223 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 7.3 p -124.36 125.23 70.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 75.4 m-20 76.5 -33.91 0.22 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.276 0.63 . . . . 0.0 111.146 -178.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.517 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 7.7 mpt_? -76.03 112.94 12.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.714 0.292 . . . . 0.0 110.518 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.6 p -82.19 173.52 12.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.635 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.11 82.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.938 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 t -64.23 -39.44 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.3 mmt -61.52 -42.96 99.6 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.618 HG23 HG12 ' A' ' 25' ' ' VAL . 72.0 mt -66.47 -45.48 88.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.428 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 39.0 ttpt -56.03 -50.87 69.72 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.531 0.681 . . . . 0.0 109.853 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.27 -40.42 93.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.429 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -60.75 -42.23 97.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.436 ' CD2' HG21 ' A' ' 29' ' ' VAL . 23.4 t-105 -61.18 -43.01 99.56 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -56.26 -45.31 80.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.038 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.54 ' CE3' ' HG2' ' A' ' 57' ' ' ARG . 11.7 m95 . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 121.19 0.519 . . . . 0.0 111.873 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 51.1 p -82.13 157.04 24.2 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.596 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.633 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 8.0 p -60.24 -38.66 78.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.78 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.22 -49.33 78.27 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.711 0.291 . . . . 0.0 110.803 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.593 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 48.1 mt-10 -59.43 -41.66 90.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.336 0.589 . . . . 0.0 111.502 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.693 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.8 m -66.61 -29.63 69.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.555 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.633 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 70.9 mm-40 -68.4 -36.72 79.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.593 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 33.2 m0 -63.61 -41.51 98.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.377 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 22' ' ' SER . 4.3 m -61.44 -37.61 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.386 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -65.54 -50.85 63.66 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.95 0.405 . . . . 0.0 110.725 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.0 98.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.73 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.52 -41.81 99.76 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.001 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 25' ' ' VAL . 67.9 t -65.94 -38.43 82.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.322 0.582 . . . . 0.0 109.762 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -68.99 -47.39 65.67 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.088 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -83.49 -46.53 12.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.491 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -88.01 -54.9 3.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.547 0.689 . . . . 0.0 110.647 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.39 133.57 4.17 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.669 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -52.58 146.67 9.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.047 0.451 . . . . 0.0 111.259 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.11 -37.05 3.73 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.636 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.416 ' O ' HG13 ' A' ' 40' ' ' ILE . 67.1 m-80 -82.62 48.59 1.33 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.019 0.438 . . . . 0.0 110.407 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -60.15 -40.47 89.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.73 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.35 -34.65 75.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.164 0.507 . . . . 0.0 111.158 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.71 -34.65 64.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.296 0.569 . . . . 0.0 110.187 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 36' ' ' ASN . 75.4 mt -70.61 -46.72 68.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.022 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 12.5 p -61.55 -38.16 86.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.881 0.372 . . . . 0.0 111.374 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -63.41 -45.84 89.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.413 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -85.38 -45.36 11.96 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 56.1 m-85 -73.56 150.1 88.83 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 121.033 0.444 . . . . 0.0 111.463 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.448 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 48.2 Cg_endo -68.99 44.1 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.675 2.917 . . . . 0.0 114.707 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.466 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 69.3 m-85 -73.14 107.35 5.42 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.474 ' C ' ' H ' ' A' ' 49' ' ' ARG . 2.9 p -86.53 119.56 34.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.984 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 65.4 -25.37 0.09 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.442 1.097 . . . . 0.0 112.801 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -64.91 121.07 13.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 111.025 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.8 p -78.62 171.32 15.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.07 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.79 -38.6 91.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.773 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.93 -37.16 77.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.438 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.429 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 19.9 mmt -59.86 -45.33 92.78 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.582 HG23 HG12 ' A' ' 25' ' ' VAL . 64.7 mt -65.36 -43.96 94.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.089 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -55.63 -49.59 72.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.83 0.824 . . . . 0.0 110.059 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -67.28 -42.35 83.97 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.81 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.54 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 10.0 tpp180 -59.75 -42.74 93.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.864 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -56.86 -44.11 81.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.114 0.483 . . . . 0.0 109.736 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -55.87 -45.8 78.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.424 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.399 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.514 ' HZ2' ' HB3' ' A' ' 53' ' ' MET . 10.6 m95 . . . . . 0 CA--C 1.513 -0.447 0 CA-C-O 121.287 0.565 . . . . 0.0 112.424 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -88.42 151.89 22.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.99 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.4 p -55.95 -37.24 47.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.837 -0.165 . . . . 0.0 111.377 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.501 ' HG3' ' CZ2' ' A' ' 24' ' ' TRP . 36.3 tp10 -59.32 -51.78 68.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.809 0.338 . . . . 0.0 110.777 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.497 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 52.3 mt-10 -60.73 -39.36 88.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.687 0.756 . . . . 0.0 110.862 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.662 ' O ' HG22 ' A' ' 25' ' ' VAL . 13.2 m -67.96 -34.02 75.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.259 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.71 -36.19 82.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.19 0.519 . . . . 0.0 110.337 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.501 ' CZ2' ' HG3' ' A' ' 20' ' ' GLU . 32.5 m0 -65.75 -43.98 87.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.518 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 22' ' ' SER . 3.0 m -58.82 -40.29 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.933 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -66.49 -44.85 81.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.819 0.342 . . . . 0.0 110.785 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.64 -44.31 90.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.779 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.65 96.13 Favored Glycine 0 C--O 1.224 -0.478 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.287 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.504 HG11 ' CZ2' ' A' ' 58' ' ' TRP . 22.8 t -60.08 -41.32 86.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.133 0.492 . . . . 0.0 110.965 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -74.48 -40.31 61.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.771 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.513 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 62.8 tttm -80.67 -46.13 16.07 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.513 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -91.73 -37.66 12.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.084 0.469 . . . . 0.0 111.35 -177.531 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.88 134.72 8.29 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.483 ' CG ' HG13 ' A' ' 29' ' ' VAL . 43.4 mt-10 -48.95 130.37 18.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.949 0.404 . . . . 0.0 111.47 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.18 -39.06 2.83 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.194 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.534 ' O ' HG13 ' A' ' 40' ' ' ILE . 66.6 m-80 -81.17 52.08 1.73 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.983 0.42 . . . . 0.0 110.932 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.428 ' NE1' ' HG3' ' A' ' 55' ' ' LYS . 33.8 m95 -63.7 -45.11 91.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.703 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.408 ' HA ' ' HB2' ' A' ' 51' ' ' ALA . . . -56.28 -44.03 79.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.808 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.15 -37.44 87.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.645 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 36' ' ' ASN . 82.8 mt -67.4 -48.19 78.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.356 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.559 ' HB3' HD12 ' A' ' 54' ' ' ILE . 6.4 p -61.47 -35.03 76.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.819 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -71.15 -52.27 20.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.003 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -75.09 -44.94 44.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.472 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 30.1 m-85 -71.65 154.44 93.09 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.116 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.89 38.0 0.15 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.147 2.565 . . . . 0.0 114.579 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 24' ' ' TRP . 78.9 m-85 -76.18 134.03 40.02 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.204 0.525 . . . . 0.0 109.832 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 4.3 p -134.25 135.26 54.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 74.9 m-80 76.5 -38.79 0.33 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.746 0.654 . . . . 0.0 110.422 -177.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.497 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 1.0 OUTLIER -69.87 128.96 38.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.416 179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.3 p -92.14 169.7 10.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.107 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . . . -64.85 -36.84 85.63 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.0 t -62.76 -36.25 74.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.514 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 17.9 mmt -64.77 -45.36 86.71 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.559 HD12 ' HB3' ' A' ' 41' ' ' SER . 78.6 mt -64.77 -44.2 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.18 0.514 . . . . 0.0 109.814 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HG3' ' NE1' ' A' ' 37' ' ' TRP . 39.5 ttmt -54.41 -50.81 66.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.323 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -70.93 -39.42 72.68 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.347 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.486 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 16.6 tpp180 -58.92 -35.62 73.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.714 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.504 ' CZ2' HG11 ' A' ' 29' ' ' VAL . 14.6 t-105 -59.55 -48.16 82.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.5 ttm105 -56.67 -46.93 80.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.393 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 7.5 p . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.577 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.549 ' HA ' ' NH2' ' A' ' 49' ' ' ARG . 15.1 m95 . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 121.674 0.75 . . . . 0.0 112.581 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.54 149.62 21.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.902 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.8 p -53.32 -36.76 27.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.563 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 35.8 tt0 -55.66 -60.17 3.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.737 0.303 . . . . 0.0 110.952 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.647 ' HG3' ' CZ3' ' A' ' 24' ' ' TRP . 2.7 mp0 -66.28 -30.98 71.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.193 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.662 ' O ' HG22 ' A' ' 25' ' ' VAL . 9.1 t -63.79 -39.84 95.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.761 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 21.1 mm-40 -65.28 -37.91 88.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.089 0.471 . . . . 0.0 111.08 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.647 ' CZ3' ' HG3' ' A' ' 21' ' ' GLU . 37.2 m0 -62.91 -43.1 99.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.587 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 22' ' ' SER . 4.2 m -60.21 -40.2 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.906 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -64.74 -44.59 89.66 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.875 0.369 . . . . 0.0 110.934 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.07 -43.99 73.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.244 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.95 -42.47 96.82 Favored Glycine 0 C--O 1.225 -0.426 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.924 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 25' ' ' VAL . 98.5 t -61.45 -38.95 81.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.199 0.523 . . . . 0.0 110.499 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -70.49 -45.81 64.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.794 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -78.93 -45.89 19.53 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -177.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CE1' ' HE1' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -88.32 -39.97 13.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.165 0.507 . . . . 0.0 111.336 -177.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.46 132.09 6.38 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -50.9 128.58 21.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.005 0.431 . . . . 0.0 111.053 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.73 -35.36 3.87 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.177 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.483 ' O ' HG13 ' A' ' 40' ' ' ILE . 77.2 m-20 -82.45 50.62 1.67 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.914 0.388 . . . . 0.0 111.292 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.413 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 35.7 m95 -60.66 -44.06 96.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.646 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.44 ' O ' ' HG2' ' A' ' 42' ' ' LYS . . . -59.5 -47.47 85.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.576 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.5 -42.99 93.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.702 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 36' ' ' ASN . 86.6 mt -60.8 -45.19 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.274 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.511 ' HB2' HD12 ' A' ' 54' ' ' ILE . 14.6 t -63.75 -38.19 90.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.154 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 73.0 mmtt -65.77 -46.14 79.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.059 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -82.65 -45.36 14.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.408 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 50.1 m-85 -76.15 147.39 79.85 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 120.925 0.393 . . . . 0.0 111.281 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.405 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 39.3 Cg_endo -68.28 46.85 0.36 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.777 2.985 . . . . 0.0 114.854 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -73.59 126.07 29.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.141 0.496 . . . . 0.0 111.281 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.462 ' O ' ' HD3' ' A' ' 49' ' ' ARG . 7.4 p -118.98 132.63 68.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 75.8 m-20 74.49 -40.31 0.44 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.379 0.671 . . . . 0.0 110.819 -177.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.698 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 0.8 OUTLIER -73.26 118.04 15.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.76 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.436 ' OG1' ' HG3' ' A' ' 53' ' ' MET . 45.6 p -86.93 179.08 6.78 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.19 95.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.829 0.347 . . . . 0.0 110.136 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -62.29 -37.71 79.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.821 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.698 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 90.4 mtp -61.9 -43.36 99.0 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.511 HD12 ' HB2' ' A' ' 41' ' ' SER . 75.8 mt -65.06 -44.32 95.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.413 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 37.9 ttpt -57.47 -48.24 79.71 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.715 0.769 . . . . 0.0 109.793 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.17 -37.77 84.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.007 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.449 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 26.7 tpt180 -59.63 -44.85 93.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.842 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -58.86 -45.04 91.07 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.636 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 51.4 ttm-85 -59.23 -42.74 91.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.376 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.449 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 1.2 p . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.271 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.584 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 41.5 m95 . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.077 0.465 . . . . 0.0 111.956 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.1 p -82.71 161.56 22.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.634 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.406 ' O ' ' HG3' ' A' ' 23' ' ' GLU . 10.0 t -60.79 -46.31 96.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.427 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.05 -42.57 85.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.273 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.646 ' HG2' ' CZ3' ' A' ' 24' ' ' TRP . 45.8 mt-10 -70.51 -33.53 71.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.174 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.592 ' O ' HG22 ' A' ' 25' ' ' VAL . 51.1 m -68.49 -35.5 77.6 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.233 0.539 . . . . 0.0 110.603 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 49.2 mt-10 -62.41 -37.72 86.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.83 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.646 ' CZ3' ' HG2' ' A' ' 21' ' ' GLU . 37.3 m0 -63.09 -41.96 99.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.819 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 22' ' ' SER . 2.0 m -59.01 -39.12 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.493 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.431 ' HG3' ' CH2' ' A' ' 58' ' ' TRP . 26.0 ttmt -66.21 -46.03 78.66 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.06 0.457 . . . . 0.0 110.628 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.76 -43.43 96.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.48 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.21 -39.17 96.81 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.119 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.589 HG13 ' HB2' ' A' ' 34' ' ' GLU . 54.0 t -61.95 -42.11 93.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.296 0.569 . . . . 0.0 110.332 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -72.79 -44.84 61.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.105 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -81.34 -49.5 10.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.473 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -84.84 -45.82 11.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.442 0.639 . . . . 0.0 111.017 -177.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.76 131.15 4.14 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.992 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.589 ' HB2' HG13 ' A' ' 29' ' ' VAL . 86.2 tt0 -55.34 108.57 0.43 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.065 0.459 . . . . 0.0 110.801 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.97 -35.28 1.93 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.495 ' O ' HG13 ' A' ' 40' ' ' ILE . 74.3 m-80 -82.2 53.2 2.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.14 0.495 . . . . 0.0 110.501 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.45 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 41.0 m95 -60.73 -43.17 98.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.965 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.31 99.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.68 0.276 . . . . 0.0 110.295 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -61.09 -43.0 99.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.945 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 36' ' ' ASN . 82.9 mt -63.26 -46.15 96.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.032 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.413 ' HB2' HD12 ' A' ' 54' ' ' ILE . 46.6 t -63.04 -38.32 90.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.339 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -68.1 -43.87 77.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.032 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -85.16 -46.43 11.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.41 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 50.3 m-85 -73.24 149.49 89.26 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.98 0.419 . . . . 0.0 111.171 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.506 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 37.6 Cg_endo -68.96 45.69 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.449 2.766 . . . . 0.0 114.638 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.584 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 58.6 m-85 -72.25 131.2 42.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.152 -0.343 . . . . 0.0 110.286 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.448 ' C ' ' H ' ' A' ' 49' ' ' ARG . 4.7 p -104.62 123.57 58.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.616 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 p30 63.92 -23.88 0.07 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.641 1.176 . . . . 0.0 113.431 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.598 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 5.1 mpt_? -65.42 133.19 50.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.047 0.451 . . . . 0.0 111.737 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.3 p -98.74 176.57 5.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.88 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.3 98.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.584 0.23 . . . . 0.0 111.092 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.53 -38.19 77.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.126 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.598 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 68.7 mtt -61.69 -43.74 98.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.709 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 41' ' ' SER . 62.8 mt -67.38 -42.78 87.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.224 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.45 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 40.3 ttpt -56.52 -49.12 75.67 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.541 0.686 . . . . 0.0 109.403 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -66.29 -43.17 87.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.239 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.425 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 29.8 tpt180 -58.58 -43.61 89.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.052 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.431 ' CH2' ' HG3' ' A' ' 26' ' ' LYS . 15.6 t-105 -61.14 -44.77 96.81 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -56.99 -47.63 80.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.641 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.425 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.666 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.528 ' HZ3' ' HE2' ' A' ' 46' ' ' PHE . 11.9 m95 . . . . . 0 N--CA 1.449 -0.508 0 CA-C-O 121.377 0.608 . . . . 0.0 112.047 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.5 p -84.36 151.2 24.86 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.352 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.39 -29.41 42.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.355 0.597 . . . . 0.0 109.755 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -60.68 -52.49 64.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.375 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.563 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 94.3 mt-10 -68.76 -36.56 78.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.065 0.459 . . . . 0.0 111.018 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.653 ' O ' HG22 ' A' ' 25' ' ' VAL . 23.9 m -59.23 -39.24 82.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.501 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -67.2 -32.1 72.94 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.938 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.563 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 37.9 m0 -66.28 -40.55 90.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.274 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 22' ' ' SER . 3.6 m -62.85 -36.82 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 120.847 0.356 . . . . 0.0 110.076 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -66.38 -45.0 81.57 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.972 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.54 -40.89 80.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.029 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.6 -38.81 94.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.133 -0.555 . . . . 0.0 112.841 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 25' ' ' VAL . 85.1 t -62.78 -39.16 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.357 0.599 . . . . 0.0 110.103 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -72.71 -49.99 27.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.218 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.594 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 39.7 ttmt -72.17 -47.92 47.28 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.594 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -93.96 -51.8 4.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.43 0.633 . . . . 0.0 111.123 -177.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.73 136.33 4.35 Favored Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.222 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.418 ' HB2' HG13 ' A' ' 29' ' ' VAL . 36.6 tt0 -53.06 120.74 6.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.991 0.424 . . . . 0.0 110.27 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.52 -35.05 3.87 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.943 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.471 ' O ' HG13 ' A' ' 40' ' ' ILE . 77.6 m-20 -80.1 53.75 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.008 0.432 . . . . 0.0 111.096 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -64.65 -40.7 95.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.514 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.62 -39.87 85.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.915 0.388 . . . . 0.0 110.933 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.04 -35.38 74.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.463 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 36' ' ' ASN . 89.0 mt -69.84 -45.83 75.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.616 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.607 ' HB3' HD12 ' A' ' 54' ' ' ILE . 19.8 p -64.87 -36.85 85.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.271 0.558 . . . . 0.0 110.696 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -64.75 -45.88 84.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.81 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -86.04 -50.39 7.08 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.549 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 54.8 m-85 -69.06 146.79 97.45 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.197 0.522 . . . . 0.0 111.465 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.414 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.5 Cg_endo -67.34 41.18 0.19 Allowed 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.926 3.084 . . . . 0.0 115.406 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.528 ' HE2' ' HZ3' ' A' ' 17' ' ' TRP . 73.3 m-85 -68.65 127.33 32.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.432 ' C ' ' H ' ' A' ' 49' ' ' ARG . 4.0 p -106.04 121.57 58.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.716 0.293 . . . . 0.0 110.459 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 69.97 -29.83 0.19 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.55 0.74 . . . . 0.0 112.366 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.578 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -69.18 123.08 20.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.752 0.31 . . . . 0.0 110.604 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.612 ' OG1' ' HG2' ' A' ' 53' ' ' MET . 42.1 p -86.85 174.44 8.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.799 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.02 95.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.701 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.37 -38.83 82.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.612 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 21.5 mmt -60.91 -43.37 98.65 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.607 HD12 ' HB3' ' A' ' 41' ' ' SER . 83.5 mt -65.37 -45.35 93.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.352 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -55.96 -50.34 71.07 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.367 0.603 . . . . 0.0 109.958 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.26 -40.91 94.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.225 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.507 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 12.7 tpp180 -60.61 -41.65 95.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.554 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -57.48 -42.4 82.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.961 0.41 . . . . 0.0 110.223 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -56.28 -45.17 80.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.068 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.54 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.46 ' CE3' ' HB3' ' A' ' 21' ' ' GLU . 27.5 m95 . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 121.66 0.743 . . . . 0.0 112.666 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.04 155.76 20.02 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.891 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.417 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 10.3 p -58.32 -39.03 72.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.447 0.165 . . . . 0.0 111.138 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.402 ' HG3' ' CZ2' ' A' ' 24' ' ' TRP . 5.1 tp10 -58.65 -52.76 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.111 0.482 . . . . 0.0 110.155 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.521 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 5.6 mp0 -58.35 -39.55 79.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.33 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.602 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.0 m -67.26 -35.85 80.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.001 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 65.4 mm-40 -64.58 -36.85 85.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.327 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.521 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 44.3 m0 -63.32 -46.38 86.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.419 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 22' ' ' SER . 3.5 m -61.17 -35.68 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.312 0.577 . . . . 0.0 109.983 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.52 ' HA ' ' CZ3' ' A' ' 58' ' ' TRP . 19.3 ttpt -65.59 -49.3 69.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.029 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.81 -41.3 68.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.314 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.81 -45.52 93.42 Favored Glycine 0 C--O 1.22 -0.737 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.408 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 25' ' ' VAL . 91.9 t -64.05 -39.27 84.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 117.67 0.735 . . . . 0.0 110.861 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -66.7 -37.49 84.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.399 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -90.35 -41.92 11.23 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -177.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.434 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -89.69 -52.28 5.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.387 0.613 . . . . 0.0 110.879 -178.04 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.08 134.93 4.71 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.353 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -51.77 139.64 21.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.044 0.449 . . . . 0.0 110.972 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.87 -32.9 7.01 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.479 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.45 ' O ' HG13 ' A' ' 40' ' ' ILE . 74.3 m-80 -84.25 48.64 1.52 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.037 0.446 . . . . 0.0 111.126 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.425 ' HH2' ' CD1' ' A' ' 58' ' ' TRP . 28.2 m95 -60.87 -38.2 84.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.697 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.97 89.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.608 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -68.43 -39.55 81.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.856 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 36' ' ' ASN . 60.9 mt -68.62 -44.76 82.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.821 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.545 ' HB3' HD12 ' A' ' 54' ' ' ILE . 3.7 p -65.15 -32.38 74.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.646 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -70.89 -50.69 32.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.054 0.454 . . . . 0.0 111.528 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -76.61 -47.32 22.72 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -75.89 144.63 76.5 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.092 0.472 . . . . 0.0 111.567 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.454 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 36.6 Cg_endo -67.13 46.78 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.191 3.261 . . . . 0.0 115.309 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -71.97 135.32 46.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.348 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 9.0 p -129.74 133.46 64.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 6.8 m120 76.81 -35.94 0.25 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.284 0.633 . . . . 0.0 110.574 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.719 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 7.1 mpt_? -77.46 130.04 36.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.311 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.6 p -92.9 174.21 7.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.704 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.3 -35.41 80.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -64.93 -38.61 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.599 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.719 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 60.1 mtt -62.57 -40.68 97.62 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.545 HD12 ' HB3' ' A' ' 41' ' ' SER . 86.4 mt -68.06 -44.77 84.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.403 ' HB3' ' HE3' ' A' ' 55' ' ' LYS . 24.1 ttpp -53.92 -49.91 67.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.868 0.842 . . . . 0.0 109.467 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -67.84 -44.12 77.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.573 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -58.38 -40.37 82.11 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.503 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.52 ' CZ3' ' HA ' ' A' ' 26' ' ' LYS . 30.3 t-105 -60.73 -45.37 94.54 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.864 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -56.83 -43.19 80.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.704 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.226 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.651 ' HA ' ' NH2' ' A' ' 49' ' ' ARG . 35.8 m95 . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.9 p -111.85 161.09 16.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.222 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.416 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 7.3 p -53.82 -41.58 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.473 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 87.2 tt0 -59.13 -50.12 75.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.894 0.378 . . . . 0.0 110.942 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.494 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 54.1 mt-10 -64.59 -34.27 77.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.203 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.474 ' O ' HG22 ' A' ' 25' ' ' VAL . 23.1 t -69.21 -24.7 64.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.85 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 31.6 mm-40 -69.31 -40.66 77.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.082 0.467 . . . . 0.0 110.362 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.547 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 15.2 m0 -66.48 -40.12 89.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.418 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.916 HG12 HG23 ' A' ' 54' ' ' ILE . 34.6 m -61.02 -46.13 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.692 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -65.31 -41.73 93.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.112 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.41 -43.65 80.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.056 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.42 -38.12 95.88 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.188 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.684 HG13 ' HB3' ' A' ' 34' ' ' GLU . 68.4 t -61.17 -33.6 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.477 0.656 . . . . 0.0 110.118 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -77.12 -50.99 11.79 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.923 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.705 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 14.5 tmtt? -78.41 -47.57 17.3 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.705 ' CE1' ' HD2' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -86.71 -36.03 18.92 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.321 0.581 . . . . 0.0 110.965 -177.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.9 130.78 7.1 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.684 ' HB3' HG13 ' A' ' 29' ' ' VAL . 22.1 pt-20 -54.68 125.71 21.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.222 0.534 . . . . 0.0 110.48 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.07 -40.73 1.72 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.527 ' O ' HG13 ' A' ' 40' ' ' ILE . 74.4 m-80 -82.78 51.08 1.82 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.126 0.489 . . . . 0.0 110.385 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.415 ' NE1' ' HG3' ' A' ' 55' ' ' LYS . 40.9 m95 -60.27 -40.74 91.45 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.823 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.69 -46.67 84.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.703 0.287 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.01 85.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.439 . . . . 0.0 110.764 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 36' ' ' ASN . 67.8 mt -65.76 -43.52 93.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.679 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.411 ' OG ' HD12 ' A' ' 54' ' ' ILE . 12.9 m -62.22 -40.32 95.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.839 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.708 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -64.1 -55.52 21.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.356 -179.026 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -75.47 -47.48 26.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.421 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 61.0 m-85 -72.52 148.19 90.25 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.117 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.547 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 49.6 Cg_endo -69.56 43.94 0.38 Allowed 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.504 2.803 . . . . 0.0 114.164 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 24' ' ' TRP . 47.2 m-85 -72.56 99.03 2.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.862 0.363 . . . . 0.0 110.426 178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 6.5 p -88.32 127.19 41.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.5 m120 74.34 -36.03 0.32 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.238 0.615 . . . . 0.0 111.732 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.651 ' NH2' ' HA ' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -60.46 128.45 36.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.051 0.453 . . . . 0.0 112.175 -179.009 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.4 p -90.59 165.05 13.96 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.139 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.91 82.21 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.26 -38.66 82.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.38 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.537 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 3.5 mmt -59.77 -45.41 92.35 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.916 HG23 HG12 ' A' ' 25' ' ' VAL . 75.2 mt -65.48 -44.04 94.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.181 0.515 . . . . 0.0 110.055 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.415 ' HG3' ' NE1' ' A' ' 37' ' ' TRP . 38.9 ttmt -55.11 -51.97 64.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.429 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.51 -39.29 81.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.292 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.527 HH11 ' HG3' ' A' ' 57' ' ' ARG . 3.6 tpt85 -57.5 -40.07 77.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.4 ' CE3' ' HA ' ' A' ' 58' ' ' TRP . 11.8 t-105 -63.57 -42.49 98.32 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -56.18 -44.84 79.75 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.367 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.389 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 28.8 m95 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 121.36 0.6 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -94.55 148.52 22.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.999 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.69 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 14.6 p -49.51 -37.99 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -59.12 -49.17 78.9 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -64.38 -36.41 84.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.404 0.621 . . . . 0.0 110.082 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.67 ' O ' HG22 ' A' ' 25' ' ' VAL . 47.4 m -67.45 -27.57 67.15 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.923 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.69 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 69.7 mm-40 -66.37 -40.75 89.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.219 0.533 . . . . 0.0 110.167 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.522 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 21.6 m0 -64.16 -38.04 89.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.948 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 22' ' ' SER . 4.2 m -62.92 -38.58 82.3 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.81 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -68.93 -46.5 68.09 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.053 0.454 . . . . 0.0 110.388 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.13 99.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.606 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.59 -38.96 93.72 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.265 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 25' ' ' VAL . 38.6 t -64.32 -38.23 82.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.304 0.552 . . . . 0.0 110.422 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -73.34 -43.3 61.04 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.279 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -80.49 -50.54 9.91 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.463 ' CE1' ' HE1' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -88.72 -45.18 10.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.448 0.642 . . . . 0.0 111.186 -178.354 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 29' ' ' VAL . . . 112.44 131.69 5.65 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -57.82 124.69 20.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.416 0.627 . . . . 0.0 110.608 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.06 -39.57 1.69 Allowed Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.453 ' O ' HG13 ' A' ' 40' ' ' ILE . 75.5 m-80 -82.51 51.03 1.76 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.962 0.411 . . . . 0.0 110.482 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -60.44 -38.62 84.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.565 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.28 99.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.058 0.456 . . . . 0.0 110.276 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.37 -37.04 77.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.055 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 36' ' ' ASN . 67.1 mt -67.36 -45.58 85.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.685 ' HB3' HD12 ' A' ' 54' ' ' ILE . 4.5 p -63.7 -33.85 76.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 0.0 110.8 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -67.11 -48.81 67.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.601 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -82.86 -41.38 19.07 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 45.1 m-85 -79.5 147.43 67.88 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.09 0.471 . . . . 0.0 111.528 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.25 44.26 0.19 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 124.171 3.247 . . . . 0.0 114.735 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.412 ' HB3' ' HB2' ' A' ' 49' ' ' ARG . 60.3 m-85 -76.52 106.52 8.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.888 0.375 . . . . 0.0 110.148 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 49' ' ' ARG . 7.7 p -100.14 131.08 48.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 73.14 -26.22 0.19 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.549 0.74 . . . . 0.0 111.256 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.451 ' H ' ' C ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -72.23 125.61 27.74 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 111.56 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.3 p -89.5 154.94 19.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.499 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.34 -38.91 69.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.644 0.259 . . . . 0.0 110.9 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -63.85 -41.1 91.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.359 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 68.8 mmm -63.27 -41.19 99.0 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.685 HD12 ' HB3' ' A' ' 41' ' ' SER . 76.7 mt -63.34 -44.94 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -56.92 -53.73 54.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.152 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -64.95 -37.5 87.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.728 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.425 ' O ' ' HD3' ' A' ' 57' ' ' ARG . 8.3 tpp180 -59.58 -33.81 71.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.528 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.45 ' CZ2' HG11 ' A' ' 29' ' ' VAL . 12.6 t-105 -60.68 -43.92 97.14 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -55.45 -49.19 73.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.21 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.41 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.715 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.578 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 12.3 m95 . . . . . 0 CA--C 1.519 -0.234 0 CA-C-O 120.821 0.344 . . . . 0.0 111.836 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -77.35 151.56 34.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.553 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 9.8 p -55.5 -36.17 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.919 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.486 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 32.7 tt0 -59.77 -45.49 92.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.045 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 42.1 mt-10 -64.71 -42.36 95.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.685 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.649 ' O ' HG22 ' A' ' 25' ' ' VAL . 2.0 p -66.9 -28.36 68.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.445 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 66.3 mm-40 -67.73 -35.95 79.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.897 0.38 . . . . 0.0 110.328 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.486 ' CZ2' ' HG2' ' A' ' 20' ' ' GLU . 30.9 m0 -66.57 -42.84 86.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.411 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 22' ' ' SER . 3.3 m -58.95 -39.46 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.815 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -64.67 -43.51 93.36 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.044 0.45 . . . . 0.0 110.344 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.69 -44.1 91.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.618 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.03 -38.09 95.52 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.427 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 25' ' ' VAL . 69.3 t -62.97 -39.97 87.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.253 0.549 . . . . 0.0 110.323 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -74.4 -45.95 43.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.008 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.485 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 60.3 tttm -80.98 -45.51 16.51 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -177.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.486 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -89.63 -51.22 5.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.32 0.581 . . . . 0.0 110.594 -177.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.34 135.44 4.23 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.513 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -55.16 113.54 1.42 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.979 0.418 . . . . 0.0 110.16 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.44 -35.26 2.72 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.998 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.529 ' O ' HG13 ' A' ' 40' ' ' ILE . 75.4 m-20 -80.48 49.26 1.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.006 0.432 . . . . 0.0 111.187 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 33.5 m95 -60.68 -40.45 92.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.432 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.89 -37.43 79.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 110.965 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.73 -32.75 68.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.403 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 36' ' ' ASN . 73.7 mt -71.57 -46.81 61.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.736 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.469 ' HB3' HD12 ' A' ' 54' ' ' ILE . 54.6 p -62.72 -35.31 79.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.186 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -65.6 -53.45 41.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.617 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.0 -48.43 16.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.406 ' CD1' HG23 ' A' ' 40' ' ' ILE . 62.3 m-85 -71.21 151.11 94.54 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 120.934 0.397 . . . . 0.0 111.581 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.419 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 37.1 Cg_endo -67.35 43.28 0.22 Allowed 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.787 2.991 . . . . 0.0 114.445 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.578 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 65.6 m-85 -76.33 115.48 16.11 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.458 ' C ' ' H ' ' A' ' 49' ' ' ARG . 3.6 p -95.9 125.28 48.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.193 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 p30 64.54 -30.71 0.12 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.709 1.204 . . . . 0.0 112.904 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.571 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -61.26 116.18 4.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 111.339 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.6 p -78.9 173.61 12.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.694 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.69 -39.22 93.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.223 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.6 t -62.89 -39.17 83.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.776 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 81.2 mmm -58.87 -42.82 90.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.715 178.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.474 HG23 HG12 ' A' ' 25' ' ' VAL . 67.6 mt -69.12 -44.49 80.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.298 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 39.2 ttpt -55.07 -53.8 51.17 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.829 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -62.13 -40.35 95.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.834 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.473 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 6.8 tpp180 -56.41 -42.3 77.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.924 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 15.7 t-105 -59.37 -43.42 92.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.867 0.365 . . . . 0.0 110.357 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.445 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 1.8 mpt_? -59.66 -43.95 93.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.21 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.367 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.602 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 28.6 m95 . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 57.5 p -81.98 162.18 22.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.427 ' O ' ' HG3' ' A' ' 23' ' ' GLU . 9.6 p -57.9 -40.22 75.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 121.347 -0.141 . . . . 0.0 111.233 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.507 ' HG3' ' CE2' ' A' ' 24' ' ' TRP . 45.4 tp10 -60.92 -50.81 71.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.236 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.581 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 39.1 mt-10 -58.0 -42.41 85.15 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.487 0.66 . . . . 0.0 111.164 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.63 ' O ' HG22 ' A' ' 25' ' ' VAL . 15.1 m -66.81 -36.49 82.5 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.166 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 19.9 mt-10 -67.53 -31.77 72.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.949 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.581 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 47.5 m0 -61.89 -41.93 98.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.49 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.63 HG22 ' O ' ' A' ' 22' ' ' SER . 1.4 m -63.46 -37.5 79.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.391 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -66.18 -47.97 72.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.058 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.28 -37.33 85.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.591 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.29 -39.4 94.6 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.827 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 25' ' ' VAL . 92.7 t -61.32 -37.8 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.456 0.646 . . . . 0.0 110.176 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -76.18 -47.15 25.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.027 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.8 -48.79 65.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.99 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -107.67 -47.85 3.53 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.341 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.69 142.63 5.02 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.197 -1.001 . . . . 0.0 112.479 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.94 126.3 26.46 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.67 -31.34 6.9 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.718 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.403 ' O ' HG13 ' A' ' 40' ' ' ILE . 68.3 m-80 -83.19 47.71 1.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.071 0.463 . . . . 0.0 110.808 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.42 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 36.7 m95 -61.84 -37.54 84.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.111 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.95 -47.54 85.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.045 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.83 -40.83 98.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.219 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.452 HG22 ' HE2' ' A' ' 46' ' ' PHE . 97.8 mt -63.33 -45.67 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.508 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.405 ' HB2' HD12 ' A' ' 54' ' ' ILE . 16.7 t -64.4 -34.69 78.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.225 0.536 . . . . 0.0 110.481 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -67.82 -51.14 52.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.934 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -77.5 -50.73 12.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.947 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -73.02 145.75 86.61 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.055 0.455 . . . . 0.0 111.115 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.507 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.0 Cg_endo -66.63 45.07 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.013 3.142 . . . . 0.0 115.102 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.602 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 70.5 m-85 -71.18 122.74 20.73 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.262 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 p -103.76 124.0 57.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.861 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 m120 70.73 -39.14 0.44 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.537 0.735 . . . . 0.0 111.939 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.05 118.95 5.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.2 p -80.61 175.26 10.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.163 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.29 -36.93 84.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 t -63.98 -38.83 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.603 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 84.9 mmm -59.39 -43.16 93.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.429 HG23 HG12 ' A' ' 25' ' ' VAL . 70.9 mt -67.43 -44.35 86.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.405 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 40.1 ttpt -57.14 -47.55 80.87 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.401 0.62 . . . . 0.0 109.828 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -67.33 -40.87 85.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.72 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.413 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 30.0 tpt180 -60.57 -40.36 91.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.099 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -59.85 -44.47 94.1 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 -59.74 -45.56 91.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.335 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.413 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 17.7 p . . . . . 0 CA--C 1.532 0.267 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.857 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.549 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 13.6 m95 . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 120.969 0.414 . . . . 0.0 111.667 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.5 p -79.3 155.33 28.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.284 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.2 p -58.38 -33.85 48.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.926 0.393 . . . . 0.0 110.668 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.73 -49.31 75.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.133 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.439 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 33.8 mt-10 -63.97 -40.15 95.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.543 0.687 . . . . 0.0 110.489 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.593 ' O ' HG22 ' A' ' 25' ' ' VAL . 25.0 m -63.05 -35.58 80.73 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.365 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -65.46 -32.39 73.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.075 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.453 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 41.1 m0 -66.76 -46.0 76.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.675 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 22' ' ' SER . 3.3 m -62.51 -37.79 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.998 0.428 . . . . 0.0 110.18 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -63.19 -46.18 88.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.913 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.31 -40.28 64.62 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.214 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.44 -41.67 97.18 Favored Glycine 0 C--O 1.226 -0.377 0 CA-C-N 116.114 -0.494 . . . . 0.0 113.052 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 34' ' ' GLU . 66.2 t -62.23 -40.32 87.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.247 0.546 . . . . 0.0 110.748 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.454 ' HB3' HE21 ' A' ' 30' ' ' GLN . 0.0 OUTLIER -73.55 -44.92 56.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.04 -179.633 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.473 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 62.1 tttp -75.46 -50.32 16.13 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.473 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -87.3 -53.15 4.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.443 0.639 . . . . 0.0 110.867 -178.283 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.21 133.2 3.53 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.687 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.607 ' HB2' HG13 ' A' ' 29' ' ' VAL . 35.5 tt0 -55.42 121.5 9.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.918 0.389 . . . . 0.0 110.661 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.15 -34.01 3.83 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.014 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.459 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.2 m-80 -80.19 53.91 1.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.075 0.464 . . . . 0.0 111.243 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -64.52 -36.56 84.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.951 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.83 98.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.072 0.463 . . . . 0.0 110.545 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.77 -37.72 73.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.006 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 36' ' ' ASN . 74.1 mt -66.56 -46.53 86.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.867 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.526 ' HB3' HD12 ' A' ' 54' ' ' ILE . 3.8 p -62.88 -37.51 87.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.193 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -65.83 -52.69 48.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.09 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -76.72 -47.08 23.01 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.402 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 53.3 m-85 -71.25 149.14 94.15 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.989 0.423 . . . . 0.0 111.07 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.453 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 40.7 Cg_endo -67.84 43.19 0.25 Allowed 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.685 2.923 . . . . 0.0 114.773 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.549 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 73.4 m-85 -74.7 127.77 33.93 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 49' ' ' ARG . 7.5 p -115.72 132.68 64.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 p30 66.03 -30.19 0.14 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.655 1.182 . . . . 0.0 112.366 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -67.8 125.77 27.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.728 0.299 . . . . 0.0 110.981 179.229 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.9 p -89.34 169.82 11.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.621 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.65 89.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.485 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.95 -38.03 80.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.501 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 14.5 mmt -62.07 -44.1 97.4 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.526 HD12 ' HB3' ' A' ' 41' ' ' SER . 77.4 mt -64.15 -44.51 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.938 0.399 . . . . 0.0 110.009 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -55.91 -50.23 71.25 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.901 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.51 -42.86 86.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.5 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.493 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 8.9 tpp180 -60.42 -38.3 83.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.623 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.482 ' CD2' HG21 ' A' ' 29' ' ' VAL . 27.4 t-105 -60.35 -44.69 95.31 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -57.86 -46.71 84.4 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.533 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.493 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.922 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 m -64.3 130.27 43.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.704 0.288 . . . . 0.0 110.81 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -62.8 -42.89 99.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.946 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.26 106.28 1.17 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.209 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -72.73 -47.26 48.48 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.537 0.684 . . . . 0.0 110.223 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -174.63 -44.55 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.097 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 m -148.55 41.77 0.96 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.192 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.7 m -59.35 -53.85 53.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.576 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.727 ' HB ' HG13 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -82.64 133.16 35.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.064 0.459 . . . . 0.0 110.742 178.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -80.57 39.2 0.46 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.486 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.727 HG13 ' HB ' ' A' ' 9' ' ' THR . 1.5 pp -90.78 19.44 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.099 0.476 . . . . 0.0 111.375 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 p -83.32 -47.78 11.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.558 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -80.22 141.98 35.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.724 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.493 ' NZ ' ' HB3' ' A' ' 14' ' ' LYS . 1.6 ttpm? 59.17 83.88 0.12 Allowed 'General case' 0 C--O 1.238 0.455 0 O-C-N 123.66 0.6 . . . . 0.0 110.869 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 63.63 -167.72 0.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.151 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -168.46 121.91 0.87 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.636 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 16.4 m95 -133.25 147.39 51.95 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -177.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -87.03 154.6 20.64 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.595 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 14.7 p -57.6 -42.53 81.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -60.37 -45.68 92.65 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.784 0.325 . . . . 0.0 110.941 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.477 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 68.7 mt-10 -61.28 -36.41 79.99 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.493 0.663 . . . . 0.0 110.107 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.675 ' O ' HG22 ' A' ' 25' ' ' VAL . 22.0 m -69.8 -29.69 67.05 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.705 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.595 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 68.1 mm-40 -69.57 -39.25 77.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.243 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.515 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 33.6 m0 -61.17 -43.77 98.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.219 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 22' ' ' SER . 3.1 m -58.63 -38.31 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 121.001 0.429 . . . . 0.0 110.263 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -67.18 -49.58 64.14 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.793 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.88 -43.22 99.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.736 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.9 -38.84 96.68 Favored Glycine 0 C--O 1.224 -0.524 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.566 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 25' ' ' VAL . 55.7 t -63.21 -35.76 73.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.037 0.446 . . . . 0.0 110.909 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.28 -46.61 15.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.947 0.403 . . . . 0.0 110.866 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.723 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 39.5 ttmt -74.46 -45.72 44.41 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.723 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -93.28 -46.11 7.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.211 0.529 . . . . 0.0 110.98 -177.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.78 134.05 5.05 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.168 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.423 ' HB2' HG13 ' A' ' 29' ' ' VAL . 87.3 tt0 -54.23 118.65 4.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.871 0.367 . . . . 0.0 110.476 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.12 -38.54 2.0 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.817 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.503 ' O ' HG13 ' A' ' 40' ' ' ILE . 74.0 m-20 -79.83 54.11 1.78 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.142 0.496 . . . . 0.0 111.114 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -62.76 -39.11 93.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.581 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.11 -46.58 89.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.105 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.68 87.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.966 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 36' ' ' ASN . 75.1 mt -66.87 -43.21 89.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.003 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.467 ' OG ' HD12 ' A' ' 54' ' ' ILE . 14.9 m -60.37 -39.05 85.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.229 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -70.61 -55.13 9.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.885 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -72.48 -40.9 66.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 60.8 m-85 -83.1 146.15 50.89 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.546 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.515 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 35.9 Cg_endo -66.09 43.12 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.723 2.949 . . . . 0.0 115.041 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.636 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 64.6 m-85 -72.92 111.56 8.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.858 0.361 . . . . 0.0 110.079 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.4 127.86 51.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 72.97 -41.52 0.51 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.475 0.71 . . . . 0.0 111.368 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.447 ' NH2' ' HA ' ' A' ' 17' ' ' TRP . 1.0 OUTLIER -58.48 120.39 8.72 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 122.598 0.359 . . . . 0.0 111.277 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.3 p -86.04 172.17 10.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.206 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.68 83.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.455 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.29 -39.78 86.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.102 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 19.1 mmt -62.09 -41.71 98.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.317 -0.402 . . . . 0.0 109.959 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.467 HD12 ' OG ' ' A' ' 41' ' ' SER . 66.0 mt -67.28 -42.3 87.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -56.94 -50.66 71.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.557 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -64.53 -44.46 90.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.627 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.415 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 32.0 tpt180 -58.47 -45.13 89.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.388 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.492 ' CD1' ' HD2' ' A' ' 62' ' ' LYS . 30.7 t-105 -62.66 -41.91 99.32 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.297 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -58.11 -44.97 88.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.934 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.583 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 24.5 p -66.02 -39.61 90.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.959 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 63.5 mmm -59.45 -47.25 86.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.998 0.428 . . . . 0.0 110.026 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.492 ' HD2' ' CD1' ' A' ' 58' ' ' TRP . 49.7 mtpt -60.72 -42.91 98.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.643 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -61.32 -42.59 98.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.892 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 60' ' ' THR . 62.4 mt -75.54 -4.56 40.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.033 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.56 37.41 35.35 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.244 -0.503 . . . . 0.0 112.199 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 69.3 mtm -119.16 47.31 1.7 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.993 0.425 . . . . 0.0 110.464 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.9 t-20 . . . . . 0 C--O 1.248 1.015 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.626 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t -164.98 120.24 1.36 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -82.75 57.49 3.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.88 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.4 mmt -125.13 63.45 1.16 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.042 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -72.24 134.57 45.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.686 0.279 . . . . 0.0 110.541 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -167.07 -169.38 1.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.177 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.8 t -171.26 -139.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.4 m -162.57 -51.26 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 m -68.04 -46.22 71.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.975 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -162.03 155.41 20.84 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.272 -0.171 . . . . 0.0 111.049 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.5 mt 69.46 112.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 124.04 0.838 . . . . 0.0 111.637 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m 70.95 -44.13 0.58 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.356 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 71.38 -178.06 0.21 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.377 0.671 . . . . 0.0 110.272 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.839 ' HA ' ' HE3' ' A' ' 14' ' ' LYS . 0.6 OUTLIER -86.13 76.1 9.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.898 0.38 . . . . 0.0 110.608 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -79.28 45.77 0.67 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.053 0.454 . . . . 0.0 110.722 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.616 ' HD3' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -66.31 143.7 57.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.088 0.47 . . . . 0.0 111.297 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.466 ' CE3' ' HB3' ' A' ' 21' ' ' GLU . 14.0 m95 -116.19 132.31 56.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.585 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -79.5 156.39 27.82 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.81 -41.83 76.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.511 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -65.75 -45.83 81.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.528 0.204 . . . . 0.0 110.5 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.466 ' HB3' ' CE3' ' A' ' 17' ' ' TRP . 35.1 mt-10 -55.55 -43.44 75.84 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.638 0.733 . . . . 0.0 110.533 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.572 ' O ' HG22 ' A' ' 25' ' ' VAL . 17.5 m -66.75 -37.15 84.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.819 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -63.66 -35.27 79.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.982 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.465 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 44.2 m0 -61.89 -44.96 95.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.822 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 22' ' ' SER . 1.4 m -62.2 -40.17 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 26' ' ' LYS . 24.2 ttpt -65.14 -46.81 79.39 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.273 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.12 -44.08 97.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.158 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.26 95.97 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.273 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.659 HG13 ' HB2' ' A' ' 34' ' ' GLU . 50.2 t -63.22 -41.06 91.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.25 0.547 . . . . 0.0 110.178 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.486 HE21 ' HB3' ' A' ' 30' ' ' GLN . 0.2 OUTLIER -75.03 -45.62 40.5 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.77 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.478 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 61.7 tttm -79.64 -52.97 7.3 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.478 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -82.68 -54.65 4.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.483 0.658 . . . . 0.0 110.456 -178.583 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.74 130.86 3.29 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.096 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.659 ' HB2' HG13 ' A' ' 29' ' ' VAL . 36.8 tt0 -51.39 128.88 23.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.811 0.339 . . . . 0.0 110.892 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.37 -35.3 4.18 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.837 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.484 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.0 m-80 -81.11 51.85 1.67 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.884 0.373 . . . . 0.0 111.08 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.451 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 32.9 m95 -62.26 -42.91 99.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.788 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.39 88.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.791 0.329 . . . . 0.0 110.731 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.66 -42.91 98.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.473 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 36' ' ' ASN . 89.0 mt -62.47 -45.6 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.598 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.543 ' HB2' HD12 ' A' ' 54' ' ' ILE . 29.5 t -61.43 -36.33 80.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.068 0.461 . . . . 0.0 111.087 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -68.18 -49.96 57.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.95 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -77.8 -52.69 8.5 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.612 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.436 ' CD1' HG23 ' A' ' 40' ' ' ILE . 57.6 m-85 -67.9 147.45 98.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.119 0.485 . . . . 0.0 111.329 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.429 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.6 Cg_endo -66.98 44.57 0.22 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.819 3.012 . . . . 0.0 115.212 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.451 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 75.7 m-85 -71.36 124.85 25.48 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.774 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.42 ' C ' ' H ' ' A' ' 49' ' ' ARG . 2.4 p -101.83 118.54 48.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.089 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.1 -30.38 0.15 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.543 1.137 . . . . 0.0 112.964 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.557 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -60.91 119.51 8.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.234 0.54 . . . . 0.0 111.771 -179.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 p -79.05 169.95 17.42 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.945 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.23 -38.61 89.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.303 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.87 -40.21 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 21.4 mmt -61.3 -40.84 95.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.543 HD12 ' HB2' ' A' ' 41' ' ' SER . 82.3 mt -67.11 -44.16 88.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 37.7 ttpt -56.98 -48.87 77.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.696 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -66.64 -39.46 88.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.883 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.445 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 27.6 tpt180 -59.32 -43.58 92.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.32 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.402 ' O ' ' HG3' ' A' ' 62' ' ' LYS . 10.9 t-105 -58.62 -45.27 89.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.464 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 57.2 ttp180 -60.9 -46.25 91.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.722 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 27.9 p -62.1 -39.12 91.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.288 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 84.3 mtp -64.38 -41.18 96.83 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.464 ' HD3' ' HA ' ' A' ' 59' ' ' ARG . 54.6 mtpt -63.74 -38.25 90.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.409 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.544 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 4.7 tpm_? -60.09 -46.14 90.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.144 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.57 -22.36 61.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.304 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.83 28.58 31.41 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 63.7 mtt -107.13 26.66 9.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.232 0.539 . . . . 0.0 110.22 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.302 179.852 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.672 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.8 m 62.42 -91.84 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.023 0.529 . . . . 0.0 112.277 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -80.09 38.12 0.4 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.201 0.524 . . . . 0.0 111.12 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 20.7 mmt -151.05 131.89 14.14 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -80.88 38.48 0.46 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.461 0.648 . . . . 0.0 110.941 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.69 -15.81 50.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.029 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.9 p 57.1 25.4 10.8 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.555 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.5 p -75.78 -43.36 46.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -69.5 138.17 53.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.772 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -67.72 129.68 40.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.2 mt -140.2 34.26 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.621 0.724 . . . . 0.0 109.906 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.7 m -66.7 -35.71 80.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.774 0.797 . . . . 0.0 109.379 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 14' ' ' LYS . 19.4 ptpt -72.82 -9.1 58.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.994 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 39.2 ttpt 76.29 145.64 0.09 Allowed 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.904 0.752 . . . . 0.0 109.446 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -50.08 125.19 11.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.398 0.618 . . . . 0.0 112.165 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -100.05 150.51 22.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.379 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.474 ' HZ3' ' HE2' ' A' ' 46' ' ' PHE . 14.3 m95 -124.25 134.12 53.32 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.435 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.0 p -79.33 156.41 28.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.344 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.52 -31.52 50.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.437 ' HG3' ' CZ2' ' A' ' 24' ' ' TRP . 3.2 tp10 -59.76 -51.74 68.47 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.593 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.511 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 29.1 mt-10 -64.31 -38.15 90.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.596 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.585 ' O ' HG22 ' A' ' 25' ' ' VAL . 22.6 m -64.89 -41.92 95.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.341 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -63.04 -32.9 74.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.96 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.511 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 47.0 m0 -65.88 -46.23 79.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.887 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 22' ' ' SER . 2.3 m -60.93 -39.31 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -67.21 -47.31 71.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.621 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.66 -42.39 98.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.516 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.32 -36.46 93.1 Favored Glycine 0 C--O 1.222 -0.645 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.969 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 25' ' ' VAL . 53.7 t -65.7 -34.28 69.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.181 0.515 . . . . 0.0 110.072 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -75.43 -48.08 24.42 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.214 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.496 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 24.8 ttmm -79.9 -48.22 13.8 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -177.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.496 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -90.8 -44.01 9.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.414 0.626 . . . . 0.0 111.101 -178.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 29' ' ' VAL . . . 106.97 132.37 6.98 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -56.62 139.17 50.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.373 0.606 . . . . 0.0 110.834 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.31 -38.11 3.01 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -85.65 49.34 1.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.107 0.479 . . . . 0.0 110.148 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.425 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 42.1 m95 -60.22 -38.28 82.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.222 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.22 -45.66 90.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.995 0.426 . . . . 0.0 110.133 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 -44.59 91.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.81 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.5 mt -61.31 -44.1 97.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.786 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.503 ' HB2' HD12 ' A' ' 54' ' ' ILE . 31.9 t -64.65 -37.66 88.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.814 0.34 . . . . 0.0 111.039 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -64.9 -49.23 71.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.258 0.551 . . . . 0.0 111.604 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -79.0 -48.61 14.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.956 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -75.31 141.53 73.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 0.0 111.869 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.511 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.4 Cg_endo -66.39 48.93 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 124.298 3.332 . . . . 0.0 115.257 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.474 ' HE2' ' HZ3' ' A' ' 17' ' ' TRP . 60.8 m-85 -72.15 109.85 6.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.87 0.366 . . . . 0.0 110.202 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 49' ' ' ARG . 4.0 p -84.82 122.26 37.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.471 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.7 m120 69.88 -34.04 0.27 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.557 0.743 . . . . 0.0 112.27 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.626 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -63.06 127.88 33.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.248 0.547 . . . . 0.0 111.789 -179.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.4 p -93.29 176.56 6.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.127 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.95 -38.57 91.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.667 0.27 . . . . 0.0 110.299 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.7 t -63.52 -38.76 83.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.485 ' HA ' ' CE ' ' A' ' 53' ' ' MET . 14.0 mmt -59.37 -44.99 92.65 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.551 HG23 HG12 ' A' ' 25' ' ' VAL . 68.4 mt -65.49 -46.49 89.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.504 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 36.0 ttpt -55.05 -50.44 69.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.345 0.593 . . . . 0.0 110.378 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -66.33 -39.55 89.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.401 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.444 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 30.8 tpt180 -59.99 -41.6 92.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.587 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.46 ' CE2' HG21 ' A' ' 29' ' ' VAL . 16.0 t-105 -61.18 -45.5 94.36 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.81 -44.45 86.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.901 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.619 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.6 OUTLIER -63.89 -45.63 88.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.461 179.388 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 75.6 mtp -58.34 -41.63 85.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.856 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.403 ' HD2' ' CD1' ' A' ' 58' ' ' TRP . 52.6 mtpt -66.05 -40.56 91.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.821 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -66.52 -46.09 77.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.656 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 60' ' ' THR . 64.7 mt -65.51 -30.47 71.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.337 0.589 . . . . 0.0 110.464 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.23 34.99 5.65 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.776 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 88.2 mtp -82.71 -43.5 16.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.256 0.551 . . . . 0.0 109.703 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.0 t30 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.386 -0.816 . . . . 0.0 110.448 179.499 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.8 p 66.83 -42.59 0.42 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.138 1.375 . . . . 0.0 112.611 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.47 127.03 4.19 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -26.15 60.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.304 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.623 ' OE1' ' HA ' ' A' ' 48' ' ' ASN . 40.1 mt-10 -58.51 137.18 57.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.08 0.467 . . . . 0.0 111.504 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -74.61 148.86 40.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.422 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.55 ' HB3' HD11 ' A' ' 11' ' ' ILE . 27.0 m 62.57 54.73 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.441 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -64.98 -24.68 67.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.353 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.1 m -56.95 141.47 45.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.26 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.577 ' HB2' ' HG2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -68.19 50.81 0.07 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.55 HD11 ' HB3' ' A' ' 7' ' ' SER . 28.7 pt -83.89 28.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.734 0.302 . . . . 0.0 111.794 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.3 m -157.35 -51.18 0.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.577 ' HG2' ' HB2' ' A' ' 10' ' ' ASN . 35.7 mtmm 54.44 57.68 5.6 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.567 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -58.15 105.47 0.28 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.849 0.356 . . . . 0.0 110.575 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.421 ' O ' ' HD1' ' A' ' 17' ' ' TRP . 89.3 mm-40 -71.87 -24.93 61.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.62 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -66.12 120.86 13.92 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.103 0.477 . . . . 0.0 110.13 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.457 ' HZ2' ' HB3' ' A' ' 53' ' ' MET . 17.3 m95 -135.97 140.08 43.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.218 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.3 p -76.81 152.74 35.42 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 10.9 p -60.51 -38.61 78.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.219 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -59.71 -54.1 50.29 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.532 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 50.3 mt-10 -58.57 -39.28 79.85 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.429 0.633 . . . . 0.0 111.096 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.538 ' O ' HG22 ' A' ' 25' ' ' VAL . 15.5 m -68.16 -37.6 81.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.203 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 68.0 mm-40 -61.26 -34.64 75.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.873 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.532 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 42.5 m0 -62.54 -43.66 98.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.15 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 29' ' ' VAL . 1.1 m -60.04 -37.55 73.12 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.436 ' HE2' ' O ' ' A' ' 66' ' ' MET . 19.5 ttmt -62.21 -46.3 89.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.639 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.86 78.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.744 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.06 -40.68 99.24 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 25' ' ' VAL . 51.5 t -61.09 -37.39 77.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.006 0.432 . . . . 0.0 111.01 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -79.28 -41.42 28.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.696 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -78.81 -49.49 12.88 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.431 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -86.05 -42.12 14.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.462 0.648 . . . . 0.0 110.805 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.17 131.54 5.88 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -50.55 130.4 23.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.808 0.337 . . . . 0.0 110.914 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.41 -37.07 3.44 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.906 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.464 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.9 m-80 -81.53 53.72 2.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.102 0.477 . . . . 0.0 111.115 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -63.83 -38.3 90.57 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.559 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.54 -46.2 90.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.51 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.23 -43.08 99.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.64 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 36' ' ' ASN . 79.6 mt -63.05 -45.07 99.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.449 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.566 ' HB2' HD12 ' A' ' 54' ' ' ILE . 47.6 t -62.91 -36.0 81.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.229 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -68.76 -47.91 65.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.908 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -80.34 -49.96 10.8 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.409 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 51.0 m-85 -70.41 145.56 93.18 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 121.171 0.51 . . . . 0.0 111.826 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.47 44.28 0.24 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 124.073 3.182 . . . . 0.0 114.841 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.437 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 53.4 m-85 -68.65 122.95 19.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.969 0.414 . . . . 0.0 110.489 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.484 HG22 ' ND2' ' A' ' 48' ' ' ASN . 7.4 p -106.58 127.25 62.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.256 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.631 ' C ' ' HD2' ' A' ' 49' ' ' ARG . 73.2 m-80 61.79 17.18 8.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.738 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.631 ' HD2' ' C ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -118.03 124.37 47.96 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -178.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.517 ' OG1' ' HG2' ' A' ' 53' ' ' MET . 31.1 p -87.01 175.38 8.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.624 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.78 -38.59 86.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.538 0.208 . . . . 0.0 110.824 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.72 -36.23 74.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.517 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 79.8 mmm -61.79 -45.27 94.61 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.566 HD12 ' HB2' ' A' ' 41' ' ' SER . 66.3 mt -66.45 -41.96 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.958 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -54.92 -49.28 71.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.148 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 3.5 t0 -71.31 -36.59 71.68 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.262 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.457 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 27.8 tpt180 -59.7 -40.52 88.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.116 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.4 t-105 -59.59 -43.34 93.71 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 56' ' ' ASP . 21.7 ttm180 -58.06 -49.46 76.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.457 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.457 ' OG1' ' HA ' ' A' ' 57' ' ' ARG . 1.7 p -61.73 -46.06 91.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.955 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.558 ' HB3' ' HB2' ' A' ' 66' ' ' MET . 4.6 mtm -57.11 -41.36 78.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.622 0.249 . . . . 0.0 111.0 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.407 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 8.3 mtpm? -61.62 -35.37 77.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.301 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.524 ' HB3' HD22 ' A' ' 64' ' ' LEU . 29.8 ttp180 -59.88 -60.7 3.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.623 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.534 ' H ' HD22 ' A' ' 64' ' ' LEU . 2.7 mm? -63.37 -53.0 59.38 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.493 0.663 . . . . 0.0 110.155 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.37 40.63 0.3 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.7 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.558 ' HB2' ' HB3' ' A' ' 61' ' ' MET . 78.0 mtp -95.58 38.8 1.14 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.959 0.409 . . . . 0.0 110.439 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.407 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 13.0 p-10 . . . . . 0 C--O 1.25 1.116 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.608 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.7 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 14' ' ' LYS . 41.7 m -141.92 45.89 1.67 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.179 0.514 . . . . 0.0 110.287 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -76.87 113.92 15.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.527 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.44 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 51.2 ttm -174.51 129.7 0.34 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.282 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.433 ' HB2' ' HG2' ' A' ' 13' ' ' LYS . 55.1 mt-10 49.82 54.9 10.24 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.672 0.607 . . . . 0.0 110.42 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -71.83 55.52 0.28 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.093 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 t -75.32 -27.37 59.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.672 0.749 . . . . 0.0 109.122 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.1 m -155.78 -51.8 0.08 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.986 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 10' ' ' ASN . 1.5 m -147.85 -140.56 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.487 ' C ' ' HD3' ' A' ' 13' ' ' LYS . 7.1 p-10 -139.01 33.9 2.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.096 0.474 . . . . 0.0 110.297 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.419 ' O ' ' CB ' ' A' ' 12' ' ' THR . 57.9 mt -78.1 117.9 24.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.419 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 23.6 m 100.64 -19.0 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.064 1.345 . . . . 0.0 109.086 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.487 ' HD3' ' C ' ' A' ' 10' ' ' ASN . 1.7 mptp? -88.3 134.09 33.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.83 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.465 ' HD3' ' HA ' ' A' ' 2' ' ' SER . 29.5 mtpp 52.79 57.96 5.84 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.6 0.563 . . . . 0.0 111.379 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -62.69 106.5 0.8 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -102.52 133.12 48.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.27 0.557 . . . . 0.0 111.283 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.515 ' HZ3' ' HE2' ' A' ' 46' ' ' PHE . 10.6 m95 -77.59 141.97 39.22 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.243 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -77.3 154.43 32.9 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.1 p -57.21 -35.29 48.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.503 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -60.23 -53.92 51.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.682 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.62 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 37.7 mt-10 -59.44 -42.4 91.83 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.689 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.662 ' O ' HG22 ' A' ' 25' ' ' VAL . 8.5 m -65.59 -34.87 79.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.145 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -69.52 -33.14 72.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.906 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.62 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 44.6 m0 -61.82 -42.8 99.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.653 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 22' ' ' SER . 2.5 m -62.3 -38.16 80.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -63.76 -48.96 74.86 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.276 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.32 -40.78 90.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.721 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.05 -38.05 94.91 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.659 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 25' ' ' VAL . 54.8 t -63.16 -36.15 74.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.958 0.408 . . . . 0.0 110.752 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -78.84 -43.92 24.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.225 0.536 . . . . 0.0 111.102 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.577 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 88.1 tttt -74.09 -45.68 47.62 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.577 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -96.61 -49.04 5.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.275 0.56 . . . . 0.0 111.053 -178.206 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.07 134.58 4.4 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.166 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.517 ' HB2' HG13 ' A' ' 29' ' ' VAL . 76.3 tt0 -55.15 106.69 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.168 0.509 . . . . 0.0 110.658 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.39 -37.9 1.51 Allowed Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.673 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.494 ' O ' HG13 ' A' ' 40' ' ' ILE . 73.0 m-80 -78.88 54.58 1.58 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.042 0.448 . . . . 0.0 111.386 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.433 ' NE1' ' HG3' ' A' ' 55' ' ' LYS . 36.0 m95 -65.31 -37.08 86.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.279 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.44 -42.1 96.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.163 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.62 -37.04 81.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.022 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 36' ' ' ASN . 74.4 mt -66.96 -45.81 86.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.66 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.474 ' HB3' HD12 ' A' ' 54' ' ' ILE . 4.1 p -65.4 -34.67 78.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.135 0.493 . . . . 0.0 111.154 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.52 -43.28 81.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.087 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -88.03 -44.64 10.83 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.45 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 55.6 m-85 -76.05 146.72 79.23 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 121.108 0.48 . . . . 0.0 111.627 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.32 46.3 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.08 3.187 . . . . 0.0 115.47 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.515 ' HE2' ' HZ3' ' A' ' 17' ' ' TRP . 75.6 m-85 -71.47 134.63 46.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.564 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.422 ' C ' ' H ' ' A' ' 49' ' ' ARG . 3.5 p -123.05 132.3 71.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 75.9 m-20 73.91 -39.87 0.44 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.567 0.747 . . . . 0.0 110.709 -177.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.5 ' HD3' ' OE2' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -67.31 138.39 56.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.266 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.7 p -102.77 177.45 4.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.628 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.02 -39.56 90.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.713 0.292 . . . . 0.0 110.415 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.9 t -63.49 -37.21 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.438 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 18.7 mmt -62.4 -42.31 99.33 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.484 HG23 HG12 ' A' ' 25' ' ' VAL . 82.4 mt -65.6 -44.49 93.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.012 0.434 . . . . 0.0 109.864 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.433 ' HG3' ' NE1' ' A' ' 37' ' ' TRP . 25.8 ttpp -56.47 -49.51 74.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.655 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 37.7 t70 -67.59 -39.4 84.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.838 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.492 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 13.0 tpp180 -59.84 -37.74 80.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.204 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.544 ' CD1' ' HD2' ' A' ' 62' ' ' LYS . 8.5 t-105 -60.61 -42.88 97.71 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 56' ' ' ASP . 98.5 mtt180 -53.54 -49.95 66.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.021 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.555 ' O ' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -62.71 -45.16 94.02 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.8 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.417 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 91.0 mmm -56.79 -44.95 82.39 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.038 0.447 . . . . 0.0 110.783 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.544 ' HD2' ' CD1' ' A' ' 58' ' ' TRP . 46.9 mtpt -65.86 -29.67 70.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.946 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.521 ' HB3' ' O ' ' A' ' 60' ' ' THR . 57.7 ttm-85 -55.24 -58.04 9.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.15 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.74 ' H ' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -65.05 -51.33 62.12 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.286 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.65 31.34 0.41 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.609 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.9 mtt -91.82 50.38 1.68 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.134 0.493 . . . . 0.0 109.756 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 . . . . . 0 C--O 1.249 1.071 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.646 -179.115 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.832 0 N-CA-C 112.375 -0.29 . . . . 0.0 112.375 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 t -69.3 144.64 53.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -144.22 126.06 15.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.91 0.386 . . . . 0.0 110.59 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.5 ptp -87.85 144.92 26.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.238 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.412 ' HB2' ' NZ ' ' A' ' 16' ' ' LYS . 73.9 tt0 -82.94 149.77 26.84 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.922 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -51.35 125.62 14.76 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.525 0.516 . . . . 0.0 109.715 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.462 ' HB2' HG12 ' A' ' 11' ' ' ILE . 27.5 t -159.89 138.07 10.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.163 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 p -69.81 -37.63 76.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.483 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.3 m -148.34 -52.47 0.18 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.843 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -167.3 120.44 0.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.813 0.816 . . . . 0.0 112.045 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.497 HG22 ' HG2' ' A' ' 13' ' ' LYS . 50.4 mm -100.29 147.18 7.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -70.31 53.97 0.14 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.497 ' HG2' HG22 ' A' ' 11' ' ' ILE . 46.6 pttt 178.44 49.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 124.095 0.958 . . . . 0.0 108.536 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.407 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 32.6 mtmm -69.09 131.95 45.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.394 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 70.16 138.27 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.765 0.826 . . . . 0.0 112.775 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 16' ' ' LYS . 41.6 mmtm -83.72 151.1 25.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.304 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.557 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 16.8 m95 -109.64 142.49 40.7 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.563 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.5 p -82.53 160.88 22.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.346 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.73 -40.71 80.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.426 0.155 . . . . 0.0 111.152 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -61.94 -47.29 85.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.691 0.281 . . . . 0.0 111.585 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.521 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 49.8 mt-10 -63.66 -36.23 83.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.333 0.587 . . . . 0.0 110.695 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.616 ' O ' HG22 ' A' ' 25' ' ' VAL . 40.2 m -67.58 -36.03 80.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.02 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -65.65 -35.3 80.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.833 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.527 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 44.6 m0 -62.18 -46.73 87.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.379 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 22' ' ' SER . 3.3 m -60.75 -37.46 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.873 0.368 . . . . 0.0 110.815 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -66.17 -46.12 78.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.771 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.2 -38.57 75.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.039 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.07 -36.18 80.34 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.625 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 25' ' ' VAL . 97.5 t -62.28 -36.38 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.518 0.675 . . . . 0.0 110.074 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -81.18 -49.08 11.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.395 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.526 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 84.5 tttt -69.11 -42.49 76.02 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.917 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.526 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -102.74 -55.7 2.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.338 0.59 . . . . 0.0 110.973 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.89 138.23 3.96 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.228 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.5 ' HB2' HG13 ' A' ' 29' ' ' VAL . 7.8 tm-20 -57.04 117.81 4.37 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.26 -32.1 4.65 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.019 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.473 ' O ' HG13 ' A' ' 40' ' ' ILE . 71.4 m-80 -81.62 48.19 1.16 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.896 0.379 . . . . 0.0 111.345 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 36.9 m95 -62.85 -37.91 88.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.832 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.17 -48.93 78.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 0.0 110.528 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.27 98.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.689 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 36' ' ' ASN . 79.1 mt -60.72 -45.54 97.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.593 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.492 ' HB2' HD12 ' A' ' 54' ' ' ILE . 23.1 t -64.69 -35.02 79.7 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.096 0.474 . . . . 0.0 110.924 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -67.65 -47.45 69.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.754 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -82.31 -49.45 10.04 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.474 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 56.4 m-85 -70.23 143.31 90.87 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.095 0.474 . . . . 0.0 111.374 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.527 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 39.4 Cg_endo -67.6 48.27 0.35 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.922 3.081 . . . . 0.0 115.204 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.557 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 67.8 m-85 -72.48 133.47 44.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.761 0.315 . . . . 0.0 110.283 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.596 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 5.9 p -110.48 121.11 62.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.84 -30.92 0.14 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.6 1.16 . . . . 0.0 112.293 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.596 ' HD2' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -61.71 118.0 6.56 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.964 0.411 . . . . 0.0 110.9 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.404 ' OG1' ' HG2' ' A' ' 53' ' ' MET . 34.2 p -81.02 167.39 19.84 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.703 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.56 85.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.9 t -63.23 -36.96 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.45 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 61.1 mmm -64.17 -41.33 97.16 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.596 HG23 HG12 ' A' ' 25' ' ' VAL . 85.1 mt -65.36 -45.01 94.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.814 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.566 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 38.8 ttpt -56.7 -49.61 74.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.337 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -63.47 -44.88 93.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.523 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.554 ' O ' ' HG2' ' A' ' 61' ' ' MET . 30.9 tpt180 -60.55 -38.59 84.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.144 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.679 ' CE2' ' HE2' ' A' ' 62' ' ' LYS . 15.4 t-105 -58.8 -43.17 90.48 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.635 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.685 ' HA ' ' HE3' ' A' ' 62' ' ' LYS . 1.6 mpt_? -60.04 -49.17 78.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.758 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.495 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 2.9 p -61.79 -35.71 78.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.796 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.554 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 89.8 mmm -57.02 -40.49 76.77 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.217 0.532 . . . . 0.0 109.991 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.685 ' HE3' ' HA ' ' A' ' 59' ' ' ARG . 49.0 mttt -64.45 -44.36 91.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.787 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 50.7 ttt85 -59.22 -41.6 89.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.654 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 60' ' ' THR . 69.2 mt -72.71 -5.97 41.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.39 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.06 45.58 19.66 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.464 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 70.0 mtm -132.45 56.54 1.83 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.306 0.574 . . . . 0.0 109.571 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.586 -179.352 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 112.162 -0.375 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.6 m -81.95 131.65 35.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.644 0.259 . . . . 0.0 111.287 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.5 m170 57.8 44.51 20.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.79 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.1 mmt -70.49 125.87 28.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.119 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 65.14 104.82 0.04 OUTLIER 'General case' 0 C--O 1.235 0.305 0 O-C-N 124.23 0.956 . . . . 0.0 110.317 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -60.05 126.24 26.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.1 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.483 ' HB3' ' ND2' ' A' ' 10' ' ' ASN . 66.4 m 57.76 54.23 6.42 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.6 m -44.29 -47.85 9.49 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.703 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.7 p -133.97 116.87 16.07 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.228 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.491 ' OD1' HG23 ' A' ' 12' ' ' THR . 0.5 OUTLIER -179.25 164.95 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.058 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 27.6 pt -71.01 27.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -176.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.491 HG23 ' OD1' ' A' ' 10' ' ' ASN . 7.3 p -85.54 -49.85 7.71 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.551 -0.718 . . . . 0.0 110.276 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.814 ' HD3' ' H ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -99.78 -21.71 15.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.732 -179.029 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.798 ' HE3' HG21 ' A' ' 60' ' ' THR . 0.7 OUTLIER -170.39 164.12 8.68 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -57.84 147.25 29.03 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.5 0.5 . . . . 0.0 110.445 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -75.83 128.45 35.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.395 0.617 . . . . 0.0 110.015 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.439 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 10.4 m95 -100.62 138.86 37.12 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.67 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.9 p -78.66 147.74 33.44 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.439 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 11.5 p -53.71 -35.58 27.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.61 0.243 . . . . 0.0 110.969 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.419 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 39.8 tt0 -59.71 -53.46 57.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.362 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.569 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 45.5 mt-10 -61.09 -39.45 89.99 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.439 0.638 . . . . 0.0 111.015 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.606 ' O ' HG22 ' A' ' 25' ' ' VAL . 6.4 m -66.09 -33.36 75.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.613 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 58.7 mm-40 -68.29 -30.91 70.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.777 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.569 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 43.1 m0 -64.27 -42.99 96.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.736 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 22' ' ' SER . 2.0 m -60.81 -38.16 78.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.094 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -65.7 -50.4 65.02 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.469 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.52 -41.84 98.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.741 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.47 -37.86 94.83 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.471 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 25' ' ' VAL . 47.5 t -64.9 -43.16 96.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.08 0.467 . . . . 0.0 110.337 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -71.38 -42.28 68.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.207 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.458 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 63.7 tttp -76.72 -48.52 18.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.458 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -94.76 -55.87 2.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.599 0.714 . . . . 0.0 110.975 -178.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.19 132.0 3.45 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -58.48 118.46 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.546 0.688 . . . . 0.0 110.554 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.45 -37.5 1.87 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.415 ' O ' HG13 ' A' ' 40' ' ' ILE . 62.2 m-80 -83.49 50.77 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.039 0.447 . . . . 0.0 110.228 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -62.2 -41.45 98.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.908 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.78 -45.41 89.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.871 0.367 . . . . 0.0 110.332 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.93 -43.27 93.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.485 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 36' ' ' ASN . 82.0 mt -62.55 -46.55 96.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.451 ' HB2' HD12 ' A' ' 54' ' ' ILE . 32.4 t -60.71 -36.66 79.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.199 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -69.11 -51.16 41.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.69 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -74.54 -43.73 54.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.722 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.456 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 47.4 m-85 -77.49 146.91 74.48 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 120.983 0.42 . . . . 0.0 110.928 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.466 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 36.8 Cg_endo -66.31 43.02 0.18 Allowed 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.774 2.982 . . . . 0.0 115.304 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.439 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 77.0 m-85 -74.05 128.36 35.31 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.941 -0.474 . . . . 0.0 110.12 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.59 129.2 72.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.0 m120 71.33 -40.67 0.48 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.19 0.596 . . . . 0.0 111.924 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.493 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 2.0 mpt_? -60.74 127.16 30.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.682 0.277 . . . . 0.0 110.612 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.471 ' OG1' ' HG3' ' A' ' 53' ' ' MET . 67.5 p -89.55 169.03 11.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.333 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.7 -37.33 83.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.805 0.336 . . . . 0.0 110.263 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.23 -38.41 82.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.829 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.471 ' HG3' ' OG1' ' A' ' 50' ' ' THR . 68.1 mtt -62.3 -42.1 99.07 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.508 HG23 HG12 ' A' ' 25' ' ' VAL . 70.2 mt -67.22 -44.36 87.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.868 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -55.56 -49.98 71.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.007 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.64 -37.0 79.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.388 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 53' ' ' MET . 15.0 tpt85 -61.28 -39.73 91.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.343 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.434 ' CD2' HG21 ' A' ' 29' ' ' VAL . 36.7 t-105 -67.49 -43.7 80.3 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.5 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 81.3 mtt-85 -59.39 -42.75 92.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.383 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.798 HG21 ' HE3' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -61.44 -38.98 89.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.794 178.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.43 ' HG3' ' O ' ' A' ' 57' ' ' ARG . 84.2 mtp -62.42 -41.86 99.01 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.033 0.444 . . . . 0.0 109.897 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.5 ' HD3' ' HA ' ' A' ' 59' ' ' ARG . 6.1 mtpm? -65.92 -40.67 91.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.076 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -60.97 -45.99 92.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.536 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 60' ' ' THR . 71.4 mt -72.7 -37.02 67.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.513 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.45 39.23 2.45 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.139 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 63.9 mtt -100.89 38.09 1.61 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.89 0.376 . . . . 0.0 110.671 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.1 p30 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.063 -179.562 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 111.893 -0.483 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 p -141.71 29.19 1.74 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.932 0.366 . . . . 0.0 111.829 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -91.61 -38.76 12.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.379 0.609 . . . . 0.0 109.77 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 88.8 mmm -142.37 -125.77 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.765 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -161.21 144.81 13.0 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -63.54 -47.26 82.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.244 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 p -171.72 -53.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.702 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 m 64.25 -77.1 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.666 0.786 . . . . 0.0 111.25 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.7 p 61.04 -40.41 0.11 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -62.27 -17.47 58.59 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.6 pt -79.61 2.47 2.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.224 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -92.29 -40.85 10.71 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.494 0.664 . . . . 0.0 109.682 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -88.44 133.63 34.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.934 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -156.12 31.77 0.34 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.932 0.872 . . . . 0.0 109.026 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.45 ' O ' ' HD1' ' A' ' 17' ' ' TRP . 1.9 pm0 -159.09 43.77 0.25 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.543 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HE2' ' HB3' ' A' ' 16' ' ' LYS . 43.7 mtpt -66.5 136.79 56.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.471 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.45 ' HD1' ' O ' ' A' ' 15' ' ' GLN . 11.2 m95 -125.16 136.55 53.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.248 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.7 p -77.83 154.22 32.03 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 13.8 p -57.51 -38.46 63.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.265 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.515 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 87.2 tt0 -64.07 -48.05 77.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.793 0.33 . . . . 0.0 111.076 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.536 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 68.0 mt-10 -59.59 -37.35 78.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.344 0.592 . . . . 0.0 111.58 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.618 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.3 m -67.86 -32.03 72.25 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.997 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 5.7 mm-40 -65.68 -38.29 88.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.4 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.536 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 35.3 m0 -61.4 -43.68 98.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.837 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 22' ' ' SER . 3.8 m -62.59 -36.45 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.168 0.508 . . . . 0.0 110.248 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -66.93 -49.32 65.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.753 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.63 -39.91 76.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.299 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.72 -41.21 98.93 Favored Glycine 0 C--O 1.224 -0.476 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.999 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.62 HG13 ' HB2' ' A' ' 34' ' ' GLU . 54.8 t -64.72 -41.79 93.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 117.237 0.518 . . . . 0.0 110.72 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -70.82 -36.72 73.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.323 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.614 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 5.1 ttmp? -84.77 -52.08 6.31 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.614 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -84.77 -54.17 4.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.28 0.562 . . . . 0.0 111.221 -177.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.56 130.75 3.33 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.62 ' HB2' HG13 ' A' ' 29' ' ' VAL . 86.9 tt0 -55.56 125.57 21.58 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.958 0.409 . . . . 0.0 110.852 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.49 -35.13 3.41 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.457 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.4 m-80 -82.97 52.81 2.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.986 0.422 . . . . 0.0 110.532 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 40.8 m95 -61.18 -40.26 93.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.636 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.6 97.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.965 0.412 . . . . 0.0 110.384 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -67.82 -38.14 82.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.097 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 36' ' ' ASN . 78.5 mt -67.45 -47.31 81.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.531 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.523 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 5.7 p -63.52 -37.18 86.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.519 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -62.99 -48.42 78.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.515 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -80.41 -50.31 10.28 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.424 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 55.7 m-85 -69.09 146.32 97.03 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.01 0.433 . . . . 0.0 110.895 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.472 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 44.4 Cg_endo -68.68 46.46 0.38 Allowed 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.537 2.824 . . . . 0.0 114.799 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -69.72 126.49 29.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.1 0.476 . . . . 0.0 110.564 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.525 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 5.6 p -118.3 131.25 71.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 74.5 m-80 74.35 -43.5 0.53 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.039 0.535 . . . . 0.0 110.378 -177.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.699 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -66.45 125.67 26.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.346 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.8 p -96.15 175.58 6.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.919 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.3 -42.72 99.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.491 0.186 . . . . 0.0 110.91 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.09 -37.57 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.699 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 63.6 mtt -59.96 -42.42 94.04 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.539 HG23 HG12 ' A' ' 25' ' ' VAL . 63.6 mt -66.99 -44.51 88.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.027 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -55.7 -47.5 76.71 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.171 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -69.79 -41.95 74.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.99 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.501 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 12.1 tpp180 -60.18 -39.15 85.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.267 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.442 ' HA ' ' CE3' ' A' ' 58' ' ' TRP . 16.7 t-105 -61.74 -45.3 94.51 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.345 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.9 mtt85 -58.5 -44.47 89.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.377 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.506 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 24.5 p -66.51 -41.46 88.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.735 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.407 ' SD ' ' HE3' ' A' ' 66' ' ' MET . 79.3 mmm -57.33 -42.69 82.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.122 0.487 . . . . 0.0 110.241 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.526 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 52.6 mtpt -66.73 -45.1 79.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.867 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -62.3 -42.51 99.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.839 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 60' ' ' THR . 80.2 mt -72.77 -18.77 61.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.115 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.53 52.14 4.59 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.194 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.407 ' HE3' ' SD ' ' A' ' 61' ' ' MET . 66.4 mtm -128.94 46.81 2.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.201 0.524 . . . . 0.0 110.299 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.526 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 14.1 p-10 . . . . . 0 C--O 1.247 0.973 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.177 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.878 0 N-CA-C 112.115 -0.394 . . . . 0.0 112.115 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.8 t -166.33 133.46 2.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -90.69 51.68 2.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.124 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.7 mmt 58.33 54.61 5.54 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.234 0.54 . . . . 0.0 110.739 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -53.27 141.1 24.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.588 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -87.35 53.4 2.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.907 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.2 m -86.19 127.63 34.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.417 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.34 -31.56 10.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.694 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.1 m -61.89 116.31 4.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.655 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.427 ' C ' HG13 ' A' ' 11' ' ' ILE . 29.1 t30 61.31 117.12 0.02 OUTLIER 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.188 -0.914 . . . . 0.0 113.266 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.427 HG13 ' C ' ' A' ' 10' ' ' ASN . 17.5 mt -144.9 41.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.8 m -89.35 -47.01 8.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.948 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 16.6 pttp -66.77 -29.46 69.43 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER 53.27 -160.75 0.12 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.97 0.908 . . . . 0.0 110.638 -178.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -74.84 114.71 13.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.173 0.511 . . . . 0.0 110.315 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.72 135.23 34.28 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.192 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -119.54 130.01 54.96 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.75 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.2 p -80.38 151.12 29.57 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.495 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 7.2 p -55.44 -39.16 51.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.64 0.257 . . . . 0.0 110.734 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.542 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 84.6 tt0 -62.13 -46.6 88.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.911 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 53.6 mt-10 -62.53 -38.89 91.74 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.236 0.541 . . . . 0.0 110.676 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.61 ' O ' HG22 ' A' ' 25' ' ' VAL . 24.3 t -64.58 -34.51 78.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.302 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 49.7 mm-40 -66.87 -37.59 84.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.707 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.564 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 40.0 m0 -62.46 -44.68 95.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.509 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.618 HG12 HG23 ' A' ' 54' ' ' ILE . 3.3 m -62.0 -35.77 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 121.143 0.497 . . . . 0.0 109.988 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 26' ' ' LYS . 18.0 ttpt -69.7 -47.7 62.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.759 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.32 -42.9 78.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.766 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.94 -33.02 67.41 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-N 116.191 -0.458 . . . . 0.0 113.133 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 25' ' ' VAL . 78.4 t -66.41 -36.91 78.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.174 0.511 . . . . 0.0 110.658 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -79.35 -44.68 21.08 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.188 0.518 . . . . 0.0 110.933 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -73.85 -46.33 45.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.491 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.413 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -98.02 -57.45 2.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.467 0.651 . . . . 0.0 110.888 -179.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 29' ' ' VAL . . . 126.53 133.31 3.83 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.43 ' HB3' HG13 ' A' ' 29' ' ' VAL . 11.1 pt-20 -59.12 138.71 57.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.327 0.585 . . . . 0.0 110.438 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.18 -37.29 3.55 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -84.95 46.49 1.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.154 0.502 . . . . 0.0 110.546 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.44 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 41.5 m95 -61.17 -36.51 80.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.786 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.46 92.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 0.0 110.223 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.09 84.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.661 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.44 HG23 ' CD1' ' A' ' 44' ' ' TYR . 61.6 mt -61.77 -47.54 92.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.413 ' HB2' HD12 ' A' ' 54' ' ' ILE . 44.2 t -63.47 -36.27 83.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.973 0.416 . . . . 0.0 110.468 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -63.4 -47.53 81.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.658 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -82.93 -52.33 6.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.396 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.44 ' CD1' HG23 ' A' ' 40' ' ' ILE . 65.0 m-85 -68.45 140.19 92.36 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 121.066 0.46 . . . . 0.0 110.986 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.564 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 32.5 Cg_endo -64.87 47.17 0.16 Allowed 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.155 3.237 . . . . 0.0 115.395 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -74.16 134.9 42.83 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.965 -0.46 . . . . 0.0 110.223 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 7.3 p -124.36 125.23 70.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 75.4 m-20 76.5 -33.91 0.22 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.276 0.63 . . . . 0.0 111.146 -178.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.517 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 7.7 mpt_? -76.03 112.94 12.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.714 0.292 . . . . 0.0 110.518 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.6 p -82.19 173.52 12.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.635 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.11 82.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.938 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 t -64.23 -39.44 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 25.3 mmt -61.52 -42.96 99.6 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.618 HG23 HG12 ' A' ' 25' ' ' VAL . 72.0 mt -66.47 -45.48 88.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.428 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 39.0 ttpt -56.03 -50.87 69.72 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.531 0.681 . . . . 0.0 109.853 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.27 -40.42 93.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.429 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 61' ' ' MET . 14.1 tpp180 -60.75 -42.23 97.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.099 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.436 ' CD2' HG21 ' A' ' 29' ' ' VAL . 23.4 t-105 -61.18 -43.01 99.56 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.654 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 40.5 ttp180 -56.26 -45.31 80.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.038 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.633 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -64.2 -39.31 93.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 178.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 98.0 mmm -59.31 -39.52 83.32 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.098 0.475 . . . . 0.0 110.273 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.654 ' HD3' ' HA ' ' A' ' 59' ' ' ARG . 5.9 mtpm? -64.35 -39.22 93.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.975 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -68.43 -42.41 78.95 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.956 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 60' ' ' THR . 83.0 mt -64.77 -28.85 69.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.447 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.53 29.79 42.74 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 82.5 mtp -107.51 51.18 0.75 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.248 -0.476 . . . . 0.0 110.008 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.9 p30 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.241 -179.312 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 112.111 -0.395 . . . . 0.0 112.111 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -64.58 125.72 25.59 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.907 0.384 . . . . 0.0 110.708 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 59.4 37.88 23.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.482 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 10.2 tpt -171.8 32.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.233 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -85.4 61.26 6.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.35 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -160.04 151.88 20.2 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.0 m -55.77 131.89 47.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.029 0.443 . . . . 0.0 111.592 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.5 p -75.68 -34.15 60.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.819 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 m -68.91 123.96 22.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.402 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.62 ' HA ' ' HB3' ' A' ' 13' ' ' LYS . 47.1 t30 63.18 -154.69 0.33 Allowed 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.612 0.57 . . . . 0.0 109.989 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.42 ' H ' ' CG ' ' A' ' 10' ' ' ASN . 46.8 mt 49.25 70.25 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.998 0.428 . . . . 0.0 110.662 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m 68.31 45.4 1.21 Allowed 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.62 ' HB3' ' HA ' ' A' ' 10' ' ' ASN . 15.5 ptmt -61.82 -52.38 64.42 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.765 -1.561 . . . . 0.0 112.954 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.3 tptp 53.94 44.31 29.59 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 122.002 0.906 . . . . 0.0 108.674 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 13' ' ' LYS . 72.9 mt-30 -116.41 61.74 0.72 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.408 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -65.94 153.42 42.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.269 0.557 . . . . 0.0 110.651 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.54 ' CE3' ' HG2' ' A' ' 57' ' ' ARG . 11.7 m95 -98.24 136.92 37.74 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.873 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 51.1 p -82.13 157.04 24.2 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.596 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.633 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 8.0 p -60.24 -38.66 78.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.78 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.22 -49.33 78.27 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.711 0.291 . . . . 0.0 110.803 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.593 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 48.1 mt-10 -59.43 -41.66 90.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.336 0.589 . . . . 0.0 111.502 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.693 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.8 m -66.61 -29.63 69.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.555 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.633 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 70.9 mm-40 -68.4 -36.72 79.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.593 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 33.2 m0 -63.61 -41.51 98.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.377 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 22' ' ' SER . 4.3 m -61.44 -37.61 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.098 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.386 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 66' ' ' MET . 36.0 mtmt -65.54 -50.85 63.66 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.95 0.405 . . . . 0.0 110.725 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.0 98.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.73 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.52 -41.81 99.76 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.001 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 25' ' ' VAL . 67.9 t -65.94 -38.43 82.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.322 0.582 . . . . 0.0 109.762 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -68.99 -47.39 65.67 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.088 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -83.49 -46.53 12.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.491 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -88.01 -54.9 3.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.547 0.689 . . . . 0.0 110.647 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.39 133.57 4.17 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.669 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -52.58 146.67 9.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.047 0.451 . . . . 0.0 111.259 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.11 -37.05 3.73 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.636 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.416 ' O ' HG13 ' A' ' 40' ' ' ILE . 67.1 m-80 -82.62 48.59 1.33 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.019 0.438 . . . . 0.0 110.407 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -60.15 -40.47 89.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.73 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.35 -34.65 75.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.164 0.507 . . . . 0.0 111.158 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.71 -34.65 64.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.296 0.569 . . . . 0.0 110.187 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 36' ' ' ASN . 75.4 mt -70.61 -46.72 68.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.022 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 12.5 p -61.55 -38.16 86.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.881 0.372 . . . . 0.0 111.374 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -63.41 -45.84 89.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.413 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -85.38 -45.36 11.96 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 56.1 m-85 -73.56 150.1 88.83 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 121.033 0.444 . . . . 0.0 111.463 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.448 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 48.2 Cg_endo -68.99 44.1 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.675 2.917 . . . . 0.0 114.707 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.466 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 69.3 m-85 -73.14 107.35 5.42 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.474 ' C ' ' H ' ' A' ' 49' ' ' ARG . 2.9 p -86.53 119.56 34.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.984 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 65.4 -25.37 0.09 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.442 1.097 . . . . 0.0 112.801 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -64.91 121.07 13.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 111.025 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.8 p -78.62 171.32 15.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.07 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.79 -38.6 91.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.773 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.93 -37.16 77.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.438 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.429 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 19.9 mmt -59.86 -45.33 92.78 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.582 HG23 HG12 ' A' ' 25' ' ' VAL . 64.7 mt -65.36 -43.96 94.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.089 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -55.63 -49.59 72.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.83 0.824 . . . . 0.0 110.059 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -67.28 -42.35 83.97 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.81 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.54 ' HG2' ' CE3' ' A' ' 17' ' ' TRP . 10.0 tpp180 -59.75 -42.74 93.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.864 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.437 ' CD1' ' HD2' ' A' ' 62' ' ' LYS . 26.2 t-105 -56.86 -44.11 81.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.114 0.483 . . . . 0.0 109.736 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -55.87 -45.8 78.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.424 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.509 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -63.33 -43.13 98.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.399 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.452 ' SD ' ' HB3' ' A' ' 22' ' ' SER . 90.0 mmm -57.51 -40.76 79.43 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.236 0.541 . . . . 0.0 109.891 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.512 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 6.9 mtpm? -66.66 -40.19 88.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.586 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -62.39 -40.98 98.23 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 121.384 0.611 . . . . 0.0 109.567 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 60' ' ' THR . 77.2 mt -71.66 -19.92 62.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.184 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.09 33.86 56.36 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.513 ' O ' ' HD3' ' A' ' 26' ' ' LYS . 93.3 mmm -107.41 44.99 1.02 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.911 0.386 . . . . 0.0 110.946 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.512 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 9.3 p-10 . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.683 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -84.72 135.13 34.27 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.856 0.36 . . . . 0.0 110.91 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.45 ' HB3' ' H ' ' A' ' 4' ' ' MET . 3.7 m-70 -92.37 -140.89 0.2 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.236 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.45 ' H ' ' HB3' ' A' ' 3' ' ' HIS . 86.6 mtp 53.08 35.67 20.25 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.368 0.604 . . . . 0.0 110.03 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -84.38 142.89 29.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.136 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.36 -26.74 68.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.192 0.52 . . . . 0.0 110.16 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.549 ' OG ' ' HA ' ' A' ' 12' ' ' THR . 8.1 t -78.05 39.85 0.32 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.695 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.6 t -84.99 -19.82 31.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.494 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.8 p -81.75 -152.85 0.1 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.109 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -90.02 -2.29 58.11 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.782 -0.574 . . . . 0.0 110.52 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.8 mt -83.11 45.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.92 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.549 ' HA ' ' OG ' ' A' ' 7' ' ' SER . 20.5 p -75.07 -22.16 58.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.431 0.634 . . . . 0.0 110.206 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -65.48 146.24 55.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.701 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.593 ' HB2' ' OE1' ' A' ' 15' ' ' GLN . 22.7 pttm -129.2 -158.7 0.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.02 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.593 ' OE1' ' HB2' ' A' ' 14' ' ' LYS . 6.1 pm0 -64.73 -28.76 69.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.557 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -71.55 138.23 48.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.514 ' HZ2' ' HB3' ' A' ' 53' ' ' MET . 10.6 m95 -110.19 145.25 37.58 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.287 0.565 . . . . 0.0 112.424 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -88.42 151.89 22.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.99 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.4 p -55.95 -37.24 47.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.837 -0.165 . . . . 0.0 111.377 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.501 ' HG3' ' CZ2' ' A' ' 24' ' ' TRP . 36.3 tp10 -59.32 -51.78 68.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.809 0.338 . . . . 0.0 110.777 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.497 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 52.3 mt-10 -60.73 -39.36 88.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.687 0.756 . . . . 0.0 110.862 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.662 ' O ' HG22 ' A' ' 25' ' ' VAL . 13.2 m -67.96 -34.02 75.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.259 -179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.71 -36.19 82.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.19 0.519 . . . . 0.0 110.337 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.501 ' CZ2' ' HG3' ' A' ' 20' ' ' GLU . 32.5 m0 -65.75 -43.98 87.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.518 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 22' ' ' SER . 3.0 m -58.82 -40.29 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.933 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -66.49 -44.85 81.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.819 0.342 . . . . 0.0 110.785 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.64 -44.31 90.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.779 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.65 96.13 Favored Glycine 0 C--O 1.224 -0.478 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.287 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.504 HG11 ' CZ2' ' A' ' 58' ' ' TRP . 22.8 t -60.08 -41.32 86.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.133 0.492 . . . . 0.0 110.965 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -74.48 -40.31 61.92 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.771 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.513 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 62.8 tttm -80.67 -46.13 16.07 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.513 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -91.73 -37.66 12.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.084 0.469 . . . . 0.0 111.35 -177.531 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.88 134.72 8.29 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.483 ' CG ' HG13 ' A' ' 29' ' ' VAL . 43.4 mt-10 -48.95 130.37 18.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.949 0.404 . . . . 0.0 111.47 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.18 -39.06 2.83 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.194 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.534 ' O ' HG13 ' A' ' 40' ' ' ILE . 66.6 m-80 -81.17 52.08 1.73 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.983 0.42 . . . . 0.0 110.932 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.428 ' NE1' ' HG3' ' A' ' 55' ' ' LYS . 33.8 m95 -63.7 -45.11 91.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.703 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.408 ' HA ' ' HB2' ' A' ' 51' ' ' ALA . . . -56.28 -44.03 79.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.808 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.15 -37.44 87.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.645 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 36' ' ' ASN . 82.8 mt -67.4 -48.19 78.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.356 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.559 ' HB3' HD12 ' A' ' 54' ' ' ILE . 6.4 p -61.47 -35.03 76.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.819 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -71.15 -52.27 20.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.003 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -75.09 -44.94 44.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.472 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 30.1 m-85 -71.65 154.44 93.09 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.116 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.89 38.0 0.15 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.147 2.565 . . . . 0.0 114.579 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 24' ' ' TRP . 78.9 m-85 -76.18 134.03 40.02 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.204 0.525 . . . . 0.0 109.832 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 4.3 p -134.25 135.26 54.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 74.9 m-80 76.5 -38.79 0.33 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.746 0.654 . . . . 0.0 110.422 -177.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.497 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 1.0 OUTLIER -69.87 128.96 38.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.416 179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.3 p -92.14 169.7 10.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.107 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . . . -64.85 -36.84 85.63 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.0 t -62.76 -36.25 74.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.514 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 17.9 mmt -64.77 -45.36 86.71 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.559 HD12 ' HB3' ' A' ' 41' ' ' SER . 78.6 mt -64.77 -44.2 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.18 0.514 . . . . 0.0 109.814 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HG3' ' NE1' ' A' ' 37' ' ' TRP . 39.5 ttmt -54.41 -50.81 66.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.323 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -70.93 -39.42 72.68 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.347 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.518 ' O ' ' HG2' ' A' ' 61' ' ' MET . 16.6 tpp180 -58.92 -35.62 73.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.714 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.504 ' CZ2' HG11 ' A' ' 29' ' ' VAL . 14.6 t-105 -59.55 -48.16 82.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 34.5 ttm105 -56.67 -46.93 80.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.393 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.494 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 7.5 p -63.98 -37.91 89.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.577 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 97.0 mmm -61.99 -42.03 98.69 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.571 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 5.6 mtpm? -65.19 -40.52 94.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.83 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -59.9 -44.26 94.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.146 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 60' ' ' THR . 75.5 mt -70.28 -19.57 63.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.412 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.54 31.79 26.49 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.341 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 86.7 mtp -99.17 47.03 0.97 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.878 0.37 . . . . 0.0 110.368 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.571 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 11.2 p-10 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.672 -0.68 . . . . 0.0 109.738 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 111.939 -0.465 . . . . 0.0 111.939 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -77.66 151.34 34.31 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.553 0.215 . . . . 0.0 110.691 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -63.72 146.4 53.92 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.5 mmt 67.05 -127.5 0.18 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -76.14 127.78 33.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -63.7 -34.86 78.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.913 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.2 p 53.46 47.22 24.55 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.618 0.723 . . . . 0.0 110.873 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.6 m -156.3 56.65 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.671 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 t -63.33 134.8 56.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.332 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.426 ' N ' HD22 ' A' ' 10' ' ' ASN . 0.0 OUTLIER -177.43 -144.75 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.95 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.4 mm -104.95 26.85 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.27 0.557 . . . . 0.0 111.575 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.412 ' H ' ' ND2' ' A' ' 10' ' ' ASN . 78.6 m -81.37 -43.12 19.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.374 0.607 . . . . 0.0 109.824 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -129.85 154.71 47.01 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.504 178.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -53.77 127.18 24.81 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.619 0.574 . . . . 0.0 110.571 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -76.59 54.77 0.98 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.947 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HE3' ' HB3' ' A' ' 16' ' ' LYS . 28.0 mtpp -56.77 128.69 37.87 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.291 0.567 . . . . 0.0 110.956 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.549 ' HA ' ' NH2' ' A' ' 49' ' ' ARG . 15.1 m95 -87.44 138.41 31.5 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.674 0.75 . . . . 0.0 112.581 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.54 149.62 21.08 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.902 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.8 p -53.32 -36.76 27.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.563 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 35.8 tt0 -55.66 -60.17 3.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.737 0.303 . . . . 0.0 110.952 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.647 ' HG3' ' CZ3' ' A' ' 24' ' ' TRP . 2.7 mp0 -66.28 -30.98 71.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.193 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.662 ' O ' HG22 ' A' ' 25' ' ' VAL . 9.1 t -63.79 -39.84 95.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.761 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 21.1 mm-40 -65.28 -37.91 88.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.089 0.471 . . . . 0.0 111.08 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.647 ' CZ3' ' HG3' ' A' ' 21' ' ' GLU . 37.2 m0 -62.91 -43.1 99.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.587 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 22' ' ' SER . 4.2 m -60.21 -40.2 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.906 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -64.74 -44.59 89.66 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.875 0.369 . . . . 0.0 110.934 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.07 -43.99 73.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.244 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.95 -42.47 96.82 Favored Glycine 0 C--O 1.225 -0.426 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.924 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 25' ' ' VAL . 98.5 t -61.45 -38.95 81.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.199 0.523 . . . . 0.0 110.499 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -70.49 -45.81 64.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.794 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -78.93 -45.89 19.53 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -177.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CE1' ' HE1' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -88.32 -39.97 13.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.165 0.507 . . . . 0.0 111.336 -177.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.46 132.09 6.38 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -50.9 128.58 21.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.005 0.431 . . . . 0.0 111.053 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.73 -35.36 3.87 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.177 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.483 ' O ' HG13 ' A' ' 40' ' ' ILE . 77.2 m-20 -82.45 50.62 1.67 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.914 0.388 . . . . 0.0 111.292 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.413 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 35.7 m95 -60.66 -44.06 96.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.646 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.44 ' O ' ' HG2' ' A' ' 42' ' ' LYS . . . -59.5 -47.47 85.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.576 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.5 -42.99 93.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.702 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 36' ' ' ASN . 86.6 mt -60.8 -45.19 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.274 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.511 ' HB2' HD12 ' A' ' 54' ' ' ILE . 14.6 t -63.75 -38.19 90.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.154 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 73.0 mmtt -65.77 -46.14 79.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.059 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -82.65 -45.36 14.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.408 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 50.1 m-85 -76.15 147.39 79.85 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 120.925 0.393 . . . . 0.0 111.281 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.405 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 39.3 Cg_endo -68.28 46.85 0.36 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.777 2.985 . . . . 0.0 114.854 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -73.59 126.07 29.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.141 0.496 . . . . 0.0 111.281 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.462 ' O ' ' HD3' ' A' ' 49' ' ' ARG . 7.4 p -118.98 132.63 68.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 75.8 m-20 74.49 -40.31 0.44 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.379 0.671 . . . . 0.0 110.819 -177.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.698 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 0.8 OUTLIER -73.26 118.04 15.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.76 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.436 ' OG1' ' HG3' ' A' ' 53' ' ' MET . 45.6 p -86.93 179.08 6.78 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.19 95.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.829 0.347 . . . . 0.0 110.136 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -62.29 -37.71 79.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.821 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.698 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 90.4 mtp -61.9 -43.36 99.0 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.511 HD12 ' HB2' ' A' ' 41' ' ' SER . 75.8 mt -65.06 -44.32 95.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.413 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 37.9 ttpt -57.47 -48.24 79.71 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.715 0.769 . . . . 0.0 109.793 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.17 -37.77 84.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.007 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.449 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 26.7 tpt180 -59.63 -44.85 93.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.842 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -58.86 -45.04 91.07 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.636 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.414 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 51.4 ttm-85 -59.23 -42.74 91.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.376 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.553 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 1.2 p -68.07 -37.21 81.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.271 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 90.4 mmm -58.76 -44.31 90.55 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.096 0.475 . . . . 0.0 110.176 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 59' ' ' ARG . 47.7 mtpt -64.23 -41.76 96.85 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.93 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -62.98 -47.9 81.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.293 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 60' ' ' THR . 66.2 mt -68.08 -26.39 65.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.887 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.51 39.38 6.32 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.7 mmt -124.28 7.12 8.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.107 0.48 . . . . 0.0 110.554 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.346 179.533 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.1 p -171.43 -41.27 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.962 0.411 . . . . 0.0 110.68 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -96.75 44.18 1.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.393 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.5 ttt -174.8 -50.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.238 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 61.3 mp0 -73.1 58.59 0.5 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.11 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -81.68 -122.66 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 m -81.2 -44.02 18.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.02 0.438 . . . . 0.0 110.252 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.91 61.0 5.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.266 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -59.84 130.88 48.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.697 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -112.57 -10.9 13.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.396 0.617 . . . . 0.0 110.795 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 11' ' ' ILE . 10.2 tt -76.81 -2.16 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 121.703 0.764 . . . . 0.0 111.181 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.3 m -82.55 -44.84 15.4 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.776 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -76.32 58.38 1.28 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.672 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -63.89 149.21 47.61 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -73.03 39.31 0.09 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -73.55 130.68 40.58 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.584 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 41.5 m95 -67.53 126.73 30.24 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.956 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.1 p -82.71 161.56 22.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.634 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.406 ' O ' ' HG3' ' A' ' 23' ' ' GLU . 10.0 t -60.79 -46.31 96.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.427 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.05 -42.57 85.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.273 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.646 ' HG2' ' CZ3' ' A' ' 24' ' ' TRP . 45.8 mt-10 -70.51 -33.53 71.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.174 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.592 ' O ' HG22 ' A' ' 25' ' ' VAL . 51.1 m -68.49 -35.5 77.6 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.233 0.539 . . . . 0.0 110.603 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 49.2 mt-10 -62.41 -37.72 86.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.83 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.646 ' CZ3' ' HG2' ' A' ' 21' ' ' GLU . 37.3 m0 -63.09 -41.96 99.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.819 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 22' ' ' SER . 2.0 m -59.01 -39.12 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.493 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.431 ' HG3' ' CH2' ' A' ' 58' ' ' TRP . 26.0 ttmt -66.21 -46.03 78.66 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.06 0.457 . . . . 0.0 110.628 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.76 -43.43 96.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.48 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.21 -39.17 96.81 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.119 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.589 HG13 ' HB2' ' A' ' 34' ' ' GLU . 54.0 t -61.95 -42.11 93.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.296 0.569 . . . . 0.0 110.332 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -72.79 -44.84 61.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.105 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -81.34 -49.5 10.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.473 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -84.84 -45.82 11.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.442 0.639 . . . . 0.0 111.017 -177.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.76 131.15 4.14 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.992 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.589 ' HB2' HG13 ' A' ' 29' ' ' VAL . 86.2 tt0 -55.34 108.57 0.43 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.065 0.459 . . . . 0.0 110.801 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.97 -35.28 1.93 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.495 ' O ' HG13 ' A' ' 40' ' ' ILE . 74.3 m-80 -82.2 53.2 2.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.14 0.495 . . . . 0.0 110.501 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.45 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 41.0 m95 -60.73 -43.17 98.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.965 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.31 99.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.68 0.276 . . . . 0.0 110.295 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -61.09 -43.0 99.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.945 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 36' ' ' ASN . 82.9 mt -63.26 -46.15 96.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.032 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.413 ' HB2' HD12 ' A' ' 54' ' ' ILE . 46.6 t -63.04 -38.32 90.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.339 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -68.1 -43.87 77.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.032 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -85.16 -46.43 11.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.41 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 50.3 m-85 -73.24 149.49 89.26 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.98 0.419 . . . . 0.0 111.171 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.506 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 37.6 Cg_endo -68.96 45.69 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.449 2.766 . . . . 0.0 114.638 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.584 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 58.6 m-85 -72.25 131.2 42.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.152 -0.343 . . . . 0.0 110.286 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.448 ' C ' ' H ' ' A' ' 49' ' ' ARG . 4.7 p -104.62 123.57 58.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.616 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 p30 63.92 -23.88 0.07 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.641 1.176 . . . . 0.0 113.431 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.598 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 5.1 mpt_? -65.42 133.19 50.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.047 0.451 . . . . 0.0 111.737 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.3 p -98.74 176.57 5.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.88 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.3 98.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.584 0.23 . . . . 0.0 111.092 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.53 -38.19 77.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.126 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.598 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 68.7 mtt -61.69 -43.74 98.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.709 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 41' ' ' SER . 62.8 mt -67.38 -42.78 87.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.224 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.45 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 40.3 ttpt -56.52 -49.12 75.67 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.541 0.686 . . . . 0.0 109.403 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -66.29 -43.17 87.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.239 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.425 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 29.8 tpt180 -58.58 -43.61 89.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.052 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.436 ' O ' ' HG3' ' A' ' 62' ' ' LYS . 15.6 t-105 -61.14 -44.77 96.81 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -56.99 -47.63 80.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.641 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -63.1 -41.52 99.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.666 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 57' ' ' ARG . 83.7 mtp -62.7 -41.69 99.26 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.524 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 56.5 mtpt -63.61 -42.05 98.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.311 0.577 . . . . 0.0 109.74 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -62.0 -50.11 73.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.796 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 60' ' ' THR . 73.0 mt -70.15 -27.73 64.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.289 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.54 36.54 5.32 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.174 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.3 mtt -99.23 41.49 1.15 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.017 0.437 . . . . 0.0 109.863 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.524 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 13.0 p-10 . . . . . 0 C--O 1.248 0.974 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.832 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -66.95 -39.14 87.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 0.0 110.789 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -136.15 139.25 42.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.348 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.0 ttt -145.78 47.69 1.25 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 62.77 -155.28 0.34 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.339 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.8 t70 56.55 -114.83 0.86 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.389 0.276 . . . . 0.0 110.401 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 t -171.22 -156.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -91.31 45.1 1.22 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.293 0.568 . . . . 0.0 111.202 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.98 70.28 4.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.04 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.84 40.19 0.11 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.9 mt -116.02 44.13 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 14' ' ' LYS . 7.5 m -70.39 -65.42 0.73 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.813 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.5 mttm 68.54 -45.75 0.53 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.707 0.803 . . . . 0.0 112.353 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.433 ' O ' HG22 ' A' ' 12' ' ' THR . 21.7 ptmt -155.23 -158.76 0.86 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -67.18 121.5 15.77 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.078 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -103.57 133.91 47.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.614 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.528 ' HZ3' ' HE2' ' A' ' 46' ' ' PHE . 11.9 m95 -105.9 141.97 36.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.377 0.608 . . . . 0.0 112.047 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.5 p -84.36 151.2 24.86 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.352 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.39 -29.41 42.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.355 0.597 . . . . 0.0 109.755 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -60.68 -52.49 64.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.375 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.563 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 94.3 mt-10 -68.76 -36.56 78.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.065 0.459 . . . . 0.0 111.018 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.653 ' O ' HG22 ' A' ' 25' ' ' VAL . 23.9 m -59.23 -39.24 82.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.501 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -67.2 -32.1 72.94 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.938 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.563 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 37.9 m0 -66.28 -40.55 90.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.274 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 22' ' ' SER . 3.6 m -62.85 -36.82 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 120.847 0.356 . . . . 0.0 110.076 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -66.38 -45.0 81.57 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.972 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.54 -40.89 80.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.029 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.6 -38.81 94.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.133 -0.555 . . . . 0.0 112.841 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 25' ' ' VAL . 85.1 t -62.78 -39.16 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.357 0.599 . . . . 0.0 110.103 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -72.71 -49.99 27.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.218 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.594 ' HD2' ' HE1' ' A' ' 32' ' ' TYR . 39.7 ttmt -72.17 -47.92 47.28 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.594 ' HE1' ' HD2' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -93.96 -51.8 4.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.43 0.633 . . . . 0.0 111.123 -177.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.73 136.33 4.35 Favored Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.222 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.418 ' HB2' HG13 ' A' ' 29' ' ' VAL . 36.6 tt0 -53.06 120.74 6.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.991 0.424 . . . . 0.0 110.27 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.52 -35.05 3.87 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.943 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.471 ' O ' HG13 ' A' ' 40' ' ' ILE . 77.6 m-20 -80.1 53.75 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.008 0.432 . . . . 0.0 111.096 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -64.65 -40.7 95.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.514 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.62 -39.87 85.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.915 0.388 . . . . 0.0 110.933 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.04 -35.38 74.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.463 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 36' ' ' ASN . 89.0 mt -69.84 -45.83 75.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.616 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.607 ' HB3' HD12 ' A' ' 54' ' ' ILE . 19.8 p -64.87 -36.85 85.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.271 0.558 . . . . 0.0 110.696 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -64.75 -45.88 84.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.81 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -86.04 -50.39 7.08 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.549 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 54.8 m-85 -69.06 146.79 97.45 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.197 0.522 . . . . 0.0 111.465 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.414 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.5 Cg_endo -67.34 41.18 0.19 Allowed 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.926 3.084 . . . . 0.0 115.406 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.528 ' HE2' ' HZ3' ' A' ' 17' ' ' TRP . 73.3 m-85 -68.65 127.33 32.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.432 ' C ' ' H ' ' A' ' 49' ' ' ARG . 4.0 p -106.04 121.57 58.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.716 0.293 . . . . 0.0 110.459 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 69.97 -29.83 0.19 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.55 0.74 . . . . 0.0 112.366 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.578 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -69.18 123.08 20.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.752 0.31 . . . . 0.0 110.604 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.612 ' OG1' ' HG2' ' A' ' 53' ' ' MET . 42.1 p -86.85 174.44 8.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.799 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.02 95.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.701 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.37 -38.83 82.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.612 ' HG2' ' OG1' ' A' ' 50' ' ' THR . 21.5 mmt -60.91 -43.37 98.65 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.607 HD12 ' HB3' ' A' ' 41' ' ' SER . 83.5 mt -65.37 -45.35 93.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.352 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -55.96 -50.34 71.07 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.367 0.603 . . . . 0.0 109.958 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.26 -40.91 94.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.225 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.513 ' O ' ' HG2' ' A' ' 61' ' ' MET . 12.7 tpp180 -60.61 -41.65 95.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.554 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -57.48 -42.4 82.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.961 0.41 . . . . 0.0 110.223 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -56.28 -45.17 80.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.068 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.524 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -69.01 -39.07 79.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.54 179.094 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.513 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 90.9 mmm -56.75 -44.13 81.44 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.151 0.501 . . . . 0.0 110.123 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -62.69 -42.43 99.63 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.276 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 43.8 ttm-85 -61.35 -40.27 93.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.075 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 60' ' ' THR . 60.1 mt -73.34 -6.69 47.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.62 32.0 47.95 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.914 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 81.5 mtp -103.59 44.68 1.0 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.225 0.536 . . . . 0.0 110.215 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.0 t30 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.372 179.847 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 3' ' ' HIS . 53.3 m 63.41 -164.9 0.25 Allowed 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.713 0.405 . . . . 0.0 110.545 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' A' ' 2' ' ' SER . 77.1 t60 71.4 -47.98 0.67 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.231 0.612 . . . . 0.0 111.135 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.6 ttm -166.99 114.67 0.82 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 1.0 OUTLIER -72.02 131.67 43.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.105 0.478 . . . . 0.0 110.912 -179.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -166.15 -147.09 0.09 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 p -99.48 39.74 1.28 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.18 0.514 . . . . 0.0 110.149 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.5 m 60.22 44.54 12.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.387 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.91 -43.13 10.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.972 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -98.7 150.94 21.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.945 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.502 ' O ' HG22 ' A' ' 11' ' ' ILE . 48.1 mm 56.01 45.85 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 122.298 1.047 . . . . 0.0 109.48 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.5 p -65.87 -46.9 76.71 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.616 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt 64.13 130.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.383 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -84.58 -168.47 2.2 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.467 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -79.65 52.39 1.42 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -53.16 131.97 37.72 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.677 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.46 ' CE3' ' HB3' ' A' ' 21' ' ' GLU . 27.5 m95 -64.42 127.86 33.29 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.666 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.04 155.76 20.02 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.891 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.417 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 10.3 p -58.32 -39.03 72.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.447 0.165 . . . . 0.0 111.138 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.402 ' HG3' ' CZ2' ' A' ' 24' ' ' TRP . 5.1 tp10 -58.65 -52.76 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.111 0.482 . . . . 0.0 110.155 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.521 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 5.6 mp0 -58.35 -39.55 79.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.33 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.602 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.0 m -67.26 -35.85 80.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.001 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 65.4 mm-40 -64.58 -36.85 85.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.327 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.521 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 44.3 m0 -63.32 -46.38 86.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.419 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 22' ' ' SER . 3.5 m -61.17 -35.68 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.312 0.577 . . . . 0.0 109.983 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.52 ' HA ' ' CZ3' ' A' ' 58' ' ' TRP . 19.3 ttpt -65.59 -49.3 69.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.029 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.81 -41.3 68.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.314 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.81 -45.52 93.42 Favored Glycine 0 C--O 1.22 -0.737 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.408 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 25' ' ' VAL . 91.9 t -64.05 -39.27 84.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 117.67 0.735 . . . . 0.0 110.861 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -66.7 -37.49 84.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.399 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -90.35 -41.92 11.23 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -177.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.434 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -89.69 -52.28 5.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.387 0.613 . . . . 0.0 110.879 -178.04 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.08 134.93 4.71 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.353 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -51.77 139.64 21.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.044 0.449 . . . . 0.0 110.972 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.87 -32.9 7.01 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.479 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.45 ' O ' HG13 ' A' ' 40' ' ' ILE . 74.3 m-80 -84.25 48.64 1.52 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.037 0.446 . . . . 0.0 111.126 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.425 ' HH2' ' CD1' ' A' ' 58' ' ' TRP . 28.2 m95 -60.87 -38.2 84.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.697 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.97 89.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.608 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -68.43 -39.55 81.5 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.856 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 36' ' ' ASN . 60.9 mt -68.62 -44.76 82.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.821 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.545 ' HB3' HD12 ' A' ' 54' ' ' ILE . 3.7 p -65.15 -32.38 74.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.646 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -70.89 -50.69 32.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.054 0.454 . . . . 0.0 111.528 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -76.61 -47.32 22.72 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -75.89 144.63 76.5 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.092 0.472 . . . . 0.0 111.567 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.454 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 36.6 Cg_endo -67.13 46.78 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.191 3.261 . . . . 0.0 115.309 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -71.97 135.32 46.39 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.348 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 9.0 p -129.74 133.46 64.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 6.8 m120 76.81 -35.94 0.25 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.284 0.633 . . . . 0.0 110.574 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.719 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 7.1 mpt_? -77.46 130.04 36.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.311 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.6 p -92.9 174.21 7.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.704 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.3 -35.41 80.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.9 t -64.93 -38.61 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.599 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.719 ' SD ' ' HA ' ' A' ' 49' ' ' ARG . 60.1 mtt -62.57 -40.68 97.62 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.545 HD12 ' HB3' ' A' ' 41' ' ' SER . 86.4 mt -68.06 -44.77 84.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.403 ' HB3' ' HE3' ' A' ' 55' ' ' LYS . 24.1 ttpp -53.92 -49.91 67.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.868 0.842 . . . . 0.0 109.467 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -67.84 -44.12 77.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.573 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -58.38 -40.37 82.11 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.503 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.536 ' CD1' ' HD2' ' A' ' 62' ' ' LYS . 30.3 t-105 -60.73 -45.37 94.54 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.864 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -56.83 -43.19 80.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.704 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.55 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -63.46 -41.68 98.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.226 179.237 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 92.9 mmm -59.86 -39.8 86.44 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.26 0.553 . . . . 0.0 109.893 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.536 ' HD2' ' CD1' ' A' ' 58' ' ' TRP . 52.8 mtpt -69.27 -39.45 78.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.423 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 50.9 ttm-85 -60.55 -45.88 92.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.958 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 60' ' ' THR . 54.0 mt -70.54 -29.5 65.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.143 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.06 41.34 7.58 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.867 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 51.1 mtm -114.21 53.7 0.78 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.936 0.398 . . . . 0.0 110.485 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 62' ' ' LYS . 8.7 p30 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.771 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.4 m -106.44 122.48 46.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.829 0.347 . . . . 0.0 110.412 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -78.26 -34.11 49.24 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 96.8 mmm 71.98 132.98 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.323 1.014 . . . . 0.0 110.797 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.22 141.65 57.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.929 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -59.1 -45.84 89.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.456 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 p -169.89 -62.15 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.315 0.579 . . . . 0.0 110.44 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.5 m -158.43 -41.85 0.06 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.54 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.416 ' OG1' HG12 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -159.55 155.88 27.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.195 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -2.04 10.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.416 HG12 ' OG1' ' A' ' 9' ' ' THR . 41.3 pt -90.25 32.59 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.889 0.852 . . . . 0.0 109.994 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 m -149.79 42.19 0.87 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -86.68 46.95 1.42 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.25 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -150.77 140.28 21.52 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.574 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.571 ' HB3' ' NH1' ' A' ' 49' ' ' ARG . 80.9 mm-40 61.86 45.12 7.85 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.521 0.513 . . . . 0.0 110.478 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -59.53 120.21 8.98 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.119 0.485 . . . . 0.0 109.833 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.651 ' HA ' ' NH2' ' A' ' 49' ' ' ARG . 35.8 m95 -67.48 143.2 56.32 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.9 p -111.85 161.09 16.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.222 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.416 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 7.3 p -53.82 -41.58 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.473 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 87.2 tt0 -59.13 -50.12 75.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.894 0.378 . . . . 0.0 110.942 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.494 ' CD ' ' HE ' ' A' ' 49' ' ' ARG . 54.1 mt-10 -64.59 -34.27 77.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.203 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.474 ' O ' HG22 ' A' ' 25' ' ' VAL . 23.1 t -69.21 -24.7 64.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.85 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 31.6 mm-40 -69.31 -40.66 77.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.082 0.467 . . . . 0.0 110.362 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.547 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 15.2 m0 -66.48 -40.12 89.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.418 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.916 HG12 HG23 ' A' ' 54' ' ' ILE . 34.6 m -61.02 -46.13 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.692 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -65.31 -41.73 93.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.112 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.41 -43.65 80.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.056 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.42 -38.12 95.88 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.188 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.684 HG13 ' HB3' ' A' ' 34' ' ' GLU . 68.4 t -61.17 -33.6 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.477 0.656 . . . . 0.0 110.118 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -77.12 -50.99 11.79 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.923 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.705 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 14.5 tmtt? -78.41 -47.57 17.3 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.705 ' CE1' ' HD2' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -86.71 -36.03 18.92 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.321 0.581 . . . . 0.0 110.965 -177.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.9 130.78 7.1 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.684 ' HB3' HG13 ' A' ' 29' ' ' VAL . 22.1 pt-20 -54.68 125.71 21.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.222 0.534 . . . . 0.0 110.48 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.07 -40.73 1.72 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.527 ' O ' HG13 ' A' ' 40' ' ' ILE . 74.4 m-80 -82.78 51.08 1.82 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.126 0.489 . . . . 0.0 110.385 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.415 ' NE1' ' HG3' ' A' ' 55' ' ' LYS . 40.9 m95 -60.27 -40.74 91.45 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.823 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.69 -46.67 84.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.703 0.287 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.01 85.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.439 . . . . 0.0 110.764 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 36' ' ' ASN . 67.8 mt -65.76 -43.52 93.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.679 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.411 ' OG ' HD12 ' A' ' 54' ' ' ILE . 12.9 m -62.22 -40.32 95.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.839 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.708 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -64.1 -55.52 21.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.356 -179.026 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -75.47 -47.48 26.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.421 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 61.0 m-85 -72.52 148.19 90.25 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.117 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.547 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 49.6 Cg_endo -69.56 43.94 0.38 Allowed 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.504 2.803 . . . . 0.0 114.164 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 24' ' ' TRP . 47.2 m-85 -72.56 99.03 2.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.862 0.363 . . . . 0.0 110.426 178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 6.5 p -88.32 127.19 41.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 3.5 m120 74.34 -36.03 0.32 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.238 0.615 . . . . 0.0 111.732 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.651 ' NH2' ' HA ' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -60.46 128.45 36.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.051 0.453 . . . . 0.0 112.175 -179.009 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.4 p -90.59 165.05 13.96 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.139 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.91 82.21 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.26 -38.66 82.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.38 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.537 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 3.5 mmt -59.77 -45.41 92.35 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.916 HG23 HG12 ' A' ' 25' ' ' VAL . 75.2 mt -65.48 -44.04 94.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.181 0.515 . . . . 0.0 110.055 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.415 ' HG3' ' NE1' ' A' ' 37' ' ' TRP . 38.9 ttmt -55.11 -51.97 64.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.429 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.51 -39.29 81.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.292 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.527 HH11 ' HG3' ' A' ' 57' ' ' ARG . 3.6 tpt85 -57.5 -40.07 77.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.564 ' CD1' ' HD2' ' A' ' 62' ' ' LYS . 11.8 t-105 -63.57 -42.49 98.32 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.463 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 64.8 ttt180 -56.18 -44.84 79.75 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.367 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -59.48 -44.89 92.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.389 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 77.5 mtp -62.4 -45.53 92.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.673 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.564 ' HD2' ' CD1' ' A' ' 58' ' ' TRP . 6.0 mtpm? -59.58 -42.06 91.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.174 0.511 . . . . 0.0 110.386 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -60.24 -40.72 91.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.653 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 60' ' ' THR . 59.9 mt -82.57 -3.25 55.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.027 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.55 40.14 47.81 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.039 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 75.4 mtp -115.41 36.89 3.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.813 0.34 . . . . 0.0 110.713 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.506 ' HA ' ' CH2' ' A' ' 58' ' ' TRP . 27.2 t-20 . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.613 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m 57.48 41.05 26.63 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.078 0.466 . . . . 0.0 110.972 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.579 ' HD2' ' HB3' ' A' ' 5' ' ' GLU . 55.8 t60 -95.3 -34.39 12.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.452 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.8 mtp 60.67 57.39 2.72 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.661 0.601 . . . . 0.0 110.722 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.579 ' HB3' ' HD2' ' A' ' 3' ' ' HIS . 8.6 tm-20 -169.56 -56.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 44.83 41.32 5.03 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.2 p -74.22 -43.84 55.51 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 m -154.48 34.99 0.41 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.8 m -73.12 -43.08 62.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.988 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -67.74 119.27 12.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.433 0.635 . . . . 0.0 111.279 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.8 mt -94.49 36.79 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.547 ' HB ' ' SD ' ' A' ' 53' ' ' MET . 19.5 m 71.97 -64.61 0.38 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.387 -177.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp 52.57 -164.26 0.08 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.453 0.701 . . . . 0.0 112.351 177.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt 63.56 169.68 0.16 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.506 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 56.74 89.18 0.05 OUTLIER 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.157 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -61.74 134.48 56.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.016 0.436 . . . . 0.0 109.95 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 28.8 m95 -73.12 132.94 43.89 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.462 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -94.55 148.52 22.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.999 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.69 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 14.6 p -49.51 -37.99 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -59.12 -49.17 78.9 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -64.38 -36.41 84.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.404 0.621 . . . . 0.0 110.082 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.67 ' O ' HG22 ' A' ' 25' ' ' VAL . 47.4 m -67.45 -27.57 67.15 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.923 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.69 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 69.7 mm-40 -66.37 -40.75 89.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.219 0.533 . . . . 0.0 110.167 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.522 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 21.6 m0 -64.16 -38.04 89.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.948 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 22' ' ' SER . 4.2 m -62.92 -38.58 82.3 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.81 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -68.93 -46.5 68.09 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.053 0.454 . . . . 0.0 110.388 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.13 99.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.606 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.59 -38.96 93.72 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.265 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 25' ' ' VAL . 38.6 t -64.32 -38.23 82.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 117.304 0.552 . . . . 0.0 110.422 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -73.34 -43.3 61.04 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.279 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -80.49 -50.54 9.91 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.463 ' CE1' ' HE1' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -88.72 -45.18 10.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.448 0.642 . . . . 0.0 111.186 -178.354 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 29' ' ' VAL . . . 112.44 131.69 5.65 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -57.82 124.69 20.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.416 0.627 . . . . 0.0 110.608 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.06 -39.57 1.69 Allowed Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.453 ' O ' HG13 ' A' ' 40' ' ' ILE . 75.5 m-80 -82.51 51.03 1.76 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.962 0.411 . . . . 0.0 110.482 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -60.44 -38.62 84.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.565 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.28 99.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.058 0.456 . . . . 0.0 110.276 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.37 -37.04 77.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.055 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 36' ' ' ASN . 67.1 mt -67.36 -45.58 85.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.685 ' HB3' HD12 ' A' ' 54' ' ' ILE . 4.5 p -63.7 -33.85 76.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 0.0 110.8 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -67.11 -48.81 67.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.601 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -82.86 -41.38 19.07 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' A' ' 24' ' ' TRP . 45.1 m-85 -79.5 147.43 67.88 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.09 0.471 . . . . 0.0 111.528 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.25 44.26 0.19 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 124.171 3.247 . . . . 0.0 114.735 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.412 ' HB3' ' HB2' ' A' ' 49' ' ' ARG . 60.3 m-85 -76.52 106.52 8.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.888 0.375 . . . . 0.0 110.148 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 49' ' ' ARG . 7.7 p -100.14 131.08 48.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 73.14 -26.22 0.19 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.549 0.74 . . . . 0.0 111.256 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.451 ' H ' ' C ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -72.23 125.61 27.74 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 111.56 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.3 p -89.5 154.94 19.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.499 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.34 -38.91 69.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.644 0.259 . . . . 0.0 110.9 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -63.85 -41.1 91.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.359 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.547 ' SD ' ' HB ' ' A' ' 12' ' ' THR . 68.8 mmm -63.27 -41.19 99.0 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.685 HD12 ' HB3' ' A' ' 41' ' ' SER . 76.7 mt -63.34 -44.94 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -56.92 -53.73 54.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.152 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -64.95 -37.5 87.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.728 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.534 ' O ' ' HG2' ' A' ' 61' ' ' MET . 8.3 tpp180 -59.58 -33.81 71.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.528 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.45 ' CZ2' HG11 ' A' ' 29' ' ' VAL . 12.6 t-105 -60.68 -43.92 97.14 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -55.45 -49.19 73.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.21 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.6 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.89 -38.58 88.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.715 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 96.9 mmm -60.59 -44.39 96.29 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.595 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 46.3 mtpt -65.26 -38.92 91.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.711 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -60.48 -46.1 91.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.084 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 60' ' ' THR . 67.0 mt -71.21 -17.66 62.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.029 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.91 26.58 31.3 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 65.3 mtt -97.63 50.91 1.06 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.874 0.369 . . . . 0.0 110.298 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.595 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 13.3 p-10 . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.686 -0.673 . . . . 0.0 109.77 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.0 t -66.92 128.52 36.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.962 0.41 . . . . 0.0 110.268 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.463 ' HB3' ' HG2' ' A' ' 5' ' ' GLU . 91.2 m-70 -141.89 135.24 29.3 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.95 53.56 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.357 0.599 . . . . 0.0 109.965 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.463 ' HG2' ' HB3' ' A' ' 3' ' ' HIS . 4.8 mm-40 -86.47 -41.96 13.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.353 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.666 ' HA ' ' HD3' ' A' ' 16' ' ' LYS . 70.7 m-20 -65.44 135.96 55.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.666 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.479 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 61.7 p -65.82 129.45 39.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.997 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.919 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 7.5 t -167.76 131.31 1.69 Allowed 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.422 0.629 . . . . 0.0 110.843 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.514 ' H ' ' HB3' ' A' ' 13' ' ' LYS . 9.3 t 177.11 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.456 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.43 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 11.5 p30 -179.02 149.11 0.42 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 10' ' ' ASN . 62.2 mt 69.82 -52.81 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.1 t -118.44 28.1 8.55 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.613 -178.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.919 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 38.2 pttt -70.92 -42.23 70.17 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.528 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -106.55 32.65 4.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.487 0.66 . . . . 0.0 109.704 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -144.01 60.03 1.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.37 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.666 ' HD3' ' HA ' ' A' ' 6' ' ' ASP . 19.3 tptm -70.93 132.95 45.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.419 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.578 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 12.3 m95 -127.46 134.72 49.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.821 0.344 . . . . 0.0 111.836 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.9 p -77.35 151.56 34.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.553 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 9.8 p -55.5 -36.17 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.919 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.486 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 32.7 tt0 -59.77 -45.49 92.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.045 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 42.1 mt-10 -64.71 -42.36 95.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.685 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.649 ' O ' HG22 ' A' ' 25' ' ' VAL . 2.0 p -66.9 -28.36 68.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.445 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 66.3 mm-40 -67.73 -35.95 79.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.897 0.38 . . . . 0.0 110.328 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.486 ' CZ2' ' HG2' ' A' ' 20' ' ' GLU . 30.9 m0 -66.57 -42.84 86.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.411 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 22' ' ' SER . 3.3 m -58.95 -39.46 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.815 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 66' ' ' MET . 22.1 ttmt -64.67 -43.51 93.36 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.044 0.45 . . . . 0.0 110.344 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.69 -44.1 91.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.618 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.03 -38.09 95.52 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.427 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 25' ' ' VAL . 69.3 t -62.97 -39.97 87.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.253 0.549 . . . . 0.0 110.323 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -74.4 -45.95 43.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.008 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.485 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 60.3 tttm -80.98 -45.51 16.51 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -177.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.486 ' N ' ' HD1' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -89.63 -51.22 5.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.32 0.581 . . . . 0.0 110.594 -177.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.34 135.44 4.23 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.513 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -55.16 113.54 1.42 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.979 0.418 . . . . 0.0 110.16 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.44 -35.26 2.72 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.998 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.529 ' O ' HG13 ' A' ' 40' ' ' ILE . 75.4 m-20 -80.48 49.26 1.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.006 0.432 . . . . 0.0 111.187 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 33.5 m95 -60.68 -40.45 92.2 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.432 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.89 -37.43 79.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 110.965 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.73 -32.75 68.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.403 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 36' ' ' ASN . 73.7 mt -71.57 -46.81 61.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.736 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.469 ' HB3' HD12 ' A' ' 54' ' ' ILE . 54.6 p -62.72 -35.31 79.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.186 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -65.6 -53.45 41.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.617 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.0 -48.43 16.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.406 ' CD1' HG23 ' A' ' 40' ' ' ILE . 62.3 m-85 -71.21 151.11 94.54 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 120.934 0.397 . . . . 0.0 111.581 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.419 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 37.1 Cg_endo -67.35 43.28 0.22 Allowed 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.787 2.991 . . . . 0.0 114.445 -179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.578 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 65.6 m-85 -76.33 115.48 16.11 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.458 ' C ' ' H ' ' A' ' 49' ' ' ARG . 3.6 p -95.9 125.28 48.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.193 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 p30 64.54 -30.71 0.12 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.709 1.204 . . . . 0.0 112.904 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.571 ' HD2' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -61.26 116.18 4.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 111.339 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.6 p -78.9 173.61 12.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.694 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.69 -39.22 93.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.223 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.6 t -62.89 -39.17 83.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.776 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 81.2 mmm -58.87 -42.82 90.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.715 178.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.474 HG23 HG12 ' A' ' 25' ' ' VAL . 67.6 mt -69.12 -44.49 80.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.298 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 39.2 ttpt -55.07 -53.8 51.17 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.829 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -62.13 -40.35 95.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.834 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.52 ' O ' ' HG2' ' A' ' 61' ' ' MET . 6.8 tpp180 -56.41 -42.3 77.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.924 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 15.7 t-105 -59.37 -43.42 92.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.867 0.365 . . . . 0.0 110.357 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.445 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 1.8 mpt_? -59.66 -43.95 93.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.21 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.583 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -60.95 -44.12 97.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.367 178.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 86.2 mmm -56.91 -46.7 81.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.22 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.574 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 19.9 mtpp -62.8 -39.5 94.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.119 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -68.75 -44.08 74.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.681 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 60' ' ' THR . 72.9 mt -71.62 -21.8 61.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.167 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.16 30.58 19.46 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.445 ' O ' ' HE2' ' A' ' 26' ' ' LYS . 65.5 mtt -100.1 47.05 0.94 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.574 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 16.9 p-10 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.655 -0.688 . . . . 0.0 109.733 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' ' 6' ' ' ASP . 15.0 m 56.65 36.29 27.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.779 0.432 . . . . 0.0 111.634 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -73.02 -43.56 61.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.45 0.643 . . . . 0.0 109.535 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 53.6 ttm -155.8 -41.82 0.08 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -129.66 134.3 47.59 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.514 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 3.1 t70 -155.01 24.95 0.43 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.549 0.69 . . . . 0.0 109.291 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 p -144.86 85.51 1.76 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.969 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 m -58.89 -45.07 91.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.238 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -84.13 -92.87 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.812 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -172.21 126.75 0.55 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.453 ' O ' HG22 ' A' ' 11' ' ' ILE . 32.0 mm 57.61 48.03 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 122.291 1.043 . . . . 0.0 109.678 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.53 -22.44 18.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.824 -178.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.514 ' HG2' ' HB3' ' A' ' 6' ' ' ASP . 9.9 mtmp? -67.79 -66.82 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.89 128.79 43.09 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 53.16 57.1 6.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.818 -1.083 . . . . 0.0 113.724 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.46 ' HE3' ' HB3' ' A' ' 16' ' ' LYS . 1.2 tmmt? -79.03 112.3 16.09 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.602 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 28.6 m95 -139.71 134.92 32.59 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.908 -177.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 57.5 p -81.98 162.18 22.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.427 ' O ' ' HG3' ' A' ' 23' ' ' GLU . 9.6 p -57.9 -40.22 75.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 121.347 -0.141 . . . . 0.0 111.233 -178.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.507 ' HG3' ' CE2' ' A' ' 24' ' ' TRP . 45.4 tp10 -60.92 -50.81 71.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.236 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.581 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 39.1 mt-10 -58.0 -42.41 85.15 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.487 0.66 . . . . 0.0 111.164 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.63 ' O ' HG22 ' A' ' 25' ' ' VAL . 15.1 m -66.81 -36.49 82.5 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.166 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 19.9 mt-10 -67.53 -31.77 72.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.949 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.581 ' CE3' ' HA ' ' A' ' 21' ' ' GLU . 47.5 m0 -61.89 -41.93 98.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.49 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.63 HG22 ' O ' ' A' ' 22' ' ' SER . 1.4 m -63.46 -37.5 79.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.391 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -66.18 -47.97 72.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.058 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.28 -37.33 85.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.591 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.29 -39.4 94.6 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.827 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 25' ' ' VAL . 92.7 t -61.32 -37.8 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.456 0.646 . . . . 0.0 110.176 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -76.18 -47.15 25.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.027 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.8 -48.79 65.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.99 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -107.67 -47.85 3.53 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.341 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.69 142.63 5.02 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.197 -1.001 . . . . 0.0 112.479 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.94 126.3 26.46 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.67 -31.34 6.9 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.644 -0.789 . . . . 0.0 111.718 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.403 ' O ' HG13 ' A' ' 40' ' ' ILE . 68.3 m-80 -83.19 47.71 1.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.071 0.463 . . . . 0.0 110.808 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.42 ' CD1' ' HB2' ' A' ' 55' ' ' LYS . 36.7 m95 -61.84 -37.54 84.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.111 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.95 -47.54 85.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.045 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.83 -40.83 98.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.219 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.452 HG22 ' HE2' ' A' ' 46' ' ' PHE . 97.8 mt -63.33 -45.67 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.508 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.405 ' HB2' HD12 ' A' ' 54' ' ' ILE . 16.7 t -64.4 -34.69 78.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.225 0.536 . . . . 0.0 110.481 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -67.82 -51.14 52.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.934 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -77.5 -50.73 12.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.947 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -73.02 145.75 86.61 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.055 0.455 . . . . 0.0 111.115 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.507 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 38.0 Cg_endo -66.63 45.07 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 124.013 3.142 . . . . 0.0 115.102 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.602 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 70.5 m-85 -71.18 122.74 20.73 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.262 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 p -103.76 124.0 57.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.861 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 m120 70.73 -39.14 0.44 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.537 0.735 . . . . 0.0 111.939 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.05 118.95 5.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.2 p -80.61 175.26 10.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.163 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.29 -36.93 84.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 t -63.98 -38.83 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.603 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 84.9 mmm -59.39 -43.16 93.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.429 HG23 HG12 ' A' ' 25' ' ' VAL . 70.9 mt -67.43 -44.35 86.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.405 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 40.1 ttpt -57.14 -47.55 80.87 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.401 0.62 . . . . 0.0 109.828 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -67.33 -40.87 85.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.72 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.413 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 30.0 tpt180 -60.57 -40.36 91.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.099 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.435 ' O ' ' HG3' ' A' ' 62' ' ' LYS . 12.4 t-105 -59.85 -44.47 94.1 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 57.3 ttm-85 -59.74 -45.56 91.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.335 178.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.507 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 17.7 p -62.42 -39.41 93.21 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.857 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.8 mmm -62.13 -46.42 89.11 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.076 0.465 . . . . 0.0 110.007 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 58' ' ' TRP . 23.7 mtpp -61.47 -42.44 98.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.0 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 -61.92 -44.22 97.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.424 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 60' ' ' THR . 79.9 mt -68.1 -28.53 67.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.157 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.58 31.57 7.4 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.646 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 84.1 mtp -95.16 51.96 1.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.938 0.399 . . . . 0.0 110.491 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.473 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.814 -0.515 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.5 p -53.87 -45.0 70.87 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.112 0.482 . . . . 0.0 110.559 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -120.81 -55.19 2.01 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 53.7 tpp -179.42 -92.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.976 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 47.55 50.03 15.43 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 123.736 0.647 . . . . 0.0 111.47 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -80.76 42.02 0.6 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.71 0.766 . . . . 0.0 110.701 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.8 t -82.96 -16.16 48.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.192 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.8 p 51.55 48.27 23.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.623 0.725 . . . . 0.0 110.333 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.612 HG23 HG13 ' A' ' 11' ' ' ILE . 11.8 t -65.34 134.04 52.7 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.882 -178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.502 ' N ' HD22 ' A' ' 10' ' ' ASN . 0.0 OUTLIER -75.05 64.77 1.39 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.132 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.612 HG13 HG23 ' A' ' 9' ' ' THR . 60.2 mt -56.05 128.74 16.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 O-C-N 122.297 -0.252 . . . . 0.0 110.626 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 m 75.63 -29.01 0.18 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.336 0.654 . . . . 0.0 112.029 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.0 mttm 58.05 -140.59 0.77 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.03 26.55 8.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 176.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -94.8 26.75 3.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.219 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -75.63 126.22 30.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.549 ' HZ3' ' HE1' ' A' ' 46' ' ' PHE . 13.6 m95 -102.85 137.91 40.43 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.667 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.5 p -79.3 155.33 28.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.284 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.2 p -58.38 -33.85 48.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.926 0.393 . . . . 0.0 110.668 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.73 -49.31 75.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.133 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.439 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 33.8 mt-10 -63.97 -40.15 95.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.543 0.687 . . . . 0.0 110.489 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.593 ' O ' HG22 ' A' ' 25' ' ' VAL . 25.0 m -63.05 -35.58 80.73 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.365 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -65.46 -32.39 73.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.075 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.453 ' CZ2' ' HG2' ' A' ' 45' ' ' PRO . 41.1 m0 -66.76 -46.0 76.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.675 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 22' ' ' SER . 3.3 m -62.51 -37.79 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.998 0.428 . . . . 0.0 110.18 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -63.19 -46.18 88.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.913 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.31 -40.28 64.62 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.214 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.44 -41.67 97.18 Favored Glycine 0 C--O 1.226 -0.377 0 CA-C-N 116.114 -0.494 . . . . 0.0 113.052 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 34' ' ' GLU . 66.2 t -62.23 -40.32 87.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.247 0.546 . . . . 0.0 110.748 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.454 ' HB3' HE21 ' A' ' 30' ' ' GLN . 0.0 OUTLIER -73.55 -44.92 56.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.04 -179.633 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.473 ' HD3' ' HE1' ' A' ' 32' ' ' TYR . 62.1 tttp -75.46 -50.32 16.13 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.473 ' HE1' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -87.3 -53.15 4.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.443 0.639 . . . . 0.0 110.867 -178.283 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.21 133.2 3.53 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.687 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.607 ' HB2' HG13 ' A' ' 29' ' ' VAL . 35.5 tt0 -55.42 121.5 9.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.918 0.389 . . . . 0.0 110.661 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.15 -34.01 3.83 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.014 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.459 ' O ' HG13 ' A' ' 40' ' ' ILE . 72.2 m-80 -80.19 53.91 1.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.075 0.464 . . . . 0.0 111.243 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -64.52 -36.56 84.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.951 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.75 -40.83 98.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.072 0.463 . . . . 0.0 110.545 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.77 -37.72 73.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.006 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 36' ' ' ASN . 74.1 mt -66.56 -46.53 86.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.867 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.526 ' HB3' HD12 ' A' ' 54' ' ' ILE . 3.8 p -62.88 -37.51 87.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.193 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -65.83 -52.69 48.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.09 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -76.72 -47.08 23.01 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.402 ' HE1' ' CE1' ' A' ' 32' ' ' TYR . 53.3 m-85 -71.25 149.14 94.15 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.989 0.423 . . . . 0.0 111.07 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.453 ' HG2' ' CZ2' ' A' ' 24' ' ' TRP . 40.7 Cg_endo -67.84 43.19 0.25 Allowed 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.685 2.923 . . . . 0.0 114.773 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.549 ' HE1' ' HZ3' ' A' ' 17' ' ' TRP . 73.4 m-85 -74.7 127.77 33.93 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 49' ' ' ARG . 7.5 p -115.72 132.68 64.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 p30 66.03 -30.19 0.14 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.655 1.182 . . . . 0.0 112.366 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -67.8 125.77 27.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.728 0.299 . . . . 0.0 110.981 179.229 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 24.9 p -89.34 169.82 11.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.621 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.65 89.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.485 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.95 -38.03 80.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.501 ' HB3' ' HZ2' ' A' ' 17' ' ' TRP . 14.5 mmt -62.07 -44.1 97.4 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.526 HD12 ' HB3' ' A' ' 41' ' ' SER . 77.4 mt -64.15 -44.51 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.938 0.399 . . . . 0.0 110.009 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -55.91 -50.23 71.25 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.901 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.51 -42.86 86.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.5 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.509 ' O ' ' HG2' ' A' ' 61' ' ' MET . 8.9 tpp180 -60.42 -38.3 83.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.623 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.482 ' CD2' HG21 ' A' ' 29' ' ' VAL . 27.4 t-105 -60.35 -44.69 95.31 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.56 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 68.2 mtp85 -57.86 -46.71 84.4 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.533 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.499 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -63.81 -36.96 85.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.922 179.085 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 57' ' ' ARG . 87.5 mmm -62.56 -45.07 94.62 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.583 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 22.3 mtpp -61.37 -40.19 93.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.144 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.0 mtp85 -62.94 -47.5 82.97 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.921 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 60' ' ' THR . 74.9 mt -72.36 -10.17 59.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.613 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.18 32.11 60.73 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.255 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 88.3 mtp -98.74 47.86 0.98 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.089 0.471 . . . . 0.0 110.124 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.583 ' OD1' ' HA ' ' A' ' 62' ' ' LYS . 14.8 p-10 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.222 -0.894 . . . . 0.0 109.61 -179.475 . . . . . . . . 1 1 . 1 stop_ save_